data_1f40_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1f40 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 106.08 -2.808 . . . . 6.3300000000000001 106.08 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.33 142.58 43.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 101.707 -3.442 . . . . 6.3499999999999996 101.707 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -117.16 130.05 56.36 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 102.802 -3.036 . . . . 16.98 102.802 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.9 t -109.53 117.12 53.85 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 103.663 -2.717 . . . . 5.5800000000000001 103.663 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.66 124.65 46.81 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 118.871 -2.393 . . . . 12.800000000000001 104.839 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.8 m -75.66 139.9 42.24 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.28 -2.138 . . . . 3.2400000000000002 115.656 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.41 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.5 mt -101.51 -52.02 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.86 -1.904 . . . . 4.79 105.86 171.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.5 m -138.89 139.13 22.76 Favored Pre-proline 0 C--O 1.244 0.783 0 O-C-N 119.548 -1.97 . . . . 11.59 106.27 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.8 Cg_exo -67.86 154.84 71.93 Favored 'Trans proline' 0 C--N 1.329 -0.454 0 C-N-CA 123.546 2.83 . . . . 4.5499999999999998 112.196 -176.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.72 -161.14 28.85 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.102 -1.599 . . . . 2.0 109.102 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -82.43 -9.27 59.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 117.659 -3.26 . . . . 3.2400000000000002 113.165 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.07 9.77 76.86 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-O 117.71 -1.606 . . . . 3.3799999999999999 113.87 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.7 mtp85 -137.66 -26.66 0.96 Allowed 'General case' 0 C--O 1.241 0.608 0 CA-C-N 122.593 3.196 . . . . 26.59 114.305 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.59 94.04 4.99 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 119.039 -2.288 . . . . 3.02 109.435 -175.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.2 142.52 24.78 Favored Pre-proline 0 C--O 1.252 1.211 0 O-C-N 125.007 1.442 . . . . 4.7000000000000002 109.761 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.59 146.73 68.4 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.728 2.285 . . . . 2.9399999999999999 110.688 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.49 156.2 33.31 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.932 -1.485 . . . . 15.960000000000001 107.121 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.42 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.6 ttp180 -52.17 130.36 30.18 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 124.263 1.982 . . . . 11.69 112.765 174.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.21 -13.97 65.97 Favored Glycine 0 N--CA 1.424 -2.122 0 O-C-N 119.919 -1.738 . . . . 3.6299999999999999 112.734 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.24 149.42 25.09 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-N 120.123 1.961 . . . . 5.9000000000000004 112.381 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.85 120.28 30.95 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.146 1.529 . . . . 3.0699999999999998 111.799 174.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.9 m -93.43 131.02 39.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.485 1.136 . . . . 4.1100000000000003 109.878 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -112.03 111.47 36.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 101.624 -3.473 . . . . 2.1600000000000001 101.624 -174.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.3 m -129.63 154.39 40.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.866 0.841 . . . . 3.5899999999999999 112.193 -172.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 145.45 30.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.264 -2.124 . . . . 3.1299999999999999 105.264 164.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.84 156.09 43.34 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 120.128 1.331 . . . . 2.5499999999999998 111.9 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.6 m -133.83 121.63 22.07 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 102.88 -3.007 . . . . 4.4699999999999998 102.88 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.21 131.84 10.73 Favored Glycine 0 N--CA 1.471 0.999 0 N-CA-C 109.237 -1.545 . . . . 3.4100000000000001 109.237 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.31 152.2 51.5 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 125.277 2.465 . . . . 18.219999999999999 110.421 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.56 164.59 22.82 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.694 -2.503 . . . . 5.9299999999999997 106.444 172.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.08 -20.56 40.59 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 117.19 -3.444 . . . . 12.33 117.684 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -87.64 5.31 40.24 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 119.603 -1.936 . . . . 7.1900000000000004 113.956 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.17 -10.42 69.74 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-O 123.896 1.831 . . . . 6.4699999999999998 113.661 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.64 124.26 22.37 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 116.724 -3.809 . . . . 21.859999999999999 110.529 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.82 130.86 37.2 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 107.349 -1.352 . . . . 16.18 107.349 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.7 -17.84 13.98 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.099 -1.04 . . . . 5.7300000000000004 110.809 173.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.71 155.37 3.24 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 118.08 -0.962 . . . . 6.1299999999999999 110.605 176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -158.78 128.19 5.61 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.518 1.127 . . . . 2.9300000000000002 110.38 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.6 p -76.1 -20.51 57.61 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.757 -0.777 . . . . 2.2999999999999998 109.043 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.72 84.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.637 -1.616 . . . . 10.550000000000001 106.637 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.58 -28.56 67.87 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.247 -1.533 . . . . 8.0199999999999996 110.827 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.6 -10.12 49.81 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 120.906 -1.121 . . . . 10.210000000000001 112.368 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.56 34.2 23.98 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 123.382 1.563 . . . . 16.379999999999999 111.007 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -139.65 120.21 9.39 Favored Pre-proline 0 C--O 1.247 0.928 0 O-C-N 117.698 -3.126 . . . . 20.210000000000001 103.882 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.24 152.34 60.79 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 124.234 3.29 . . . . 8.75 110.43 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -95.95 138.17 33.97 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.518 -1.66 . . . . 4.6500000000000004 106.518 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.61 136.9 50.18 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 120.541 1.518 . . . . 10.619999999999999 111.313 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.67 150.71 40.55 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.458 1.481 . . . . 4.3099999999999996 107.308 169.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.443 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.5 126.68 37.69 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.304 1.411 . . . . 2.6699999999999999 110.549 172.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 129.84 42.14 Favored 'General case' 0 N--CA 1.426 -1.643 0 O-C-N 125.228 1.58 . . . . 3.0800000000000001 110.647 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.01 -4.19 84.73 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 123.806 0.717 . . . . 4.9500000000000002 114.035 176.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.7 tttt -84.13 -3.05 57.85 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.752 -1.44 . . . . 10.26 114.561 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.55 39.56 6.64 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 120.132 -1.605 . . . . 10.24 113.778 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.74 13.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 114.75 1.389 . . . . 10.56 114.75 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.42 172.67 9.31 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.057 -1.09 . . . . 2.4500000000000002 108.057 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.81 152.1 8.35 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.98 1.371 . . . . 5.5700000000000003 109.768 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.24 -35.88 67.88 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 114.343 -1.298 . . . . 19.109999999999999 114.386 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.62 -23.37 72.17 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-N 123.392 2.814 . . . . 2.9300000000000002 112.384 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.55 -54.65 7.09 Favored 'General case' 0 C--O 1.249 1.071 0 CA-C-N 118.559 1.179 . . . . 7.96 111.575 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.04 -44.39 15.26 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 124.026 1.87 . . . . 15.050000000000001 111.467 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.37 -35.29 47.54 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.544 -1.207 . . . . 20.27 114.065 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.06 -45.72 6.18 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.502 -1.332 . . . . 4.04 114.612 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.55 -27.09 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 O-C-N 121.383 -1.069 . . . . 5.3499999999999996 109.486 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.86 64.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.537 -2.602 . . . . 3.0299999999999998 112.398 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.54 0.41 49.98 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 118.456 -0.783 . . . . 3.4900000000000002 113.025 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.624 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.9 mtp -107.95 143.02 37.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 120.812 1.642 . . . . 3.75 109.436 -171.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.402 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 11.0 p -94.66 155.01 17.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.678 0.791 . . . . 2.2999999999999998 109.852 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.68 130.19 20.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 119.88 1.218 . . . . 2.4700000000000002 109.796 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.11 -12.53 52.28 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 113.35 -1.75 . . . . 2.6099999999999999 113.133 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.624 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.4 144.75 28.59 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.95 0.881 . . . . 6.5300000000000002 112.567 -171.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.99 123.92 41.44 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 102.576 -3.12 . . . . 12.359999999999999 102.576 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.8 156.73 45.01 Favored 'General case' 0 C--O 1.244 0.806 0 O-C-N 126.393 2.308 . . . . 5.8399999999999999 114.283 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.26 122.55 43.87 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 123.429 1.585 . . . . 16.57 108.671 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.15 114.49 28.65 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.859 -2.401 . . . . 5.8600000000000003 106.745 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.4 m -98.73 120.42 39.13 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 105.766 -1.939 . . . . 5.7599999999999998 105.766 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.5 mt -119.55 122.57 69.21 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 N-CA-C 108.712 -0.847 . . . . 3.3599999999999999 108.712 -167.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.43 153.93 91.85 Favored Pre-proline 0 C--O 1.244 0.807 0 CA-C-O 117.878 -1.058 . . . . 4.9400000000000004 110.676 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -55.16 -35.26 90.4 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.328 2.686 . . . . 6.21 114.829 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -69.99 -13.92 62.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.869 1.062 . . . . 15.85 113.869 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -103.69 11.05 36.44 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 126.051 1.74 . . . . 11.52 111.751 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.74 -116.39 0.16 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 105.808 -1.923 . . . . 3.7000000000000002 105.808 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.68 4.16 37.85 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 122.067 2.212 . . . . 6.8399999999999999 115.447 -173.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.42 -137.11 50.45 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 123.686 1.714 . . . . 5.9900000000000002 111.096 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.28 -18.8 41.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 111.738 -2.231 . . . . 10.109999999999999 110.932 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.26 -43.93 63.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.129 1.786 . . . . 13.76 112.547 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.23 -169.28 53.23 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 107.76 -2.136 . . . . 9.9800000000000004 107.76 -170.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.78 114.9 35.41 Favored Pre-proline 0 C--O 1.246 0.873 0 O-C-N 118.003 -3.057 . . . . 15.880000000000001 103.262 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -48.24 122.36 7.42 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.638 3.559 . . . . 11.41 110.939 -166.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.35 -27.07 3.28 Favored Glycine 0 CA--C 1.547 2.073 0 CA-C-N 111.788 -2.46 . . . . 14.199999999999999 117.374 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.8 mt -102.87 -50.05 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.041 2.421 . . . . 11.06 114.942 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.6 mm -112.9 131.83 22.6 Favored Pre-proline 0 CA--C 1.516 -0.334 0 N-CA-C 103.174 -2.899 . . . . 8.0099999999999998 103.174 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.07 163.03 35.6 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.259 3.973 . . . . 6.5199999999999996 112.865 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.33 144.55 71.39 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.392 2.061 . . . . 4.8200000000000003 110.321 162.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.35 27.21 16.25 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 112.878 -1.965 . . . . 7.4199999999999999 113.579 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.87 132.42 35.27 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 117.345 2.35 . . . . 2.2200000000000002 117.345 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -80.56 132.45 35.65 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 121.695 2.043 . . . . 4.6100000000000003 106.31 168.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.5 mt -108.82 146.79 33.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.321 -1.487 . . . . 5.3399999999999999 110.281 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.27 119.93 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 103.743 -2.688 . . . . 3.9700000000000002 103.743 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.445 ' HB3' HG22 ' A' ' 101' ' ' VAL . 49.0 m-85 -116.7 136.96 52.55 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.796 -1.19 . . . . 4.4199999999999999 109.596 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.76 112.67 25.72 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.874 -4.491 . . . . 2.0899999999999999 98.874 174.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 99' ' ' PHE . 86.5 t -126.72 132.3 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 114.206 -1.361 . . . . 3.5299999999999998 110.841 -172.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.44 121.91 39.56 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.578 -2.008 . . . . 14.210000000000001 105.578 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.02 109.07 19.95 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.498 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.5 -43.27 13.7 Favored 'General case' 0 C--O 1.253 1.28 0 N-CA-C 115.203 1.557 . . . . 2.6200000000000001 115.203 -171.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -161.82 153.63 19.03 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 113.509 -1.678 . . . . 11.710000000000001 109.167 -167.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.7 mt -120.04 133.17 55.61 Favored 'General case' 0 C--O 1.251 1.165 0 N-CA-C 105.25 -2.13 . . . . 4.7000000000000002 105.25 170.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.697 -1.592 . . . . 13.02 109.805 -179.746 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.695 0 N-CA-C 106.067 -2.813 . . . . 6.3300000000000001 106.067 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.41 142.56 43.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 101.672 -3.455 . . . . 6.3499999999999996 101.672 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -117.13 130.16 56.44 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 102.682 -3.081 . . . . 16.98 102.682 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.4 t -109.51 117.01 53.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 103.737 -2.69 . . . . 5.5800000000000001 103.737 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.58 124.72 47.05 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 118.893 -2.379 . . . . 12.800000000000001 104.872 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.4 m -75.77 140.1 42.17 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 119.226 -2.171 . . . . 3.2400000000000002 115.55 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.41 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.67 -52.05 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 105.832 -1.914 . . . . 4.79 105.832 171.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.8 m -138.97 139.0 22.13 Favored Pre-proline 0 C--O 1.241 0.652 0 O-C-N 119.53 -1.981 . . . . 11.59 106.331 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 30.2 Cg_exo -67.67 154.85 72.22 Favored 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.501 2.801 . . . . 4.5499999999999998 112.125 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.84 -161.24 28.74 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 109.071 -1.611 . . . . 2.0 109.071 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.43 -9.1 59.57 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 117.674 -3.251 . . . . 3.2400000000000002 113.258 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.07 9.78 76.86 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.639 -1.645 . . . . 3.3799999999999999 113.793 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.7 mtp85 -137.7 -26.69 0.95 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-N 122.583 3.191 . . . . 26.59 114.244 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.44 94.08 5.02 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 119.049 -2.282 . . . . 3.02 109.503 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.24 142.55 24.85 Favored Pre-proline 0 C--O 1.252 1.211 0 O-C-N 124.963 1.414 . . . . 4.7000000000000002 109.799 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.549 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.6 146.74 68.41 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.754 2.303 . . . . 2.9399999999999999 110.6 -174.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.57 156.14 33.55 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.889 -1.505 . . . . 15.960000000000001 106.988 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.4 ttp180 -52.04 130.24 29.34 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 124.134 1.921 . . . . 11.69 112.709 174.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.36 -14.13 65.58 Favored Glycine 0 N--CA 1.423 -2.184 0 O-C-N 120.009 -1.682 . . . . 3.6299999999999999 112.762 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.16 149.32 25.2 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 120.085 1.943 . . . . 5.9000000000000004 112.242 174.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.8 m -89.83 120.25 30.91 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.283 1.614 . . . . 3.0699999999999998 111.806 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.2 m -93.55 131.04 39.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 122.716 1.246 . . . . 4.1100000000000003 109.813 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -112.0 111.41 36.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 101.593 -3.484 . . . . 2.1600000000000001 101.593 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.57 154.34 40.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-O 121.795 0.807 . . . . 3.5899999999999999 112.243 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.42 30.57 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.129 -2.174 . . . . 3.1299999999999999 105.129 164.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.0 p90 -145.74 156.11 43.4 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 120.003 1.274 . . . . 2.5499999999999998 112.02 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -133.81 121.53 21.94 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 102.968 -2.975 . . . . 4.4699999999999998 102.968 167.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.19 131.94 10.76 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 109.28 -1.528 . . . . 3.4100000000000001 109.28 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.4 152.18 51.57 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 125.259 2.457 . . . . 18.219999999999999 110.435 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 164.59 22.9 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 111.746 -2.479 . . . . 5.9299999999999997 106.38 172.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.16 -20.55 41.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 117.283 -3.385 . . . . 12.33 117.639 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.67 5.29 40.44 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.56 -1.962 . . . . 7.1900000000000004 113.906 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.16 -10.34 69.77 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-O 124.04 1.911 . . . . 6.4699999999999998 113.785 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.62 124.23 22.26 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 116.632 -3.864 . . . . 21.859999999999999 110.58 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.81 130.83 37.17 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.359 -1.348 . . . . 16.18 107.359 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -107.76 -17.76 14.0 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 118.998 -1.081 . . . . 5.7300000000000004 110.799 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -172.71 155.5 3.28 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 118.093 -0.956 . . . . 6.1299999999999999 110.652 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.87 128.08 5.51 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.428 1.091 . . . . 2.9300000000000002 110.314 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.2 p -75.83 -20.75 57.91 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 119.866 -0.733 . . . . 2.2999999999999998 109.117 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.63 -36.65 84.53 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.754 -1.573 . . . . 10.550000000000001 106.754 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.61 -28.5 67.8 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.253 -1.529 . . . . 8.0199999999999996 110.807 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.6 mtm-85 -88.72 -9.98 50.02 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 120.914 -1.116 . . . . 10.210000000000001 112.403 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.54 34.21 23.98 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 123.316 1.531 . . . . 16.379999999999999 111.034 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -139.7 120.24 9.37 Favored Pre-proline 0 C--N 1.315 -0.934 0 O-C-N 117.645 -3.16 . . . . 20.210000000000001 103.879 178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.27 152.3 61.28 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.269 3.313 . . . . 8.75 110.402 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -95.89 138.12 33.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.534 -1.654 . . . . 4.6500000000000004 106.534 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -111.64 136.87 50.27 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.496 1.498 . . . . 10.619999999999999 111.285 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.67 150.69 40.53 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 120.397 1.453 . . . . 4.3099999999999996 107.366 169.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.442 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.39 126.62 37.56 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-N 120.244 1.384 . . . . 2.6699999999999999 110.617 172.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.89 129.81 42.05 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 125.217 1.573 . . . . 3.0800000000000001 110.68 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.98 -4.13 84.76 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.605 -0.725 . . . . 4.9500000000000002 114.044 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.442 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.09 -3.06 57.81 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 120.823 -1.398 . . . . 10.26 114.679 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.48 39.6 6.75 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.117 -1.615 . . . . 10.24 113.775 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.31 -0.88 13.71 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 114.725 1.38 . . . . 10.56 114.725 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.37 172.62 9.32 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.085 -1.08 . . . . 2.4500000000000002 108.085 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.73 152.07 8.41 Favored 'Isoleucine or valine' 0 C--O 1.257 1.496 0 CA-C-O 122.937 1.351 . . . . 5.5700000000000003 109.851 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.25 -35.73 67.74 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.361 -1.29 . . . . 19.109999999999999 114.466 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.73 -23.34 72.35 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-N 123.383 2.81 . . . . 2.9300000000000002 112.389 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.53 -54.67 7.07 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.51 1.155 . . . . 7.96 111.633 173.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.0 -44.43 15.06 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.951 1.834 . . . . 15.050000000000001 111.461 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.36 -35.3 47.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.485 -1.234 . . . . 20.27 114.084 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.11 -45.63 6.19 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 119.471 -1.347 . . . . 4.04 114.615 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.53 -27.17 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 121.348 -1.089 . . . . 5.3499999999999996 109.425 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.06 -18.83 64.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 118.538 -2.601 . . . . 3.0299999999999998 112.378 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.5 0.31 50.24 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 118.439 -0.791 . . . . 3.4900000000000002 113.016 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.623 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.7 mtp -107.82 143.18 36.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 120.821 1.646 . . . . 3.75 109.524 -171.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.402 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.9 p -94.79 154.93 17.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.695 0.798 . . . . 2.2999999999999998 109.842 174.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.3 t -57.53 130.09 20.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 119.965 1.257 . . . . 2.4700000000000002 109.868 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.21 -12.44 51.93 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 113.422 -1.717 . . . . 2.6099999999999999 113.069 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.623 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.4 144.8 28.55 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.883 0.849 . . . . 6.5300000000000002 112.623 -171.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.9 ttt180 -124.05 124.02 41.63 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 102.588 -3.116 . . . . 12.359999999999999 102.588 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.81 44.99 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.421 2.326 . . . . 5.8399999999999999 114.303 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.28 122.45 43.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.47 1.605 . . . . 16.57 108.556 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.02 114.51 28.69 Favored 'General case' 0 N--CA 1.44 -0.975 0 O-C-N 118.864 -2.398 . . . . 5.8600000000000003 106.786 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.5 m -98.81 120.49 39.34 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 105.801 -1.925 . . . . 5.7599999999999998 105.801 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.6 mt -119.65 122.55 69.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 108.671 -0.862 . . . . 3.3599999999999999 108.671 -167.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.38 154.03 91.52 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-O 117.802 -1.094 . . . . 4.9400000000000004 110.655 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.4 -35.07 91.09 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.333 2.689 . . . . 6.21 114.761 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.13 -13.88 62.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.795 1.035 . . . . 15.85 113.795 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.68 11.03 36.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 126.004 1.722 . . . . 11.52 111.734 175.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.86 -116.55 0.15 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 105.72 -1.955 . . . . 3.7000000000000002 105.72 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.61 4.16 38.05 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 122.025 2.193 . . . . 6.8399999999999999 115.511 -173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.45 -137.16 50.41 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-O 123.769 1.761 . . . . 5.9900000000000002 111.131 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.33 -18.64 41.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 111.603 -2.299 . . . . 10.109999999999999 111.024 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.36 -43.9 63.35 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.04 1.745 . . . . 13.76 112.497 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.28 -169.16 53.38 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 107.641 -2.184 . . . . 9.9800000000000004 107.641 -170.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.89 114.83 35.23 Favored Pre-proline 0 C--O 1.246 0.899 0 O-C-N 118.128 -2.984 . . . . 15.880000000000001 103.198 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -48.14 122.43 7.41 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 124.622 3.548 . . . . 11.41 110.975 -166.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.18 -26.96 3.22 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.979 -2.373 . . . . 14.199999999999999 117.412 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.0 mt -102.93 -50.02 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 121.102 2.451 . . . . 11.06 114.943 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.86 131.82 22.59 Favored Pre-proline 0 CA--C 1.516 -0.328 0 N-CA-C 103.233 -2.877 . . . . 8.0099999999999998 103.233 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.08 163.01 35.7 Favored 'Trans proline' 0 C--O 1.24 0.619 0 C-N-CA 125.229 3.953 . . . . 6.5199999999999996 112.909 171.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.27 144.49 71.08 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.547 2.165 . . . . 4.8200000000000003 110.275 162.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.26 27.26 16.34 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 112.886 -1.961 . . . . 7.4199999999999999 113.607 172.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.73 132.45 35.29 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.446 2.387 . . . . 2.2200000000000002 117.446 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -80.53 132.47 35.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.737 2.062 . . . . 4.6100000000000003 106.298 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.1 mt -108.99 146.69 33.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.469 -1.394 . . . . 5.3399999999999999 110.24 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.0 t -123.12 120.08 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 N-CA-C 103.657 -2.72 . . . . 3.9700000000000002 103.657 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 101' ' ' VAL . 49.2 m-85 -116.75 136.97 52.54 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.594 -1.316 . . . . 4.4199999999999999 109.608 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.5 t0 -103.8 112.65 25.7 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.911 -4.477 . . . . 2.0899999999999999 98.911 174.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 99' ' ' PHE . 88.0 t -126.77 132.4 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 114.194 -1.367 . . . . 3.5299999999999998 110.763 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.47 121.92 39.53 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.449 -2.056 . . . . 14.210000000000001 105.449 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.13 109.06 19.97 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 123.636 1.684 . . . . 2.4199999999999999 107.492 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.43 -43.33 13.71 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 115.193 1.553 . . . . 2.6200000000000001 115.193 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -161.78 153.59 19.06 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 113.475 -1.693 . . . . 11.710000000000001 109.153 -167.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.8 mt -120.01 133.24 55.6 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 105.186 -2.153 . . . . 4.7000000000000002 105.186 170.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.31 -1.141 0 CA-C-N 113.64 -1.618 . . . . 13.02 109.94 -179.848 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 106.096 -2.802 . . . . 6.3300000000000001 106.096 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.31 142.62 43.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 101.693 -3.447 . . . . 6.3499999999999996 101.693 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -117.13 130.12 56.42 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.736 -3.061 . . . . 16.98 102.736 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.57 117.2 54.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 103.58 -2.748 . . . . 5.5800000000000001 103.58 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.75 124.78 47.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 118.863 -2.398 . . . . 12.800000000000001 104.757 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.3 m -75.74 139.95 42.15 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 119.3 -2.125 . . . . 3.2400000000000002 115.646 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 7' ' ' ILE . 91.2 mt -101.62 -51.94 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 105.837 -1.912 . . . . 4.79 105.837 171.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.4 m -138.94 138.9 22.03 Favored Pre-proline 0 C--O 1.242 0.684 0 O-C-N 119.603 -1.936 . . . . 11.59 106.347 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.9 Cg_exo -67.57 154.73 72.73 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.636 2.891 . . . . 4.5499999999999998 112.191 -176.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.7 -161.13 28.86 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 109.075 -1.61 . . . . 2.0 109.075 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -82.49 -9.22 59.52 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 117.618 -3.284 . . . . 3.2400000000000002 113.167 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.17 9.6 76.94 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-O 117.625 -1.653 . . . . 3.3799999999999999 113.81 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -137.63 -26.66 0.96 Allowed 'General case' 0 C--O 1.241 0.655 0 CA-C-N 122.703 3.252 . . . . 26.59 114.189 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.45 93.95 4.95 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 119.121 -2.237 . . . . 3.02 109.496 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.22 142.49 24.72 Favored Pre-proline 0 C--O 1.25 1.122 0 O-C-N 124.975 1.422 . . . . 4.7000000000000002 109.8 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.549 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.58 146.65 68.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.748 2.298 . . . . 2.9399999999999999 110.674 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.44 156.09 33.48 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.899 -1.5 . . . . 15.960000000000001 107.015 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.42 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.03 130.25 29.31 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 124.118 1.913 . . . . 11.69 112.797 174.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.22 -13.88 66.11 Favored Glycine 0 N--CA 1.422 -2.296 0 O-C-N 119.978 -1.701 . . . . 3.6299999999999999 112.694 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -86.24 149.41 25.1 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 120.094 1.947 . . . . 5.9000000000000004 112.253 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.92 120.21 30.94 Favored 'General case' 0 C--O 1.25 1.12 0 O-C-N 125.248 1.593 . . . . 3.0699999999999998 111.729 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.45 131.02 39.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.654 1.216 . . . . 4.1100000000000003 109.859 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.92 111.31 35.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 101.67 -3.456 . . . . 2.1600000000000001 101.67 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.53 154.5 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 121.885 0.85 . . . . 3.5899999999999999 112.263 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.15 145.46 30.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 105.178 -2.156 . . . . 3.1299999999999999 105.178 164.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.2 p90 -145.8 156.11 43.37 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 120.124 1.329 . . . . 2.5499999999999998 111.988 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -133.77 121.64 22.16 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 102.948 -2.982 . . . . 4.4699999999999998 102.948 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.22 131.99 10.78 Favored Glycine 0 N--CA 1.472 1.041 0 N-CA-C 109.184 -1.566 . . . . 3.4100000000000001 109.184 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.5 152.09 51.68 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 125.269 2.462 . . . . 18.219999999999999 110.383 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.49 164.63 22.85 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.664 -2.516 . . . . 5.9299999999999997 106.454 172.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.07 -20.64 41.06 Favored 'General case' 0 C--O 1.219 -0.512 0 O-C-N 117.262 -3.399 . . . . 12.33 117.708 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.73 5.38 40.17 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.663 -1.898 . . . . 7.1900000000000004 113.893 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.24 -10.39 69.58 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-O 123.976 1.876 . . . . 6.4699999999999998 113.678 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.58 124.24 22.28 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 116.628 -3.866 . . . . 21.859999999999999 110.532 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.9 130.78 37.02 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.381 -1.341 . . . . 16.18 107.381 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -107.67 -17.89 13.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.021 -1.072 . . . . 5.7300000000000004 110.693 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -172.68 155.49 3.29 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 118.181 -0.914 . . . . 6.1299999999999999 110.509 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.82 128.15 5.57 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.451 1.101 . . . . 2.9300000000000002 110.361 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.1 p -76.0 -20.66 57.66 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.982 -0.748 . . . . 2.2999999999999998 108.982 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.7 -36.61 84.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.722 -1.585 . . . . 10.550000000000001 106.722 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.71 -28.42 67.65 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.197 -1.565 . . . . 8.0199999999999996 110.833 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.68 -10.08 49.75 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.89 -1.131 . . . . 10.210000000000001 112.361 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.48 34.31 24.07 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-O 123.4 1.571 . . . . 16.379999999999999 111.007 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -139.66 120.16 9.38 Favored Pre-proline 0 C--O 1.248 1.017 0 O-C-N 117.693 -3.129 . . . . 20.210000000000001 103.897 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -59.24 152.31 61.02 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 124.277 3.318 . . . . 8.75 110.383 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -96.0 138.11 34.1 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.541 -1.652 . . . . 4.6500000000000004 106.541 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.62 136.87 50.24 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 120.539 1.518 . . . . 10.619999999999999 111.372 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.66 150.61 40.44 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.415 1.461 . . . . 4.3099999999999996 107.377 169.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.444 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.44 126.68 37.63 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.297 1.408 . . . . 2.6699999999999999 110.48 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.92 129.7 41.54 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 125.286 1.616 . . . . 3.0800000000000001 110.723 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.11 -4.22 84.56 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.879 0.752 . . . . 4.9500000000000002 113.989 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.05 -3.01 57.74 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.648 -1.501 . . . . 10.26 114.603 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.47 39.58 6.79 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.017 -1.677 . . . . 10.24 113.841 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.33 -0.84 13.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 114.736 1.384 . . . . 10.56 114.736 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.32 172.58 9.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 108.099 -1.074 . . . . 2.4500000000000002 108.099 171.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.71 152.07 8.42 Favored 'Isoleucine or valine' 0 C--O 1.259 1.567 0 CA-C-O 123.026 1.393 . . . . 5.5700000000000003 109.757 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.27 -35.73 67.79 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 114.391 -1.277 . . . . 19.109999999999999 114.432 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.86 -23.31 72.55 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.33 2.786 . . . . 2.9300000000000002 112.304 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.62 -54.61 7.13 Favored 'General case' 0 C--O 1.249 1.071 0 CA-C-N 118.616 1.208 . . . . 7.96 111.572 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.05 -44.35 15.27 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 123.983 1.849 . . . . 15.050000000000001 111.447 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.3 -35.42 47.91 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.541 -1.208 . . . . 20.27 114.093 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.03 -45.65 6.22 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 119.497 -1.335 . . . . 4.04 114.596 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.51 -27.28 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 O-C-N 121.37 -1.076 . . . . 5.3499999999999996 109.382 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.93 -18.88 64.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.688 -2.508 . . . . 3.0299999999999998 112.403 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.55 0.33 50.34 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 118.448 -0.787 . . . . 3.4900000000000002 112.985 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.624 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.9 mtp -107.89 143.02 37.09 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 120.791 1.632 . . . . 3.75 109.464 -171.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.402 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.8 p -94.78 155.01 17.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.625 0.77 . . . . 2.2999999999999998 109.762 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.62 130.17 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 119.841 1.2 . . . . 2.4700000000000002 109.858 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.58 52.07 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 113.272 -1.785 . . . . 2.6099999999999999 113.064 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.624 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.43 144.75 28.56 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 121.907 0.86 . . . . 6.5300000000000002 112.57 -171.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.97 123.93 41.47 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 102.671 -3.085 . . . . 12.359999999999999 102.671 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.8 44.99 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 126.4 2.313 . . . . 5.8399999999999999 114.273 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.23 122.53 43.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.516 1.627 . . . . 16.57 108.62 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.12 114.47 28.63 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 118.854 -2.404 . . . . 5.8600000000000003 106.728 -176.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -98.77 120.47 39.25 Favored 'General case' 0 C--O 1.247 0.925 0 N-CA-C 105.858 -1.905 . . . . 5.7599999999999998 105.858 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.72 122.62 69.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.653 -0.869 . . . . 3.3599999999999999 108.653 -167.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.36 154.08 91.34 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.861 -1.066 . . . . 4.9400000000000004 110.682 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -55.48 -35.12 91.59 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.298 2.665 . . . . 6.21 114.752 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.03 -13.84 62.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.922 1.082 . . . . 15.85 113.922 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.64 11.07 36.54 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 126.009 1.723 . . . . 11.52 111.674 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.9 -116.6 0.15 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 105.739 -1.949 . . . . 3.7000000000000002 105.739 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -102.59 4.11 38.04 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 122.07 2.214 . . . . 6.8399999999999999 115.498 -173.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.47 -137.09 50.49 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-O 123.739 1.744 . . . . 5.9900000000000002 111.136 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.69 41.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 111.686 -2.257 . . . . 10.109999999999999 111.009 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.47 -43.89 63.08 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 121.039 1.745 . . . . 13.76 112.464 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.39 -169.16 53.46 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 107.606 -2.197 . . . . 9.9800000000000004 107.606 -170.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.85 114.76 35.34 Favored Pre-proline 0 C--O 1.246 0.896 0 O-C-N 117.924 -3.103 . . . . 15.880000000000001 103.253 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.14 122.35 7.3 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 124.679 3.586 . . . . 11.41 110.936 -166.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.15 -26.85 3.24 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-N 111.933 -2.394 . . . . 14.199999999999999 117.385 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.0 mt -102.99 -49.97 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 121.107 2.454 . . . . 11.06 114.938 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.4 mm -112.84 131.87 22.56 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 103.118 -2.919 . . . . 8.0099999999999998 103.118 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.95 163.02 35.38 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 125.236 3.957 . . . . 6.5199999999999996 112.945 171.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.31 144.41 71.84 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.571 2.181 . . . . 4.8200000000000003 110.331 162.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.31 27.33 16.34 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 112.938 -1.937 . . . . 7.4199999999999999 113.577 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.79 132.31 35.28 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.388 2.366 . . . . 2.2200000000000002 117.388 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.37 132.42 35.77 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 121.799 2.091 . . . . 4.6100000000000003 106.349 168.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -109.0 146.79 33.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.379 -1.45 . . . . 5.3399999999999999 110.284 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.9 t -123.16 120.03 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 103.679 -2.711 . . . . 3.9700000000000002 103.679 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 101' ' ' VAL . 49.0 m-85 -116.8 137.02 52.5 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.701 -1.25 . . . . 4.4199999999999999 109.577 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.8 t0 -103.8 112.72 25.79 Favored 'General case' 0 C--N 1.314 -0.95 1 N-CA-C 98.876 -4.49 . . . . 2.0899999999999999 98.876 174.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 99' ' ' PHE . 87.7 t -126.75 132.43 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.153 -1.385 . . . . 3.5299999999999998 110.821 -172.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.48 121.93 39.56 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.466 -2.05 . . . . 14.210000000000001 105.466 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 tp -89.06 109.11 20.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.405 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.58 -43.25 13.66 Favored 'General case' 0 C--O 1.255 1.344 0 N-CA-C 115.19 1.552 . . . . 2.6200000000000001 115.19 -171.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -161.87 153.64 18.94 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 113.612 -1.631 . . . . 11.710000000000001 109.154 -167.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.9 mt -120.12 133.28 55.55 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 105.097 -2.186 . . . . 4.7000000000000002 105.097 170.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.311 -1.082 0 CA-C-N 113.552 -1.658 . . . . 13.02 109.82 -179.812 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 106.038 -2.825 . . . . 6.3300000000000001 106.038 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.28 142.6 43.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 101.745 -3.428 . . . . 6.3499999999999996 101.745 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.12 130.07 56.39 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.726 -3.065 . . . . 16.98 102.726 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.57 117.11 53.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 N-CA-C 103.674 -2.713 . . . . 5.5800000000000001 103.674 -175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.68 124.72 46.96 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 118.877 -2.389 . . . . 12.800000000000001 104.759 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.6 m -75.82 140.0 42.05 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.279 -2.138 . . . . 3.2400000000000002 115.603 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.54 -52.03 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 105.899 -1.889 . . . . 4.79 105.899 171.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.8 m -138.86 139.01 22.45 Favored Pre-proline 0 C--O 1.243 0.737 0 O-C-N 119.518 -1.989 . . . . 11.59 106.357 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.3 Cg_exo -67.69 154.73 72.51 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 123.627 2.885 . . . . 4.5499999999999998 112.23 -176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.68 -161.22 28.9 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.09 -1.604 . . . . 2.0 109.09 175.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.54 -9.04 59.58 Favored 'General case' 0 C--O 1.241 0.628 0 O-C-N 117.639 -3.271 . . . . 3.2400000000000002 113.18 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.12 9.65 76.86 Favored Glycine 0 C--O 1.218 -0.887 0 CA-C-O 117.637 -1.646 . . . . 3.3799999999999999 113.874 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.7 mtp85 -137.62 -26.73 0.96 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 122.508 3.154 . . . . 26.59 114.241 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.4 93.98 4.97 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.072 -2.268 . . . . 3.02 109.579 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.21 142.54 24.82 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 125.023 1.452 . . . . 4.7000000000000002 109.79 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.58 146.75 68.59 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.704 2.269 . . . . 2.9399999999999999 110.702 -174.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.46 156.15 33.37 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.913 -1.494 . . . . 15.960000000000001 107.073 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.3 ttp180 -52.07 130.27 29.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 124.24 1.972 . . . . 11.69 112.804 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.29 -14.02 65.83 Favored Glycine 0 N--CA 1.422 -2.246 0 O-C-N 119.929 -1.732 . . . . 3.6299999999999999 112.757 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -86.24 149.47 25.05 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 120.029 1.915 . . . . 5.9000000000000004 112.243 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.2 m -89.97 120.29 31.05 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.312 1.633 . . . . 3.0699999999999998 111.746 174.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.46 131.0 39.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 122.55 1.167 . . . . 4.1100000000000003 109.891 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.96 111.39 35.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 101.624 -3.473 . . . . 2.1600000000000001 101.624 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 m -129.48 154.42 40.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.806 0.812 . . . . 3.5899999999999999 112.282 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.4 30.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.187 -2.153 . . . . 3.1299999999999999 105.187 164.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.0 p90 -145.79 156.1 43.36 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 120.126 1.33 . . . . 2.5499999999999998 112.055 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -133.83 121.47 21.85 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 102.952 -2.981 . . . . 4.4699999999999998 102.952 167.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.11 131.87 10.73 Favored Glycine 0 N--CA 1.471 0.999 0 N-CA-C 109.248 -1.541 . . . . 3.4100000000000001 109.248 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.37 152.11 51.58 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 125.16 2.41 . . . . 18.219999999999999 110.481 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 164.64 22.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.745 -2.48 . . . . 5.9299999999999997 106.447 172.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -58.03 -20.62 40.37 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 117.17 -3.457 . . . . 12.33 117.699 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -87.74 5.32 40.52 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 119.545 -1.972 . . . . 7.1900000000000004 113.851 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.08 -10.2 69.96 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 124.013 1.896 . . . . 6.4699999999999998 113.789 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.7 124.27 22.41 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 116.688 -3.831 . . . . 21.859999999999999 110.564 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.84 130.78 37.07 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.404 -1.332 . . . . 16.18 107.404 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -107.67 -17.9 13.97 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.124 -1.03 . . . . 5.7300000000000004 110.667 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -172.76 155.4 3.21 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 118.087 -0.959 . . . . 6.1299999999999999 110.587 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -158.76 128.12 5.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.47 1.108 . . . . 2.9300000000000002 110.385 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.4 p -76.01 -20.67 57.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.937 -0.764 . . . . 2.2999999999999998 108.937 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.61 -36.74 84.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.742 -1.577 . . . . 10.550000000000001 106.742 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -67.55 -28.53 67.87 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.172 -1.58 . . . . 8.0199999999999996 110.807 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.68 -10.01 50.02 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 120.859 -1.15 . . . . 10.210000000000001 112.366 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.47 34.32 24.07 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-O 123.33 1.538 . . . . 16.379999999999999 110.945 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -139.76 120.14 9.29 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 117.594 -3.191 . . . . 20.210000000000001 103.887 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -59.22 152.27 61.14 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 124.231 3.288 . . . . 8.75 110.378 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -95.91 138.24 33.83 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.58 -1.637 . . . . 4.6500000000000004 106.58 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.7 136.84 50.39 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 120.622 1.555 . . . . 10.619999999999999 111.311 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.61 150.71 40.66 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 120.466 1.485 . . . . 4.3099999999999996 107.337 169.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.444 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.51 126.72 37.72 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 120.313 1.415 . . . . 2.6699999999999999 110.563 172.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 129.8 41.92 Favored 'General case' 0 N--CA 1.426 -1.627 0 O-C-N 125.285 1.616 . . . . 3.0800000000000001 110.639 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.97 -4.18 84.77 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.901 0.762 . . . . 4.9500000000000002 114.009 176.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.03 -3.09 57.78 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.788 -1.419 . . . . 10.26 114.647 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 64.57 39.48 6.63 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.046 -1.659 . . . . 10.24 113.756 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.23 -0.79 13.8 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 114.767 1.395 . . . . 10.56 114.767 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.42 172.7 9.25 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 107.978 -1.119 . . . . 2.4500000000000002 107.978 171.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.76 152.13 8.37 Favored 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.91 1.338 . . . . 5.5700000000000003 109.851 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.42 -35.68 68.08 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.381 -1.282 . . . . 19.109999999999999 114.386 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.62 -23.5 72.23 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 123.333 2.788 . . . . 2.9300000000000002 112.363 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.47 -54.67 7.1 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 118.535 1.168 . . . . 7.96 111.633 173.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.06 -44.43 15.37 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 124.028 1.871 . . . . 15.050000000000001 111.449 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.18 -35.49 48.63 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.639 -1.164 . . . . 20.27 114.111 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.95 -45.75 6.21 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 119.572 -1.299 . . . . 4.04 114.64 -175.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.49 -27.21 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 O-C-N 121.404 -1.056 . . . . 5.3499999999999996 109.454 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.92 -18.93 64.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 118.625 -2.547 . . . . 3.0299999999999998 112.343 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.49 0.27 50.35 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.454 -0.784 . . . . 3.4900000000000002 113.026 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.623 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.8 mtp -107.76 143.09 36.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 120.831 1.65 . . . . 3.75 109.476 -171.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.403 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.7 p -94.86 155.02 16.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.66 0.784 . . . . 2.2999999999999998 109.8 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.1 t -57.63 130.2 20.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 119.954 1.252 . . . . 2.4700000000000002 109.711 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.7 52.05 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.381 -1.736 . . . . 2.6099999999999999 113.077 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.623 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.37 144.73 28.63 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.998 0.904 . . . . 6.5300000000000002 112.566 -171.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.96 123.87 41.35 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 102.65 -3.092 . . . . 12.359999999999999 102.65 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.82 156.79 45.01 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 126.501 2.376 . . . . 5.8399999999999999 114.323 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.28 122.38 43.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 123.449 1.595 . . . . 16.57 108.617 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.39 28.5 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 118.85 -2.406 . . . . 5.8600000000000003 106.793 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -98.69 120.47 39.17 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 105.822 -1.918 . . . . 5.7599999999999998 105.822 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.72 122.68 69.34 Favored 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 108.589 -0.893 . . . . 3.3599999999999999 108.589 -167.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.1 p -66.41 153.99 91.67 Favored Pre-proline 0 C--O 1.243 0.721 0 CA-C-O 117.838 -1.077 . . . . 4.9400000000000004 110.77 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -55.26 -35.11 90.53 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 123.285 2.656 . . . . 6.21 114.899 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.12 -13.85 62.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.792 1.034 . . . . 15.85 113.792 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -103.67 11.0 36.55 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 126.105 1.762 . . . . 11.52 111.737 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.83 -116.58 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.693 -1.965 . . . . 3.7000000000000002 105.693 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.54 4.04 38.1 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 122.036 2.198 . . . . 6.8399999999999999 115.453 -173.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.49 -137.15 50.44 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-O 123.733 1.74 . . . . 5.9900000000000002 111.078 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.22 -18.78 41.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 111.725 -2.238 . . . . 10.109999999999999 110.993 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.1 m -72.28 -43.98 63.46 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 121.064 1.756 . . . . 13.76 112.529 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.39 -169.25 53.39 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 107.715 -2.154 . . . . 9.9800000000000004 107.715 -170.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.85 114.93 35.27 Favored Pre-proline 0 C--O 1.247 0.962 0 O-C-N 118.012 -3.052 . . . . 15.880000000000001 103.164 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -48.14 122.36 7.32 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 124.781 3.654 . . . . 11.41 110.876 -166.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.17 -26.94 3.23 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.94 -2.391 . . . . 14.199999999999999 117.416 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.6 mt -102.87 -50.16 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 121.056 2.428 . . . . 11.06 114.918 -175.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.5 mm -112.85 131.88 22.55 Favored Pre-proline 0 CA--C 1.516 -0.337 0 N-CA-C 103.209 -2.885 . . . . 8.0099999999999998 103.209 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.03 163.05 35.45 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.282 3.988 . . . . 6.5199999999999996 112.915 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.2 Cg_exo -55.3 144.48 71.42 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.521 2.147 . . . . 4.8200000000000003 110.232 162.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.14 27.46 16.53 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 112.924 -1.943 . . . . 7.4199999999999999 113.622 172.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.91 132.42 35.27 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 117.382 2.364 . . . . 2.2200000000000002 117.382 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.55 132.37 35.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 121.695 2.043 . . . . 4.6100000000000003 106.359 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.82 146.84 32.99 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.457 -1.402 . . . . 5.3399999999999999 110.308 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.18 120.01 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 103.74 -2.689 . . . . 3.9700000000000002 103.74 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.444 ' HB3' HG22 ' A' ' 101' ' ' VAL . 48.7 m-85 -116.79 136.93 52.56 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.734 -1.229 . . . . 4.4199999999999999 109.553 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.6 t0 -103.78 112.77 25.86 Favored 'General case' 0 C--N 1.315 -0.933 1 N-CA-C 98.863 -4.495 . . . . 2.0899999999999999 98.863 174.014 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 99' ' ' PHE . 87.2 t -126.86 132.31 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 114.143 -1.39 . . . . 3.5299999999999998 110.765 -172.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.42 121.99 39.74 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.45 -2.055 . . . . 14.210000000000001 105.45 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 tp -89.14 109.07 19.98 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 123.643 1.687 . . . . 2.4199999999999999 107.496 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.6 mt -85.53 -43.25 13.7 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.203 1.557 . . . . 2.6200000000000001 115.203 -171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -161.85 153.57 18.9 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.509 -1.678 . . . . 11.710000000000001 109.189 -167.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.1 mt -120.01 133.21 55.61 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 105.177 -2.157 . . . . 4.7000000000000002 105.177 170.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 . . . . . 0 C--N 1.312 -1.049 0 CA-C-N 113.591 -1.641 . . . . 13.02 109.823 -179.805 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 106.024 -2.83 . . . . 6.3300000000000001 106.024 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.33 142.48 43.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 101.784 -3.413 . . . . 6.3499999999999996 101.784 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -116.98 130.16 56.51 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 102.807 -3.034 . . . . 16.98 102.807 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.5 t -109.54 117.04 53.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 103.718 -2.697 . . . . 5.5800000000000001 103.718 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.65 124.7 46.94 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 118.927 -2.358 . . . . 12.800000000000001 104.834 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.3 m -75.7 140.03 42.25 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 119.365 -2.084 . . . . 3.2400000000000002 115.68 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.9 mt -101.63 -51.92 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 105.874 -1.899 . . . . 4.79 105.874 171.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.3 m -138.93 139.06 22.45 Favored Pre-proline 0 C--O 1.242 0.704 0 O-C-N 119.572 -1.955 . . . . 11.59 106.299 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.7 Cg_exo -67.73 154.71 72.49 Favored 'Trans proline' 0 C--N 1.328 -0.522 0 C-N-CA 123.626 2.884 . . . . 4.5499999999999998 112.166 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.71 -161.29 28.88 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 109.15 -1.58 . . . . 2.0 109.15 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -82.33 -9.21 59.56 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 117.677 -3.249 . . . . 3.2400000000000002 113.21 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.17 9.67 77.07 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-O 117.585 -1.675 . . . . 3.3799999999999999 113.799 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.7 mtp85 -137.62 -26.79 0.96 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.669 3.234 . . . . 26.59 114.225 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.47 94.04 4.99 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 119.111 -2.243 . . . . 3.02 109.525 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.27 142.53 24.8 Favored Pre-proline 0 C--O 1.251 1.14 0 O-C-N 124.95 1.406 . . . . 4.7000000000000002 109.769 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.549 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.62 146.71 68.18 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.743 2.295 . . . . 2.9399999999999999 110.671 -174.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -121.47 156.25 33.16 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.925 -1.489 . . . . 15.960000000000001 106.994 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.42 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.3 ttp180 -52.1 130.27 29.67 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 124.121 1.915 . . . . 11.69 112.831 174.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.21 -14.05 65.84 Favored Glycine 0 N--CA 1.421 -2.307 0 O-C-N 119.971 -1.706 . . . . 3.6299999999999999 112.763 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.15 149.41 25.13 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.098 1.949 . . . . 5.9000000000000004 112.311 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.6 m -89.97 120.42 31.16 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 125.257 1.598 . . . . 3.0699999999999998 111.689 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.52 131.06 39.12 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.592 1.187 . . . . 4.1100000000000003 109.799 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.06 111.33 35.69 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.649 -3.463 . . . . 2.1600000000000001 101.649 -174.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.9 m -129.43 154.43 40.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.77 0.795 . . . . 3.5899999999999999 112.313 -172.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.12 145.41 30.58 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.274 -2.121 . . . . 3.1299999999999999 105.274 164.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.86 156.13 43.35 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 120.172 1.351 . . . . 2.5499999999999998 111.87 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -133.86 121.48 21.82 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 102.924 -2.991 . . . . 4.4699999999999998 102.924 167.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.27 131.93 10.76 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 109.173 -1.571 . . . . 3.4100000000000001 109.173 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.46 152.18 51.61 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 125.291 2.472 . . . . 18.219999999999999 110.374 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 164.55 22.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 111.65 -2.523 . . . . 5.9299999999999997 106.435 172.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -57.96 -20.69 39.78 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 117.263 -3.398 . . . . 12.33 117.705 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.75 5.4 40.18 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.564 -1.96 . . . . 7.1900000000000004 113.874 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.36 69.71 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-O 124.113 1.952 . . . . 6.4699999999999998 113.754 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.42 124.18 22.04 Favored 'General case' 0 N--CA 1.438 -1.037 0 O-C-N 116.601 -3.882 . . . . 21.859999999999999 110.686 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.91 130.79 37.01 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.37 -1.344 . . . . 16.18 107.37 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.61 -17.93 13.97 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.095 -1.042 . . . . 5.7300000000000004 110.74 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.68 155.44 3.28 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 118.041 -0.98 . . . . 6.1299999999999999 110.665 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -158.77 128.2 5.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.484 1.113 . . . . 2.9300000000000002 110.312 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.9 p -76.03 -20.61 57.64 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.001 -0.74 . . . . 2.2999999999999998 109.001 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.63 84.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.685 -1.598 . . . . 10.550000000000001 106.685 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -67.64 -28.56 67.83 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.143 -1.598 . . . . 8.0199999999999996 110.827 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.3 mtm-85 -88.58 -10.04 50.14 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.861 -1.149 . . . . 10.210000000000001 112.427 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.5 34.26 24.0 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.311 1.529 . . . . 16.379999999999999 110.951 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -139.7 120.2 9.36 Favored Pre-proline 0 C--O 1.247 0.972 0 O-C-N 117.571 -3.206 . . . . 20.210000000000001 103.921 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -59.33 152.29 61.77 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.292 3.328 . . . . 8.75 110.276 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -95.85 138.18 33.86 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.572 -1.64 . . . . 4.6500000000000004 106.572 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.67 136.88 50.3 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 120.525 1.512 . . . . 10.619999999999999 111.253 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.6 150.7 40.67 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 120.475 1.489 . . . . 4.3099999999999996 107.368 169.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.443 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.46 126.61 37.62 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.324 1.42 . . . . 2.6699999999999999 110.542 172.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.87 129.9 42.45 Favored 'General case' 0 N--CA 1.427 -1.576 0 O-C-N 125.33 1.644 . . . . 3.0800000000000001 110.699 176.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.79 -4.02 84.92 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 123.862 0.744 . . . . 4.9500000000000002 114.043 176.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.08 -3.13 57.86 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.686 -1.479 . . . . 10.26 114.633 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 64.56 39.52 6.65 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 120.012 -1.68 . . . . 10.24 113.858 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.34 -0.89 13.69 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 114.722 1.378 . . . . 10.56 114.722 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.4 172.67 9.28 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 N-CA-C 108.085 -1.08 . . . . 2.4500000000000002 108.085 171.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 pt -71.82 152.17 8.32 Favored 'Isoleucine or valine' 0 C--O 1.256 1.445 0 CA-C-O 123.029 1.395 . . . . 5.5700000000000003 109.725 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -56.26 -35.71 67.75 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 114.316 -1.311 . . . . 19.109999999999999 114.471 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.86 -23.22 72.53 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 123.4 2.818 . . . . 2.9300000000000002 112.432 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.52 -54.76 6.89 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 118.555 1.178 . . . . 7.96 111.583 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.86 -44.43 14.36 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 124.045 1.878 . . . . 15.050000000000001 111.503 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.44 -35.35 46.98 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.564 -1.198 . . . . 20.27 114.007 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.94 -45.7 6.23 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 119.615 -1.279 . . . . 4.04 114.724 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.58 -27.18 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 119.09 -1.044 . . . . 5.3499999999999996 109.425 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.85 64.71 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.541 -2.6 . . . . 3.0299999999999998 112.35 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.42 0.18 50.46 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 118.425 -0.798 . . . . 3.4900000000000002 113.068 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.624 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.6 mtp -107.7 143.1 36.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 120.81 1.641 . . . . 3.75 109.572 -171.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.401 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.9 p -94.84 154.96 17.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.715 0.806 . . . . 2.2999999999999998 109.806 174.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.2 t -57.62 130.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 119.867 1.212 . . . . 2.4700000000000002 109.783 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 -12.53 52.08 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 113.35 -1.75 . . . . 2.6099999999999999 112.995 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.624 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.46 144.76 28.52 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.919 0.866 . . . . 6.5300000000000002 112.575 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.95 123.89 41.4 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 102.632 -3.099 . . . . 12.359999999999999 102.632 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.91 156.64 44.94 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 126.471 2.357 . . . . 5.8399999999999999 114.285 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.15 122.45 43.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 123.551 1.643 . . . . 16.57 108.638 174.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.05 114.59 28.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 118.741 -2.474 . . . . 5.8600000000000003 106.76 -176.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.9 m -98.74 120.44 39.18 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 105.77 -1.937 . . . . 5.7599999999999998 105.77 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.66 122.59 69.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 108.687 -0.857 . . . . 3.3599999999999999 108.687 -167.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.35 154.03 91.41 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.907 -1.044 . . . . 4.9400000000000004 110.683 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -55.45 -35.09 91.39 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.355 2.704 . . . . 6.21 114.738 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.07 -13.84 62.4 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.897 1.073 . . . . 15.85 113.897 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.61 10.99 36.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 126.106 1.762 . . . . 11.52 111.692 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.86 -116.6 0.15 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 105.712 -1.958 . . . . 3.7000000000000002 105.712 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.59 4.0 37.92 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-N 121.991 2.178 . . . . 6.8399999999999999 115.444 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.49 -137.15 50.44 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-O 123.739 1.744 . . . . 5.9900000000000002 111.032 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.29 -18.73 41.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 111.674 -2.263 . . . . 10.109999999999999 110.982 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.1 m -72.19 -43.98 63.69 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 121.131 1.787 . . . . 13.76 112.608 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.3 -169.17 53.38 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 107.652 -2.179 . . . . 9.9800000000000004 107.652 -170.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -118.83 114.9 35.32 Favored Pre-proline 0 C--O 1.247 0.959 0 O-C-N 117.982 -3.069 . . . . 15.880000000000001 103.268 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.21 122.44 7.5 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.622 3.548 . . . . 11.41 110.903 -166.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.21 -26.98 3.23 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.863 -2.426 . . . . 14.199999999999999 117.416 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.6 mt -102.88 -50.04 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 121.03 2.415 . . . . 11.06 114.894 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.7 mm -112.92 131.91 22.56 Favored Pre-proline 0 CA--C 1.516 -0.328 0 N-CA-C 103.203 -2.888 . . . . 8.0099999999999998 103.203 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.01 163.02 35.53 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.284 3.99 . . . . 6.5199999999999996 112.918 171.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.34 144.48 71.81 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.563 2.175 . . . . 4.8200000000000003 110.244 162.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.33 27.22 16.27 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 112.785 -2.007 . . . . 7.4199999999999999 113.581 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.84 132.35 35.27 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 117.396 2.369 . . . . 2.2200000000000002 117.396 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -80.51 132.43 35.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 121.722 2.055 . . . . 4.6100000000000003 106.328 168.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.89 146.86 33.06 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.451 -1.406 . . . . 5.3399999999999999 110.276 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.3 t -123.21 119.95 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 N-CA-C 103.743 -2.688 . . . . 3.9700000000000002 103.743 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.444 ' HB3' HG22 ' A' ' 101' ' ' VAL . 48.6 m-85 -116.77 137.01 52.5 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.724 -1.235 . . . . 4.4199999999999999 109.562 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.81 112.7 25.77 Favored 'General case' 0 C--N 1.314 -0.959 1 N-CA-C 98.91 -4.478 . . . . 2.0899999999999999 98.91 173.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 99' ' ' PHE . 86.4 t -126.8 132.33 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.12 -1.4 . . . . 3.5299999999999998 110.82 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.44 121.84 39.39 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.524 -2.028 . . . . 14.210000000000001 105.524 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.09 109.01 19.92 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 123.618 1.675 . . . . 2.4199999999999999 107.484 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.41 -43.34 13.72 Favored 'General case' 0 C--O 1.255 1.378 0 N-CA-C 115.175 1.546 . . . . 2.6200000000000001 115.175 -171.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -161.79 153.59 19.05 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 113.559 -1.655 . . . . 11.710000000000001 109.229 -167.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.07 133.19 55.59 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 105.201 -2.148 . . . . 4.7000000000000002 105.201 170.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.31 -1.138 0 CA-C-N 113.554 -1.657 . . . . 13.02 109.912 -179.795 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 106.073 -2.811 . . . . 6.3300000000000001 106.073 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.34 142.55 43.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 101.741 -3.429 . . . . 6.3499999999999996 101.741 176.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.05 130.13 56.46 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 102.734 -3.061 . . . . 16.98 102.734 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.9 t -109.53 117.04 53.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 103.741 -2.689 . . . . 5.5800000000000001 103.741 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.62 124.72 47.01 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 118.957 -2.339 . . . . 12.800000000000001 104.824 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.4 m -75.68 140.02 42.28 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 119.292 -2.13 . . . . 3.2400000000000002 115.635 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.41 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.3 mt -101.61 -52.02 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.832 -1.914 . . . . 4.79 105.832 171.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.6 m -138.95 139.03 22.27 Favored Pre-proline 0 C--O 1.241 0.652 0 O-C-N 119.5 -2.0 . . . . 11.59 106.301 177.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.7 Cg_exo -67.7 154.78 72.34 Favored 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.46 2.774 . . . . 4.5499999999999998 112.201 -176.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.71 -161.17 28.86 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 109.135 -1.586 . . . . 2.0 109.135 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.49 -9.21 59.52 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 117.606 -3.291 . . . . 3.2400000000000002 113.161 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.15 9.68 77.02 Favored Glycine 0 C--O 1.219 -0.8 0 CA-C-O 117.691 -1.616 . . . . 3.3799999999999999 113.846 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.7 mtp85 -137.67 -26.58 0.96 Allowed 'General case' 0 C--O 1.24 0.587 0 CA-C-N 122.592 3.196 . . . . 26.59 114.214 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.57 94.0 4.96 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 119.057 -2.277 . . . . 3.02 109.45 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.13 142.53 24.81 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 125.01 1.444 . . . . 4.7000000000000002 109.798 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.56 146.76 68.69 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.754 2.303 . . . . 2.9399999999999999 110.627 -174.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.48 156.09 33.53 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.919 -1.491 . . . . 15.960000000000001 107.047 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.03 130.23 29.28 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 124.189 1.947 . . . . 11.69 112.721 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.36 -14.08 65.67 Favored Glycine 0 N--CA 1.423 -2.21 0 O-C-N 119.952 -1.717 . . . . 3.6299999999999999 112.713 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.12 149.36 25.18 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.061 1.93 . . . . 5.9000000000000004 112.326 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.92 120.36 31.08 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.176 1.548 . . . . 3.0699999999999998 111.766 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.51 130.94 39.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 122.606 1.193 . . . . 4.1100000000000003 109.874 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.89 111.39 35.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.638 -3.467 . . . . 2.1600000000000001 101.638 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.54 154.39 40.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 121.817 0.817 . . . . 3.5899999999999999 112.262 -172.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.04 145.49 30.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.173 -2.158 . . . . 3.1299999999999999 105.173 164.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.1 p90 -145.89 156.11 43.33 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 120.048 1.294 . . . . 2.5499999999999998 112.038 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.8 m -133.84 121.63 22.06 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 102.88 -3.007 . . . . 4.4699999999999998 102.88 167.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.24 131.94 10.76 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 109.22 -1.552 . . . . 3.4100000000000001 109.22 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.4 152.12 51.6 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 125.198 2.427 . . . . 18.219999999999999 110.405 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 164.62 22.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.741 -2.481 . . . . 5.9299999999999997 106.447 172.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -58.04 -20.58 40.22 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.238 -3.414 . . . . 12.33 117.708 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.75 5.3 40.65 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.59 -1.943 . . . . 7.1900000000000004 113.914 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.23 -10.33 69.62 Favored Glycine 0 C--N 1.357 1.697 0 CA-C-O 123.956 1.864 . . . . 6.4699999999999998 113.646 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.59 124.22 22.23 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 116.622 -3.869 . . . . 21.859999999999999 110.583 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -77.77 130.83 37.21 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.457 -1.312 . . . . 16.18 107.457 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.71 -17.87 13.97 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.075 -1.05 . . . . 5.7300000000000004 110.802 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -172.76 155.49 3.24 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 118.241 -0.885 . . . . 6.1299999999999999 110.55 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.81 128.05 5.54 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.48 1.112 . . . . 2.9300000000000002 110.371 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.3 p -75.89 -20.59 57.92 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.846 -0.741 . . . . 2.2999999999999998 109.093 175.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.73 -36.69 84.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.696 -1.594 . . . . 10.550000000000001 106.696 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -67.62 -28.49 67.78 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.191 -1.568 . . . . 8.0199999999999996 110.812 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.63 -10.1 49.81 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 120.854 -1.154 . . . . 10.210000000000001 112.341 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.51 34.28 24.05 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.346 1.546 . . . . 16.379999999999999 111.017 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -139.68 120.18 9.37 Favored Pre-proline 0 C--O 1.247 0.972 0 O-C-N 117.627 -3.171 . . . . 20.210000000000001 103.914 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -59.32 152.28 61.72 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 124.321 3.347 . . . . 8.75 110.32 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -95.84 138.13 33.92 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.534 -1.654 . . . . 4.6500000000000004 106.534 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -111.61 136.89 50.2 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 120.572 1.533 . . . . 10.619999999999999 111.297 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.66 150.7 40.55 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.402 1.456 . . . . 4.3099999999999996 107.373 169.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.443 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.51 126.67 37.7 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 120.311 1.414 . . . . 2.6699999999999999 110.585 172.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 129.86 42.19 Favored 'General case' 0 N--CA 1.426 -1.643 0 O-C-N 125.251 1.594 . . . . 3.0800000000000001 110.647 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.93 -4.12 84.8 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 123.841 0.734 . . . . 4.9500000000000002 114.099 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.1 -3.12 57.86 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.797 -1.414 . . . . 10.26 114.561 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.51 39.62 6.69 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.106 -1.621 . . . . 10.24 113.784 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.38 -0.81 13.69 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 114.676 1.361 . . . . 10.56 114.676 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.37 172.63 9.33 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.118 -1.067 . . . . 2.4500000000000002 108.118 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.2 pt -71.82 152.12 8.34 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.98 1.371 . . . . 5.5700000000000003 109.785 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -56.22 -35.75 67.69 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.354 -1.294 . . . . 19.109999999999999 114.458 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.76 -23.31 72.38 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.423 2.828 . . . . 2.9300000000000002 112.357 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.59 -54.68 7.0 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 118.621 1.21 . . . . 7.96 111.611 173.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -45.93 -44.45 14.74 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 124.015 1.864 . . . . 15.050000000000001 111.512 173.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.33 -35.31 47.77 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.517 -1.22 . . . . 20.27 114.084 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.05 -45.65 6.21 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.424 -1.37 . . . . 4.04 114.663 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.47 -27.25 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 121.317 -1.108 . . . . 5.3499999999999996 109.456 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.95 -18.89 64.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.506 -2.621 . . . . 3.0299999999999998 112.363 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.48 0.34 50.04 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.078 0.77 . . . . 3.4900000000000002 113.078 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.623 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.9 mtp -107.88 143.08 36.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 120.765 1.62 . . . . 3.75 109.493 -171.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.402 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.9 p -94.71 154.92 17.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.714 0.805 . . . . 2.2999999999999998 109.877 174.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -57.58 130.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 119.965 1.257 . . . . 2.4700000000000002 109.828 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.12 -12.54 52.26 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 113.366 -1.743 . . . . 2.6099999999999999 113.124 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.623 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.48 144.8 28.49 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.915 0.864 . . . . 6.5300000000000002 112.605 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -124.01 123.99 41.57 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 102.578 -3.119 . . . . 12.359999999999999 102.578 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.82 45.01 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.467 2.354 . . . . 5.8399999999999999 114.292 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.28 122.39 43.59 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.463 1.601 . . . . 16.57 108.651 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.59 28.82 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.847 -2.408 . . . . 5.8600000000000003 106.709 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.2 m -98.79 120.47 39.28 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 105.822 -1.918 . . . . 5.7599999999999998 105.822 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.73 122.55 69.01 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 108.616 -0.883 . . . . 3.3599999999999999 108.616 -167.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.34 154.02 91.43 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-O 117.787 -1.101 . . . . 4.9400000000000004 110.737 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.4 -35.08 91.11 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.312 2.675 . . . . 6.21 114.749 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.17 -13.83 62.36 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 113.777 1.029 . . . . 15.85 113.777 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.69 11.05 36.45 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 126.038 1.735 . . . . 11.52 111.693 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.79 -116.54 0.15 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 105.751 -1.944 . . . . 3.7000000000000002 105.751 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.73 4.22 37.8 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 122.033 2.197 . . . . 6.8399999999999999 115.452 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.36 -137.18 50.33 Favored Glycine 0 C--N 1.354 1.578 0 CA-C-O 123.708 1.727 . . . . 5.9900000000000002 111.073 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.17 -18.75 41.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 111.661 -2.27 . . . . 10.109999999999999 111.047 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.25 -43.98 63.53 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 121.048 1.749 . . . . 13.76 112.575 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.4 -169.24 53.4 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 107.603 -2.199 . . . . 9.9800000000000004 107.603 -170.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.87 114.9 35.23 Favored Pre-proline 0 C--O 1.246 0.913 0 O-C-N 118.097 -3.002 . . . . 15.880000000000001 103.151 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.13 122.43 7.4 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.667 3.578 . . . . 11.41 110.901 -166.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.17 -27.05 3.2 Favored Glycine 0 CA--C 1.545 1.935 0 CA-C-N 111.897 -2.41 . . . . 14.199999999999999 117.454 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.9 mt -102.85 -50.08 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.046 2.423 . . . . 11.06 114.972 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.84 131.93 22.52 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 103.124 -2.917 . . . . 8.0099999999999998 103.124 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.09 163.08 35.43 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 125.218 3.945 . . . . 6.5199999999999996 112.871 171.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.3 Cg_exo -55.4 144.54 72.21 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.428 2.085 . . . . 4.8200000000000003 110.311 162.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.19 27.26 16.38 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 112.886 -1.961 . . . . 7.4199999999999999 113.722 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.67 132.36 35.29 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 117.381 2.363 . . . . 2.2200000000000002 117.381 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.47 132.46 35.71 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 121.796 2.089 . . . . 4.6100000000000003 106.348 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -108.94 146.78 33.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 120.379 -1.45 . . . . 5.3399999999999999 110.241 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.17 120.01 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 103.768 -2.679 . . . . 3.9700000000000002 103.768 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 101' ' ' VAL . 48.6 m-85 -116.76 136.95 52.55 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.724 -1.235 . . . . 4.4199999999999999 109.591 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.8 t0 -103.75 112.7 25.77 Favored 'General case' 0 C--N 1.313 -1.0 1 N-CA-C 98.925 -4.472 . . . . 2.0899999999999999 98.925 173.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 99' ' ' PHE . 87.6 t -126.82 132.34 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.212 -1.358 . . . . 3.5299999999999998 110.804 -172.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -120.47 121.9 39.5 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.464 -2.05 . . . . 14.210000000000001 105.464 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.6 tp -89.05 109.04 19.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 123.606 1.67 . . . . 2.4199999999999999 107.516 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.46 -43.26 13.74 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.181 1.549 . . . . 2.6200000000000001 115.181 -171.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -161.8 153.58 19.02 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 113.503 -1.68 . . . . 11.710000000000001 109.115 -167.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.04 133.24 55.59 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 105.206 -2.146 . . . . 4.7000000000000002 105.206 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.582 -1.645 . . . . 13.02 109.912 -179.84 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 106.082 -2.807 . . . . 6.3300000000000001 106.082 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.36 142.54 43.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 101.712 -3.44 . . . . 6.3499999999999996 101.712 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.06 130.11 56.44 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 102.824 -3.028 . . . . 16.98 102.824 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.1 t -109.49 117.12 53.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 103.67 -2.715 . . . . 5.5800000000000001 103.67 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.63 124.68 46.92 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 118.949 -2.345 . . . . 12.800000000000001 104.83 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.6 m -75.66 139.96 42.27 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.333 -2.105 . . . . 3.2400000000000002 115.621 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.5 mt -101.66 -52.01 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 105.82 -1.919 . . . . 4.79 105.82 171.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.5 m -138.93 139.1 22.58 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 119.652 -1.905 . . . . 11.59 106.233 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.3 Cg_exo -67.66 154.76 72.49 Favored 'Trans proline' 0 C--N 1.33 -0.433 0 C-N-CA 123.568 2.846 . . . . 4.5499999999999998 112.224 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.68 -161.08 28.88 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.106 -1.597 . . . . 2.0 109.106 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -82.55 -9.17 59.52 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 117.694 -3.239 . . . . 3.2400000000000002 113.146 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.1 9.77 76.98 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.636 -1.647 . . . . 3.3799999999999999 113.843 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -137.74 -26.66 0.95 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.592 3.196 . . . . 26.59 114.226 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 m -105.52 94.03 4.98 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 119.143 -2.223 . . . . 3.02 109.439 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.21 142.5 24.75 Favored Pre-proline 0 C--O 1.25 1.091 0 O-C-N 125.003 1.439 . . . . 4.7000000000000002 109.77 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.549 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.53 146.59 68.31 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.789 2.326 . . . . 2.9399999999999999 110.682 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.42 156.18 33.25 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.895 -1.502 . . . . 15.960000000000001 106.99 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.6 ttp180 -52.17 130.31 30.06 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 124.201 1.953 . . . . 11.69 112.828 174.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.28 -13.96 65.94 Favored Glycine 0 N--CA 1.424 -2.147 0 O-C-N 120.009 -1.682 . . . . 3.6299999999999999 112.682 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.47 25.09 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 120.111 1.956 . . . . 5.9000000000000004 112.356 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.9 m -89.89 120.31 31.01 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.308 1.63 . . . . 3.0699999999999998 111.726 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.55 131.05 39.17 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.614 1.197 . . . . 4.1100000000000003 109.851 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.0 111.41 36.04 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.643 -3.466 . . . . 2.1600000000000001 101.643 -174.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.1 m -129.6 154.4 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.89 0.852 . . . . 3.5899999999999999 112.249 -172.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.05 145.39 30.54 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.258 -2.127 . . . . 3.1299999999999999 105.258 164.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.8 156.19 43.42 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 120.173 1.351 . . . . 2.5499999999999998 111.923 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.4 m -133.86 121.54 21.91 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 102.99 -2.967 . . . . 4.4699999999999998 102.99 167.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.2 131.95 10.77 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 109.3 -1.52 . . . . 3.4100000000000001 109.3 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.39 152.19 51.56 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 125.263 2.459 . . . . 18.219999999999999 110.381 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.6 164.66 22.73 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.706 -2.497 . . . . 5.9299999999999997 106.408 172.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -58.11 -20.64 41.69 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 117.28 -3.387 . . . . 12.33 117.67 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.57 5.21 40.45 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 119.536 -1.977 . . . . 7.1900000000000004 113.927 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.22 -10.24 69.65 Favored Glycine 0 C--N 1.354 1.54 0 CA-C-O 123.973 1.874 . . . . 6.4699999999999998 113.67 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.67 124.32 22.54 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 116.728 -3.807 . . . . 21.859999999999999 110.583 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.97 130.76 36.93 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.383 -1.34 . . . . 16.18 107.383 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.56 -17.9 13.98 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.142 -1.023 . . . . 5.7300000000000004 110.845 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -172.71 155.44 3.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.064 -0.97 . . . . 6.1299999999999999 110.614 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -158.82 128.17 5.58 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.421 1.088 . . . . 2.9300000000000002 110.284 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.2 p -75.97 -20.74 57.66 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.841 -0.743 . . . . 2.2999999999999998 109.006 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.63 -36.67 84.6 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.674 -1.602 . . . . 10.550000000000001 106.674 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.59 -28.47 67.79 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.191 -1.568 . . . . 8.0199999999999996 110.881 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.67 -10.11 49.69 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 120.847 -1.158 . . . . 10.210000000000001 112.331 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.49 34.32 24.1 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-O 123.4 1.571 . . . . 16.379999999999999 110.989 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -139.69 120.2 9.36 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 117.703 -3.123 . . . . 20.210000000000001 103.926 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -59.24 152.26 61.35 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 124.209 3.273 . . . . 8.75 110.383 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -95.86 138.31 33.69 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.518 -1.66 . . . . 4.6500000000000004 106.518 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.76 136.78 50.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.588 1.54 . . . . 10.619999999999999 111.326 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -142.56 150.59 40.57 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 120.437 1.472 . . . . 4.3099999999999996 107.442 169.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.445 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.47 126.71 37.68 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.365 1.439 . . . . 2.6699999999999999 110.634 172.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.87 129.83 42.14 Favored 'General case' 0 N--CA 1.428 -1.56 0 O-C-N 125.32 1.637 . . . . 3.0800000000000001 110.654 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.87 -4.06 84.85 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 123.9 0.762 . . . . 4.9500000000000002 114.093 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.11 -3.01 57.79 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.765 -1.432 . . . . 10.26 114.64 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.51 39.55 6.72 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.045 -1.659 . . . . 10.24 113.795 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.73 13.7 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 114.671 1.36 . . . . 10.56 114.671 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.46 172.68 9.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 N-CA-C 107.938 -1.134 . . . . 2.4500000000000002 107.938 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 pt -71.77 152.12 8.37 Favored 'Isoleucine or valine' 0 C--O 1.259 1.604 0 CA-C-O 122.944 1.354 . . . . 5.5700000000000003 109.765 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.34 -35.73 67.96 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 114.401 -1.272 . . . . 19.109999999999999 114.395 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.78 -23.34 72.42 Favored Glycine 0 CA--C 1.539 1.583 0 O-C-N 118.226 -2.796 . . . . 2.9300000000000002 112.344 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.62 -54.55 7.23 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 118.556 1.178 . . . . 7.96 111.628 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.99 -44.45 15.03 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 124.015 1.864 . . . . 15.050000000000001 111.502 173.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.35 -35.25 47.71 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.544 -1.207 . . . . 20.27 114.101 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.04 -45.75 6.18 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.534 -1.317 . . . . 4.04 114.623 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.51 -27.22 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 121.338 -1.095 . . . . 5.3499999999999996 109.425 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.97 -18.8 64.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 118.531 -2.606 . . . . 3.0299999999999998 112.439 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.52 0.25 50.54 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.468 -0.777 . . . . 3.4900000000000002 113.026 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.624 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.8 mtp -107.8 143.05 36.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 120.852 1.66 . . . . 3.75 109.577 -171.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.402 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.9 p -94.77 154.96 17.03 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.693 0.797 . . . . 2.2999999999999998 109.86 174.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.2 t -57.62 130.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 119.957 1.253 . . . . 2.4700000000000002 109.763 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.15 -12.46 52.12 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 113.311 -1.768 . . . . 2.6099999999999999 113.049 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.624 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.48 144.77 28.51 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-O 121.854 0.835 . . . . 6.5300000000000002 112.562 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.97 123.98 41.58 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 102.626 -3.102 . . . . 12.359999999999999 102.626 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.91 156.82 44.97 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.472 2.357 . . . . 5.8399999999999999 114.221 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.36 122.42 43.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 123.443 1.592 . . . . 16.57 108.699 174.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.98 114.4 28.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 O-C-N 118.841 -2.412 . . . . 5.8600000000000003 106.797 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -98.68 120.51 39.24 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 105.855 -1.905 . . . . 5.7599999999999998 105.855 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.63 122.61 69.25 Favored 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 108.714 -0.847 . . . . 3.3599999999999999 108.714 -167.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.38 154.03 91.52 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.915 -1.04 . . . . 4.9400000000000004 110.739 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.32 -35.19 90.99 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 123.268 2.645 . . . . 6.21 114.786 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -69.95 -13.96 62.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.927 1.084 . . . . 15.85 113.927 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.6 11.06 36.61 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 126.113 1.765 . . . . 11.52 111.757 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.79 -116.62 0.15 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 105.786 -1.931 . . . . 3.7000000000000002 105.786 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -102.51 3.94 38.08 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 122.032 2.196 . . . . 6.8399999999999999 115.545 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.58 -137.17 50.48 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-O 123.757 1.754 . . . . 5.9900000000000002 111.011 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.64 41.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 111.622 -2.289 . . . . 10.109999999999999 110.983 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.26 -44.09 63.34 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 121.112 1.778 . . . . 13.76 112.529 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.4 -169.19 53.44 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.659 -2.177 . . . . 9.9800000000000004 107.659 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.81 114.8 35.4 Favored Pre-proline 0 C--O 1.247 0.922 0 O-C-N 117.999 -3.06 . . . . 15.880000000000001 103.323 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -48.19 122.47 7.52 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 124.707 3.605 . . . . 11.41 110.89 -166.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.19 -26.97 3.23 Favored Glycine 0 CA--C 1.547 2.079 0 CA-C-N 111.87 -2.423 . . . . 14.199999999999999 117.361 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.1 mt -102.96 -50.04 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 121.074 2.437 . . . . 11.06 114.917 -175.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.95 131.92 22.57 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 103.17 -2.9 . . . . 8.0099999999999998 103.17 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.0 163.07 35.32 Favored 'Trans proline' 0 C--O 1.24 0.592 1 C-N-CA 125.34 4.027 . . . . 6.5199999999999996 112.853 171.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.34 144.45 71.94 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.534 2.156 . . . . 4.8200000000000003 110.307 162.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.32 27.3 16.32 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 112.846 -1.979 . . . . 7.4199999999999999 113.562 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.86 132.35 35.27 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 117.392 2.367 . . . . 2.2200000000000002 117.392 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -80.57 132.45 35.65 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 121.696 2.043 . . . . 4.6100000000000003 106.283 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.88 146.78 33.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.442 -1.411 . . . . 5.3399999999999999 110.285 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.19 119.96 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 103.78 -2.674 . . . . 3.9700000000000002 103.78 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.444 ' HB3' HG22 ' A' ' 101' ' ' VAL . 48.4 m-85 -116.81 137.09 52.45 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.77 -1.206 . . . . 4.4199999999999999 109.541 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.81 112.73 25.81 Favored 'General case' 0 C--N 1.314 -0.975 1 N-CA-C 98.912 -4.477 . . . . 2.0899999999999999 98.912 174.019 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 99' ' ' PHE . 86.5 t -126.72 132.36 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.109 -1.405 . . . . 3.5299999999999998 110.805 -172.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.49 121.82 39.29 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.57 -2.011 . . . . 14.210000000000001 105.57 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 tp -89.02 109.11 19.99 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.498 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.9 mt -85.47 -43.34 13.67 Favored 'General case' 0 C--O 1.254 1.34 0 N-CA-C 115.255 1.576 . . . . 2.6200000000000001 115.255 -171.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -161.86 153.54 18.84 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.422 -1.717 . . . . 11.710000000000001 109.153 -167.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.0 133.28 55.59 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 105.155 -2.165 . . . . 4.7000000000000002 105.155 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.313 -1.018 0 CA-C-N 113.548 -1.66 . . . . 13.02 109.8 -179.798 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 106.034 -2.826 . . . . 6.3300000000000001 106.034 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.31 142.46 43.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 101.725 -3.435 . . . . 6.3499999999999996 101.725 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -116.92 130.21 56.55 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 102.818 -3.03 . . . . 16.98 102.818 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.8 t -109.71 117.1 53.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 103.613 -2.736 . . . . 5.5800000000000001 103.613 -175.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.61 124.65 46.85 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 118.919 -2.363 . . . . 12.800000000000001 104.82 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.7 m -75.57 139.97 42.41 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.183 -2.198 . . . . 3.2400000000000002 115.598 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.409 HD12 HG22 ' A' ' 7' ' ' ILE . 91.7 mt -101.64 -52.07 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 105.844 -1.91 . . . . 4.79 105.844 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.7 m -138.9 139.03 22.4 Favored Pre-proline 0 C--O 1.243 0.723 0 O-C-N 119.684 -1.885 . . . . 11.59 106.358 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.7 Cg_exo -67.66 154.78 72.44 Favored 'Trans proline' 0 C--N 1.329 -0.48 0 C-N-CA 123.536 2.824 . . . . 4.5499999999999998 112.15 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.63 -161.1 28.93 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 109.222 -1.551 . . . . 2.0 109.222 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.49 -9.21 59.52 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 117.65 -3.265 . . . . 3.2400000000000002 113.163 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.14 9.69 76.98 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-O 117.585 -1.675 . . . . 3.3799999999999999 113.806 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -137.63 -26.81 0.96 Allowed 'General case' 0 C--O 1.24 0.568 0 CA-C-N 122.669 3.234 . . . . 26.59 114.208 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.38 93.92 4.93 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 119.101 -2.249 . . . . 3.02 109.602 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -104.22 142.46 24.65 Favored Pre-proline 0 C--O 1.25 1.08 0 O-C-N 125.005 1.441 . . . . 4.7000000000000002 109.82 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.48 146.67 68.91 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.704 2.27 . . . . 2.9399999999999999 110.657 -174.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.46 156.29 33.08 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.836 -1.529 . . . . 15.960000000000001 106.962 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.418 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.24 130.27 30.21 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 124.253 1.977 . . . . 11.69 112.764 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.3 -14.08 65.72 Favored Glycine 0 N--CA 1.424 -2.159 0 O-C-N 119.999 -1.688 . . . . 3.6299999999999999 112.766 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -86.18 149.43 25.11 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.095 1.948 . . . . 5.9000000000000004 112.333 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.95 120.29 31.04 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 125.308 1.63 . . . . 3.0699999999999998 111.729 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.3 m -93.57 131.09 39.17 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 122.616 1.198 . . . . 4.1100000000000003 109.827 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.99 111.5 36.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 N-CA-C 101.625 -3.472 . . . . 2.1600000000000001 101.625 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.58 154.42 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.82 0.819 . . . . 3.5899999999999999 112.3 -172.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.46 30.52 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.215 -2.143 . . . . 3.1299999999999999 105.215 164.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.82 156.17 43.4 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 120.04 1.291 . . . . 2.5499999999999998 111.927 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.79 121.57 22.03 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 102.929 -2.989 . . . . 4.4699999999999998 102.929 167.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.22 131.93 10.76 Favored Glycine 0 N--CA 1.471 1.013 0 N-CA-C 109.192 -1.563 . . . . 3.4100000000000001 109.192 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.38 152.13 51.58 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 125.142 2.401 . . . . 18.219999999999999 110.435 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 164.56 22.85 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 111.797 -2.456 . . . . 5.9299999999999997 106.384 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.08 -20.54 40.39 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.242 -3.411 . . . . 12.33 117.684 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -87.75 5.29 40.67 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 119.659 -1.901 . . . . 7.1900000000000004 113.885 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.22 69.72 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-O 123.966 1.87 . . . . 6.4699999999999998 113.684 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.65 124.2 22.2 Favored 'General case' 0 N--CA 1.438 -1.045 0 O-C-N 116.678 -3.836 . . . . 21.859999999999999 110.593 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.81 130.81 37.14 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 107.477 -1.305 . . . . 16.18 107.477 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -107.62 -17.88 13.98 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.041 -1.064 . . . . 5.7300000000000004 110.913 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.68 155.5 3.3 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 118.16 -0.924 . . . . 6.1299999999999999 110.504 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.85 128.16 5.55 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.451 1.101 . . . . 2.9300000000000002 110.328 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.6 p -75.97 -20.59 57.77 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.827 -0.749 . . . . 2.2999999999999998 109.052 175.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.86 -36.54 84.25 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.639 -1.615 . . . . 10.550000000000001 106.639 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -67.74 -28.4 67.6 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.219 -1.551 . . . . 8.0199999999999996 110.819 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.57 -10.22 49.56 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 120.767 -1.208 . . . . 10.210000000000001 112.436 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.63 34.21 24.1 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 123.286 1.517 . . . . 16.379999999999999 110.908 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -139.71 120.18 9.34 Favored Pre-proline 0 C--N 1.315 -0.931 0 O-C-N 117.632 -3.168 . . . . 20.210000000000001 103.894 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.3 152.4 60.74 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 124.23 3.287 . . . . 8.75 110.318 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -96.05 138.09 34.17 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.505 -1.665 . . . . 4.6500000000000004 106.505 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -111.51 136.85 50.12 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 120.521 1.51 . . . . 10.619999999999999 111.367 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -142.57 150.62 40.6 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 120.513 1.506 . . . . 4.3099999999999996 107.457 169.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.444 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.46 126.69 37.65 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.348 1.431 . . . . 2.6699999999999999 110.613 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.96 129.91 42.44 Favored 'General case' 0 N--CA 1.428 -1.536 0 O-C-N 125.265 1.603 . . . . 3.0800000000000001 110.624 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.04 -4.27 84.69 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 115.603 -0.726 . . . . 4.9500000000000002 114.035 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.4 tttt -83.99 -3.13 57.78 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.735 -1.45 . . . . 10.26 114.566 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.52 39.53 6.73 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.156 -1.59 . . . . 10.24 113.836 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.76 13.69 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.69 1.367 . . . . 10.56 114.69 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.34 172.65 9.25 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 108.173 -1.047 . . . . 2.4500000000000002 108.173 171.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.82 152.1 8.35 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.987 1.375 . . . . 5.5700000000000003 109.803 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.27 -35.77 67.81 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.362 -1.29 . . . . 19.109999999999999 114.473 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.71 -23.34 72.3 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 123.254 2.752 . . . . 2.9300000000000002 112.373 177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -74.52 -54.63 7.15 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.552 1.176 . . . . 7.96 111.628 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.03 -44.4 15.19 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 124.007 1.86 . . . . 15.050000000000001 111.453 173.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.38 -35.4 47.36 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.637 -1.165 . . . . 20.27 114.001 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.02 -45.64 6.22 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 119.451 -1.357 . . . . 4.04 114.668 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.53 -27.23 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 119.125 -1.03 . . . . 5.3499999999999996 109.414 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.93 -18.88 64.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.498 -2.626 . . . . 3.0299999999999998 112.386 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.4 0.2 50.34 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 118.401 -0.809 . . . . 3.4900000000000002 113.083 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.623 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.8 mtp -107.72 143.07 36.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 120.81 1.641 . . . . 3.75 109.557 -171.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.4 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.8 p -94.78 155.05 16.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.706 0.802 . . . . 2.2999999999999998 109.771 174.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.3 t -57.66 130.1 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 119.835 1.198 . . . . 2.4700000000000002 109.795 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.41 52.01 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 113.309 -1.769 . . . . 2.6099999999999999 113.041 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.623 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.4 144.74 28.6 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 121.874 0.845 . . . . 6.5300000000000002 112.608 -171.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.97 123.98 41.58 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 102.671 -3.085 . . . . 12.359999999999999 102.671 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.71 44.99 Favored 'General case' 0 C--O 1.243 0.726 0 O-C-N 126.408 2.318 . . . . 5.8399999999999999 114.261 -176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.35 122.52 43.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.564 1.649 . . . . 16.57 108.584 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.07 114.56 28.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 118.825 -2.422 . . . . 5.8600000000000003 106.76 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -98.69 120.39 39.04 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 105.814 -1.921 . . . . 5.7599999999999998 105.814 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.55 122.63 69.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.733 -0.84 . . . . 3.3599999999999999 108.733 -167.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.36 153.97 91.59 Favored Pre-proline 0 C--O 1.243 0.738 0 CA-C-O 117.958 -1.02 . . . . 4.9400000000000004 110.632 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.33 -35.09 90.82 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.263 2.642 . . . . 6.21 114.85 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.13 -13.76 62.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.784 1.031 . . . . 15.85 113.784 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.67 10.84 36.62 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 126.145 1.778 . . . . 11.52 111.809 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.64 -116.52 0.16 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 105.763 -1.94 . . . . 3.7000000000000002 105.763 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -102.51 3.91 38.04 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 122.045 2.202 . . . . 6.8399999999999999 115.502 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.48 -137.08 50.51 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-O 123.679 1.711 . . . . 5.9900000000000002 111.101 172.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.2 -18.8 41.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 111.708 -2.246 . . . . 10.109999999999999 111.071 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.26 -43.93 63.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.048 1.749 . . . . 13.76 112.61 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.22 -169.2 53.29 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 107.746 -2.141 . . . . 9.9800000000000004 107.746 -170.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.82 114.81 35.39 Favored Pre-proline 0 C--O 1.246 0.913 0 O-C-N 118.048 -3.031 . . . . 15.880000000000001 103.252 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -48.17 122.44 7.47 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 124.682 3.588 . . . . 11.41 110.933 -166.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.15 -26.95 3.21 Favored Glycine 0 CA--C 1.547 2.044 0 CA-C-N 111.865 -2.425 . . . . 14.199999999999999 117.389 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.88 -50.04 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 121.14 2.47 . . . . 11.06 115.045 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.6 mm -112.87 131.89 22.55 Favored Pre-proline 0 CA--C 1.516 -0.334 0 N-CA-C 103.19 -2.893 . . . . 8.0099999999999998 103.19 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.0 163.04 35.44 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.268 3.978 . . . . 6.5199999999999996 112.969 171.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 12.9 Cg_exo -55.28 144.5 71.1 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.578 2.185 . . . . 4.8200000000000003 110.31 162.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.13 27.34 16.47 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 112.9 -1.954 . . . . 7.4199999999999999 113.692 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.78 132.42 35.28 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 117.409 2.374 . . . . 2.2200000000000002 117.409 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.53 132.36 35.66 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 121.698 2.045 . . . . 4.6100000000000003 106.382 168.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -108.84 146.72 33.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 120.423 -1.423 . . . . 5.3399999999999999 110.318 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.1 120.11 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 103.729 -2.693 . . . . 3.9700000000000002 103.729 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 101' ' ' VAL . 48.9 m-85 -116.83 136.91 52.58 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.768 -1.208 . . . . 4.4199999999999999 109.539 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 33.0 t0 -103.74 112.73 25.81 Favored 'General case' 0 C--N 1.315 -0.917 1 N-CA-C 98.96 -4.459 . . . . 2.0899999999999999 98.96 173.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 99' ' ' PHE . 86.9 t -126.78 132.29 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.045 -1.434 . . . . 3.5299999999999998 110.844 -172.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -120.47 121.91 39.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.485 -2.043 . . . . 14.210000000000001 105.485 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 tp -89.09 109.2 20.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 123.659 1.695 . . . . 2.4199999999999999 107.434 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.4 mt -85.65 -43.24 13.61 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 115.128 1.529 . . . . 2.6200000000000001 115.128 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -161.9 153.56 18.79 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 113.565 -1.652 . . . . 11.710000000000001 109.151 -167.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.8 mt -120.06 133.26 55.58 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 105.153 -2.166 . . . . 4.7000000000000002 105.153 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 113.505 -1.679 . . . . 13.02 109.711 -179.726 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 105.992 -2.843 . . . . 6.3300000000000001 105.992 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.42 142.51 43.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 101.754 -3.424 . . . . 6.3499999999999996 101.754 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -116.94 130.14 56.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 102.844 -3.021 . . . . 16.98 102.844 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.56 117.02 53.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 N-CA-C 103.692 -2.707 . . . . 5.5800000000000001 103.692 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.66 124.68 46.87 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 118.946 -2.346 . . . . 12.800000000000001 104.824 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.9 m -75.66 139.83 42.21 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.234 -2.166 . . . . 3.2400000000000002 115.624 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.42 -52.09 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 105.935 -1.876 . . . . 4.79 105.935 171.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.6 m -138.89 139.02 22.42 Favored Pre-proline 0 C--O 1.243 0.737 0 O-C-N 119.622 -1.924 . . . . 11.59 106.275 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.4 Cg_exo -67.69 154.77 72.41 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 123.538 2.825 . . . . 4.5499999999999998 112.194 -176.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.63 -161.16 28.94 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.169 -1.573 . . . . 2.0 109.169 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -82.41 -9.2 59.54 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 117.645 -3.268 . . . . 3.2400000000000002 113.188 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.01 9.78 76.67 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.654 -1.637 . . . . 3.3799999999999999 113.886 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -137.72 -26.57 0.96 Allowed 'General case' 0 C--O 1.241 0.631 0 CA-C-N 122.567 3.183 . . . . 26.59 114.251 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.54 93.96 4.95 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 119.08 -2.262 . . . . 3.02 109.544 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -104.22 142.52 24.78 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 124.969 1.418 . . . . 4.7000000000000002 109.84 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.59 146.75 68.48 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.738 2.292 . . . . 2.9399999999999999 110.636 -173.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.49 156.13 33.46 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.918 -1.492 . . . . 15.960000000000001 107.053 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.07 130.25 29.49 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 124.169 1.938 . . . . 11.69 112.819 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.24 -14.01 65.88 Favored Glycine 0 N--CA 1.421 -2.307 0 O-C-N 120.021 -1.674 . . . . 3.6299999999999999 112.845 -178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.4 25.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 120.047 1.924 . . . . 5.9000000000000004 112.396 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.94 120.37 31.1 Favored 'General case' 0 C--O 1.25 1.101 0 O-C-N 125.305 1.628 . . . . 3.0699999999999998 111.734 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.9 m -93.5 131.04 39.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.649 1.214 . . . . 4.1100000000000003 109.856 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.02 111.38 35.92 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 N-CA-C 101.607 -3.479 . . . . 2.1600000000000001 101.607 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.53 154.44 40.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.842 0.829 . . . . 3.5899999999999999 112.242 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.14 145.44 30.56 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.259 -2.126 . . . . 3.1299999999999999 105.259 164.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.2 p90 -145.85 156.06 43.31 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 120.177 1.353 . . . . 2.5499999999999998 111.928 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.77 121.55 22.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 102.968 -2.975 . . . . 4.4699999999999998 102.968 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.24 131.96 10.77 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 109.198 -1.561 . . . . 3.4100000000000001 109.198 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.43 152.18 51.59 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 125.238 2.447 . . . . 18.219999999999999 110.391 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.56 164.58 22.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.694 -2.503 . . . . 5.9299999999999997 106.444 172.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.03 -20.64 40.5 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.16 -3.462 . . . . 12.33 117.624 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -87.7 5.34 40.29 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 119.634 -1.916 . . . . 7.1900000000000004 113.918 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.15 -10.23 69.82 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-O 124.009 1.894 . . . . 6.4699999999999998 113.719 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.56 124.19 22.13 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 116.616 -3.873 . . . . 21.859999999999999 110.554 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.89 130.77 37.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.415 -1.328 . . . . 16.18 107.415 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -107.67 -17.77 14.0 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.076 -1.05 . . . . 5.7300000000000004 110.811 173.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.77 155.36 3.19 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 118.121 -0.942 . . . . 6.1299999999999999 110.564 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.6 t -158.74 128.14 5.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.462 1.105 . . . . 2.9300000000000002 110.341 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.3 p -75.94 -20.65 57.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.006 -0.738 . . . . 2.2999999999999998 109.006 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.71 -36.65 84.57 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.698 -1.593 . . . . 10.550000000000001 106.698 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -67.64 -28.42 67.7 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.205 -1.559 . . . . 8.0199999999999996 110.906 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtm-85 -88.65 -10.03 50.03 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.859 -1.15 . . . . 10.210000000000001 112.411 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.46 34.29 24.02 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 123.329 1.538 . . . . 16.379999999999999 110.996 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -139.73 120.27 9.35 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 117.722 -3.111 . . . . 20.210000000000001 103.806 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -59.39 152.35 61.7 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 124.204 3.27 . . . . 8.75 110.294 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -95.99 138.15 34.03 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.47 -1.678 . . . . 4.6500000000000004 106.47 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.62 136.86 50.27 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.49 1.495 . . . . 10.619999999999999 111.316 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.6 150.62 40.56 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 120.424 1.465 . . . . 4.3099999999999996 107.372 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.444 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.48 126.63 37.65 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 120.31 1.414 . . . . 2.6699999999999999 110.583 172.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.83 129.77 41.91 Favored 'General case' 0 N--CA 1.427 -1.576 0 O-C-N 125.198 1.561 . . . . 3.0800000000000001 110.742 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.96 -4.04 84.75 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 123.874 0.75 . . . . 4.9500000000000002 113.968 176.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.12 -3.11 57.88 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 120.707 -1.467 . . . . 10.26 114.62 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.59 39.53 6.56 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.129 -1.607 . . . . 10.24 113.8 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.36 -0.84 13.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 114.701 1.371 . . . . 10.56 114.701 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.39 172.65 9.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 N-CA-C 108.078 -1.082 . . . . 2.4500000000000002 108.078 171.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.75 152.07 8.39 Favored 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.946 1.355 . . . . 5.5700000000000003 109.782 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.25 -35.85 67.87 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 114.327 -1.306 . . . . 19.109999999999999 114.393 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.65 -23.33 72.21 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-N 123.338 2.79 . . . . 2.9300000000000002 112.496 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.57 -54.62 7.13 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 118.49 1.145 . . . . 7.96 111.665 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.01 -44.45 15.12 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 123.982 1.848 . . . . 15.050000000000001 111.431 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.35 -35.31 47.65 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.531 -1.213 . . . . 20.27 114.06 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.98 -45.68 6.22 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 119.547 -1.311 . . . . 4.04 114.67 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.62 -27.15 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 O-C-N 121.382 -1.07 . . . . 5.3499999999999996 109.419 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.83 64.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.57 -2.581 . . . . 3.0299999999999998 112.35 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.49 0.36 50.02 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.107 0.78 . . . . 3.4900000000000002 113.107 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.624 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.7 mtp -107.9 143.08 37.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 120.786 1.63 . . . . 3.75 109.492 -171.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.402 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.8 p -94.82 155.04 16.97 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.604 0.762 . . . . 2.2999999999999998 109.786 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.72 130.27 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 119.917 1.235 . . . . 2.4700000000000002 109.757 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 -12.63 52.12 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 113.289 -1.778 . . . . 2.6099999999999999 113.056 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.624 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.42 144.79 28.55 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.915 0.864 . . . . 6.5300000000000002 112.558 -171.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -124.02 123.96 41.52 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 102.619 -3.104 . . . . 12.359999999999999 102.619 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.86 156.81 45.0 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.518 2.386 . . . . 5.8399999999999999 114.307 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.3 122.5 43.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.516 1.627 . . . . 16.57 108.587 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.1 114.48 28.65 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 118.822 -2.424 . . . . 5.8600000000000003 106.737 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.4 m -98.8 120.42 39.2 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 105.853 -1.906 . . . . 5.7599999999999998 105.853 176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.63 122.58 69.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 108.683 -0.858 . . . . 3.3599999999999999 108.683 -167.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.38 153.95 91.7 Favored Pre-proline 0 C--O 1.244 0.777 0 CA-C-O 117.826 -1.083 . . . . 4.9400000000000004 110.731 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.3 -35.14 90.75 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.328 2.685 . . . . 6.21 114.754 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.06 -13.9 62.43 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.883 1.068 . . . . 15.85 113.883 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.67 11.04 36.51 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 126.088 1.755 . . . . 11.52 111.74 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.76 -116.51 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.765 -1.939 . . . . 3.7000000000000002 105.765 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.64 4.15 37.96 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-N 121.99 2.177 . . . . 6.8399999999999999 115.48 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.44 -137.13 50.43 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-O 123.745 1.747 . . . . 5.9900000000000002 111.038 171.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.66 41.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 111.624 -2.288 . . . . 10.109999999999999 110.972 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.37 -43.89 63.36 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 121.093 1.77 . . . . 13.76 112.581 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.32 -169.27 53.3 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 107.607 -2.197 . . . . 9.9800000000000004 107.607 -170.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.8 114.85 35.39 Favored Pre-proline 0 C--O 1.246 0.882 0 O-C-N 118.04 -3.036 . . . . 15.880000000000001 103.292 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -48.16 122.43 7.43 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 124.61 3.54 . . . . 11.41 110.909 -166.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.19 -26.94 3.23 Favored Glycine 0 CA--C 1.547 2.038 0 CA-C-N 111.881 -2.418 . . . . 14.199999999999999 117.4 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.2 mt -102.84 -50.1 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.05 2.425 . . . . 11.06 114.992 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.7 mm -112.83 131.99 22.5 Favored Pre-proline 0 CA--C 1.516 -0.343 0 N-CA-C 103.159 -2.904 . . . . 8.0099999999999998 103.159 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.09 163.08 35.44 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 125.218 3.945 . . . . 6.5199999999999996 112.871 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.3 144.47 71.37 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.518 2.146 . . . . 4.8200000000000003 110.307 162.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.31 27.24 16.29 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 112.886 -1.961 . . . . 7.4199999999999999 113.609 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.8 132.29 35.28 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 117.36 2.356 . . . . 2.2200000000000002 117.36 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.44 132.34 35.71 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 121.686 2.039 . . . . 4.6100000000000003 106.347 168.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.7 mt -108.81 146.87 32.94 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 120.451 -1.405 . . . . 5.3399999999999999 110.274 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.19 119.97 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 103.779 -2.674 . . . . 3.9700000000000002 103.779 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 101' ' ' VAL . 49.2 m-85 -116.79 137.05 52.48 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.734 -1.229 . . . . 4.4199999999999999 109.519 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.6 t0 -103.92 112.74 25.84 Favored 'General case' 0 C--N 1.315 -0.928 1 N-CA-C 98.875 -4.491 . . . . 2.0899999999999999 98.875 174.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 99' ' ' PHE . 86.9 t -126.79 132.37 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.077 -1.42 . . . . 3.5299999999999998 110.794 -172.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.52 121.84 39.32 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.509 -2.034 . . . . 14.210000000000001 105.509 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 tp -88.95 109.06 19.92 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.536 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.46 -43.31 13.7 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.193 1.553 . . . . 2.6200000000000001 115.193 -171.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -161.85 153.56 18.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 113.534 -1.666 . . . . 11.710000000000001 109.131 -167.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.2 mt -119.98 133.19 55.63 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 105.19 -2.152 . . . . 4.7000000000000002 105.19 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.589 -1.642 . . . . 13.02 109.884 -179.828 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 N-CA-C 106.07 -2.812 . . . . 6.3300000000000001 106.07 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.26 142.58 43.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 101.723 -3.436 . . . . 6.3499999999999996 101.723 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.11 130.01 56.35 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.776 -3.046 . . . . 16.98 102.776 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.3 t -109.44 117.07 53.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 103.771 -2.677 . . . . 5.5800000000000001 103.771 -175.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.61 124.69 46.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 118.863 -2.398 . . . . 12.800000000000001 104.83 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.8 m -75.72 139.97 42.19 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 119.313 -2.117 . . . . 3.2400000000000002 115.643 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.41 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.58 -52.05 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 105.84 -1.911 . . . . 4.79 105.84 171.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.4 m -138.85 139.11 22.82 Favored Pre-proline 0 C--O 1.244 0.77 0 O-C-N 119.647 -1.908 . . . . 11.59 106.305 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.3 Cg_exo -67.71 154.75 72.41 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 123.634 2.889 . . . . 4.5499999999999998 112.174 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.7 -161.22 28.88 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.09 -1.604 . . . . 2.0 109.09 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.43 -9.15 59.55 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 117.708 -3.231 . . . . 3.2400000000000002 113.205 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.09 9.73 76.87 Favored Glycine 0 C--O 1.218 -0.851 0 CA-C-O 117.647 -1.641 . . . . 3.3799999999999999 113.884 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -137.72 -26.62 0.96 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.576 3.188 . . . . 26.59 114.251 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.52 94.04 4.99 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 119.111 -2.243 . . . . 3.02 109.503 -175.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.18 142.53 24.8 Favored Pre-proline 0 C--O 1.252 1.204 0 O-C-N 125.016 1.448 . . . . 4.7000000000000002 109.867 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.5 Cg_endo -68.67 146.78 68.13 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.715 2.277 . . . . 2.9399999999999999 110.588 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.52 156.16 33.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.866 -1.516 . . . . 15.960000000000001 107.026 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.4 ttp180 -52.07 130.25 29.49 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 124.169 1.938 . . . . 11.69 112.819 174.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.33 -14.14 65.6 Favored Glycine 0 N--CA 1.422 -2.246 0 O-C-N 120.021 -1.674 . . . . 3.6299999999999999 112.755 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.37 25.17 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 120.066 1.933 . . . . 5.9000000000000004 112.357 174.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.85 120.31 30.98 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.249 1.593 . . . . 3.0699999999999998 111.684 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.53 130.99 39.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 122.65 1.214 . . . . 4.1100000000000003 109.86 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.92 111.39 35.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 N-CA-C 101.643 -3.465 . . . . 2.1600000000000001 101.643 -174.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.9 m -129.5 154.39 40.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-O 121.822 0.82 . . . . 3.5899999999999999 112.242 -172.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.06 145.43 30.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.22 -2.141 . . . . 3.1299999999999999 105.22 164.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.1 p90 -145.81 156.1 43.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 120.18 1.355 . . . . 2.5499999999999998 111.967 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.76 121.49 21.95 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 103.024 -2.954 . . . . 4.4699999999999998 103.024 167.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.13 131.87 10.74 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 109.251 -1.54 . . . . 3.4100000000000001 109.251 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.4 152.12 51.6 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 125.242 2.449 . . . . 18.219999999999999 110.391 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 164.59 22.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.707 -2.497 . . . . 5.9299999999999997 106.444 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -57.97 -20.65 39.72 Favored 'General case' 0 C--O 1.22 -0.469 0 O-C-N 117.197 -3.439 . . . . 12.33 117.737 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.75 5.44 39.95 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 119.642 -1.911 . . . . 7.1900000000000004 113.894 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.03 -10.26 70.07 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 123.956 1.864 . . . . 6.4699999999999998 113.807 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.53 124.23 22.24 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 116.803 -3.763 . . . . 21.859999999999999 110.556 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.89 130.84 37.11 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.403 -1.332 . . . . 16.18 107.403 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.67 -17.84 13.99 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.07 -1.052 . . . . 5.7300000000000004 110.809 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.77 155.43 3.22 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.153 -0.927 . . . . 6.1299999999999999 110.567 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -158.81 128.13 5.57 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.527 1.131 . . . . 2.9300000000000002 110.345 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.4 p -75.97 -20.65 57.73 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.977 -0.749 . . . . 2.2999999999999998 108.977 175.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.68 84.65 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.685 -1.598 . . . . 10.550000000000001 106.685 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -67.58 -28.57 67.87 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.215 -1.553 . . . . 8.0199999999999996 110.809 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.6 -10.12 49.81 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.9 -1.125 . . . . 10.210000000000001 112.368 176.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.62 34.22 24.11 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.349 1.547 . . . . 16.379999999999999 110.95 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -139.73 120.18 9.32 Favored Pre-proline 0 C--N 1.315 -0.934 0 O-C-N 117.627 -3.171 . . . . 20.210000000000001 103.882 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -59.24 152.27 61.32 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 124.274 3.316 . . . . 8.75 110.326 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -95.93 138.22 33.88 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.566 -1.642 . . . . 4.6500000000000004 106.566 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.72 136.87 50.38 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 120.584 1.538 . . . . 10.619999999999999 111.244 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.63 150.71 40.62 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 120.397 1.453 . . . . 4.3099999999999996 107.28 169.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.443 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.41 126.64 37.58 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 120.243 1.383 . . . . 2.6699999999999999 110.584 172.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 129.81 42.03 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.288 1.617 . . . . 3.0800000000000001 110.719 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.0 -4.12 84.73 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 123.865 0.745 . . . . 4.9500000000000002 114.009 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.1 -3.09 57.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.752 -1.44 . . . . 10.26 114.561 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 64.52 39.57 6.7 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 120.081 -1.637 . . . . 10.24 113.808 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.37 -0.82 13.69 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 114.684 1.365 . . . . 10.56 114.684 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.35 172.65 9.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 108.09 -1.078 . . . . 2.4500000000000002 108.09 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.79 152.04 8.38 Favored 'Isoleucine or valine' 0 C--O 1.259 1.567 0 CA-C-O 122.974 1.368 . . . . 5.5700000000000003 109.855 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.22 -35.8 67.74 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 114.442 1.275 . . . . 19.109999999999999 114.442 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.67 -23.35 72.24 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.351 2.796 . . . . 2.9300000000000002 112.415 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.58 -54.58 7.19 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 118.574 1.187 . . . . 7.96 111.643 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.0 -44.43 15.09 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 124.02 1.867 . . . . 15.050000000000001 111.514 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.36 -35.29 47.63 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.495 -1.23 . . . . 20.27 114.037 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.06 -45.73 6.17 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.571 -1.299 . . . . 4.04 114.6 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.6 t -67.46 -27.23 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 121.378 -1.072 . . . . 5.3499999999999996 109.495 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.83 64.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.506 -2.621 . . . . 3.0299999999999998 112.35 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.48 0.28 50.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.489 -0.767 . . . . 3.4900000000000002 113.057 175.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.623 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.8 mtp -107.83 143.03 36.97 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 120.831 1.65 . . . . 3.75 109.555 -171.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.402 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.9 p -94.73 155.06 17.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.692 0.797 . . . . 2.2999999999999998 109.822 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.7 130.19 20.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 119.91 1.232 . . . . 2.4700000000000002 109.734 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.54 52.07 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.333 -1.758 . . . . 2.6099999999999999 112.989 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.623 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.39 144.69 28.63 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-O 121.874 0.845 . . . . 6.5300000000000002 112.601 -171.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.9 ttt180 -123.93 123.9 41.43 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 102.677 -3.083 . . . . 12.359999999999999 102.677 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.78 45.0 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 126.442 2.339 . . . . 5.8399999999999999 114.322 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.21 122.45 43.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 123.465 1.602 . . . . 16.57 108.59 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.07 114.49 28.66 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 118.787 -2.445 . . . . 5.8600000000000003 106.775 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.7 m -98.78 120.42 39.19 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 105.772 -1.936 . . . . 5.7599999999999998 105.772 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.63 122.55 69.09 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 108.71 -0.848 . . . . 3.3599999999999999 108.71 -167.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.37 153.99 91.57 Favored Pre-proline 0 C--O 1.243 0.723 0 CA-C-O 117.934 -1.031 . . . . 4.9400000000000004 110.712 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.21 -35.26 90.61 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.374 2.716 . . . . 6.21 114.803 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.03 -13.87 62.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.883 1.068 . . . . 15.85 113.883 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.73 11.09 36.32 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 125.959 1.703 . . . . 11.52 111.671 175.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.82 -116.53 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.754 -1.943 . . . . 3.7000000000000002 105.754 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.61 4.1 37.98 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 122.025 2.193 . . . . 6.8399999999999999 115.511 -173.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.53 -137.12 50.5 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 123.728 1.738 . . . . 5.9900000000000002 111.048 171.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.22 -18.71 41.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 111.705 -2.247 . . . . 10.109999999999999 111.036 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.38 -43.97 63.22 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.076 1.762 . . . . 13.76 112.458 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.34 -169.19 53.39 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.693 -2.163 . . . . 9.9800000000000004 107.693 -170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.87 114.77 35.3 Favored Pre-proline 0 C--O 1.247 0.962 0 O-C-N 118.014 -3.05 . . . . 15.880000000000001 103.215 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -48.03 122.3 7.13 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 124.72 3.613 . . . . 11.41 110.928 -166.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.3 -27.05 3.26 Favored Glycine 0 CA--C 1.546 2.022 0 CA-C-N 111.961 -2.382 . . . . 14.199999999999999 117.388 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.1 mt -102.89 -50.04 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 121.022 2.411 . . . . 11.06 114.971 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.88 131.97 22.52 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 103.178 -2.897 . . . . 8.0099999999999998 103.178 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.18 163.11 35.49 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.198 3.932 . . . . 6.5199999999999996 112.859 171.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.27 144.51 70.91 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.476 2.117 . . . . 4.8200000000000003 110.357 162.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.28 27.21 16.3 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 112.969 -1.923 . . . . 7.4199999999999999 113.618 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.8 132.4 35.28 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 117.358 2.355 . . . . 2.2200000000000002 117.358 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.47 132.41 35.7 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 121.667 2.031 . . . . 4.6100000000000003 106.347 168.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.8 mt -108.94 146.76 33.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.414 -1.429 . . . . 5.3399999999999999 110.239 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.1 t -123.08 120.02 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 103.764 -2.68 . . . . 3.9700000000000002 103.764 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.445 ' HB3' HG22 ' A' ' 101' ' ' VAL . 48.9 m-85 -116.79 136.96 52.55 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.705 -1.247 . . . . 4.4199999999999999 109.553 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.7 t0 -103.81 112.69 25.75 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.853 -4.499 . . . . 2.0899999999999999 98.853 174.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 99' ' ' PHE . 87.5 t -126.79 132.28 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.092 -1.413 . . . . 3.5299999999999998 110.836 -172.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.38 121.89 39.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 105.563 -2.014 . . . . 14.210000000000001 105.563 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.08 109.02 19.92 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 123.653 1.692 . . . . 2.4199999999999999 107.494 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.46 -43.25 13.76 Favored 'General case' 0 C--O 1.254 1.293 0 N-CA-C 115.26 1.578 . . . . 2.6200000000000001 115.26 -171.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -161.8 153.62 19.08 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 113.501 -1.681 . . . . 11.710000000000001 109.248 -167.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.08 133.21 55.58 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 105.204 -2.147 . . . . 4.7000000000000002 105.204 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.568 -1.651 . . . . 13.02 109.761 -179.719 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 106.08 -2.808 . . . . 6.3300000000000001 106.08 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.33 142.58 43.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 101.707 -3.442 . . . . 6.3499999999999996 101.707 176.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -117.16 130.05 56.36 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 102.802 -3.036 . . . . 16.98 102.802 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.9 t -109.53 117.12 53.85 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 103.663 -2.717 . . . . 5.5800000000000001 103.663 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.66 124.65 46.81 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 118.871 -2.393 . . . . 12.800000000000001 104.839 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.8 m -75.66 139.9 42.24 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.28 -2.138 . . . . 3.2400000000000002 115.656 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.41 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.5 mt -101.51 -52.02 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.86 -1.904 . . . . 4.79 105.86 171.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.5 m -138.89 139.13 22.76 Favored Pre-proline 0 C--O 1.244 0.783 0 O-C-N 119.548 -1.97 . . . . 11.59 106.27 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.8 Cg_exo -67.86 154.84 71.93 Favored 'Trans proline' 0 C--N 1.329 -0.454 0 C-N-CA 123.546 2.83 . . . . 4.5499999999999998 112.196 -176.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.72 -161.14 28.85 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.102 -1.599 . . . . 2.0 109.102 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -82.43 -9.27 59.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 117.659 -3.26 . . . . 3.2400000000000002 113.165 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.07 9.77 76.86 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-O 117.71 -1.606 . . . . 3.3799999999999999 113.87 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.7 mtp85 -137.66 -26.66 0.96 Allowed 'General case' 0 C--O 1.241 0.608 0 CA-C-N 122.593 3.196 . . . . 26.59 114.305 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.59 94.04 4.99 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 119.039 -2.288 . . . . 3.02 109.435 -175.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.2 142.52 24.78 Favored Pre-proline 0 C--O 1.252 1.211 0 O-C-N 125.007 1.442 . . . . 4.7000000000000002 109.761 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.59 146.73 68.4 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.728 2.285 . . . . 2.9399999999999999 110.688 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.49 156.2 33.31 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.932 -1.485 . . . . 15.960000000000001 107.121 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.42 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.6 ttp180 -52.17 130.36 30.18 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 124.263 1.982 . . . . 11.69 112.765 174.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.21 -13.97 65.97 Favored Glycine 0 N--CA 1.424 -2.122 0 O-C-N 119.919 -1.738 . . . . 3.6299999999999999 112.734 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.24 149.42 25.09 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-N 120.123 1.961 . . . . 5.9000000000000004 112.381 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.85 120.28 30.95 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.146 1.529 . . . . 3.0699999999999998 111.799 174.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.9 m -93.43 131.02 39.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.485 1.136 . . . . 4.1100000000000003 109.878 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -112.03 111.47 36.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 101.624 -3.473 . . . . 2.1600000000000001 101.624 -174.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.3 m -129.63 154.39 40.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.866 0.841 . . . . 3.5899999999999999 112.193 -172.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 145.45 30.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.264 -2.124 . . . . 3.1299999999999999 105.264 164.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.84 156.09 43.34 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 120.128 1.331 . . . . 2.5499999999999998 111.9 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.6 m -133.83 121.63 22.07 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 102.88 -3.007 . . . . 4.4699999999999998 102.88 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.21 131.84 10.73 Favored Glycine 0 N--CA 1.471 0.999 0 N-CA-C 109.237 -1.545 . . . . 3.4100000000000001 109.237 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.31 152.2 51.5 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 125.277 2.465 . . . . 18.219999999999999 110.421 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.56 164.59 22.82 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.694 -2.503 . . . . 5.9299999999999997 106.444 172.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.08 -20.56 40.59 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 117.19 -3.444 . . . . 12.33 117.684 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -87.64 5.31 40.24 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 119.603 -1.936 . . . . 7.1900000000000004 113.956 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.17 -10.42 69.74 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-O 123.896 1.831 . . . . 6.4699999999999998 113.661 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.64 124.26 22.37 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 116.724 -3.809 . . . . 21.859999999999999 110.529 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.82 130.86 37.2 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 107.349 -1.352 . . . . 16.18 107.349 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.7 -17.84 13.98 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.099 -1.04 . . . . 5.7300000000000004 110.809 173.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.71 155.37 3.24 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 118.08 -0.962 . . . . 6.1299999999999999 110.605 176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -158.78 128.19 5.61 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.518 1.127 . . . . 2.9300000000000002 110.38 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.6 p -76.1 -20.51 57.61 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.757 -0.777 . . . . 2.2999999999999998 109.043 175.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.72 84.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.637 -1.616 . . . . 10.550000000000001 106.637 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.58 -28.56 67.87 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.247 -1.533 . . . . 8.0199999999999996 110.827 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.6 -10.12 49.81 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 120.906 -1.121 . . . . 10.210000000000001 112.368 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.56 34.2 23.98 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 123.382 1.563 . . . . 16.379999999999999 111.007 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -139.65 120.21 9.39 Favored Pre-proline 0 C--O 1.247 0.928 0 O-C-N 117.698 -3.126 . . . . 20.210000000000001 103.882 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.24 152.34 60.79 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 124.234 3.29 . . . . 8.75 110.43 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.478 ' CZ ' ' H32' ' A' ' 108' ' ' GPI . 84.9 t80 -95.95 138.17 33.97 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.518 -1.66 . . . . 4.6500000000000004 106.518 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.61 136.9 50.18 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 120.541 1.518 . . . . 10.619999999999999 111.313 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.67 150.71 40.55 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.458 1.481 . . . . 4.3099999999999996 107.308 169.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.443 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.5 126.68 37.69 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.304 1.411 . . . . 2.6699999999999999 110.549 172.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 129.84 42.14 Favored 'General case' 0 N--CA 1.426 -1.643 0 O-C-N 125.228 1.58 . . . . 3.0800000000000001 110.647 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.01 -4.19 84.73 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 123.806 0.717 . . . . 4.9500000000000002 114.035 176.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.7 tttt -84.13 -3.05 57.85 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.752 -1.44 . . . . 10.26 114.561 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.55 39.56 6.64 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 120.132 -1.605 . . . . 10.24 113.778 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.74 13.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 114.75 1.389 . . . . 10.56 114.75 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.42 172.67 9.31 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.057 -1.09 . . . . 2.4500000000000002 108.057 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.81 152.1 8.35 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.98 1.371 . . . . 5.5700000000000003 109.768 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.24 -35.88 67.88 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 114.343 -1.298 . . . . 19.109999999999999 114.386 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.62 -23.37 72.17 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-N 123.392 2.814 . . . . 2.9300000000000002 112.384 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.55 -54.65 7.09 Favored 'General case' 0 C--O 1.249 1.071 0 CA-C-N 118.559 1.179 . . . . 7.96 111.575 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.04 -44.39 15.26 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 124.026 1.87 . . . . 15.050000000000001 111.467 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.37 -35.29 47.54 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.544 -1.207 . . . . 20.27 114.065 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.06 -45.72 6.18 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.502 -1.332 . . . . 4.04 114.612 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.55 -27.09 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 O-C-N 121.383 -1.069 . . . . 5.3499999999999996 109.486 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.86 64.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.537 -2.602 . . . . 3.0299999999999998 112.398 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.54 0.41 49.98 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 118.456 -0.783 . . . . 3.4900000000000002 113.025 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.624 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.9 mtp -107.95 143.02 37.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 120.812 1.642 . . . . 3.75 109.436 -171.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.402 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 11.0 p -94.66 155.01 17.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.678 0.791 . . . . 2.2999999999999998 109.852 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.68 130.19 20.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 119.88 1.218 . . . . 2.4700000000000002 109.796 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.11 -12.53 52.28 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 113.35 -1.75 . . . . 2.6099999999999999 113.133 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.624 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.4 144.75 28.59 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.95 0.881 . . . . 6.5300000000000002 112.567 -171.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.99 123.92 41.44 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 102.576 -3.12 . . . . 12.359999999999999 102.576 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.8 156.73 45.01 Favored 'General case' 0 C--O 1.244 0.806 0 O-C-N 126.393 2.308 . . . . 5.8399999999999999 114.283 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.26 122.55 43.87 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 123.429 1.585 . . . . 16.57 108.671 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.15 114.49 28.65 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.859 -2.401 . . . . 5.8600000000000003 106.745 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.4 m -98.73 120.42 39.13 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 105.766 -1.939 . . . . 5.7599999999999998 105.766 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.5 mt -119.55 122.57 69.21 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 N-CA-C 108.712 -0.847 . . . . 3.3599999999999999 108.712 -167.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.43 153.93 91.85 Favored Pre-proline 0 C--O 1.244 0.807 0 CA-C-O 117.878 -1.058 . . . . 4.9400000000000004 110.676 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -55.16 -35.26 90.4 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.328 2.686 . . . . 6.21 114.829 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -69.99 -13.92 62.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.869 1.062 . . . . 15.85 113.869 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -103.69 11.05 36.44 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 126.051 1.74 . . . . 11.52 111.751 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.74 -116.39 0.16 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 105.808 -1.923 . . . . 3.7000000000000002 105.808 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.68 4.16 37.85 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 122.067 2.212 . . . . 6.8399999999999999 115.447 -173.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.42 -137.11 50.45 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 123.686 1.714 . . . . 5.9900000000000002 111.096 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.28 -18.8 41.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 111.738 -2.231 . . . . 10.109999999999999 110.932 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.26 -43.93 63.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.129 1.786 . . . . 13.76 112.547 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.23 -169.28 53.23 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 107.76 -2.136 . . . . 9.9800000000000004 107.76 -170.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.78 114.9 35.41 Favored Pre-proline 0 C--O 1.246 0.873 0 O-C-N 118.003 -3.057 . . . . 15.880000000000001 103.262 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -48.24 122.36 7.42 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.638 3.559 . . . . 11.41 110.939 -166.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.35 -27.07 3.28 Favored Glycine 0 CA--C 1.547 2.073 0 CA-C-N 111.788 -2.46 . . . . 14.199999999999999 117.374 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.8 mt -102.87 -50.05 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.041 2.421 . . . . 11.06 114.942 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.6 mm -112.9 131.83 22.6 Favored Pre-proline 0 CA--C 1.516 -0.334 0 N-CA-C 103.174 -2.899 . . . . 8.0099999999999998 103.174 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.07 163.03 35.6 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.259 3.973 . . . . 6.5199999999999996 112.865 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.33 144.55 71.39 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.392 2.061 . . . . 4.8200000000000003 110.321 162.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.35 27.21 16.25 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 112.878 -1.965 . . . . 7.4199999999999999 113.579 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.87 132.42 35.27 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 117.345 2.35 . . . . 2.2200000000000002 117.345 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -80.56 132.45 35.65 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 121.695 2.043 . . . . 4.6100000000000003 106.31 168.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.5 mt -108.82 146.79 33.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.321 -1.487 . . . . 5.3399999999999999 110.281 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.27 119.93 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 103.743 -2.688 . . . . 3.9700000000000002 103.743 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.445 ' HB3' HG22 ' A' ' 101' ' ' VAL . 49.0 m-85 -116.7 136.96 52.55 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.796 -1.19 . . . . 4.4199999999999999 109.596 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.76 112.67 25.72 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.874 -4.491 . . . . 2.0899999999999999 98.874 174.017 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 99' ' ' PHE . 86.5 t -126.72 132.3 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 114.206 -1.361 . . . . 3.5299999999999998 110.841 -172.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.44 121.91 39.56 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.578 -2.008 . . . . 14.210000000000001 105.578 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.02 109.07 19.95 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.498 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.5 -43.27 13.7 Favored 'General case' 0 C--O 1.253 1.28 0 N-CA-C 115.203 1.557 . . . . 2.6200000000000001 115.203 -171.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -161.82 153.63 19.03 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 113.509 -1.678 . . . . 11.710000000000001 109.167 -167.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.7 mt -120.04 133.17 55.61 Favored 'General case' 0 C--O 1.251 1.165 0 N-CA-C 105.25 -2.13 . . . . 4.7000000000000002 105.25 170.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.697 -1.592 . . . . 13.02 109.805 -179.746 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GPI . . . . . 0.478 ' H32' ' CZ ' ' A' ' 46' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.695 0 N-CA-C 106.067 -2.813 . . . . 6.3300000000000001 106.067 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.41 142.56 43.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 101.672 -3.455 . . . . 6.3499999999999996 101.672 176.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -117.13 130.16 56.44 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 102.682 -3.081 . . . . 16.98 102.682 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.4 t -109.51 117.01 53.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 103.737 -2.69 . . . . 5.5800000000000001 103.737 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.58 124.72 47.05 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 118.893 -2.379 . . . . 12.800000000000001 104.872 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.4 m -75.77 140.1 42.17 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 119.226 -2.171 . . . . 3.2400000000000002 115.55 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.41 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.67 -52.05 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 105.832 -1.914 . . . . 4.79 105.832 171.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.8 m -138.97 139.0 22.13 Favored Pre-proline 0 C--O 1.241 0.652 0 O-C-N 119.53 -1.981 . . . . 11.59 106.331 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 30.2 Cg_exo -67.67 154.85 72.22 Favored 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.501 2.801 . . . . 4.5499999999999998 112.125 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.84 -161.24 28.74 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 109.071 -1.611 . . . . 2.0 109.071 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.43 -9.1 59.57 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 117.674 -3.251 . . . . 3.2400000000000002 113.258 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.07 9.78 76.86 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.639 -1.645 . . . . 3.3799999999999999 113.793 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.7 mtp85 -137.7 -26.69 0.95 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-N 122.583 3.191 . . . . 26.59 114.244 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.44 94.08 5.02 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 119.049 -2.282 . . . . 3.02 109.503 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.24 142.55 24.85 Favored Pre-proline 0 C--O 1.252 1.211 0 O-C-N 124.963 1.414 . . . . 4.7000000000000002 109.799 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.549 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.6 146.74 68.41 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.754 2.303 . . . . 2.9399999999999999 110.6 -174.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.57 156.14 33.55 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.889 -1.505 . . . . 15.960000000000001 106.988 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.4 ttp180 -52.04 130.24 29.34 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 124.134 1.921 . . . . 11.69 112.709 174.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.36 -14.13 65.58 Favored Glycine 0 N--CA 1.423 -2.184 0 O-C-N 120.009 -1.682 . . . . 3.6299999999999999 112.762 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.16 149.32 25.2 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 120.085 1.943 . . . . 5.9000000000000004 112.242 174.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.8 m -89.83 120.25 30.91 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.283 1.614 . . . . 3.0699999999999998 111.806 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.2 m -93.55 131.04 39.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 122.716 1.246 . . . . 4.1100000000000003 109.813 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -112.0 111.41 36.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 101.593 -3.484 . . . . 2.1600000000000001 101.593 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.57 154.34 40.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-O 121.795 0.807 . . . . 3.5899999999999999 112.243 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.42 30.57 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.129 -2.174 . . . . 3.1299999999999999 105.129 164.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.0 p90 -145.74 156.11 43.4 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 120.003 1.274 . . . . 2.5499999999999998 112.02 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -133.81 121.53 21.94 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 102.968 -2.975 . . . . 4.4699999999999998 102.968 167.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.19 131.94 10.76 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 109.28 -1.528 . . . . 3.4100000000000001 109.28 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.4 152.18 51.57 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 125.259 2.457 . . . . 18.219999999999999 110.435 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 164.59 22.9 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 111.746 -2.479 . . . . 5.9299999999999997 106.38 172.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.16 -20.55 41.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 117.283 -3.385 . . . . 12.33 117.639 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.67 5.29 40.44 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.56 -1.962 . . . . 7.1900000000000004 113.906 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.16 -10.34 69.77 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-O 124.04 1.911 . . . . 6.4699999999999998 113.785 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.62 124.23 22.26 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 116.632 -3.864 . . . . 21.859999999999999 110.58 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.81 130.83 37.17 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.359 -1.348 . . . . 16.18 107.359 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -107.76 -17.76 14.0 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 118.998 -1.081 . . . . 5.7300000000000004 110.799 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -172.71 155.5 3.28 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 118.093 -0.956 . . . . 6.1299999999999999 110.652 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.87 128.08 5.51 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.428 1.091 . . . . 2.9300000000000002 110.314 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.2 p -75.83 -20.75 57.91 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 119.866 -0.733 . . . . 2.2999999999999998 109.117 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.63 -36.65 84.53 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.754 -1.573 . . . . 10.550000000000001 106.754 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.61 -28.5 67.8 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.253 -1.529 . . . . 8.0199999999999996 110.807 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.6 mtm-85 -88.72 -9.98 50.02 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 120.914 -1.116 . . . . 10.210000000000001 112.403 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.54 34.21 23.98 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 123.316 1.531 . . . . 16.379999999999999 111.034 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -139.7 120.24 9.37 Favored Pre-proline 0 C--N 1.315 -0.934 0 O-C-N 117.645 -3.16 . . . . 20.210000000000001 103.879 178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.27 152.3 61.28 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.269 3.313 . . . . 8.75 110.402 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.444 ' CE2' ' H32' ' A' ' 108' ' ' GPI . 85.1 t80 -95.89 138.12 33.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.534 -1.654 . . . . 4.6500000000000004 106.534 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -111.64 136.87 50.27 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.496 1.498 . . . . 10.619999999999999 111.285 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.67 150.69 40.53 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 120.397 1.453 . . . . 4.3099999999999996 107.366 169.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.442 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.39 126.62 37.56 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-N 120.244 1.384 . . . . 2.6699999999999999 110.617 172.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.89 129.81 42.05 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 125.217 1.573 . . . . 3.0800000000000001 110.68 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.98 -4.13 84.76 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.605 -0.725 . . . . 4.9500000000000002 114.044 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.442 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.09 -3.06 57.81 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 120.823 -1.398 . . . . 10.26 114.679 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.48 39.6 6.75 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.117 -1.615 . . . . 10.24 113.775 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.31 -0.88 13.71 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 114.725 1.38 . . . . 10.56 114.725 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.37 172.62 9.32 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.085 -1.08 . . . . 2.4500000000000002 108.085 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.73 152.07 8.41 Favored 'Isoleucine or valine' 0 C--O 1.257 1.496 0 CA-C-O 122.937 1.351 . . . . 5.5700000000000003 109.851 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.25 -35.73 67.74 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.361 -1.29 . . . . 19.109999999999999 114.466 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.73 -23.34 72.35 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-N 123.383 2.81 . . . . 2.9300000000000002 112.389 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.53 -54.67 7.07 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.51 1.155 . . . . 7.96 111.633 173.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.0 -44.43 15.06 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.951 1.834 . . . . 15.050000000000001 111.461 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.36 -35.3 47.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.485 -1.234 . . . . 20.27 114.084 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.11 -45.63 6.19 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 119.471 -1.347 . . . . 4.04 114.615 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.53 -27.17 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 121.348 -1.089 . . . . 5.3499999999999996 109.425 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.06 -18.83 64.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 118.538 -2.601 . . . . 3.0299999999999998 112.378 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.5 0.31 50.24 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 118.439 -0.791 . . . . 3.4900000000000002 113.016 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.623 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.7 mtp -107.82 143.18 36.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 120.821 1.646 . . . . 3.75 109.524 -171.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.402 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.9 p -94.79 154.93 17.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.695 0.798 . . . . 2.2999999999999998 109.842 174.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.3 t -57.53 130.09 20.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 119.965 1.257 . . . . 2.4700000000000002 109.868 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.21 -12.44 51.93 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 113.422 -1.717 . . . . 2.6099999999999999 113.069 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.623 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.4 144.8 28.55 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.883 0.849 . . . . 6.5300000000000002 112.623 -171.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.9 ttt180 -124.05 124.02 41.63 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 102.588 -3.116 . . . . 12.359999999999999 102.588 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.81 44.99 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.421 2.326 . . . . 5.8399999999999999 114.303 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.28 122.45 43.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.47 1.605 . . . . 16.57 108.556 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.02 114.51 28.69 Favored 'General case' 0 N--CA 1.44 -0.975 0 O-C-N 118.864 -2.398 . . . . 5.8600000000000003 106.786 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.5 m -98.81 120.49 39.34 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 105.801 -1.925 . . . . 5.7599999999999998 105.801 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.6 mt -119.65 122.55 69.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 108.671 -0.862 . . . . 3.3599999999999999 108.671 -167.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.38 154.03 91.52 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-O 117.802 -1.094 . . . . 4.9400000000000004 110.655 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.4 -35.07 91.09 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.333 2.689 . . . . 6.21 114.761 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.13 -13.88 62.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.795 1.035 . . . . 15.85 113.795 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.68 11.03 36.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 126.004 1.722 . . . . 11.52 111.734 175.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.86 -116.55 0.15 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 105.72 -1.955 . . . . 3.7000000000000002 105.72 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.61 4.16 38.05 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 122.025 2.193 . . . . 6.8399999999999999 115.511 -173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.45 -137.16 50.41 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-O 123.769 1.761 . . . . 5.9900000000000002 111.131 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.33 -18.64 41.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 111.603 -2.299 . . . . 10.109999999999999 111.024 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.36 -43.9 63.35 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.04 1.745 . . . . 13.76 112.497 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.28 -169.16 53.38 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 107.641 -2.184 . . . . 9.9800000000000004 107.641 -170.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.89 114.83 35.23 Favored Pre-proline 0 C--O 1.246 0.899 0 O-C-N 118.128 -2.984 . . . . 15.880000000000001 103.198 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -48.14 122.43 7.41 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 124.622 3.548 . . . . 11.41 110.975 -166.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.18 -26.96 3.22 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.979 -2.373 . . . . 14.199999999999999 117.412 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.415 HD13 ' C11' ' A' ' 108' ' ' GPI . 60.0 mt -102.93 -50.02 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 121.102 2.451 . . . . 11.06 114.943 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.86 131.82 22.59 Favored Pre-proline 0 CA--C 1.516 -0.328 0 N-CA-C 103.233 -2.877 . . . . 8.0099999999999998 103.233 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.08 163.01 35.7 Favored 'Trans proline' 0 C--O 1.24 0.619 0 C-N-CA 125.229 3.953 . . . . 6.5199999999999996 112.909 171.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.27 144.49 71.08 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.547 2.165 . . . . 4.8200000000000003 110.275 162.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.26 27.26 16.34 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 112.886 -1.961 . . . . 7.4199999999999999 113.607 172.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.73 132.45 35.29 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.446 2.387 . . . . 2.2200000000000002 117.446 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -80.53 132.47 35.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.737 2.062 . . . . 4.6100000000000003 106.298 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.1 mt -108.99 146.69 33.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.469 -1.394 . . . . 5.3399999999999999 110.24 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.0 t -123.12 120.08 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 N-CA-C 103.657 -2.72 . . . . 3.9700000000000002 103.657 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 101' ' ' VAL . 49.2 m-85 -116.75 136.97 52.54 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.594 -1.316 . . . . 4.4199999999999999 109.608 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.5 t0 -103.8 112.65 25.7 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.911 -4.477 . . . . 2.0899999999999999 98.911 174.018 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 99' ' ' PHE . 88.0 t -126.77 132.4 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 114.194 -1.367 . . . . 3.5299999999999998 110.763 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.47 121.92 39.53 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.449 -2.056 . . . . 14.210000000000001 105.449 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.13 109.06 19.97 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 123.636 1.684 . . . . 2.4199999999999999 107.492 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.43 -43.33 13.71 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 115.193 1.553 . . . . 2.6200000000000001 115.193 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -161.78 153.59 19.06 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 113.475 -1.693 . . . . 11.710000000000001 109.153 -167.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.8 mt -120.01 133.24 55.6 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 105.186 -2.153 . . . . 4.7000000000000002 105.186 170.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.31 -1.141 0 CA-C-N 113.64 -1.618 . . . . 13.02 109.94 -179.848 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GPI . . . . . 0.444 ' H32' ' CE2' ' A' ' 46' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 106.096 -2.802 . . . . 6.3300000000000001 106.096 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.31 142.62 43.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 101.693 -3.447 . . . . 6.3499999999999996 101.693 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -117.13 130.12 56.42 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.736 -3.061 . . . . 16.98 102.736 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.57 117.2 54.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 103.58 -2.748 . . . . 5.5800000000000001 103.58 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.75 124.78 47.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 118.863 -2.398 . . . . 12.800000000000001 104.757 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.3 m -75.74 139.95 42.15 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 119.3 -2.125 . . . . 3.2400000000000002 115.646 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.41 HD12 HG22 ' A' ' 7' ' ' ILE . 91.2 mt -101.62 -51.94 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 105.837 -1.912 . . . . 4.79 105.837 171.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.4 m -138.94 138.9 22.03 Favored Pre-proline 0 C--O 1.242 0.684 0 O-C-N 119.603 -1.936 . . . . 11.59 106.347 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.9 Cg_exo -67.57 154.73 72.73 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.636 2.891 . . . . 4.5499999999999998 112.191 -176.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.7 -161.13 28.86 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 109.075 -1.61 . . . . 2.0 109.075 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -82.49 -9.22 59.52 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 117.618 -3.284 . . . . 3.2400000000000002 113.167 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.17 9.6 76.94 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-O 117.625 -1.653 . . . . 3.3799999999999999 113.81 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -137.63 -26.66 0.96 Allowed 'General case' 0 C--O 1.241 0.655 0 CA-C-N 122.703 3.252 . . . . 26.59 114.189 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.45 93.95 4.95 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 119.121 -2.237 . . . . 3.02 109.496 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.22 142.49 24.72 Favored Pre-proline 0 C--O 1.25 1.122 0 O-C-N 124.975 1.422 . . . . 4.7000000000000002 109.8 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.549 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.58 146.65 68.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.748 2.298 . . . . 2.9399999999999999 110.674 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.44 156.09 33.48 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.899 -1.5 . . . . 15.960000000000001 107.015 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.42 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.03 130.25 29.31 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 124.118 1.913 . . . . 11.69 112.797 174.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.22 -13.88 66.11 Favored Glycine 0 N--CA 1.422 -2.296 0 O-C-N 119.978 -1.701 . . . . 3.6299999999999999 112.694 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -86.24 149.41 25.1 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 120.094 1.947 . . . . 5.9000000000000004 112.253 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.92 120.21 30.94 Favored 'General case' 0 C--O 1.25 1.12 0 O-C-N 125.248 1.593 . . . . 3.0699999999999998 111.729 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.45 131.02 39.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.654 1.216 . . . . 4.1100000000000003 109.859 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.92 111.31 35.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 101.67 -3.456 . . . . 2.1600000000000001 101.67 -174.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.53 154.5 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 121.885 0.85 . . . . 3.5899999999999999 112.263 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.15 145.46 30.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 105.178 -2.156 . . . . 3.1299999999999999 105.178 164.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.2 p90 -145.8 156.11 43.37 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 120.124 1.329 . . . . 2.5499999999999998 111.988 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -133.77 121.64 22.16 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 102.948 -2.982 . . . . 4.4699999999999998 102.948 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.22 131.99 10.78 Favored Glycine 0 N--CA 1.472 1.041 0 N-CA-C 109.184 -1.566 . . . . 3.4100000000000001 109.184 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.5 152.09 51.68 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 125.269 2.462 . . . . 18.219999999999999 110.383 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.49 164.63 22.85 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.664 -2.516 . . . . 5.9299999999999997 106.454 172.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.07 -20.64 41.06 Favored 'General case' 0 C--O 1.219 -0.512 0 O-C-N 117.262 -3.399 . . . . 12.33 117.708 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.73 5.38 40.17 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.663 -1.898 . . . . 7.1900000000000004 113.893 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.24 -10.39 69.58 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-O 123.976 1.876 . . . . 6.4699999999999998 113.678 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.58 124.24 22.28 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 116.628 -3.866 . . . . 21.859999999999999 110.532 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.9 130.78 37.02 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.381 -1.341 . . . . 16.18 107.381 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -107.67 -17.89 13.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.021 -1.072 . . . . 5.7300000000000004 110.693 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -172.68 155.49 3.29 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 118.181 -0.914 . . . . 6.1299999999999999 110.509 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.82 128.15 5.57 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.451 1.101 . . . . 2.9300000000000002 110.361 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.1 p -76.0 -20.66 57.66 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.982 -0.748 . . . . 2.2999999999999998 108.982 175.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.7 -36.61 84.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.722 -1.585 . . . . 10.550000000000001 106.722 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.71 -28.42 67.65 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.197 -1.565 . . . . 8.0199999999999996 110.833 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.68 -10.08 49.75 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.89 -1.131 . . . . 10.210000000000001 112.361 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.48 34.31 24.07 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-O 123.4 1.571 . . . . 16.379999999999999 111.007 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -139.66 120.16 9.38 Favored Pre-proline 0 C--O 1.248 1.017 0 O-C-N 117.693 -3.129 . . . . 20.210000000000001 103.897 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -59.24 152.31 61.02 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 124.277 3.318 . . . . 8.75 110.383 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.427 ' CE2' ' H32' ' A' ' 108' ' ' GPI . 84.9 t80 -96.0 138.11 34.1 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.541 -1.652 . . . . 4.6500000000000004 106.541 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.62 136.87 50.24 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 120.539 1.518 . . . . 10.619999999999999 111.372 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.66 150.61 40.44 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.415 1.461 . . . . 4.3099999999999996 107.377 169.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.444 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.44 126.68 37.63 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.297 1.408 . . . . 2.6699999999999999 110.48 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.92 129.7 41.54 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 125.286 1.616 . . . . 3.0800000000000001 110.723 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.11 -4.22 84.56 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.879 0.752 . . . . 4.9500000000000002 113.989 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.05 -3.01 57.74 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.648 -1.501 . . . . 10.26 114.603 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.47 39.58 6.79 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.017 -1.677 . . . . 10.24 113.841 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.33 -0.84 13.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 114.736 1.384 . . . . 10.56 114.736 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.32 172.58 9.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 108.099 -1.074 . . . . 2.4500000000000002 108.099 171.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.71 152.07 8.42 Favored 'Isoleucine or valine' 0 C--O 1.259 1.567 0 CA-C-O 123.026 1.393 . . . . 5.5700000000000003 109.757 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.27 -35.73 67.79 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 114.391 -1.277 . . . . 19.109999999999999 114.432 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.86 -23.31 72.55 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.33 2.786 . . . . 2.9300000000000002 112.304 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.62 -54.61 7.13 Favored 'General case' 0 C--O 1.249 1.071 0 CA-C-N 118.616 1.208 . . . . 7.96 111.572 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.05 -44.35 15.27 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 123.983 1.849 . . . . 15.050000000000001 111.447 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.3 -35.42 47.91 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.541 -1.208 . . . . 20.27 114.093 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.03 -45.65 6.22 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 119.497 -1.335 . . . . 4.04 114.596 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.51 -27.28 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 O-C-N 121.37 -1.076 . . . . 5.3499999999999996 109.382 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.93 -18.88 64.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.688 -2.508 . . . . 3.0299999999999998 112.403 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.55 0.33 50.34 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 118.448 -0.787 . . . . 3.4900000000000002 112.985 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.624 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.9 mtp -107.89 143.02 37.09 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 120.791 1.632 . . . . 3.75 109.464 -171.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.402 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.8 p -94.78 155.01 17.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.625 0.77 . . . . 2.2999999999999998 109.762 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.62 130.17 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 119.841 1.2 . . . . 2.4700000000000002 109.858 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.58 52.07 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 113.272 -1.785 . . . . 2.6099999999999999 113.064 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.624 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.43 144.75 28.56 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 121.907 0.86 . . . . 6.5300000000000002 112.57 -171.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.97 123.93 41.47 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 102.671 -3.085 . . . . 12.359999999999999 102.671 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.8 44.99 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 126.4 2.313 . . . . 5.8399999999999999 114.273 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.23 122.53 43.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.516 1.627 . . . . 16.57 108.62 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.12 114.47 28.63 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 118.854 -2.404 . . . . 5.8600000000000003 106.728 -176.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -98.77 120.47 39.25 Favored 'General case' 0 C--O 1.247 0.925 0 N-CA-C 105.858 -1.905 . . . . 5.7599999999999998 105.858 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.72 122.62 69.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.653 -0.869 . . . . 3.3599999999999999 108.653 -167.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.36 154.08 91.34 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.861 -1.066 . . . . 4.9400000000000004 110.682 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -55.48 -35.12 91.59 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.298 2.665 . . . . 6.21 114.752 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.03 -13.84 62.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.922 1.082 . . . . 15.85 113.922 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.64 11.07 36.54 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 126.009 1.723 . . . . 11.52 111.674 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.9 -116.6 0.15 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 105.739 -1.949 . . . . 3.7000000000000002 105.739 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -102.59 4.11 38.04 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 122.07 2.214 . . . . 6.8399999999999999 115.498 -173.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.47 -137.09 50.49 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-O 123.739 1.744 . . . . 5.9900000000000002 111.136 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.69 41.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 111.686 -2.257 . . . . 10.109999999999999 111.009 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.47 -43.89 63.08 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 121.039 1.745 . . . . 13.76 112.464 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.39 -169.16 53.46 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 107.606 -2.197 . . . . 9.9800000000000004 107.606 -170.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.85 114.76 35.34 Favored Pre-proline 0 C--O 1.246 0.896 0 O-C-N 117.924 -3.103 . . . . 15.880000000000001 103.253 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.14 122.35 7.3 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 124.679 3.586 . . . . 11.41 110.936 -166.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.15 -26.85 3.24 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-N 111.933 -2.394 . . . . 14.199999999999999 117.385 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.419 HG21 ' C11' ' A' ' 108' ' ' GPI . 60.0 mt -102.99 -49.97 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 121.107 2.454 . . . . 11.06 114.938 -175.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.4 mm -112.84 131.87 22.56 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 103.118 -2.919 . . . . 8.0099999999999998 103.118 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.95 163.02 35.38 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 125.236 3.957 . . . . 6.5199999999999996 112.945 171.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.31 144.41 71.84 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.571 2.181 . . . . 4.8200000000000003 110.331 162.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.31 27.33 16.34 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 112.938 -1.937 . . . . 7.4199999999999999 113.577 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.79 132.31 35.28 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.388 2.366 . . . . 2.2200000000000002 117.388 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.37 132.42 35.77 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 121.799 2.091 . . . . 4.6100000000000003 106.349 168.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -109.0 146.79 33.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.379 -1.45 . . . . 5.3399999999999999 110.284 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.9 t -123.16 120.03 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 103.679 -2.711 . . . . 3.9700000000000002 103.679 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 101' ' ' VAL . 49.0 m-85 -116.8 137.02 52.5 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.701 -1.25 . . . . 4.4199999999999999 109.577 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.8 t0 -103.8 112.72 25.79 Favored 'General case' 0 C--N 1.314 -0.95 1 N-CA-C 98.876 -4.49 . . . . 2.0899999999999999 98.876 174.026 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 99' ' ' PHE . 87.7 t -126.75 132.43 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.153 -1.385 . . . . 3.5299999999999998 110.821 -172.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.48 121.93 39.56 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.466 -2.05 . . . . 14.210000000000001 105.466 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 tp -89.06 109.11 20.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.405 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.58 -43.25 13.66 Favored 'General case' 0 C--O 1.255 1.344 0 N-CA-C 115.19 1.552 . . . . 2.6200000000000001 115.19 -171.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -161.87 153.64 18.94 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 113.612 -1.631 . . . . 11.710000000000001 109.154 -167.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.9 mt -120.12 133.28 55.55 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 105.097 -2.186 . . . . 4.7000000000000002 105.097 170.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.311 -1.082 0 CA-C-N 113.552 -1.658 . . . . 13.02 109.82 -179.812 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GPI . . . . . 0.428 ' O7 ' ' C1 ' ' A' ' 108' ' ' GPI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 106.038 -2.825 . . . . 6.3300000000000001 106.038 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.28 142.6 43.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 101.745 -3.428 . . . . 6.3499999999999996 101.745 176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.12 130.07 56.39 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.726 -3.065 . . . . 16.98 102.726 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.57 117.11 53.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 N-CA-C 103.674 -2.713 . . . . 5.5800000000000001 103.674 -175.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.68 124.72 46.96 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 118.877 -2.389 . . . . 12.800000000000001 104.759 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.6 m -75.82 140.0 42.05 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.279 -2.138 . . . . 3.2400000000000002 115.603 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.54 -52.03 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 105.899 -1.889 . . . . 4.79 105.899 171.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.8 m -138.86 139.01 22.45 Favored Pre-proline 0 C--O 1.243 0.737 0 O-C-N 119.518 -1.989 . . . . 11.59 106.357 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.3 Cg_exo -67.69 154.73 72.51 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 123.627 2.885 . . . . 4.5499999999999998 112.23 -176.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.68 -161.22 28.9 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.09 -1.604 . . . . 2.0 109.09 175.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.54 -9.04 59.58 Favored 'General case' 0 C--O 1.241 0.628 0 O-C-N 117.639 -3.271 . . . . 3.2400000000000002 113.18 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.12 9.65 76.86 Favored Glycine 0 C--O 1.218 -0.887 0 CA-C-O 117.637 -1.646 . . . . 3.3799999999999999 113.874 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.7 mtp85 -137.62 -26.73 0.96 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 122.508 3.154 . . . . 26.59 114.241 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.4 93.98 4.97 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.072 -2.268 . . . . 3.02 109.579 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.21 142.54 24.82 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 125.023 1.452 . . . . 4.7000000000000002 109.79 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.58 146.75 68.59 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.704 2.269 . . . . 2.9399999999999999 110.702 -174.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.46 156.15 33.37 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.913 -1.494 . . . . 15.960000000000001 107.073 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.3 ttp180 -52.07 130.27 29.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 124.24 1.972 . . . . 11.69 112.804 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.29 -14.02 65.83 Favored Glycine 0 N--CA 1.422 -2.246 0 O-C-N 119.929 -1.732 . . . . 3.6299999999999999 112.757 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -86.24 149.47 25.05 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 120.029 1.915 . . . . 5.9000000000000004 112.243 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.2 m -89.97 120.29 31.05 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.312 1.633 . . . . 3.0699999999999998 111.746 174.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.46 131.0 39.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 122.55 1.167 . . . . 4.1100000000000003 109.891 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.96 111.39 35.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 101.624 -3.473 . . . . 2.1600000000000001 101.624 -174.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 m -129.48 154.42 40.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.806 0.812 . . . . 3.5899999999999999 112.282 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.4 30.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.187 -2.153 . . . . 3.1299999999999999 105.187 164.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.0 p90 -145.79 156.1 43.36 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 120.126 1.33 . . . . 2.5499999999999998 112.055 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -133.83 121.47 21.85 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 102.952 -2.981 . . . . 4.4699999999999998 102.952 167.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.11 131.87 10.73 Favored Glycine 0 N--CA 1.471 0.999 0 N-CA-C 109.248 -1.541 . . . . 3.4100000000000001 109.248 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.37 152.11 51.58 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 125.16 2.41 . . . . 18.219999999999999 110.481 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 164.64 22.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.745 -2.48 . . . . 5.9299999999999997 106.447 172.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -58.03 -20.62 40.37 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 117.17 -3.457 . . . . 12.33 117.699 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -87.74 5.32 40.52 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 119.545 -1.972 . . . . 7.1900000000000004 113.851 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.08 -10.2 69.96 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 124.013 1.896 . . . . 6.4699999999999998 113.789 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.7 124.27 22.41 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 116.688 -3.831 . . . . 21.859999999999999 110.564 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.84 130.78 37.07 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.404 -1.332 . . . . 16.18 107.404 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -107.67 -17.9 13.97 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.124 -1.03 . . . . 5.7300000000000004 110.667 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -172.76 155.4 3.21 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 118.087 -0.959 . . . . 6.1299999999999999 110.587 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -158.76 128.12 5.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.47 1.108 . . . . 2.9300000000000002 110.385 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.4 p -76.01 -20.67 57.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.937 -0.764 . . . . 2.2999999999999998 108.937 175.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.61 -36.74 84.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.742 -1.577 . . . . 10.550000000000001 106.742 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -67.55 -28.53 67.87 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.172 -1.58 . . . . 8.0199999999999996 110.807 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.68 -10.01 50.02 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 120.859 -1.15 . . . . 10.210000000000001 112.366 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.47 34.32 24.07 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-O 123.33 1.538 . . . . 16.379999999999999 110.945 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -139.76 120.14 9.29 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 117.594 -3.191 . . . . 20.210000000000001 103.887 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -59.22 152.27 61.14 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 124.231 3.288 . . . . 8.75 110.378 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.429 ' CE2' ' H32' ' A' ' 108' ' ' GPI . 84.9 t80 -95.91 138.24 33.83 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.58 -1.637 . . . . 4.6500000000000004 106.58 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.7 136.84 50.39 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 120.622 1.555 . . . . 10.619999999999999 111.311 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.61 150.71 40.66 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 120.466 1.485 . . . . 4.3099999999999996 107.337 169.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.444 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.51 126.72 37.72 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 120.313 1.415 . . . . 2.6699999999999999 110.563 172.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 129.8 41.92 Favored 'General case' 0 N--CA 1.426 -1.627 0 O-C-N 125.285 1.616 . . . . 3.0800000000000001 110.639 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.97 -4.18 84.77 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.901 0.762 . . . . 4.9500000000000002 114.009 176.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.03 -3.09 57.78 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.788 -1.419 . . . . 10.26 114.647 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 64.57 39.48 6.63 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.046 -1.659 . . . . 10.24 113.756 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.23 -0.79 13.8 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 114.767 1.395 . . . . 10.56 114.767 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.42 172.7 9.25 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 107.978 -1.119 . . . . 2.4500000000000002 107.978 171.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.76 152.13 8.37 Favored 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.91 1.338 . . . . 5.5700000000000003 109.851 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.42 -35.68 68.08 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.381 -1.282 . . . . 19.109999999999999 114.386 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.62 -23.5 72.23 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 123.333 2.788 . . . . 2.9300000000000002 112.363 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.47 -54.67 7.1 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 118.535 1.168 . . . . 7.96 111.633 173.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.06 -44.43 15.37 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 124.028 1.871 . . . . 15.050000000000001 111.449 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.18 -35.49 48.63 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.639 -1.164 . . . . 20.27 114.111 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.95 -45.75 6.21 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 119.572 -1.299 . . . . 4.04 114.64 -175.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.49 -27.21 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 O-C-N 121.404 -1.056 . . . . 5.3499999999999996 109.454 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.92 -18.93 64.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 118.625 -2.547 . . . . 3.0299999999999998 112.343 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.49 0.27 50.35 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.454 -0.784 . . . . 3.4900000000000002 113.026 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.623 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.8 mtp -107.76 143.09 36.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 120.831 1.65 . . . . 3.75 109.476 -171.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.403 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.7 p -94.86 155.02 16.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.66 0.784 . . . . 2.2999999999999998 109.8 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.1 t -57.63 130.2 20.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 119.954 1.252 . . . . 2.4700000000000002 109.711 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.7 52.05 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.381 -1.736 . . . . 2.6099999999999999 113.077 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.623 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.37 144.73 28.63 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.998 0.904 . . . . 6.5300000000000002 112.566 -171.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.96 123.87 41.35 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 102.65 -3.092 . . . . 12.359999999999999 102.65 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.82 156.79 45.01 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 126.501 2.376 . . . . 5.8399999999999999 114.323 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.28 122.38 43.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 123.449 1.595 . . . . 16.57 108.617 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.39 28.5 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 118.85 -2.406 . . . . 5.8600000000000003 106.793 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -98.69 120.47 39.17 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 105.822 -1.918 . . . . 5.7599999999999998 105.822 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.72 122.68 69.34 Favored 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 108.589 -0.893 . . . . 3.3599999999999999 108.589 -167.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.1 p -66.41 153.99 91.67 Favored Pre-proline 0 C--O 1.243 0.721 0 CA-C-O 117.838 -1.077 . . . . 4.9400000000000004 110.77 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -55.26 -35.11 90.53 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 123.285 2.656 . . . . 6.21 114.899 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.12 -13.85 62.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.792 1.034 . . . . 15.85 113.792 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -103.67 11.0 36.55 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 126.105 1.762 . . . . 11.52 111.737 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.83 -116.58 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.693 -1.965 . . . . 3.7000000000000002 105.693 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.54 4.04 38.1 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 122.036 2.198 . . . . 6.8399999999999999 115.453 -173.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.49 -137.15 50.44 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-O 123.733 1.74 . . . . 5.9900000000000002 111.078 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.22 -18.78 41.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 111.725 -2.238 . . . . 10.109999999999999 110.993 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.1 m -72.28 -43.98 63.46 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 121.064 1.756 . . . . 13.76 112.529 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.39 -169.25 53.39 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 107.715 -2.154 . . . . 9.9800000000000004 107.715 -170.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.85 114.93 35.27 Favored Pre-proline 0 C--O 1.247 0.962 0 O-C-N 118.012 -3.052 . . . . 15.880000000000001 103.164 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -48.14 122.36 7.32 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 124.781 3.654 . . . . 11.41 110.876 -166.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.17 -26.94 3.23 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.94 -2.391 . . . . 14.199999999999999 117.416 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.415 HD13 ' C11' ' A' ' 108' ' ' GPI . 59.6 mt -102.87 -50.16 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 121.056 2.428 . . . . 11.06 114.918 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.5 mm -112.85 131.88 22.55 Favored Pre-proline 0 CA--C 1.516 -0.337 0 N-CA-C 103.209 -2.885 . . . . 8.0099999999999998 103.209 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.03 163.05 35.45 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.282 3.988 . . . . 6.5199999999999996 112.915 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.2 Cg_exo -55.3 144.48 71.42 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.521 2.147 . . . . 4.8200000000000003 110.232 162.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.14 27.46 16.53 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 112.924 -1.943 . . . . 7.4199999999999999 113.622 172.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.91 132.42 35.27 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 117.382 2.364 . . . . 2.2200000000000002 117.382 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.55 132.37 35.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 121.695 2.043 . . . . 4.6100000000000003 106.359 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.82 146.84 32.99 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.457 -1.402 . . . . 5.3399999999999999 110.308 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.18 120.01 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 103.74 -2.689 . . . . 3.9700000000000002 103.74 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.444 ' HB3' HG22 ' A' ' 101' ' ' VAL . 48.7 m-85 -116.79 136.93 52.56 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.734 -1.229 . . . . 4.4199999999999999 109.553 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.6 t0 -103.78 112.77 25.86 Favored 'General case' 0 C--N 1.315 -0.933 1 N-CA-C 98.863 -4.495 . . . . 2.0899999999999999 98.863 174.014 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 99' ' ' PHE . 87.2 t -126.86 132.31 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 114.143 -1.39 . . . . 3.5299999999999998 110.765 -172.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.42 121.99 39.74 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.45 -2.055 . . . . 14.210000000000001 105.45 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 tp -89.14 109.07 19.98 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 123.643 1.687 . . . . 2.4199999999999999 107.496 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.6 mt -85.53 -43.25 13.7 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.203 1.557 . . . . 2.6200000000000001 115.203 -171.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -161.85 153.57 18.9 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.509 -1.678 . . . . 11.710000000000001 109.189 -167.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.1 mt -120.01 133.21 55.61 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 105.177 -2.157 . . . . 4.7000000000000002 105.177 170.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 . . . . . 0 C--N 1.312 -1.049 0 CA-C-N 113.591 -1.641 . . . . 13.02 109.823 -179.805 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GPI . . . . . 0.429 ' H32' ' CE2' ' A' ' 46' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 106.024 -2.83 . . . . 6.3300000000000001 106.024 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.33 142.48 43.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 101.784 -3.413 . . . . 6.3499999999999996 101.784 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -116.98 130.16 56.51 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 102.807 -3.034 . . . . 16.98 102.807 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.5 t -109.54 117.04 53.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 103.718 -2.697 . . . . 5.5800000000000001 103.718 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.65 124.7 46.94 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 118.927 -2.358 . . . . 12.800000000000001 104.834 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.3 m -75.7 140.03 42.25 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 119.365 -2.084 . . . . 3.2400000000000002 115.68 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.9 mt -101.63 -51.92 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 105.874 -1.899 . . . . 4.79 105.874 171.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.3 m -138.93 139.06 22.45 Favored Pre-proline 0 C--O 1.242 0.704 0 O-C-N 119.572 -1.955 . . . . 11.59 106.299 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.7 Cg_exo -67.73 154.71 72.49 Favored 'Trans proline' 0 C--N 1.328 -0.522 0 C-N-CA 123.626 2.884 . . . . 4.5499999999999998 112.166 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.71 -161.29 28.88 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 109.15 -1.58 . . . . 2.0 109.15 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -82.33 -9.21 59.56 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 117.677 -3.249 . . . . 3.2400000000000002 113.21 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.17 9.67 77.07 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-O 117.585 -1.675 . . . . 3.3799999999999999 113.799 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.7 mtp85 -137.62 -26.79 0.96 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.669 3.234 . . . . 26.59 114.225 -178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.47 94.04 4.99 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 119.111 -2.243 . . . . 3.02 109.525 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.27 142.53 24.8 Favored Pre-proline 0 C--O 1.251 1.14 0 O-C-N 124.95 1.406 . . . . 4.7000000000000002 109.769 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.549 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.62 146.71 68.18 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.743 2.295 . . . . 2.9399999999999999 110.671 -174.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -121.47 156.25 33.16 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.925 -1.489 . . . . 15.960000000000001 106.994 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.42 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.3 ttp180 -52.1 130.27 29.67 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 124.121 1.915 . . . . 11.69 112.831 174.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.21 -14.05 65.84 Favored Glycine 0 N--CA 1.421 -2.307 0 O-C-N 119.971 -1.706 . . . . 3.6299999999999999 112.763 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.15 149.41 25.13 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.098 1.949 . . . . 5.9000000000000004 112.311 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.6 m -89.97 120.42 31.16 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 125.257 1.598 . . . . 3.0699999999999998 111.689 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.52 131.06 39.12 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.592 1.187 . . . . 4.1100000000000003 109.799 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.06 111.33 35.69 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.649 -3.463 . . . . 2.1600000000000001 101.649 -174.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.9 m -129.43 154.43 40.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.77 0.795 . . . . 3.5899999999999999 112.313 -172.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.12 145.41 30.58 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.274 -2.121 . . . . 3.1299999999999999 105.274 164.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.86 156.13 43.35 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 120.172 1.351 . . . . 2.5499999999999998 111.87 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -133.86 121.48 21.82 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 102.924 -2.991 . . . . 4.4699999999999998 102.924 167.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.27 131.93 10.76 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 109.173 -1.571 . . . . 3.4100000000000001 109.173 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.46 152.18 51.61 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 125.291 2.472 . . . . 18.219999999999999 110.374 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 164.55 22.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 111.65 -2.523 . . . . 5.9299999999999997 106.435 172.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -57.96 -20.69 39.78 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 117.263 -3.398 . . . . 12.33 117.705 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.75 5.4 40.18 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.564 -1.96 . . . . 7.1900000000000004 113.874 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.36 69.71 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-O 124.113 1.952 . . . . 6.4699999999999998 113.754 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.42 124.18 22.04 Favored 'General case' 0 N--CA 1.438 -1.037 0 O-C-N 116.601 -3.882 . . . . 21.859999999999999 110.686 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.91 130.79 37.01 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.37 -1.344 . . . . 16.18 107.37 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.61 -17.93 13.97 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.095 -1.042 . . . . 5.7300000000000004 110.74 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.68 155.44 3.28 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 118.041 -0.98 . . . . 6.1299999999999999 110.665 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -158.77 128.2 5.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.484 1.113 . . . . 2.9300000000000002 110.312 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.9 p -76.03 -20.61 57.64 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.001 -0.74 . . . . 2.2999999999999998 109.001 175.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.63 84.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.685 -1.598 . . . . 10.550000000000001 106.685 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -67.64 -28.56 67.83 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.143 -1.598 . . . . 8.0199999999999996 110.827 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.3 mtm-85 -88.58 -10.04 50.14 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.861 -1.149 . . . . 10.210000000000001 112.427 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.5 34.26 24.0 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.311 1.529 . . . . 16.379999999999999 110.951 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -139.7 120.2 9.36 Favored Pre-proline 0 C--O 1.247 0.972 0 O-C-N 117.571 -3.206 . . . . 20.210000000000001 103.921 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -59.33 152.29 61.77 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.292 3.328 . . . . 8.75 110.276 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.422 ' CE2' ' H32' ' A' ' 108' ' ' GPI . 85.1 t80 -95.85 138.18 33.86 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.572 -1.64 . . . . 4.6500000000000004 106.572 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.67 136.88 50.3 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 120.525 1.512 . . . . 10.619999999999999 111.253 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.6 150.7 40.67 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 120.475 1.489 . . . . 4.3099999999999996 107.368 169.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.443 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.46 126.61 37.62 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.324 1.42 . . . . 2.6699999999999999 110.542 172.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.87 129.9 42.45 Favored 'General case' 0 N--CA 1.427 -1.576 0 O-C-N 125.33 1.644 . . . . 3.0800000000000001 110.699 176.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.42 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.79 -4.02 84.92 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 123.862 0.744 . . . . 4.9500000000000002 114.043 176.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.08 -3.13 57.86 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.686 -1.479 . . . . 10.26 114.633 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 64.56 39.52 6.65 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 120.012 -1.68 . . . . 10.24 113.858 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.34 -0.89 13.69 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 114.722 1.378 . . . . 10.56 114.722 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.4 172.67 9.28 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 N-CA-C 108.085 -1.08 . . . . 2.4500000000000002 108.085 171.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 pt -71.82 152.17 8.32 Favored 'Isoleucine or valine' 0 C--O 1.256 1.445 0 CA-C-O 123.029 1.395 . . . . 5.5700000000000003 109.725 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -56.26 -35.71 67.75 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 114.316 -1.311 . . . . 19.109999999999999 114.471 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.86 -23.22 72.53 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 123.4 2.818 . . . . 2.9300000000000002 112.432 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.52 -54.76 6.89 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 118.555 1.178 . . . . 7.96 111.583 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.86 -44.43 14.36 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 124.045 1.878 . . . . 15.050000000000001 111.503 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.44 -35.35 46.98 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.564 -1.198 . . . . 20.27 114.007 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.94 -45.7 6.23 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 119.615 -1.279 . . . . 4.04 114.724 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.58 -27.18 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 119.09 -1.044 . . . . 5.3499999999999996 109.425 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.85 64.71 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.541 -2.6 . . . . 3.0299999999999998 112.35 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.42 0.18 50.46 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 118.425 -0.798 . . . . 3.4900000000000002 113.068 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.624 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.6 mtp -107.7 143.1 36.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 120.81 1.641 . . . . 3.75 109.572 -171.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.401 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.9 p -94.84 154.96 17.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.715 0.806 . . . . 2.2999999999999998 109.806 174.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.2 t -57.62 130.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 119.867 1.212 . . . . 2.4700000000000002 109.783 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 -12.53 52.08 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 113.35 -1.75 . . . . 2.6099999999999999 112.995 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.624 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.46 144.76 28.52 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.919 0.866 . . . . 6.5300000000000002 112.575 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.95 123.89 41.4 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 102.632 -3.099 . . . . 12.359999999999999 102.632 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.91 156.64 44.94 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 126.471 2.357 . . . . 5.8399999999999999 114.285 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.15 122.45 43.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 123.551 1.643 . . . . 16.57 108.638 174.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.05 114.59 28.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 118.741 -2.474 . . . . 5.8600000000000003 106.76 -176.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.9 m -98.74 120.44 39.18 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 105.77 -1.937 . . . . 5.7599999999999998 105.77 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.66 122.59 69.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 108.687 -0.857 . . . . 3.3599999999999999 108.687 -167.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.35 154.03 91.41 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.907 -1.044 . . . . 4.9400000000000004 110.683 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -55.45 -35.09 91.39 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.355 2.704 . . . . 6.21 114.738 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.07 -13.84 62.4 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.897 1.073 . . . . 15.85 113.897 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.61 10.99 36.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 126.106 1.762 . . . . 11.52 111.692 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.86 -116.6 0.15 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 105.712 -1.958 . . . . 3.7000000000000002 105.712 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.59 4.0 37.92 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-N 121.991 2.178 . . . . 6.8399999999999999 115.444 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.49 -137.15 50.44 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-O 123.739 1.744 . . . . 5.9900000000000002 111.032 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.29 -18.73 41.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 111.674 -2.263 . . . . 10.109999999999999 110.982 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.1 m -72.19 -43.98 63.69 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 121.131 1.787 . . . . 13.76 112.608 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.3 -169.17 53.38 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 107.652 -2.179 . . . . 9.9800000000000004 107.652 -170.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -118.83 114.9 35.32 Favored Pre-proline 0 C--O 1.247 0.959 0 O-C-N 117.982 -3.069 . . . . 15.880000000000001 103.268 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.21 122.44 7.5 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.622 3.548 . . . . 11.41 110.903 -166.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.21 -26.98 3.23 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.863 -2.426 . . . . 14.199999999999999 117.416 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.6 mt -102.88 -50.04 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 121.03 2.415 . . . . 11.06 114.894 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.7 mm -112.92 131.91 22.56 Favored Pre-proline 0 CA--C 1.516 -0.328 0 N-CA-C 103.203 -2.888 . . . . 8.0099999999999998 103.203 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.01 163.02 35.53 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.284 3.99 . . . . 6.5199999999999996 112.918 171.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.34 144.48 71.81 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.563 2.175 . . . . 4.8200000000000003 110.244 162.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.33 27.22 16.27 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 112.785 -2.007 . . . . 7.4199999999999999 113.581 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.84 132.35 35.27 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 117.396 2.369 . . . . 2.2200000000000002 117.396 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -80.51 132.43 35.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 121.722 2.055 . . . . 4.6100000000000003 106.328 168.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.89 146.86 33.06 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.451 -1.406 . . . . 5.3399999999999999 110.276 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.3 t -123.21 119.95 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 N-CA-C 103.743 -2.688 . . . . 3.9700000000000002 103.743 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.444 ' HB3' HG22 ' A' ' 101' ' ' VAL . 48.6 m-85 -116.77 137.01 52.5 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.724 -1.235 . . . . 4.4199999999999999 109.562 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.81 112.7 25.77 Favored 'General case' 0 C--N 1.314 -0.959 1 N-CA-C 98.91 -4.478 . . . . 2.0899999999999999 98.91 173.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 99' ' ' PHE . 86.4 t -126.8 132.33 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.12 -1.4 . . . . 3.5299999999999998 110.82 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.44 121.84 39.39 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.524 -2.028 . . . . 14.210000000000001 105.524 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.09 109.01 19.92 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 123.618 1.675 . . . . 2.4199999999999999 107.484 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.41 -43.34 13.72 Favored 'General case' 0 C--O 1.255 1.378 0 N-CA-C 115.175 1.546 . . . . 2.6200000000000001 115.175 -171.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -161.79 153.59 19.05 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 113.559 -1.655 . . . . 11.710000000000001 109.229 -167.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.07 133.19 55.59 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 105.201 -2.148 . . . . 4.7000000000000002 105.201 170.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.31 -1.138 0 CA-C-N 113.554 -1.657 . . . . 13.02 109.912 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GPI . . . . . 0.435 ' C5 ' ' CZ ' ' A' ' 26' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 106.073 -2.811 . . . . 6.3300000000000001 106.073 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.34 142.55 43.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 101.741 -3.429 . . . . 6.3499999999999996 101.741 176.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.05 130.13 56.46 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 102.734 -3.061 . . . . 16.98 102.734 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.9 t -109.53 117.04 53.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 103.741 -2.689 . . . . 5.5800000000000001 103.741 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.62 124.72 47.01 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 118.957 -2.339 . . . . 12.800000000000001 104.824 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.4 m -75.68 140.02 42.28 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 119.292 -2.13 . . . . 3.2400000000000002 115.635 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.41 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.3 mt -101.61 -52.02 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.832 -1.914 . . . . 4.79 105.832 171.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.6 m -138.95 139.03 22.27 Favored Pre-proline 0 C--O 1.241 0.652 0 O-C-N 119.5 -2.0 . . . . 11.59 106.301 177.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.7 Cg_exo -67.7 154.78 72.34 Favored 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.46 2.774 . . . . 4.5499999999999998 112.201 -176.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.71 -161.17 28.86 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 109.135 -1.586 . . . . 2.0 109.135 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.49 -9.21 59.52 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 117.606 -3.291 . . . . 3.2400000000000002 113.161 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.15 9.68 77.02 Favored Glycine 0 C--O 1.219 -0.8 0 CA-C-O 117.691 -1.616 . . . . 3.3799999999999999 113.846 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.7 mtp85 -137.67 -26.58 0.96 Allowed 'General case' 0 C--O 1.24 0.587 0 CA-C-N 122.592 3.196 . . . . 26.59 114.214 -178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.57 94.0 4.96 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 119.057 -2.277 . . . . 3.02 109.45 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.13 142.53 24.81 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 125.01 1.444 . . . . 4.7000000000000002 109.798 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.56 146.76 68.69 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.754 2.303 . . . . 2.9399999999999999 110.627 -174.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.48 156.09 33.53 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.919 -1.491 . . . . 15.960000000000001 107.047 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.03 130.23 29.28 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 124.189 1.947 . . . . 11.69 112.721 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.36 -14.08 65.67 Favored Glycine 0 N--CA 1.423 -2.21 0 O-C-N 119.952 -1.717 . . . . 3.6299999999999999 112.713 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.12 149.36 25.18 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.061 1.93 . . . . 5.9000000000000004 112.326 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.92 120.36 31.08 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.176 1.548 . . . . 3.0699999999999998 111.766 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.51 130.94 39.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 122.606 1.193 . . . . 4.1100000000000003 109.874 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.3 t -111.89 111.39 35.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.638 -3.467 . . . . 2.1600000000000001 101.638 -174.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.54 154.39 40.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 121.817 0.817 . . . . 3.5899999999999999 112.262 -172.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.04 145.49 30.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.173 -2.158 . . . . 3.1299999999999999 105.173 164.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.501 ' CZ ' ' H51' ' A' ' 108' ' ' GPI . 33.1 p90 -145.89 156.11 43.33 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 120.048 1.294 . . . . 2.5499999999999998 112.038 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.8 m -133.84 121.63 22.06 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 102.88 -3.007 . . . . 4.4699999999999998 102.88 167.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.24 131.94 10.76 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 109.22 -1.552 . . . . 3.4100000000000001 109.22 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.4 152.12 51.6 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 125.198 2.427 . . . . 18.219999999999999 110.405 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 164.62 22.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.741 -2.481 . . . . 5.9299999999999997 106.447 172.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -58.04 -20.58 40.22 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.238 -3.414 . . . . 12.33 117.708 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.75 5.3 40.65 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.59 -1.943 . . . . 7.1900000000000004 113.914 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.23 -10.33 69.62 Favored Glycine 0 C--N 1.357 1.697 0 CA-C-O 123.956 1.864 . . . . 6.4699999999999998 113.646 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.59 124.22 22.23 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 116.622 -3.869 . . . . 21.859999999999999 110.583 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -77.77 130.83 37.21 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.457 -1.312 . . . . 16.18 107.457 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.71 -17.87 13.97 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.075 -1.05 . . . . 5.7300000000000004 110.802 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -172.76 155.49 3.24 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 118.241 -0.885 . . . . 6.1299999999999999 110.55 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.81 128.05 5.54 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.48 1.112 . . . . 2.9300000000000002 110.371 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.3 p -75.89 -20.59 57.92 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.846 -0.741 . . . . 2.2999999999999998 109.093 175.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.73 -36.69 84.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.696 -1.594 . . . . 10.550000000000001 106.696 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -67.62 -28.49 67.78 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.191 -1.568 . . . . 8.0199999999999996 110.812 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.63 -10.1 49.81 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 120.854 -1.154 . . . . 10.210000000000001 112.341 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.51 34.28 24.05 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.346 1.546 . . . . 16.379999999999999 111.017 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -139.68 120.18 9.37 Favored Pre-proline 0 C--O 1.247 0.972 0 O-C-N 117.627 -3.171 . . . . 20.210000000000001 103.914 178.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -59.32 152.28 61.72 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 124.321 3.347 . . . . 8.75 110.32 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.479 ' CZ ' ' H42' ' A' ' 108' ' ' GPI . 85.1 t80 -95.84 138.13 33.92 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.534 -1.654 . . . . 4.6500000000000004 106.534 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -111.61 136.89 50.2 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 120.572 1.533 . . . . 10.619999999999999 111.297 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.66 150.7 40.55 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.402 1.456 . . . . 4.3099999999999996 107.373 169.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.443 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.51 126.67 37.7 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 120.311 1.414 . . . . 2.6699999999999999 110.585 172.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 129.86 42.19 Favored 'General case' 0 N--CA 1.426 -1.643 0 O-C-N 125.251 1.594 . . . . 3.0800000000000001 110.647 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.93 -4.12 84.8 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 123.841 0.734 . . . . 4.9500000000000002 114.099 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.1 -3.12 57.86 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.797 -1.414 . . . . 10.26 114.561 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.51 39.62 6.69 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.106 -1.621 . . . . 10.24 113.784 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.38 -0.81 13.69 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 114.676 1.361 . . . . 10.56 114.676 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.37 172.63 9.33 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.118 -1.067 . . . . 2.4500000000000002 108.118 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.2 pt -71.82 152.12 8.34 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.98 1.371 . . . . 5.5700000000000003 109.785 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -56.22 -35.75 67.69 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.354 -1.294 . . . . 19.109999999999999 114.458 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.76 -23.31 72.38 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.423 2.828 . . . . 2.9300000000000002 112.357 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.59 -54.68 7.0 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 118.621 1.21 . . . . 7.96 111.611 173.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -45.93 -44.45 14.74 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 124.015 1.864 . . . . 15.050000000000001 111.512 173.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.33 -35.31 47.77 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.517 -1.22 . . . . 20.27 114.084 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.05 -45.65 6.21 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.424 -1.37 . . . . 4.04 114.663 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.47 -27.25 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 121.317 -1.108 . . . . 5.3499999999999996 109.456 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.95 -18.89 64.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.506 -2.621 . . . . 3.0299999999999998 112.363 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.48 0.34 50.04 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.078 0.77 . . . . 3.4900000000000002 113.078 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.623 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.9 mtp -107.88 143.08 36.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 120.765 1.62 . . . . 3.75 109.493 -171.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.402 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.9 p -94.71 154.92 17.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.714 0.805 . . . . 2.2999999999999998 109.877 174.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -57.58 130.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 119.965 1.257 . . . . 2.4700000000000002 109.828 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.12 -12.54 52.26 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 113.366 -1.743 . . . . 2.6099999999999999 113.124 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.623 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.48 144.8 28.49 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.915 0.864 . . . . 6.5300000000000002 112.605 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -124.01 123.99 41.57 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 102.578 -3.119 . . . . 12.359999999999999 102.578 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.82 45.01 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.467 2.354 . . . . 5.8399999999999999 114.292 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.28 122.39 43.59 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.463 1.601 . . . . 16.57 108.651 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.59 28.82 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.847 -2.408 . . . . 5.8600000000000003 106.709 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.2 m -98.79 120.47 39.28 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 105.822 -1.918 . . . . 5.7599999999999998 105.822 176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.73 122.55 69.01 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 108.616 -0.883 . . . . 3.3599999999999999 108.616 -167.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.34 154.02 91.43 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-O 117.787 -1.101 . . . . 4.9400000000000004 110.737 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.4 -35.08 91.11 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.312 2.675 . . . . 6.21 114.749 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.17 -13.83 62.36 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 113.777 1.029 . . . . 15.85 113.777 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.69 11.05 36.45 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 126.038 1.735 . . . . 11.52 111.693 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.79 -116.54 0.15 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 105.751 -1.944 . . . . 3.7000000000000002 105.751 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.73 4.22 37.8 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 122.033 2.197 . . . . 6.8399999999999999 115.452 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.36 -137.18 50.33 Favored Glycine 0 C--N 1.354 1.578 0 CA-C-O 123.708 1.727 . . . . 5.9900000000000002 111.073 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.17 -18.75 41.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 111.661 -2.27 . . . . 10.109999999999999 111.047 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.25 -43.98 63.53 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 121.048 1.749 . . . . 13.76 112.575 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.4 -169.24 53.4 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 107.603 -2.199 . . . . 9.9800000000000004 107.603 -170.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.87 114.9 35.23 Favored Pre-proline 0 C--O 1.246 0.913 0 O-C-N 118.097 -3.002 . . . . 15.880000000000001 103.151 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.13 122.43 7.4 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.667 3.578 . . . . 11.41 110.901 -166.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.17 -27.05 3.2 Favored Glycine 0 CA--C 1.545 1.935 0 CA-C-N 111.897 -2.41 . . . . 14.199999999999999 117.454 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.9 mt -102.85 -50.08 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.046 2.423 . . . . 11.06 114.972 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.84 131.93 22.52 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 103.124 -2.917 . . . . 8.0099999999999998 103.124 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.09 163.08 35.43 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 125.218 3.945 . . . . 6.5199999999999996 112.871 171.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.3 Cg_exo -55.4 144.54 72.21 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.428 2.085 . . . . 4.8200000000000003 110.311 162.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.19 27.26 16.38 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 112.886 -1.961 . . . . 7.4199999999999999 113.722 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.67 132.36 35.29 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 117.381 2.363 . . . . 2.2200000000000002 117.381 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.47 132.46 35.71 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 121.796 2.089 . . . . 4.6100000000000003 106.348 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -108.94 146.78 33.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 120.379 -1.45 . . . . 5.3399999999999999 110.241 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.17 120.01 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 103.768 -2.679 . . . . 3.9700000000000002 103.768 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 101' ' ' VAL . 48.6 m-85 -116.76 136.95 52.55 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.724 -1.235 . . . . 4.4199999999999999 109.591 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.8 t0 -103.75 112.7 25.77 Favored 'General case' 0 C--N 1.313 -1.0 1 N-CA-C 98.925 -4.472 . . . . 2.0899999999999999 98.925 173.979 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 99' ' ' PHE . 87.6 t -126.82 132.34 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.212 -1.358 . . . . 3.5299999999999998 110.804 -172.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -120.47 121.9 39.5 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.464 -2.05 . . . . 14.210000000000001 105.464 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.6 tp -89.05 109.04 19.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 123.606 1.67 . . . . 2.4199999999999999 107.516 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.46 -43.26 13.74 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.181 1.549 . . . . 2.6200000000000001 115.181 -171.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -161.8 153.58 19.02 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 113.503 -1.68 . . . . 11.710000000000001 109.115 -167.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.04 133.24 55.59 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 105.206 -2.146 . . . . 4.7000000000000002 105.206 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.582 -1.645 . . . . 13.02 109.912 -179.84 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GPI . . . . . 0.501 ' H51' ' CZ ' ' A' ' 26' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 106.082 -2.807 . . . . 6.3300000000000001 106.082 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.36 142.54 43.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 101.712 -3.44 . . . . 6.3499999999999996 101.712 176.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.06 130.11 56.44 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 102.824 -3.028 . . . . 16.98 102.824 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.1 t -109.49 117.12 53.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 103.67 -2.715 . . . . 5.5800000000000001 103.67 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.63 124.68 46.92 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 118.949 -2.345 . . . . 12.800000000000001 104.83 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.6 m -75.66 139.96 42.27 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.333 -2.105 . . . . 3.2400000000000002 115.621 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.5 mt -101.66 -52.01 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 105.82 -1.919 . . . . 4.79 105.82 171.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.5 m -138.93 139.1 22.58 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 119.652 -1.905 . . . . 11.59 106.233 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.3 Cg_exo -67.66 154.76 72.49 Favored 'Trans proline' 0 C--N 1.33 -0.433 0 C-N-CA 123.568 2.846 . . . . 4.5499999999999998 112.224 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.68 -161.08 28.88 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.106 -1.597 . . . . 2.0 109.106 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -82.55 -9.17 59.52 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 117.694 -3.239 . . . . 3.2400000000000002 113.146 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.1 9.77 76.98 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.636 -1.647 . . . . 3.3799999999999999 113.843 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -137.74 -26.66 0.95 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.592 3.196 . . . . 26.59 114.226 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 m -105.52 94.03 4.98 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 119.143 -2.223 . . . . 3.02 109.439 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.21 142.5 24.75 Favored Pre-proline 0 C--O 1.25 1.091 0 O-C-N 125.003 1.439 . . . . 4.7000000000000002 109.77 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.549 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.53 146.59 68.31 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.789 2.326 . . . . 2.9399999999999999 110.682 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.42 156.18 33.25 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.895 -1.502 . . . . 15.960000000000001 106.99 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.6 ttp180 -52.17 130.31 30.06 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 124.201 1.953 . . . . 11.69 112.828 174.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.28 -13.96 65.94 Favored Glycine 0 N--CA 1.424 -2.147 0 O-C-N 120.009 -1.682 . . . . 3.6299999999999999 112.682 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.47 25.09 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 120.111 1.956 . . . . 5.9000000000000004 112.356 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.9 m -89.89 120.31 31.01 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.308 1.63 . . . . 3.0699999999999998 111.726 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.55 131.05 39.17 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.614 1.197 . . . . 4.1100000000000003 109.851 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.0 111.41 36.04 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.643 -3.466 . . . . 2.1600000000000001 101.643 -174.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.1 m -129.6 154.4 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.89 0.852 . . . . 3.5899999999999999 112.249 -172.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.05 145.39 30.54 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.258 -2.127 . . . . 3.1299999999999999 105.258 164.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.8 156.19 43.42 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 120.173 1.351 . . . . 2.5499999999999998 111.923 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.4 m -133.86 121.54 21.91 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 102.99 -2.967 . . . . 4.4699999999999998 102.99 167.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.2 131.95 10.77 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 109.3 -1.52 . . . . 3.4100000000000001 109.3 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.39 152.19 51.56 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 125.263 2.459 . . . . 18.219999999999999 110.381 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.6 164.66 22.73 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.706 -2.497 . . . . 5.9299999999999997 106.408 172.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -58.11 -20.64 41.69 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 117.28 -3.387 . . . . 12.33 117.67 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.57 5.21 40.45 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 119.536 -1.977 . . . . 7.1900000000000004 113.927 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.22 -10.24 69.65 Favored Glycine 0 C--N 1.354 1.54 0 CA-C-O 123.973 1.874 . . . . 6.4699999999999998 113.67 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.67 124.32 22.54 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 116.728 -3.807 . . . . 21.859999999999999 110.583 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.97 130.76 36.93 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.383 -1.34 . . . . 16.18 107.383 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.56 -17.9 13.98 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.142 -1.023 . . . . 5.7300000000000004 110.845 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -172.71 155.44 3.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.064 -0.97 . . . . 6.1299999999999999 110.614 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -158.82 128.17 5.58 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.421 1.088 . . . . 2.9300000000000002 110.284 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.2 p -75.97 -20.74 57.66 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.841 -0.743 . . . . 2.2999999999999998 109.006 175.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.63 -36.67 84.6 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.674 -1.602 . . . . 10.550000000000001 106.674 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.59 -28.47 67.79 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.191 -1.568 . . . . 8.0199999999999996 110.881 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.67 -10.11 49.69 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 120.847 -1.158 . . . . 10.210000000000001 112.331 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.49 34.32 24.1 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-O 123.4 1.571 . . . . 16.379999999999999 110.989 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -139.69 120.2 9.36 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 117.703 -3.123 . . . . 20.210000000000001 103.926 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -59.24 152.26 61.35 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 124.209 3.273 . . . . 8.75 110.383 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -95.86 138.31 33.69 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.518 -1.66 . . . . 4.6500000000000004 106.518 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.76 136.78 50.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.588 1.54 . . . . 10.619999999999999 111.326 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -142.56 150.59 40.57 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 120.437 1.472 . . . . 4.3099999999999996 107.442 169.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.445 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.47 126.71 37.68 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.365 1.439 . . . . 2.6699999999999999 110.634 172.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.87 129.83 42.14 Favored 'General case' 0 N--CA 1.428 -1.56 0 O-C-N 125.32 1.637 . . . . 3.0800000000000001 110.654 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.87 -4.06 84.85 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 123.9 0.762 . . . . 4.9500000000000002 114.093 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.11 -3.01 57.79 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.765 -1.432 . . . . 10.26 114.64 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.51 39.55 6.72 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.045 -1.659 . . . . 10.24 113.795 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.73 13.7 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 114.671 1.36 . . . . 10.56 114.671 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.46 172.68 9.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 N-CA-C 107.938 -1.134 . . . . 2.4500000000000002 107.938 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 pt -71.77 152.12 8.37 Favored 'Isoleucine or valine' 0 C--O 1.259 1.604 0 CA-C-O 122.944 1.354 . . . . 5.5700000000000003 109.765 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.34 -35.73 67.96 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 114.401 -1.272 . . . . 19.109999999999999 114.395 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.78 -23.34 72.42 Favored Glycine 0 CA--C 1.539 1.583 0 O-C-N 118.226 -2.796 . . . . 2.9300000000000002 112.344 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.62 -54.55 7.23 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 118.556 1.178 . . . . 7.96 111.628 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.99 -44.45 15.03 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 124.015 1.864 . . . . 15.050000000000001 111.502 173.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.35 -35.25 47.71 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.544 -1.207 . . . . 20.27 114.101 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.04 -45.75 6.18 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.534 -1.317 . . . . 4.04 114.623 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.51 -27.22 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 121.338 -1.095 . . . . 5.3499999999999996 109.425 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.549 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.97 -18.8 64.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 118.531 -2.606 . . . . 3.0299999999999998 112.439 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.52 0.25 50.54 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.468 -0.777 . . . . 3.4900000000000002 113.026 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.624 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.8 mtp -107.8 143.05 36.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 120.852 1.66 . . . . 3.75 109.577 -171.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.402 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.9 p -94.77 154.96 17.03 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.693 0.797 . . . . 2.2999999999999998 109.86 174.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.2 t -57.62 130.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 119.957 1.253 . . . . 2.4700000000000002 109.763 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.15 -12.46 52.12 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 113.311 -1.768 . . . . 2.6099999999999999 113.049 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.624 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.48 144.77 28.51 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-O 121.854 0.835 . . . . 6.5300000000000002 112.562 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.97 123.98 41.58 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 102.626 -3.102 . . . . 12.359999999999999 102.626 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.91 156.82 44.97 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.472 2.357 . . . . 5.8399999999999999 114.221 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.36 122.42 43.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 123.443 1.592 . . . . 16.57 108.699 174.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.98 114.4 28.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 O-C-N 118.841 -2.412 . . . . 5.8600000000000003 106.797 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.6 m -98.68 120.51 39.24 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 105.855 -1.905 . . . . 5.7599999999999998 105.855 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.63 122.61 69.25 Favored 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 108.714 -0.847 . . . . 3.3599999999999999 108.714 -167.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.38 154.03 91.52 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.915 -1.04 . . . . 4.9400000000000004 110.739 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.32 -35.19 90.99 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 123.268 2.645 . . . . 6.21 114.786 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -69.95 -13.96 62.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.927 1.084 . . . . 15.85 113.927 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.6 11.06 36.61 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 126.113 1.765 . . . . 11.52 111.757 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.79 -116.62 0.15 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 105.786 -1.931 . . . . 3.7000000000000002 105.786 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -102.51 3.94 38.08 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 122.032 2.196 . . . . 6.8399999999999999 115.545 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.58 -137.17 50.48 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-O 123.757 1.754 . . . . 5.9900000000000002 111.011 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.64 41.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 111.622 -2.289 . . . . 10.109999999999999 110.983 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.26 -44.09 63.34 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 121.112 1.778 . . . . 13.76 112.529 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.4 -169.19 53.44 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.659 -2.177 . . . . 9.9800000000000004 107.659 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.81 114.8 35.4 Favored Pre-proline 0 C--O 1.247 0.922 0 O-C-N 117.999 -3.06 . . . . 15.880000000000001 103.323 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -48.19 122.47 7.52 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 124.707 3.605 . . . . 11.41 110.89 -166.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.19 -26.97 3.23 Favored Glycine 0 CA--C 1.547 2.079 0 CA-C-N 111.87 -2.423 . . . . 14.199999999999999 117.361 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.426 HD13 ' C11' ' A' ' 108' ' ' GPI . 60.1 mt -102.96 -50.04 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 121.074 2.437 . . . . 11.06 114.917 -175.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.95 131.92 22.57 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 103.17 -2.9 . . . . 8.0099999999999998 103.17 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.0 163.07 35.32 Favored 'Trans proline' 0 C--O 1.24 0.592 1 C-N-CA 125.34 4.027 . . . . 6.5199999999999996 112.853 171.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.34 144.45 71.94 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.534 2.156 . . . . 4.8200000000000003 110.307 162.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.32 27.3 16.32 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 112.846 -1.979 . . . . 7.4199999999999999 113.562 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.86 132.35 35.27 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 117.392 2.367 . . . . 2.2200000000000002 117.392 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -80.57 132.45 35.65 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 121.696 2.043 . . . . 4.6100000000000003 106.283 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.88 146.78 33.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.442 -1.411 . . . . 5.3399999999999999 110.285 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.19 119.96 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 103.78 -2.674 . . . . 3.9700000000000002 103.78 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.444 ' HB3' HG22 ' A' ' 101' ' ' VAL . 48.4 m-85 -116.81 137.09 52.45 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.77 -1.206 . . . . 4.4199999999999999 109.541 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.81 112.73 25.81 Favored 'General case' 0 C--N 1.314 -0.975 1 N-CA-C 98.912 -4.477 . . . . 2.0899999999999999 98.912 174.019 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.444 HG22 ' HB3' ' A' ' 99' ' ' PHE . 86.5 t -126.72 132.36 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.109 -1.405 . . . . 3.5299999999999998 110.805 -172.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.49 121.82 39.29 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.57 -2.011 . . . . 14.210000000000001 105.57 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 tp -89.02 109.11 19.99 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.498 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.9 mt -85.47 -43.34 13.67 Favored 'General case' 0 C--O 1.254 1.34 0 N-CA-C 115.255 1.576 . . . . 2.6200000000000001 115.255 -171.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -161.86 153.54 18.84 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.422 -1.717 . . . . 11.710000000000001 109.153 -167.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.0 133.28 55.59 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 105.155 -2.165 . . . . 4.7000000000000002 105.155 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.313 -1.018 0 CA-C-N 113.548 -1.66 . . . . 13.02 109.8 -179.798 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GPI . . . . . 0.426 ' C11' HD13 ' A' ' 90' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 106.034 -2.826 . . . . 6.3300000000000001 106.034 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.31 142.46 43.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 101.725 -3.435 . . . . 6.3499999999999996 101.725 176.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -116.92 130.21 56.55 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 102.818 -3.03 . . . . 16.98 102.818 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.8 t -109.71 117.1 53.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 103.613 -2.736 . . . . 5.5800000000000001 103.613 -175.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.61 124.65 46.85 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 118.919 -2.363 . . . . 12.800000000000001 104.82 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.7 m -75.57 139.97 42.41 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.183 -2.198 . . . . 3.2400000000000002 115.598 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.409 HD12 HG22 ' A' ' 7' ' ' ILE . 91.7 mt -101.64 -52.07 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 105.844 -1.91 . . . . 4.79 105.844 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.7 m -138.9 139.03 22.4 Favored Pre-proline 0 C--O 1.243 0.723 0 O-C-N 119.684 -1.885 . . . . 11.59 106.358 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.7 Cg_exo -67.66 154.78 72.44 Favored 'Trans proline' 0 C--N 1.329 -0.48 0 C-N-CA 123.536 2.824 . . . . 4.5499999999999998 112.15 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.63 -161.1 28.93 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 109.222 -1.551 . . . . 2.0 109.222 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.49 -9.21 59.52 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 117.65 -3.265 . . . . 3.2400000000000002 113.163 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.14 9.69 76.98 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-O 117.585 -1.675 . . . . 3.3799999999999999 113.806 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -137.63 -26.81 0.96 Allowed 'General case' 0 C--O 1.24 0.568 0 CA-C-N 122.669 3.234 . . . . 26.59 114.208 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.38 93.92 4.93 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 119.101 -2.249 . . . . 3.02 109.602 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -104.22 142.46 24.65 Favored Pre-proline 0 C--O 1.25 1.08 0 O-C-N 125.005 1.441 . . . . 4.7000000000000002 109.82 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.48 146.67 68.91 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.704 2.27 . . . . 2.9399999999999999 110.657 -174.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.46 156.29 33.08 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.836 -1.529 . . . . 15.960000000000001 106.962 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.418 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.24 130.27 30.21 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 124.253 1.977 . . . . 11.69 112.764 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.3 -14.08 65.72 Favored Glycine 0 N--CA 1.424 -2.159 0 O-C-N 119.999 -1.688 . . . . 3.6299999999999999 112.766 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -86.18 149.43 25.11 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.095 1.948 . . . . 5.9000000000000004 112.333 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.95 120.29 31.04 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 125.308 1.63 . . . . 3.0699999999999998 111.729 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.3 m -93.57 131.09 39.17 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 122.616 1.198 . . . . 4.1100000000000003 109.827 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -111.99 111.5 36.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 N-CA-C 101.625 -3.472 . . . . 2.1600000000000001 101.625 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.58 154.42 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.82 0.819 . . . . 3.5899999999999999 112.3 -172.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.46 30.52 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.215 -2.143 . . . . 3.1299999999999999 105.215 164.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.82 156.17 43.4 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 120.04 1.291 . . . . 2.5499999999999998 111.927 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.79 121.57 22.03 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 102.929 -2.989 . . . . 4.4699999999999998 102.929 167.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.22 131.93 10.76 Favored Glycine 0 N--CA 1.471 1.013 0 N-CA-C 109.192 -1.563 . . . . 3.4100000000000001 109.192 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.38 152.13 51.58 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 125.142 2.401 . . . . 18.219999999999999 110.435 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 164.56 22.85 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 111.797 -2.456 . . . . 5.9299999999999997 106.384 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.08 -20.54 40.39 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.242 -3.411 . . . . 12.33 117.684 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -87.75 5.29 40.67 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 119.659 -1.901 . . . . 7.1900000000000004 113.885 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.22 69.72 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-O 123.966 1.87 . . . . 6.4699999999999998 113.684 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.65 124.2 22.2 Favored 'General case' 0 N--CA 1.438 -1.045 0 O-C-N 116.678 -3.836 . . . . 21.859999999999999 110.593 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.81 130.81 37.14 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 107.477 -1.305 . . . . 16.18 107.477 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -107.62 -17.88 13.98 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.041 -1.064 . . . . 5.7300000000000004 110.913 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.68 155.5 3.3 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 118.16 -0.924 . . . . 6.1299999999999999 110.504 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.85 128.16 5.55 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.451 1.101 . . . . 2.9300000000000002 110.328 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.6 p -75.97 -20.59 57.77 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.827 -0.749 . . . . 2.2999999999999998 109.052 175.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.86 -36.54 84.25 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.639 -1.615 . . . . 10.550000000000001 106.639 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -67.74 -28.4 67.6 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.219 -1.551 . . . . 8.0199999999999996 110.819 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.57 -10.22 49.56 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 120.767 -1.208 . . . . 10.210000000000001 112.436 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.63 34.21 24.1 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 123.286 1.517 . . . . 16.379999999999999 110.908 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.4 tttm -139.71 120.18 9.34 Favored Pre-proline 0 C--N 1.315 -0.931 0 O-C-N 117.632 -3.168 . . . . 20.210000000000001 103.894 177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.3 152.4 60.74 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 124.23 3.287 . . . . 8.75 110.318 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.492 ' CZ ' ' H32' ' A' ' 108' ' ' GPI . 84.8 t80 -96.05 138.09 34.17 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.505 -1.665 . . . . 4.6500000000000004 106.505 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -111.51 136.85 50.12 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 120.521 1.51 . . . . 10.619999999999999 111.367 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -142.57 150.62 40.6 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 120.513 1.506 . . . . 4.3099999999999996 107.457 169.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.444 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.46 126.69 37.65 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.348 1.431 . . . . 2.6699999999999999 110.613 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.96 129.91 42.44 Favored 'General case' 0 N--CA 1.428 -1.536 0 O-C-N 125.265 1.603 . . . . 3.0800000000000001 110.624 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.04 -4.27 84.69 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 115.603 -0.726 . . . . 4.9500000000000002 114.035 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.4 tttt -83.99 -3.13 57.78 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.735 -1.45 . . . . 10.26 114.566 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.52 39.53 6.73 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.156 -1.59 . . . . 10.24 113.836 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.76 13.69 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.69 1.367 . . . . 10.56 114.69 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.34 172.65 9.25 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 108.173 -1.047 . . . . 2.4500000000000002 108.173 171.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.82 152.1 8.35 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.987 1.375 . . . . 5.5700000000000003 109.803 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.27 -35.77 67.81 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.362 -1.29 . . . . 19.109999999999999 114.473 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.71 -23.34 72.3 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 123.254 2.752 . . . . 2.9300000000000002 112.373 177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -74.52 -54.63 7.15 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.552 1.176 . . . . 7.96 111.628 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.03 -44.4 15.19 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 124.007 1.86 . . . . 15.050000000000001 111.453 173.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.38 -35.4 47.36 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.637 -1.165 . . . . 20.27 114.001 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.02 -45.64 6.22 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 119.451 -1.357 . . . . 4.04 114.668 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.53 -27.23 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 119.125 -1.03 . . . . 5.3499999999999996 109.414 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.93 -18.88 64.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.498 -2.626 . . . . 3.0299999999999998 112.386 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.4 0.2 50.34 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 118.401 -0.809 . . . . 3.4900000000000002 113.083 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.623 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.8 mtp -107.72 143.07 36.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 120.81 1.641 . . . . 3.75 109.557 -171.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.4 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.8 p -94.78 155.05 16.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.706 0.802 . . . . 2.2999999999999998 109.771 174.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.3 t -57.66 130.1 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 119.835 1.198 . . . . 2.4700000000000002 109.795 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.41 52.01 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 113.309 -1.769 . . . . 2.6099999999999999 113.041 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.623 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.4 144.74 28.6 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 121.874 0.845 . . . . 6.5300000000000002 112.608 -171.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.97 123.98 41.58 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 102.671 -3.085 . . . . 12.359999999999999 102.671 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.71 44.99 Favored 'General case' 0 C--O 1.243 0.726 0 O-C-N 126.408 2.318 . . . . 5.8399999999999999 114.261 -176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.35 122.52 43.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.564 1.649 . . . . 16.57 108.584 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.07 114.56 28.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 118.825 -2.422 . . . . 5.8600000000000003 106.76 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.3 m -98.69 120.39 39.04 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 105.814 -1.921 . . . . 5.7599999999999998 105.814 176.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.55 122.63 69.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.733 -0.84 . . . . 3.3599999999999999 108.733 -167.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.36 153.97 91.59 Favored Pre-proline 0 C--O 1.243 0.738 0 CA-C-O 117.958 -1.02 . . . . 4.9400000000000004 110.632 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.33 -35.09 90.82 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.263 2.642 . . . . 6.21 114.85 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.13 -13.76 62.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.784 1.031 . . . . 15.85 113.784 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.67 10.84 36.62 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 126.145 1.778 . . . . 11.52 111.809 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.64 -116.52 0.16 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 105.763 -1.94 . . . . 3.7000000000000002 105.763 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -102.51 3.91 38.04 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 122.045 2.202 . . . . 6.8399999999999999 115.502 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.48 -137.08 50.51 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-O 123.679 1.711 . . . . 5.9900000000000002 111.101 172.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.2 -18.8 41.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 111.708 -2.246 . . . . 10.109999999999999 111.071 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.26 -43.93 63.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.048 1.749 . . . . 13.76 112.61 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.22 -169.2 53.29 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 107.746 -2.141 . . . . 9.9800000000000004 107.746 -170.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.82 114.81 35.39 Favored Pre-proline 0 C--O 1.246 0.913 0 O-C-N 118.048 -3.031 . . . . 15.880000000000001 103.252 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -48.17 122.44 7.47 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 124.682 3.588 . . . . 11.41 110.933 -166.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.15 -26.95 3.21 Favored Glycine 0 CA--C 1.547 2.044 0 CA-C-N 111.865 -2.425 . . . . 14.199999999999999 117.389 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.88 -50.04 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 121.14 2.47 . . . . 11.06 115.045 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.6 mm -112.87 131.89 22.55 Favored Pre-proline 0 CA--C 1.516 -0.334 0 N-CA-C 103.19 -2.893 . . . . 8.0099999999999998 103.19 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.0 163.04 35.44 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.268 3.978 . . . . 6.5199999999999996 112.969 171.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 12.9 Cg_exo -55.28 144.5 71.1 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.578 2.185 . . . . 4.8200000000000003 110.31 162.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.13 27.34 16.47 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 112.9 -1.954 . . . . 7.4199999999999999 113.692 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.78 132.42 35.28 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 117.409 2.374 . . . . 2.2200000000000002 117.409 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.53 132.36 35.66 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 121.698 2.045 . . . . 4.6100000000000003 106.382 168.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -108.84 146.72 33.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 120.423 -1.423 . . . . 5.3399999999999999 110.318 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.1 120.11 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 103.729 -2.693 . . . . 3.9700000000000002 103.729 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 101' ' ' VAL . 48.9 m-85 -116.83 136.91 52.58 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.768 -1.208 . . . . 4.4199999999999999 109.539 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 33.0 t0 -103.74 112.73 25.81 Favored 'General case' 0 C--N 1.315 -0.917 1 N-CA-C 98.96 -4.459 . . . . 2.0899999999999999 98.96 173.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 99' ' ' PHE . 86.9 t -126.78 132.29 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.045 -1.434 . . . . 3.5299999999999998 110.844 -172.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -120.47 121.91 39.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.485 -2.043 . . . . 14.210000000000001 105.485 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 tp -89.09 109.2 20.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 123.659 1.695 . . . . 2.4199999999999999 107.434 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.4 mt -85.65 -43.24 13.61 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 115.128 1.529 . . . . 2.6200000000000001 115.128 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -161.9 153.56 18.79 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 113.565 -1.652 . . . . 11.710000000000001 109.151 -167.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.8 mt -120.06 133.26 55.58 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 105.153 -2.166 . . . . 4.7000000000000002 105.153 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 113.505 -1.679 . . . . 13.02 109.711 -179.726 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GPI . . . . . 0.492 ' H32' ' CZ ' ' A' ' 46' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 105.992 -2.843 . . . . 6.3300000000000001 105.992 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.42 142.51 43.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 101.754 -3.424 . . . . 6.3499999999999996 101.754 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -116.94 130.14 56.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 102.844 -3.021 . . . . 16.98 102.844 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.56 117.02 53.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 N-CA-C 103.692 -2.707 . . . . 5.5800000000000001 103.692 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.66 124.68 46.87 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 118.946 -2.346 . . . . 12.800000000000001 104.824 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.9 m -75.66 139.83 42.21 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.234 -2.166 . . . . 3.2400000000000002 115.624 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.42 -52.09 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 105.935 -1.876 . . . . 4.79 105.935 171.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.436 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.6 m -138.89 139.02 22.42 Favored Pre-proline 0 C--O 1.243 0.737 0 O-C-N 119.622 -1.924 . . . . 11.59 106.275 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.4 Cg_exo -67.69 154.77 72.41 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 123.538 2.825 . . . . 4.5499999999999998 112.194 -176.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.63 -161.16 28.94 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.169 -1.573 . . . . 2.0 109.169 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -82.41 -9.2 59.54 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 117.645 -3.268 . . . . 3.2400000000000002 113.188 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.01 9.78 76.67 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.654 -1.637 . . . . 3.3799999999999999 113.886 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -137.72 -26.57 0.96 Allowed 'General case' 0 C--O 1.241 0.631 0 CA-C-N 122.567 3.183 . . . . 26.59 114.251 -178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.54 93.96 4.95 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 119.08 -2.262 . . . . 3.02 109.544 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -104.22 142.52 24.78 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 124.969 1.418 . . . . 4.7000000000000002 109.84 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.59 146.75 68.48 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.738 2.292 . . . . 2.9399999999999999 110.636 -173.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.49 156.13 33.46 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.918 -1.492 . . . . 15.960000000000001 107.053 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.07 130.25 29.49 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 124.169 1.938 . . . . 11.69 112.819 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.24 -14.01 65.88 Favored Glycine 0 N--CA 1.421 -2.307 0 O-C-N 120.021 -1.674 . . . . 3.6299999999999999 112.845 -178.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.4 25.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 120.047 1.924 . . . . 5.9000000000000004 112.396 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.94 120.37 31.1 Favored 'General case' 0 C--O 1.25 1.101 0 O-C-N 125.305 1.628 . . . . 3.0699999999999998 111.734 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.9 m -93.5 131.04 39.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.649 1.214 . . . . 4.1100000000000003 109.856 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.02 111.38 35.92 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 N-CA-C 101.607 -3.479 . . . . 2.1600000000000001 101.607 -174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.53 154.44 40.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.842 0.829 . . . . 3.5899999999999999 112.242 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.14 145.44 30.56 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.259 -2.126 . . . . 3.1299999999999999 105.259 164.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.2 p90 -145.85 156.06 43.31 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 120.177 1.353 . . . . 2.5499999999999998 111.928 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.77 121.55 22.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 102.968 -2.975 . . . . 4.4699999999999998 102.968 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.24 131.96 10.77 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 109.198 -1.561 . . . . 3.4100000000000001 109.198 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.43 152.18 51.59 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 125.238 2.447 . . . . 18.219999999999999 110.391 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.56 164.58 22.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.694 -2.503 . . . . 5.9299999999999997 106.444 172.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.03 -20.64 40.5 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.16 -3.462 . . . . 12.33 117.624 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -87.7 5.34 40.29 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 119.634 -1.916 . . . . 7.1900000000000004 113.918 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.15 -10.23 69.82 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-O 124.009 1.894 . . . . 6.4699999999999998 113.719 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.56 124.19 22.13 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 116.616 -3.873 . . . . 21.859999999999999 110.554 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.89 130.77 37.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.415 -1.328 . . . . 16.18 107.415 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -107.67 -17.77 14.0 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.076 -1.05 . . . . 5.7300000000000004 110.811 173.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.77 155.36 3.19 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 118.121 -0.942 . . . . 6.1299999999999999 110.564 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.6 t -158.74 128.14 5.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.462 1.105 . . . . 2.9300000000000002 110.341 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.3 p -75.94 -20.65 57.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.006 -0.738 . . . . 2.2999999999999998 109.006 175.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.71 -36.65 84.57 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.698 -1.593 . . . . 10.550000000000001 106.698 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -67.64 -28.42 67.7 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.205 -1.559 . . . . 8.0199999999999996 110.906 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtm-85 -88.65 -10.03 50.03 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.859 -1.15 . . . . 10.210000000000001 112.411 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.46 34.29 24.02 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 123.329 1.538 . . . . 16.379999999999999 110.996 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -139.73 120.27 9.35 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 117.722 -3.111 . . . . 20.210000000000001 103.806 177.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -59.39 152.35 61.7 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 124.204 3.27 . . . . 8.75 110.294 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.41 ' CZ ' ' H32' ' A' ' 108' ' ' GPI . 84.8 t80 -95.99 138.15 34.03 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.47 -1.678 . . . . 4.6500000000000004 106.47 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.62 136.86 50.27 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.49 1.495 . . . . 10.619999999999999 111.316 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.6 150.62 40.56 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 120.424 1.465 . . . . 4.3099999999999996 107.372 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.444 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.48 126.63 37.65 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 120.31 1.414 . . . . 2.6699999999999999 110.583 172.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.83 129.77 41.91 Favored 'General case' 0 N--CA 1.427 -1.576 0 O-C-N 125.198 1.561 . . . . 3.0800000000000001 110.742 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.96 -4.04 84.75 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 123.874 0.75 . . . . 4.9500000000000002 113.968 176.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.12 -3.11 57.88 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 120.707 -1.467 . . . . 10.26 114.62 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.59 39.53 6.56 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.129 -1.607 . . . . 10.24 113.8 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.36 -0.84 13.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 114.701 1.371 . . . . 10.56 114.701 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.39 172.65 9.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 N-CA-C 108.078 -1.082 . . . . 2.4500000000000002 108.078 171.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.75 152.07 8.39 Favored 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.946 1.355 . . . . 5.5700000000000003 109.782 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.25 -35.85 67.87 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 114.327 -1.306 . . . . 19.109999999999999 114.393 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.65 -23.33 72.21 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-N 123.338 2.79 . . . . 2.9300000000000002 112.496 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.57 -54.62 7.13 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 118.49 1.145 . . . . 7.96 111.665 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.01 -44.45 15.12 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 123.982 1.848 . . . . 15.050000000000001 111.431 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.35 -35.31 47.65 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.531 -1.213 . . . . 20.27 114.06 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.98 -45.68 6.22 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 119.547 -1.311 . . . . 4.04 114.67 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.62 -27.15 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 O-C-N 121.382 -1.07 . . . . 5.3499999999999996 109.419 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.83 64.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.57 -2.581 . . . . 3.0299999999999998 112.35 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.49 0.36 50.02 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.107 0.78 . . . . 3.4900000000000002 113.107 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.624 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.7 mtp -107.9 143.08 37.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 120.786 1.63 . . . . 3.75 109.492 -171.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.402 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.8 p -94.82 155.04 16.97 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.604 0.762 . . . . 2.2999999999999998 109.786 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.72 130.27 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 119.917 1.235 . . . . 2.4700000000000002 109.757 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 -12.63 52.12 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 113.289 -1.778 . . . . 2.6099999999999999 113.056 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.624 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.42 144.79 28.55 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.915 0.864 . . . . 6.5300000000000002 112.558 -171.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -124.02 123.96 41.52 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 102.619 -3.104 . . . . 12.359999999999999 102.619 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.86 156.81 45.0 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.518 2.386 . . . . 5.8399999999999999 114.307 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.3 122.5 43.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.516 1.627 . . . . 16.57 108.587 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.1 114.48 28.65 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 118.822 -2.424 . . . . 5.8600000000000003 106.737 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.4 m -98.8 120.42 39.2 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 105.853 -1.906 . . . . 5.7599999999999998 105.853 176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.63 122.58 69.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 108.683 -0.858 . . . . 3.3599999999999999 108.683 -167.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.38 153.95 91.7 Favored Pre-proline 0 C--O 1.244 0.777 0 CA-C-O 117.826 -1.083 . . . . 4.9400000000000004 110.731 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.3 -35.14 90.75 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.328 2.685 . . . . 6.21 114.754 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.06 -13.9 62.43 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.883 1.068 . . . . 15.85 113.883 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.67 11.04 36.51 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 126.088 1.755 . . . . 11.52 111.74 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.76 -116.51 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.765 -1.939 . . . . 3.7000000000000002 105.765 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.64 4.15 37.96 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-N 121.99 2.177 . . . . 6.8399999999999999 115.48 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.44 -137.13 50.43 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-O 123.745 1.747 . . . . 5.9900000000000002 111.038 171.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.66 41.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 111.624 -2.288 . . . . 10.109999999999999 110.972 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.37 -43.89 63.36 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 121.093 1.77 . . . . 13.76 112.581 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.32 -169.27 53.3 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 107.607 -2.197 . . . . 9.9800000000000004 107.607 -170.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.8 114.85 35.39 Favored Pre-proline 0 C--O 1.246 0.882 0 O-C-N 118.04 -3.036 . . . . 15.880000000000001 103.292 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -48.16 122.43 7.43 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 124.61 3.54 . . . . 11.41 110.909 -166.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.19 -26.94 3.23 Favored Glycine 0 CA--C 1.547 2.038 0 CA-C-N 111.881 -2.418 . . . . 14.199999999999999 117.4 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.2 mt -102.84 -50.1 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.05 2.425 . . . . 11.06 114.992 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.7 mm -112.83 131.99 22.5 Favored Pre-proline 0 CA--C 1.516 -0.343 0 N-CA-C 103.159 -2.904 . . . . 8.0099999999999998 103.159 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.09 163.08 35.44 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 125.218 3.945 . . . . 6.5199999999999996 112.871 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.3 144.47 71.37 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.518 2.146 . . . . 4.8200000000000003 110.307 162.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.31 27.24 16.29 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 112.886 -1.961 . . . . 7.4199999999999999 113.609 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.8 132.29 35.28 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 117.36 2.356 . . . . 2.2200000000000002 117.36 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.44 132.34 35.71 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 121.686 2.039 . . . . 4.6100000000000003 106.347 168.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.7 mt -108.81 146.87 32.94 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 120.451 -1.405 . . . . 5.3399999999999999 110.274 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.19 119.97 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 103.779 -2.674 . . . . 3.9700000000000002 103.779 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' HB3' HG22 ' A' ' 101' ' ' VAL . 49.2 m-85 -116.79 137.05 52.48 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.734 -1.229 . . . . 4.4199999999999999 109.519 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.6 t0 -103.92 112.74 25.84 Favored 'General case' 0 C--N 1.315 -0.928 1 N-CA-C 98.875 -4.491 . . . . 2.0899999999999999 98.875 174.001 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.443 HG22 ' HB3' ' A' ' 99' ' ' PHE . 86.9 t -126.79 132.37 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.077 -1.42 . . . . 3.5299999999999998 110.794 -172.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.52 121.84 39.32 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.509 -2.034 . . . . 14.210000000000001 105.509 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 tp -88.95 109.06 19.92 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.536 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.46 -43.31 13.7 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.193 1.553 . . . . 2.6200000000000001 115.193 -171.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -161.85 153.56 18.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 113.534 -1.666 . . . . 11.710000000000001 109.131 -167.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.2 mt -119.98 133.19 55.63 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 105.19 -2.152 . . . . 4.7000000000000002 105.19 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.589 -1.642 . . . . 13.02 109.884 -179.828 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GPI . . . . . 0.422 ' O7 ' ' C1 ' ' A' ' 108' ' ' GPI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 N-CA-C 106.07 -2.812 . . . . 6.3300000000000001 106.07 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.26 142.58 43.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 101.723 -3.436 . . . . 6.3499999999999996 101.723 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.11 130.01 56.35 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.776 -3.046 . . . . 16.98 102.776 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.3 t -109.44 117.07 53.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 103.771 -2.677 . . . . 5.5800000000000001 103.771 -175.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.61 124.69 46.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 118.863 -2.398 . . . . 12.800000000000001 104.83 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.8 m -75.72 139.97 42.19 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 119.313 -2.117 . . . . 3.2400000000000002 115.643 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.41 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.58 -52.05 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 105.84 -1.911 . . . . 4.79 105.84 171.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.438 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.4 m -138.85 139.11 22.82 Favored Pre-proline 0 C--O 1.244 0.77 0 O-C-N 119.647 -1.908 . . . . 11.59 106.305 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.3 Cg_exo -67.71 154.75 72.41 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 123.634 2.889 . . . . 4.5499999999999998 112.174 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.7 -161.22 28.88 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.09 -1.604 . . . . 2.0 109.09 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.43 -9.15 59.55 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 117.708 -3.231 . . . . 3.2400000000000002 113.205 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.09 9.73 76.87 Favored Glycine 0 C--O 1.218 -0.851 0 CA-C-O 117.647 -1.641 . . . . 3.3799999999999999 113.884 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -137.72 -26.62 0.96 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.576 3.188 . . . . 26.59 114.251 -178.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.52 94.04 4.99 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 119.111 -2.243 . . . . 3.02 109.503 -175.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.18 142.53 24.8 Favored Pre-proline 0 C--O 1.252 1.204 0 O-C-N 125.016 1.448 . . . . 4.7000000000000002 109.867 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.548 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.5 Cg_endo -68.67 146.78 68.13 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.715 2.277 . . . . 2.9399999999999999 110.588 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.52 156.16 33.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.866 -1.516 . . . . 15.960000000000001 107.026 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.4 ttp180 -52.07 130.25 29.49 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 124.169 1.938 . . . . 11.69 112.819 174.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.33 -14.14 65.6 Favored Glycine 0 N--CA 1.422 -2.246 0 O-C-N 120.021 -1.674 . . . . 3.6299999999999999 112.755 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.37 25.17 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 120.066 1.933 . . . . 5.9000000000000004 112.357 174.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.85 120.31 30.98 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.249 1.593 . . . . 3.0699999999999998 111.684 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.53 130.99 39.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 122.65 1.214 . . . . 4.1100000000000003 109.86 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.92 111.39 35.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 N-CA-C 101.643 -3.465 . . . . 2.1600000000000001 101.643 -174.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.9 m -129.5 154.39 40.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-O 121.822 0.82 . . . . 3.5899999999999999 112.242 -172.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.06 145.43 30.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.22 -2.141 . . . . 3.1299999999999999 105.22 164.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.481 ' CZ ' ' H51' ' A' ' 108' ' ' GPI . 33.1 p90 -145.81 156.1 43.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 120.18 1.355 . . . . 2.5499999999999998 111.967 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.76 121.49 21.95 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 103.024 -2.954 . . . . 4.4699999999999998 103.024 167.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.13 131.87 10.74 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 109.251 -1.54 . . . . 3.4100000000000001 109.251 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.4 152.12 51.6 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 125.242 2.449 . . . . 18.219999999999999 110.391 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 164.59 22.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.707 -2.497 . . . . 5.9299999999999997 106.444 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -57.97 -20.65 39.72 Favored 'General case' 0 C--O 1.22 -0.469 0 O-C-N 117.197 -3.439 . . . . 12.33 117.737 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.75 5.44 39.95 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 119.642 -1.911 . . . . 7.1900000000000004 113.894 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.03 -10.26 70.07 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 123.956 1.864 . . . . 6.4699999999999998 113.807 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.53 124.23 22.24 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 116.803 -3.763 . . . . 21.859999999999999 110.556 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.89 130.84 37.11 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.403 -1.332 . . . . 16.18 107.403 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.67 -17.84 13.99 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.07 -1.052 . . . . 5.7300000000000004 110.809 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.77 155.43 3.22 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.153 -0.927 . . . . 6.1299999999999999 110.567 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -158.81 128.13 5.57 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.527 1.131 . . . . 2.9300000000000002 110.345 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 39.4 p -75.97 -20.65 57.73 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.977 -0.749 . . . . 2.2999999999999998 108.977 175.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.68 84.65 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.685 -1.598 . . . . 10.550000000000001 106.685 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -67.58 -28.57 67.87 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.215 -1.553 . . . . 8.0199999999999996 110.809 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.6 -10.12 49.81 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.9 -1.125 . . . . 10.210000000000001 112.368 176.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.62 34.22 24.11 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.349 1.547 . . . . 16.379999999999999 110.95 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -139.73 120.18 9.32 Favored Pre-proline 0 C--N 1.315 -0.934 0 O-C-N 117.627 -3.171 . . . . 20.210000000000001 103.882 178.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -59.24 152.27 61.32 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 124.274 3.316 . . . . 8.75 110.326 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -95.93 138.22 33.88 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.566 -1.642 . . . . 4.6500000000000004 106.566 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.72 136.87 50.38 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 120.584 1.538 . . . . 10.619999999999999 111.244 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.63 150.71 40.62 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 120.397 1.453 . . . . 4.3099999999999996 107.28 169.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.443 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.41 126.64 37.58 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 120.243 1.383 . . . . 2.6699999999999999 110.584 172.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 129.81 42.03 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.288 1.617 . . . . 3.0800000000000001 110.719 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.419 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.0 -4.12 84.73 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 123.865 0.745 . . . . 4.9500000000000002 114.009 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.443 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.1 -3.09 57.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.752 -1.44 . . . . 10.26 114.561 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 64.52 39.57 6.7 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 120.081 -1.637 . . . . 10.24 113.808 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.37 -0.82 13.69 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 114.684 1.365 . . . . 10.56 114.684 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.35 172.65 9.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 108.09 -1.078 . . . . 2.4500000000000002 108.09 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.79 152.04 8.38 Favored 'Isoleucine or valine' 0 C--O 1.259 1.567 0 CA-C-O 122.974 1.368 . . . . 5.5700000000000003 109.855 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.22 -35.8 67.74 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 114.442 1.275 . . . . 19.109999999999999 114.442 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.67 -23.35 72.24 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.351 2.796 . . . . 2.9300000000000002 112.415 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.58 -54.58 7.19 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 118.574 1.187 . . . . 7.96 111.643 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.0 -44.43 15.09 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 124.02 1.867 . . . . 15.050000000000001 111.514 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.36 -35.29 47.63 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.495 -1.23 . . . . 20.27 114.037 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.06 -45.73 6.17 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.571 -1.299 . . . . 4.04 114.6 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.6 t -67.46 -27.23 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 121.378 -1.072 . . . . 5.3499999999999996 109.495 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.548 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.83 64.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.506 -2.621 . . . . 3.0299999999999998 112.35 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.48 0.28 50.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.489 -0.767 . . . . 3.4900000000000002 113.057 175.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.623 ' HA ' HE22 ' A' ' 70' ' ' GLN . 87.8 mtp -107.83 143.03 36.97 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 120.831 1.65 . . . . 3.75 109.555 -171.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.402 ' H ' ' NE2' ' A' ' 70' ' ' GLN . 10.9 p -94.73 155.06 17.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.692 0.797 . . . . 2.2999999999999998 109.822 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.7 130.19 20.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 119.91 1.232 . . . . 2.4700000000000002 109.734 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.54 52.07 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.333 -1.758 . . . . 2.6099999999999999 112.989 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.623 HE22 ' HA ' ' A' ' 66' ' ' MET . 6.3 tt0 -84.39 144.69 28.63 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-O 121.874 0.845 . . . . 6.5300000000000002 112.601 -171.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.9 ttt180 -123.93 123.9 41.43 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 102.677 -3.083 . . . . 12.359999999999999 102.677 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.78 45.0 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 126.442 2.339 . . . . 5.8399999999999999 114.322 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.21 122.45 43.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 123.465 1.602 . . . . 16.57 108.59 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.07 114.49 28.66 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 118.787 -2.445 . . . . 5.8600000000000003 106.775 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.7 m -98.78 120.42 39.19 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 105.772 -1.936 . . . . 5.7599999999999998 105.772 176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.63 122.55 69.09 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 108.71 -0.848 . . . . 3.3599999999999999 108.71 -167.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.37 153.99 91.57 Favored Pre-proline 0 C--O 1.243 0.723 0 CA-C-O 117.934 -1.031 . . . . 4.9400000000000004 110.712 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.21 -35.26 90.61 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.374 2.716 . . . . 6.21 114.803 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.03 -13.87 62.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.883 1.068 . . . . 15.85 113.883 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.73 11.09 36.32 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 125.959 1.703 . . . . 11.52 111.671 175.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.82 -116.53 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.754 -1.943 . . . . 3.7000000000000002 105.754 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.61 4.1 37.98 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 122.025 2.193 . . . . 6.8399999999999999 115.511 -173.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.53 -137.12 50.5 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 123.728 1.738 . . . . 5.9900000000000002 111.048 171.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.22 -18.71 41.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 111.705 -2.247 . . . . 10.109999999999999 111.036 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.38 -43.97 63.22 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.076 1.762 . . . . 13.76 112.458 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.34 -169.19 53.39 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.693 -2.163 . . . . 9.9800000000000004 107.693 -170.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.87 114.77 35.3 Favored Pre-proline 0 C--O 1.247 0.962 0 O-C-N 118.014 -3.05 . . . . 15.880000000000001 103.215 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -48.03 122.3 7.13 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 124.72 3.613 . . . . 11.41 110.928 -166.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.3 -27.05 3.26 Favored Glycine 0 CA--C 1.546 2.022 0 CA-C-N 111.961 -2.382 . . . . 14.199999999999999 117.388 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.1 mt -102.89 -50.04 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 121.022 2.411 . . . . 11.06 114.971 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.88 131.97 22.52 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 103.178 -2.897 . . . . 8.0099999999999998 103.178 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.18 163.11 35.49 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.198 3.932 . . . . 6.5199999999999996 112.859 171.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.27 144.51 70.91 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.476 2.117 . . . . 4.8200000000000003 110.357 162.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.28 27.21 16.3 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 112.969 -1.923 . . . . 7.4199999999999999 113.618 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.8 132.4 35.28 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 117.358 2.355 . . . . 2.2200000000000002 117.358 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.47 132.41 35.7 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 121.667 2.031 . . . . 4.6100000000000003 106.347 168.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.8 mt -108.94 146.76 33.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.414 -1.429 . . . . 5.3399999999999999 110.239 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.1 t -123.08 120.02 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 103.764 -2.68 . . . . 3.9700000000000002 103.764 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.445 ' HB3' HG22 ' A' ' 101' ' ' VAL . 48.9 m-85 -116.79 136.96 52.55 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.705 -1.247 . . . . 4.4199999999999999 109.553 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.7 t0 -103.81 112.69 25.75 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.853 -4.499 . . . . 2.0899999999999999 98.853 174.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 99' ' ' PHE . 87.5 t -126.79 132.28 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.092 -1.413 . . . . 3.5299999999999998 110.836 -172.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.38 121.89 39.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 105.563 -2.014 . . . . 14.210000000000001 105.563 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.08 109.02 19.92 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 123.653 1.692 . . . . 2.4199999999999999 107.494 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.46 -43.25 13.76 Favored 'General case' 0 C--O 1.254 1.293 0 N-CA-C 115.26 1.578 . . . . 2.6200000000000001 115.26 -171.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -161.8 153.62 19.08 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 113.501 -1.681 . . . . 11.710000000000001 109.248 -167.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.08 133.21 55.58 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 105.204 -2.147 . . . . 4.7000000000000002 105.204 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.568 -1.651 . . . . 13.02 109.761 -179.719 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GPI . . . . . 0.481 ' H51' ' CZ ' ' A' ' 26' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 106.08 -2.808 . . . . 6.33 106.08 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.33 142.58 43.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 101.707 -3.442 . . . . 6.35 101.707 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -117.16 130.05 56.36 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 102.802 -3.036 . . . . 16.98 102.802 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.9 t -109.53 117.12 53.85 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 103.663 -2.717 . . . . 5.58 103.663 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.66 124.65 46.81 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 118.871 -2.393 . . . . 12.8 104.839 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.8 m -75.66 139.9 42.24 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.28 -2.138 . . . . 3.24 115.656 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.5 mt -101.51 -52.02 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.86 -1.904 . . . . 4.79 105.86 171.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.5 m -138.89 139.13 22.76 Favored Pre-proline 0 C--O 1.244 0.783 0 O-C-N 119.548 -1.97 . . . . 11.59 106.27 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.8 Cg_exo -67.86 154.84 71.93 Favored 'Trans proline' 0 C--N 1.329 -0.454 0 C-N-CA 123.546 2.83 . . . . 4.55 112.196 -176.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.72 -161.14 28.85 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.102 -1.599 . . . . 2.0 109.102 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -82.43 -9.27 59.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 117.659 -3.26 . . . . 3.24 113.165 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.07 9.77 76.86 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-O 117.71 -1.606 . . . . 3.38 113.87 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.66 -26.66 0.96 Allowed 'General case' 0 C--O 1.241 0.608 0 CA-C-N 122.593 3.196 . . . . 26.59 114.305 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.59 94.04 4.99 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 119.039 -2.288 . . . . 3.02 109.435 -175.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.2 142.52 24.78 Favored Pre-proline 0 C--O 1.252 1.211 0 O-C-N 125.007 1.442 . . . . 4.7 109.761 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.59 146.73 68.4 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.728 2.285 . . . . 2.94 110.688 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.49 156.2 33.31 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.932 -1.485 . . . . 15.96 107.121 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.6 ttp180 -52.17 130.36 30.18 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 124.263 1.982 . . . . 11.69 112.765 174.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.21 -13.97 65.97 Favored Glycine 0 N--CA 1.424 -2.122 0 O-C-N 119.919 -1.738 . . . . 3.63 112.734 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.24 149.42 25.09 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-N 120.123 1.961 . . . . 5.9 112.381 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.85 120.28 30.95 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.146 1.529 . . . . 3.07 111.799 174.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.9 m -93.43 131.02 39.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.485 1.136 . . . . 4.11 109.878 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.5 t -112.03 111.47 36.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 101.624 -3.473 . . . . 2.16 101.624 -174.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.3 m -129.63 154.39 40.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.866 0.841 . . . . 3.59 112.193 -172.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 145.45 30.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.264 -2.124 . . . . 3.13 105.264 164.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.84 156.09 43.34 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 120.128 1.331 . . . . 2.55 111.9 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.6 m -133.83 121.63 22.07 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 102.88 -3.007 . . . . 4.47 102.88 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.21 131.84 10.73 Favored Glycine 0 N--CA 1.471 0.999 0 N-CA-C 109.237 -1.545 . . . . 3.41 109.237 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.31 152.2 51.5 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 125.277 2.465 . . . . 18.22 110.421 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.56 164.59 22.82 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.694 -2.503 . . . . 5.93 106.444 172.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.08 -20.56 40.59 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 117.19 -3.444 . . . . 12.33 117.684 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -87.64 5.31 40.24 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 119.603 -1.936 . . . . 7.19 113.956 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.17 -10.42 69.74 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-O 123.896 1.831 . . . . 6.47 113.661 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.64 124.26 22.37 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 116.724 -3.809 . . . . 21.86 110.529 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.82 130.86 37.2 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 107.349 -1.352 . . . . 16.18 107.349 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.7 -17.84 13.98 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.099 -1.04 . . . . 5.73 110.809 173.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.71 155.37 3.24 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 118.08 -0.962 . . . . 6.13 110.605 176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -158.78 128.19 5.61 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.518 1.127 . . . . 2.93 110.38 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.6 p -76.1 -20.51 57.61 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.757 -0.777 . . . . 2.3 109.043 175.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.72 84.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.637 -1.616 . . . . 10.55 106.637 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.58 -28.56 67.87 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.247 -1.533 . . . . 8.02 110.827 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.6 -10.12 49.81 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 120.906 -1.121 . . . . 10.21 112.368 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.56 34.2 23.98 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 123.382 1.563 . . . . 16.38 111.007 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.3 tttm -139.65 120.21 9.39 Favored Pre-proline 0 C--O 1.247 0.928 0 O-C-N 117.698 -3.126 . . . . 20.21 103.882 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.24 152.34 60.79 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 124.234 3.29 . . . . 8.75 110.43 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -95.95 138.17 33.97 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.518 -1.66 . . . . 4.65 106.518 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.61 136.9 50.18 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 120.541 1.518 . . . . 10.62 111.313 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.67 150.71 40.55 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.458 1.481 . . . . 4.31 107.308 169.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.5 126.68 37.69 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.304 1.411 . . . . 2.67 110.549 172.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 129.84 42.14 Favored 'General case' 0 N--CA 1.426 -1.643 0 O-C-N 125.228 1.58 . . . . 3.08 110.647 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.01 -4.19 84.73 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 123.806 0.717 . . . . 4.95 114.035 176.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.7 tttt -84.13 -3.05 57.85 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.752 -1.44 . . . . 10.26 114.561 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.55 39.56 6.64 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 120.132 -1.605 . . . . 10.24 113.778 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.74 13.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 114.75 1.389 . . . . 10.56 114.75 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.42 172.67 9.31 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.057 -1.09 . . . . 2.45 108.057 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.81 152.1 8.35 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.98 1.371 . . . . 5.57 109.768 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.24 -35.88 67.88 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 114.343 -1.298 . . . . 19.11 114.386 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.62 -23.37 72.17 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-N 123.392 2.814 . . . . 2.93 112.384 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.55 -54.65 7.09 Favored 'General case' 0 C--O 1.249 1.071 0 CA-C-N 118.559 1.179 . . . . 7.96 111.575 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.04 -44.39 15.26 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 124.026 1.87 . . . . 15.05 111.467 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.37 -35.29 47.54 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.544 -1.207 . . . . 20.27 114.065 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.06 -45.72 6.18 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.502 -1.332 . . . . 4.04 114.612 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.55 -27.09 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 O-C-N 121.383 -1.069 . . . . 5.35 109.486 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.86 64.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.537 -2.602 . . . . 3.03 112.398 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.54 0.41 49.98 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 118.456 -0.783 . . . . 3.49 113.025 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.9 mtp -107.95 143.02 37.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 120.812 1.642 . . . . 3.75 109.436 -171.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.0 p -94.66 155.01 17.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.678 0.791 . . . . 2.3 109.852 174.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.68 130.19 20.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 119.88 1.218 . . . . 2.47 109.796 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.11 -12.53 52.28 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 113.35 -1.75 . . . . 2.61 113.133 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.44 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.6 tt0 -84.4 144.75 28.59 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.95 0.881 . . . . 6.53 112.567 -171.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.406 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.99 123.92 41.44 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 102.576 -3.12 . . . . 12.36 102.576 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.8 156.73 45.01 Favored 'General case' 0 C--O 1.244 0.806 0 O-C-N 126.393 2.308 . . . . 5.84 114.283 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.26 122.55 43.87 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 123.429 1.585 . . . . 16.57 108.671 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.15 114.49 28.65 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.859 -2.401 . . . . 5.86 106.745 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.4 m -98.73 120.42 39.13 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 105.766 -1.939 . . . . 5.76 105.766 176.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.5 mt -119.55 122.57 69.21 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 N-CA-C 108.712 -0.847 . . . . 3.36 108.712 -167.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.43 153.93 91.85 Favored Pre-proline 0 C--O 1.244 0.807 0 CA-C-O 117.878 -1.058 . . . . 4.94 110.676 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -55.16 -35.26 90.4 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.328 2.686 . . . . 6.21 114.829 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -69.99 -13.92 62.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.869 1.062 . . . . 15.85 113.869 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -103.69 11.05 36.44 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 126.051 1.74 . . . . 11.52 111.751 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.74 -116.39 0.16 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 105.808 -1.923 . . . . 3.7 105.808 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.68 4.16 37.85 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 122.067 2.212 . . . . 6.84 115.447 -173.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.42 -137.11 50.45 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 123.686 1.714 . . . . 5.99 111.096 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.28 -18.8 41.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 111.738 -2.231 . . . . 10.11 110.932 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.26 -43.93 63.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.129 1.786 . . . . 13.76 112.547 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.23 -169.28 53.23 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 107.76 -2.136 . . . . 9.98 107.76 -170.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.78 114.9 35.41 Favored Pre-proline 0 C--O 1.246 0.873 0 O-C-N 118.003 -3.057 . . . . 15.88 103.262 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -48.24 122.36 7.42 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.638 3.559 . . . . 11.41 110.939 -166.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.35 -27.07 3.28 Favored Glycine 0 CA--C 1.547 2.073 0 CA-C-N 111.788 -2.46 . . . . 14.2 117.374 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.8 mt -102.87 -50.05 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.041 2.421 . . . . 11.06 114.942 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.6 mm -112.9 131.83 22.6 Favored Pre-proline 0 CA--C 1.516 -0.334 0 N-CA-C 103.174 -2.899 . . . . 8.01 103.174 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.07 163.03 35.6 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.259 3.973 . . . . 6.52 112.865 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.33 144.55 71.39 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.392 2.061 . . . . 4.82 110.321 162.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.35 27.21 16.25 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 112.878 -1.965 . . . . 7.42 113.579 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.87 132.42 35.27 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 117.345 2.35 . . . . 2.22 117.345 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -80.56 132.45 35.65 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 121.695 2.043 . . . . 4.61 106.31 168.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.5 mt -108.82 146.79 33.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.321 -1.487 . . . . 5.34 110.281 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.27 119.93 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 103.743 -2.688 . . . . 3.97 103.743 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.0 m-85 -116.7 136.96 52.55 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.796 -1.19 . . . . 4.42 109.596 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.76 112.67 25.72 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.874 -4.491 . . . . 2.09 98.874 174.017 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.5 t -126.72 132.3 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 114.206 -1.361 . . . . 3.53 110.841 -172.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.44 121.91 39.56 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.578 -2.008 . . . . 14.21 105.578 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.02 109.07 19.95 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.42 107.498 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.5 -43.27 13.7 Favored 'General case' 0 C--O 1.253 1.28 0 N-CA-C 115.203 1.557 . . . . 2.62 115.203 -171.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.82 153.63 19.03 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 113.509 -1.678 . . . . 11.71 109.167 -167.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.7 mt -120.04 133.17 55.61 Favored 'General case' 0 C--O 1.251 1.165 0 N-CA-C 105.25 -2.13 . . . . 4.7 105.25 170.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.697 -1.592 . . . . 13.02 109.805 -179.746 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.695 0 N-CA-C 106.067 -2.813 . . . . 6.33 106.067 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.41 142.56 43.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 101.672 -3.455 . . . . 6.35 101.672 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -117.13 130.16 56.44 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 102.682 -3.081 . . . . 16.98 102.682 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.4 t -109.51 117.01 53.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 103.737 -2.69 . . . . 5.58 103.737 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.58 124.72 47.05 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 118.893 -2.379 . . . . 12.8 104.872 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.4 m -75.77 140.1 42.17 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 119.226 -2.171 . . . . 3.24 115.55 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.67 -52.05 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 105.832 -1.914 . . . . 4.79 105.832 171.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.8 m -138.97 139.0 22.13 Favored Pre-proline 0 C--O 1.241 0.652 0 O-C-N 119.53 -1.981 . . . . 11.59 106.331 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 30.2 Cg_exo -67.67 154.85 72.22 Favored 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.501 2.801 . . . . 4.55 112.125 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.84 -161.24 28.74 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 109.071 -1.611 . . . . 2.0 109.071 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.43 -9.1 59.57 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 117.674 -3.251 . . . . 3.24 113.258 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.07 9.78 76.86 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.639 -1.645 . . . . 3.38 113.793 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.7 -26.69 0.95 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-N 122.583 3.191 . . . . 26.59 114.244 -178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.44 94.08 5.02 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 119.049 -2.282 . . . . 3.02 109.503 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.24 142.55 24.85 Favored Pre-proline 0 C--O 1.252 1.211 0 O-C-N 124.963 1.414 . . . . 4.7 109.799 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.592 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.6 146.74 68.41 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.754 2.303 . . . . 2.94 110.6 -174.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.57 156.14 33.55 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.889 -1.505 . . . . 15.96 106.988 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.4 ttp180 -52.04 130.24 29.34 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 124.134 1.921 . . . . 11.69 112.709 174.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.36 -14.13 65.58 Favored Glycine 0 N--CA 1.423 -2.184 0 O-C-N 120.009 -1.682 . . . . 3.63 112.762 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.16 149.32 25.2 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 120.085 1.943 . . . . 5.9 112.242 174.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.8 m -89.83 120.25 30.91 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.283 1.614 . . . . 3.07 111.806 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.2 m -93.55 131.04 39.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 122.716 1.246 . . . . 4.11 109.813 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.5 t -112.0 111.41 36.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 101.593 -3.484 . . . . 2.16 101.593 -174.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.57 154.34 40.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-O 121.795 0.807 . . . . 3.59 112.243 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.42 30.57 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.129 -2.174 . . . . 3.13 105.129 164.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.0 p90 -145.74 156.11 43.4 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 120.003 1.274 . . . . 2.55 112.02 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -133.81 121.53 21.94 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 102.968 -2.975 . . . . 4.47 102.968 167.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.19 131.94 10.76 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 109.28 -1.528 . . . . 3.41 109.28 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.4 152.18 51.57 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 125.259 2.457 . . . . 18.22 110.435 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 164.59 22.9 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 111.746 -2.479 . . . . 5.93 106.38 172.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.16 -20.55 41.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 117.283 -3.385 . . . . 12.33 117.639 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.67 5.29 40.44 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.56 -1.962 . . . . 7.19 113.906 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.16 -10.34 69.77 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-O 124.04 1.911 . . . . 6.47 113.785 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.62 124.23 22.26 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 116.632 -3.864 . . . . 21.86 110.58 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.81 130.83 37.17 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.359 -1.348 . . . . 16.18 107.359 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -107.76 -17.76 14.0 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 118.998 -1.081 . . . . 5.73 110.799 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -172.71 155.5 3.28 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 118.093 -0.956 . . . . 6.13 110.652 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.87 128.08 5.51 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.428 1.091 . . . . 2.93 110.314 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 41.2 p -75.83 -20.75 57.91 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 119.866 -0.733 . . . . 2.3 109.117 175.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.63 -36.65 84.53 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.754 -1.573 . . . . 10.55 106.754 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.61 -28.5 67.8 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.253 -1.529 . . . . 8.02 110.807 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.6 mtm-85 -88.72 -9.98 50.02 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 120.914 -1.116 . . . . 10.21 112.403 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.54 34.21 23.98 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 123.316 1.531 . . . . 16.38 111.034 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.3 tttm -139.7 120.24 9.37 Favored Pre-proline 0 C--N 1.315 -0.934 0 O-C-N 117.645 -3.16 . . . . 20.21 103.879 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.27 152.3 61.28 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.269 3.313 . . . . 8.75 110.402 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -95.89 138.12 33.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.534 -1.654 . . . . 4.65 106.534 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -111.64 136.87 50.27 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.496 1.498 . . . . 10.62 111.285 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.67 150.69 40.53 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 120.397 1.453 . . . . 4.31 107.366 169.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.466 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.39 126.62 37.56 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-N 120.244 1.384 . . . . 2.67 110.617 172.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.89 129.81 42.05 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 125.217 1.573 . . . . 3.08 110.68 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.98 -4.13 84.76 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.605 -0.725 . . . . 4.95 114.044 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.09 -3.06 57.81 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 120.823 -1.398 . . . . 10.26 114.679 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.48 39.6 6.75 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.117 -1.615 . . . . 10.24 113.775 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.31 -0.88 13.71 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 114.725 1.38 . . . . 10.56 114.725 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.37 172.62 9.32 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.085 -1.08 . . . . 2.45 108.085 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.73 152.07 8.41 Favored 'Isoleucine or valine' 0 C--O 1.257 1.496 0 CA-C-O 122.937 1.351 . . . . 5.57 109.851 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.25 -35.73 67.74 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.361 -1.29 . . . . 19.11 114.466 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.73 -23.34 72.35 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-N 123.383 2.81 . . . . 2.93 112.389 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.53 -54.67 7.07 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.51 1.155 . . . . 7.96 111.633 173.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.0 -44.43 15.06 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.951 1.834 . . . . 15.05 111.461 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.36 -35.3 47.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.485 -1.234 . . . . 20.27 114.084 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.11 -45.63 6.19 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 119.471 -1.347 . . . . 4.04 114.615 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.53 -27.17 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 121.348 -1.089 . . . . 5.35 109.425 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.592 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.06 -18.83 64.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 118.538 -2.601 . . . . 3.03 112.378 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.5 0.31 50.24 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 118.439 -0.791 . . . . 3.49 113.016 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.7 mtp -107.82 143.18 36.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 120.821 1.646 . . . . 3.75 109.524 -171.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -94.79 154.93 17.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.695 0.798 . . . . 2.3 109.842 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.3 t -57.53 130.09 20.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 119.965 1.257 . . . . 2.47 109.868 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.21 -12.44 51.93 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 113.422 -1.717 . . . . 2.61 113.069 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.7 tt0 -84.4 144.8 28.55 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.883 0.849 . . . . 6.53 112.623 -171.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.9 ttt180 -124.05 124.02 41.63 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 102.588 -3.116 . . . . 12.36 102.588 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.81 44.99 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.421 2.326 . . . . 5.84 114.303 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.28 122.45 43.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.47 1.605 . . . . 16.57 108.556 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.02 114.51 28.69 Favored 'General case' 0 N--CA 1.44 -0.975 0 O-C-N 118.864 -2.398 . . . . 5.86 106.786 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.5 m -98.81 120.49 39.34 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 105.801 -1.925 . . . . 5.76 105.801 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.6 mt -119.65 122.55 69.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 108.671 -0.862 . . . . 3.36 108.671 -167.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.38 154.03 91.52 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-O 117.802 -1.094 . . . . 4.94 110.655 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.4 -35.07 91.09 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.333 2.689 . . . . 6.21 114.761 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.13 -13.88 62.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.795 1.035 . . . . 15.85 113.795 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.68 11.03 36.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 126.004 1.722 . . . . 11.52 111.734 175.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.86 -116.55 0.15 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 105.72 -1.955 . . . . 3.7 105.72 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.61 4.16 38.05 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 122.025 2.193 . . . . 6.84 115.511 -173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.45 -137.16 50.41 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-O 123.769 1.761 . . . . 5.99 111.131 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.33 -18.64 41.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 111.603 -2.299 . . . . 10.11 111.024 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.36 -43.9 63.35 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.04 1.745 . . . . 13.76 112.497 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.28 -169.16 53.38 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 107.641 -2.184 . . . . 9.98 107.641 -170.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.89 114.83 35.23 Favored Pre-proline 0 C--O 1.246 0.899 0 O-C-N 118.128 -2.984 . . . . 15.88 103.198 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -48.14 122.43 7.41 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 124.622 3.548 . . . . 11.41 110.975 -166.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.18 -26.96 3.22 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.979 -2.373 . . . . 14.2 117.412 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.0 mt -102.93 -50.02 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 121.102 2.451 . . . . 11.06 114.943 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.86 131.82 22.59 Favored Pre-proline 0 CA--C 1.516 -0.328 0 N-CA-C 103.233 -2.877 . . . . 8.01 103.233 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.08 163.01 35.7 Favored 'Trans proline' 0 C--O 1.24 0.619 0 C-N-CA 125.229 3.953 . . . . 6.52 112.909 171.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.27 144.49 71.08 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.547 2.165 . . . . 4.82 110.275 162.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.26 27.26 16.34 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 112.886 -1.961 . . . . 7.42 113.607 172.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.73 132.45 35.29 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.446 2.387 . . . . 2.22 117.446 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -80.53 132.47 35.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.737 2.062 . . . . 4.61 106.298 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.1 mt -108.99 146.69 33.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.469 -1.394 . . . . 5.34 110.24 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.0 t -123.12 120.08 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 N-CA-C 103.657 -2.72 . . . . 3.97 103.657 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.2 m-85 -116.75 136.97 52.54 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.594 -1.316 . . . . 4.42 109.608 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.5 t0 -103.8 112.65 25.7 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.911 -4.477 . . . . 2.09 98.911 174.018 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 88.0 t -126.77 132.4 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 114.194 -1.367 . . . . 3.53 110.763 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.47 121.92 39.53 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.449 -2.056 . . . . 14.21 105.449 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.13 109.06 19.97 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 123.636 1.684 . . . . 2.42 107.492 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.43 -43.33 13.71 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 115.193 1.553 . . . . 2.62 115.193 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.2 tttt -161.78 153.59 19.06 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 113.475 -1.693 . . . . 11.71 109.153 -167.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.8 mt -120.01 133.24 55.6 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 105.186 -2.153 . . . . 4.7 105.186 170.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.31 -1.141 0 CA-C-N 113.64 -1.618 . . . . 13.02 109.94 -179.848 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 106.096 -2.802 . . . . 6.33 106.096 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.31 142.62 43.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 101.693 -3.447 . . . . 6.35 101.693 176.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -117.13 130.12 56.42 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.736 -3.061 . . . . 16.98 102.736 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.57 117.2 54.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 103.58 -2.748 . . . . 5.58 103.58 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.75 124.78 47.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 118.863 -2.398 . . . . 12.8 104.757 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.3 m -75.74 139.95 42.15 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 119.3 -2.125 . . . . 3.24 115.646 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.2 mt -101.62 -51.94 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 105.837 -1.912 . . . . 4.79 105.837 171.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.4 m -138.94 138.9 22.03 Favored Pre-proline 0 C--O 1.242 0.684 0 O-C-N 119.603 -1.936 . . . . 11.59 106.347 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.9 Cg_exo -67.57 154.73 72.73 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.636 2.891 . . . . 4.55 112.191 -176.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.7 -161.13 28.86 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 109.075 -1.61 . . . . 2.0 109.075 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -82.49 -9.22 59.52 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 117.618 -3.284 . . . . 3.24 113.167 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.17 9.6 76.94 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-O 117.625 -1.653 . . . . 3.38 113.81 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.63 -26.66 0.96 Allowed 'General case' 0 C--O 1.241 0.655 0 CA-C-N 122.703 3.252 . . . . 26.59 114.189 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.45 93.95 4.95 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 119.121 -2.237 . . . . 3.02 109.496 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.22 142.49 24.72 Favored Pre-proline 0 C--O 1.25 1.122 0 O-C-N 124.975 1.422 . . . . 4.7 109.8 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.58 146.65 68.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.748 2.298 . . . . 2.94 110.674 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.44 156.09 33.48 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.899 -1.5 . . . . 15.96 107.015 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.03 130.25 29.31 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 124.118 1.913 . . . . 11.69 112.797 174.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.22 -13.88 66.11 Favored Glycine 0 N--CA 1.422 -2.296 0 O-C-N 119.978 -1.701 . . . . 3.63 112.694 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -86.24 149.41 25.1 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 120.094 1.947 . . . . 5.9 112.253 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.92 120.21 30.94 Favored 'General case' 0 C--O 1.25 1.12 0 O-C-N 125.248 1.593 . . . . 3.07 111.729 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.45 131.02 39.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.654 1.216 . . . . 4.11 109.859 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.3 t -111.92 111.31 35.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 101.67 -3.456 . . . . 2.16 101.67 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.53 154.5 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 121.885 0.85 . . . . 3.59 112.263 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.15 145.46 30.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 105.178 -2.156 . . . . 3.13 105.178 164.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.2 p90 -145.8 156.11 43.37 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 120.124 1.329 . . . . 2.55 111.988 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -133.77 121.64 22.16 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 102.948 -2.982 . . . . 4.47 102.948 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.22 131.99 10.78 Favored Glycine 0 N--CA 1.472 1.041 0 N-CA-C 109.184 -1.566 . . . . 3.41 109.184 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.5 152.09 51.68 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 125.269 2.462 . . . . 18.22 110.383 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.49 164.63 22.85 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.664 -2.516 . . . . 5.93 106.454 172.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.07 -20.64 41.06 Favored 'General case' 0 C--O 1.219 -0.512 0 O-C-N 117.262 -3.399 . . . . 12.33 117.708 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.73 5.38 40.17 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.663 -1.898 . . . . 7.19 113.893 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.24 -10.39 69.58 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-O 123.976 1.876 . . . . 6.47 113.678 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.58 124.24 22.28 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 116.628 -3.866 . . . . 21.86 110.532 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.9 130.78 37.02 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.381 -1.341 . . . . 16.18 107.381 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -107.67 -17.89 13.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.021 -1.072 . . . . 5.73 110.693 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -172.68 155.49 3.29 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 118.181 -0.914 . . . . 6.13 110.509 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.82 128.15 5.57 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.451 1.101 . . . . 2.93 110.361 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 38.1 p -76.0 -20.66 57.66 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.982 -0.748 . . . . 2.3 108.982 175.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.7 -36.61 84.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.722 -1.585 . . . . 10.55 106.722 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.71 -28.42 67.65 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.197 -1.565 . . . . 8.02 110.833 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.68 -10.08 49.75 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.89 -1.131 . . . . 10.21 112.361 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.48 34.31 24.07 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-O 123.4 1.571 . . . . 16.38 111.007 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.66 120.16 9.38 Favored Pre-proline 0 C--O 1.248 1.017 0 O-C-N 117.693 -3.129 . . . . 20.21 103.897 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -59.24 152.31 61.02 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 124.277 3.318 . . . . 8.75 110.383 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -96.0 138.11 34.1 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.541 -1.652 . . . . 4.65 106.541 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.62 136.87 50.24 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 120.539 1.518 . . . . 10.62 111.372 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.66 150.61 40.44 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.415 1.461 . . . . 4.31 107.377 169.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.47 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.44 126.68 37.63 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.297 1.408 . . . . 2.67 110.48 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.92 129.7 41.54 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 125.286 1.616 . . . . 3.08 110.723 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.11 -4.22 84.56 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.879 0.752 . . . . 4.95 113.989 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.05 -3.01 57.74 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.648 -1.501 . . . . 10.26 114.603 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.47 39.58 6.79 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.017 -1.677 . . . . 10.24 113.841 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.33 -0.84 13.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 114.736 1.384 . . . . 10.56 114.736 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.32 172.58 9.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 108.099 -1.074 . . . . 2.45 108.099 171.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.71 152.07 8.42 Favored 'Isoleucine or valine' 0 C--O 1.259 1.567 0 CA-C-O 123.026 1.393 . . . . 5.57 109.757 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.27 -35.73 67.79 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 114.391 -1.277 . . . . 19.11 114.432 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.86 -23.31 72.55 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.33 2.786 . . . . 2.93 112.304 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.62 -54.61 7.13 Favored 'General case' 0 C--O 1.249 1.071 0 CA-C-N 118.616 1.208 . . . . 7.96 111.572 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.05 -44.35 15.27 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 123.983 1.849 . . . . 15.05 111.447 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.3 -35.42 47.91 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.541 -1.208 . . . . 20.27 114.093 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.03 -45.65 6.22 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 119.497 -1.335 . . . . 4.04 114.596 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.51 -27.28 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 O-C-N 121.37 -1.076 . . . . 5.35 109.382 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.93 -18.88 64.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.688 -2.508 . . . . 3.03 112.403 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.55 0.33 50.34 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 118.448 -0.787 . . . . 3.49 112.985 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.9 mtp -107.89 143.02 37.09 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 120.791 1.632 . . . . 3.75 109.464 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 p -94.78 155.01 17.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.625 0.77 . . . . 2.3 109.762 174.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.62 130.17 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 119.841 1.2 . . . . 2.47 109.858 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.58 52.07 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 113.272 -1.785 . . . . 2.61 113.064 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.6 tt0 -84.43 144.75 28.56 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 121.907 0.86 . . . . 6.53 112.57 -171.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.97 123.93 41.47 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 102.671 -3.085 . . . . 12.36 102.671 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.8 44.99 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 126.4 2.313 . . . . 5.84 114.273 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.23 122.53 43.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.516 1.627 . . . . 16.57 108.62 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.12 114.47 28.63 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 118.854 -2.404 . . . . 5.86 106.728 -176.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 86.3 m -98.77 120.47 39.25 Favored 'General case' 0 C--O 1.247 0.925 0 N-CA-C 105.858 -1.905 . . . . 5.76 105.858 176.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.72 122.62 69.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.653 -0.869 . . . . 3.36 108.653 -167.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.36 154.08 91.34 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.861 -1.066 . . . . 4.94 110.682 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -55.48 -35.12 91.59 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.298 2.665 . . . . 6.21 114.752 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.03 -13.84 62.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.922 1.082 . . . . 15.85 113.922 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.64 11.07 36.54 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 126.009 1.723 . . . . 11.52 111.674 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.9 -116.6 0.15 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 105.739 -1.949 . . . . 3.7 105.739 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -102.59 4.11 38.04 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 122.07 2.214 . . . . 6.84 115.498 -173.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.47 -137.09 50.49 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-O 123.739 1.744 . . . . 5.99 111.136 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.69 41.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 111.686 -2.257 . . . . 10.11 111.009 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.47 -43.89 63.08 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 121.039 1.745 . . . . 13.76 112.464 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.39 -169.16 53.46 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 107.606 -2.197 . . . . 9.98 107.606 -170.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.85 114.76 35.34 Favored Pre-proline 0 C--O 1.246 0.896 0 O-C-N 117.924 -3.103 . . . . 15.88 103.253 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.14 122.35 7.3 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 124.679 3.586 . . . . 11.41 110.936 -166.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.15 -26.85 3.24 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-N 111.933 -2.394 . . . . 14.2 117.385 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.0 mt -102.99 -49.97 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 121.107 2.454 . . . . 11.06 114.938 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.4 mm -112.84 131.87 22.56 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 103.118 -2.919 . . . . 8.01 103.118 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.95 163.02 35.38 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 125.236 3.957 . . . . 6.52 112.945 171.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.31 144.41 71.84 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.571 2.181 . . . . 4.82 110.331 162.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.31 27.33 16.34 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 112.938 -1.937 . . . . 7.42 113.577 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.79 132.31 35.28 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.388 2.366 . . . . 2.22 117.388 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.37 132.42 35.77 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 121.799 2.091 . . . . 4.61 106.349 168.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -109.0 146.79 33.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.379 -1.45 . . . . 5.34 110.284 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.9 t -123.16 120.03 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 103.679 -2.711 . . . . 3.97 103.679 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.0 m-85 -116.8 137.02 52.5 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.701 -1.25 . . . . 4.42 109.577 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.8 t0 -103.8 112.72 25.79 Favored 'General case' 0 C--N 1.314 -0.95 1 N-CA-C 98.876 -4.49 . . . . 2.09 98.876 174.026 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.7 t -126.75 132.43 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.153 -1.385 . . . . 3.53 110.821 -172.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.48 121.93 39.56 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.466 -2.05 . . . . 14.21 105.466 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 tp -89.06 109.11 20.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 123.57 1.652 . . . . 2.42 107.405 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.58 -43.25 13.66 Favored 'General case' 0 C--O 1.255 1.344 0 N-CA-C 115.19 1.552 . . . . 2.62 115.19 -171.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.3 tttt -161.87 153.64 18.94 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 113.612 -1.631 . . . . 11.71 109.154 -167.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.9 mt -120.12 133.28 55.55 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 105.097 -2.186 . . . . 4.7 105.097 170.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.311 -1.082 0 CA-C-N 113.552 -1.658 . . . . 13.02 109.82 -179.812 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 106.038 -2.825 . . . . 6.33 106.038 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.28 142.6 43.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 101.745 -3.428 . . . . 6.35 101.745 176.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -117.12 130.07 56.39 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.726 -3.065 . . . . 16.98 102.726 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.57 117.11 53.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 N-CA-C 103.674 -2.713 . . . . 5.58 103.674 -175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.68 124.72 46.96 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 118.877 -2.389 . . . . 12.8 104.759 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.6 m -75.82 140.0 42.05 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.279 -2.138 . . . . 3.24 115.603 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.407 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.54 -52.03 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 105.899 -1.889 . . . . 4.79 105.899 171.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.8 m -138.86 139.01 22.45 Favored Pre-proline 0 C--O 1.243 0.737 0 O-C-N 119.518 -1.989 . . . . 11.59 106.357 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.3 Cg_exo -67.69 154.73 72.51 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 123.627 2.885 . . . . 4.55 112.23 -176.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.68 -161.22 28.9 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.09 -1.604 . . . . 2.0 109.09 175.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.54 -9.04 59.58 Favored 'General case' 0 C--O 1.241 0.628 0 O-C-N 117.639 -3.271 . . . . 3.24 113.18 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.12 9.65 76.86 Favored Glycine 0 C--O 1.218 -0.887 0 CA-C-O 117.637 -1.646 . . . . 3.38 113.874 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.62 -26.73 0.96 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 122.508 3.154 . . . . 26.59 114.241 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.4 93.98 4.97 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.072 -2.268 . . . . 3.02 109.579 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.21 142.54 24.82 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 125.023 1.452 . . . . 4.7 109.79 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.58 146.75 68.59 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.704 2.269 . . . . 2.94 110.702 -174.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.46 156.15 33.37 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.913 -1.494 . . . . 15.96 107.073 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.3 ttp180 -52.07 130.27 29.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 124.24 1.972 . . . . 11.69 112.804 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.29 -14.02 65.83 Favored Glycine 0 N--CA 1.422 -2.246 0 O-C-N 119.929 -1.732 . . . . 3.63 112.757 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -86.24 149.47 25.05 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 120.029 1.915 . . . . 5.9 112.243 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.2 m -89.97 120.29 31.05 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.312 1.633 . . . . 3.07 111.746 174.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.46 131.0 39.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 122.55 1.167 . . . . 4.11 109.891 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -111.96 111.39 35.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 101.624 -3.473 . . . . 2.16 101.624 -174.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 m -129.48 154.42 40.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.806 0.812 . . . . 3.59 112.282 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.4 30.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.187 -2.153 . . . . 3.13 105.187 164.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.0 p90 -145.79 156.1 43.36 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 120.126 1.33 . . . . 2.55 112.055 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -133.83 121.47 21.85 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 102.952 -2.981 . . . . 4.47 102.952 167.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.11 131.87 10.73 Favored Glycine 0 N--CA 1.471 0.999 0 N-CA-C 109.248 -1.541 . . . . 3.41 109.248 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.37 152.11 51.58 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 125.16 2.41 . . . . 18.22 110.481 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 164.64 22.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.745 -2.48 . . . . 5.93 106.447 172.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -58.03 -20.62 40.37 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 117.17 -3.457 . . . . 12.33 117.699 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -87.74 5.32 40.52 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 119.545 -1.972 . . . . 7.19 113.851 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.08 -10.2 69.96 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 124.013 1.896 . . . . 6.47 113.789 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.7 124.27 22.41 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 116.688 -3.831 . . . . 21.86 110.564 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.84 130.78 37.07 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.404 -1.332 . . . . 16.18 107.404 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -107.67 -17.9 13.97 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.124 -1.03 . . . . 5.73 110.667 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -172.76 155.4 3.21 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 118.087 -0.959 . . . . 6.13 110.587 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -158.76 128.12 5.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.47 1.108 . . . . 2.93 110.385 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 37.4 p -76.01 -20.67 57.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.937 -0.764 . . . . 2.3 108.937 175.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.61 -36.74 84.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.742 -1.577 . . . . 10.55 106.742 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -67.55 -28.53 67.87 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.172 -1.58 . . . . 8.02 110.807 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.68 -10.01 50.02 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 120.859 -1.15 . . . . 10.21 112.366 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.47 34.32 24.07 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-O 123.33 1.538 . . . . 16.38 110.945 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.76 120.14 9.29 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 117.594 -3.191 . . . . 20.21 103.887 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -59.22 152.27 61.14 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 124.231 3.288 . . . . 8.75 110.378 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -95.91 138.24 33.83 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.58 -1.637 . . . . 4.65 106.58 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.7 136.84 50.39 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 120.622 1.555 . . . . 10.62 111.311 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.61 150.71 40.66 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 120.466 1.485 . . . . 4.31 107.337 169.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.47 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.51 126.72 37.72 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 120.313 1.415 . . . . 2.67 110.563 172.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 129.8 41.92 Favored 'General case' 0 N--CA 1.426 -1.627 0 O-C-N 125.285 1.616 . . . . 3.08 110.639 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.97 -4.18 84.77 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.901 0.762 . . . . 4.95 114.009 176.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.03 -3.09 57.78 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.788 -1.419 . . . . 10.26 114.647 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 64.57 39.48 6.63 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.046 -1.659 . . . . 10.24 113.756 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.23 -0.79 13.8 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 114.767 1.395 . . . . 10.56 114.767 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.42 172.7 9.25 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 107.978 -1.119 . . . . 2.45 107.978 171.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.76 152.13 8.37 Favored 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.91 1.338 . . . . 5.57 109.851 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.42 -35.68 68.08 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.381 -1.282 . . . . 19.11 114.386 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.62 -23.5 72.23 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 123.333 2.788 . . . . 2.93 112.363 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.47 -54.67 7.1 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 118.535 1.168 . . . . 7.96 111.633 173.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.06 -44.43 15.37 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 124.028 1.871 . . . . 15.05 111.449 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.18 -35.49 48.63 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.639 -1.164 . . . . 20.27 114.111 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.95 -45.75 6.21 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 119.572 -1.299 . . . . 4.04 114.64 -175.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.49 -27.21 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 O-C-N 121.404 -1.056 . . . . 5.35 109.454 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.92 -18.93 64.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 118.625 -2.547 . . . . 3.03 112.343 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.49 0.27 50.35 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.454 -0.784 . . . . 3.49 113.026 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.76 143.09 36.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 120.831 1.65 . . . . 3.75 109.476 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.7 p -94.86 155.02 16.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.66 0.784 . . . . 2.3 109.8 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.1 t -57.63 130.2 20.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 119.954 1.252 . . . . 2.47 109.711 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.7 52.05 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.381 -1.736 . . . . 2.61 113.077 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.5 tt0 -84.37 144.73 28.63 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.998 0.904 . . . . 6.53 112.566 -171.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.96 123.87 41.35 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 102.65 -3.092 . . . . 12.36 102.65 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.82 156.79 45.01 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 126.501 2.376 . . . . 5.84 114.323 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.28 122.38 43.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 123.449 1.595 . . . . 16.57 108.617 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.39 28.5 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 118.85 -2.406 . . . . 5.86 106.793 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.6 m -98.69 120.47 39.17 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 105.822 -1.918 . . . . 5.76 105.822 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.72 122.68 69.34 Favored 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 108.589 -0.893 . . . . 3.36 108.589 -167.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.1 p -66.41 153.99 91.67 Favored Pre-proline 0 C--O 1.243 0.721 0 CA-C-O 117.838 -1.077 . . . . 4.94 110.77 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -55.26 -35.11 90.53 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 123.285 2.656 . . . . 6.21 114.899 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.12 -13.85 62.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.792 1.034 . . . . 15.85 113.792 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -103.67 11.0 36.55 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 126.105 1.762 . . . . 11.52 111.737 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.83 -116.58 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.693 -1.965 . . . . 3.7 105.693 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.54 4.04 38.1 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 122.036 2.198 . . . . 6.84 115.453 -173.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.49 -137.15 50.44 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-O 123.733 1.74 . . . . 5.99 111.078 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.22 -18.78 41.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 111.725 -2.238 . . . . 10.11 110.993 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.1 m -72.28 -43.98 63.46 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 121.064 1.756 . . . . 13.76 112.529 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.39 -169.25 53.39 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 107.715 -2.154 . . . . 9.98 107.715 -170.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.85 114.93 35.27 Favored Pre-proline 0 C--O 1.247 0.962 0 O-C-N 118.012 -3.052 . . . . 15.88 103.164 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -48.14 122.36 7.32 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 124.781 3.654 . . . . 11.41 110.876 -166.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.17 -26.94 3.23 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.94 -2.391 . . . . 14.2 117.416 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.6 mt -102.87 -50.16 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 121.056 2.428 . . . . 11.06 114.918 -175.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.5 mm -112.85 131.88 22.55 Favored Pre-proline 0 CA--C 1.516 -0.337 0 N-CA-C 103.209 -2.885 . . . . 8.01 103.209 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.03 163.05 35.45 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.282 3.988 . . . . 6.52 112.915 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.2 Cg_exo -55.3 144.48 71.42 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.521 2.147 . . . . 4.82 110.232 162.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.14 27.46 16.53 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 112.924 -1.943 . . . . 7.42 113.622 172.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.91 132.42 35.27 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 117.382 2.364 . . . . 2.22 117.382 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.55 132.37 35.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 121.695 2.043 . . . . 4.61 106.359 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.82 146.84 32.99 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.457 -1.402 . . . . 5.34 110.308 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.18 120.01 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 103.74 -2.689 . . . . 3.97 103.74 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.7 m-85 -116.79 136.93 52.56 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.734 -1.229 . . . . 4.42 109.553 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.6 t0 -103.78 112.77 25.86 Favored 'General case' 0 C--N 1.315 -0.933 1 N-CA-C 98.863 -4.495 . . . . 2.09 98.863 174.014 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.2 t -126.86 132.31 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 114.143 -1.39 . . . . 3.53 110.765 -172.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.42 121.99 39.74 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.45 -2.055 . . . . 14.21 105.45 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 tp -89.14 109.07 19.98 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 123.643 1.687 . . . . 2.42 107.496 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.6 mt -85.53 -43.25 13.7 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.203 1.557 . . . . 2.62 115.203 -171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.85 153.57 18.9 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.509 -1.678 . . . . 11.71 109.189 -167.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.1 mt -120.01 133.21 55.61 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 105.177 -2.157 . . . . 4.7 105.177 170.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 . . . . . 0 C--N 1.312 -1.049 0 CA-C-N 113.591 -1.641 . . . . 13.02 109.823 -179.805 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 106.024 -2.83 . . . . 6.33 106.024 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.33 142.48 43.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 101.784 -3.413 . . . . 6.35 101.784 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -116.98 130.16 56.51 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 102.807 -3.034 . . . . 16.98 102.807 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.5 t -109.54 117.04 53.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 103.718 -2.697 . . . . 5.58 103.718 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.65 124.7 46.94 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 118.927 -2.358 . . . . 12.8 104.834 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.3 m -75.7 140.03 42.25 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 119.365 -2.084 . . . . 3.24 115.68 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.9 mt -101.63 -51.92 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 105.874 -1.899 . . . . 4.79 105.874 171.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.3 m -138.93 139.06 22.45 Favored Pre-proline 0 C--O 1.242 0.704 0 O-C-N 119.572 -1.955 . . . . 11.59 106.299 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.7 Cg_exo -67.73 154.71 72.49 Favored 'Trans proline' 0 C--N 1.328 -0.522 0 C-N-CA 123.626 2.884 . . . . 4.55 112.166 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.71 -161.29 28.88 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 109.15 -1.58 . . . . 2.0 109.15 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -82.33 -9.21 59.56 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 117.677 -3.249 . . . . 3.24 113.21 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.17 9.67 77.07 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-O 117.585 -1.675 . . . . 3.38 113.799 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.62 -26.79 0.96 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.669 3.234 . . . . 26.59 114.225 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.47 94.04 4.99 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 119.111 -2.243 . . . . 3.02 109.525 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.27 142.53 24.8 Favored Pre-proline 0 C--O 1.251 1.14 0 O-C-N 124.95 1.406 . . . . 4.7 109.769 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.62 146.71 68.18 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.743 2.295 . . . . 2.94 110.671 -174.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -121.47 156.25 33.16 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.925 -1.489 . . . . 15.96 106.994 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.3 ttp180 -52.1 130.27 29.67 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 124.121 1.915 . . . . 11.69 112.831 174.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.21 -14.05 65.84 Favored Glycine 0 N--CA 1.421 -2.307 0 O-C-N 119.971 -1.706 . . . . 3.63 112.763 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.15 149.41 25.13 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.098 1.949 . . . . 5.9 112.311 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.6 m -89.97 120.42 31.16 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 125.257 1.598 . . . . 3.07 111.689 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.52 131.06 39.12 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.592 1.187 . . . . 4.11 109.799 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.4 t -112.06 111.33 35.69 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.649 -3.463 . . . . 2.16 101.649 -174.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.9 m -129.43 154.43 40.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.77 0.795 . . . . 3.59 112.313 -172.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.12 145.41 30.58 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.274 -2.121 . . . . 3.13 105.274 164.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.86 156.13 43.35 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 120.172 1.351 . . . . 2.55 111.87 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -133.86 121.48 21.82 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 102.924 -2.991 . . . . 4.47 102.924 167.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.27 131.93 10.76 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 109.173 -1.571 . . . . 3.41 109.173 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.46 152.18 51.61 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 125.291 2.472 . . . . 18.22 110.374 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 164.55 22.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 111.65 -2.523 . . . . 5.93 106.435 172.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -57.96 -20.69 39.78 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 117.263 -3.398 . . . . 12.33 117.705 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.75 5.4 40.18 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.564 -1.96 . . . . 7.19 113.874 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.36 69.71 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-O 124.113 1.952 . . . . 6.47 113.754 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.42 124.18 22.04 Favored 'General case' 0 N--CA 1.438 -1.037 0 O-C-N 116.601 -3.882 . . . . 21.86 110.686 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.91 130.79 37.01 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.37 -1.344 . . . . 16.18 107.37 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.61 -17.93 13.97 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.095 -1.042 . . . . 5.73 110.74 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.68 155.44 3.28 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 118.041 -0.98 . . . . 6.13 110.665 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -158.77 128.2 5.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.484 1.113 . . . . 2.93 110.312 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 38.9 p -76.03 -20.61 57.64 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.001 -0.74 . . . . 2.3 109.001 175.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.63 84.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.685 -1.598 . . . . 10.55 106.685 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -67.64 -28.56 67.83 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.143 -1.598 . . . . 8.02 110.827 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.3 mtm-85 -88.58 -10.04 50.14 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.861 -1.149 . . . . 10.21 112.427 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.5 34.26 24.0 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.311 1.529 . . . . 16.38 110.951 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.7 120.2 9.36 Favored Pre-proline 0 C--O 1.247 0.972 0 O-C-N 117.571 -3.206 . . . . 20.21 103.921 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -59.33 152.29 61.77 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.292 3.328 . . . . 8.75 110.276 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -95.85 138.18 33.86 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.572 -1.64 . . . . 4.65 106.572 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.67 136.88 50.3 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 120.525 1.512 . . . . 10.62 111.253 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.6 150.7 40.67 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 120.475 1.489 . . . . 4.31 107.368 169.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.466 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.46 126.61 37.62 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.324 1.42 . . . . 2.67 110.542 172.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.87 129.9 42.45 Favored 'General case' 0 N--CA 1.427 -1.576 0 O-C-N 125.33 1.644 . . . . 3.08 110.699 176.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.79 -4.02 84.92 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 123.862 0.744 . . . . 4.95 114.043 176.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.08 -3.13 57.86 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.686 -1.479 . . . . 10.26 114.633 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 64.56 39.52 6.65 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 120.012 -1.68 . . . . 10.24 113.858 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.34 -0.89 13.69 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 114.722 1.378 . . . . 10.56 114.722 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.4 172.67 9.28 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 N-CA-C 108.085 -1.08 . . . . 2.45 108.085 171.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 pt -71.82 152.17 8.32 Favored 'Isoleucine or valine' 0 C--O 1.256 1.445 0 CA-C-O 123.029 1.395 . . . . 5.57 109.725 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -56.26 -35.71 67.75 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 114.316 -1.311 . . . . 19.11 114.471 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.86 -23.22 72.53 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 123.4 2.818 . . . . 2.93 112.432 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.52 -54.76 6.89 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 118.555 1.178 . . . . 7.96 111.583 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.86 -44.43 14.36 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 124.045 1.878 . . . . 15.05 111.503 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.44 -35.35 46.98 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.564 -1.198 . . . . 20.27 114.007 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.94 -45.7 6.23 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 119.615 -1.279 . . . . 4.04 114.724 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.58 -27.18 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 119.09 -1.044 . . . . 5.35 109.425 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.85 64.71 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.541 -2.6 . . . . 3.03 112.35 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.42 0.18 50.46 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 118.425 -0.798 . . . . 3.49 113.068 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.6 mtp -107.7 143.1 36.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 120.81 1.641 . . . . 3.75 109.572 -171.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -94.84 154.96 17.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.715 0.806 . . . . 2.3 109.806 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.2 t -57.62 130.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 119.867 1.212 . . . . 2.47 109.783 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 -12.53 52.08 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 113.35 -1.75 . . . . 2.61 112.995 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.7 tt0 -84.46 144.76 28.52 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.919 0.866 . . . . 6.53 112.575 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.95 123.89 41.4 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 102.632 -3.099 . . . . 12.36 102.632 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.91 156.64 44.94 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 126.471 2.357 . . . . 5.84 114.285 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.15 122.45 43.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 123.551 1.643 . . . . 16.57 108.638 174.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.05 114.59 28.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 118.741 -2.474 . . . . 5.86 106.76 -176.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.9 m -98.74 120.44 39.18 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 105.77 -1.937 . . . . 5.76 105.77 176.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.66 122.59 69.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 108.687 -0.857 . . . . 3.36 108.687 -167.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.35 154.03 91.41 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.907 -1.044 . . . . 4.94 110.683 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -55.45 -35.09 91.39 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.355 2.704 . . . . 6.21 114.738 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.07 -13.84 62.4 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.897 1.073 . . . . 15.85 113.897 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.61 10.99 36.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 126.106 1.762 . . . . 11.52 111.692 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.86 -116.6 0.15 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 105.712 -1.958 . . . . 3.7 105.712 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.59 4.0 37.92 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-N 121.991 2.178 . . . . 6.84 115.444 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.49 -137.15 50.44 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-O 123.739 1.744 . . . . 5.99 111.032 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.29 -18.73 41.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 111.674 -2.263 . . . . 10.11 110.982 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.1 m -72.19 -43.98 63.69 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 121.131 1.787 . . . . 13.76 112.608 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.3 -169.17 53.38 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 107.652 -2.179 . . . . 9.98 107.652 -170.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -118.83 114.9 35.32 Favored Pre-proline 0 C--O 1.247 0.959 0 O-C-N 117.982 -3.069 . . . . 15.88 103.268 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.21 122.44 7.5 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.622 3.548 . . . . 11.41 110.903 -166.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.21 -26.98 3.23 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.863 -2.426 . . . . 14.2 117.416 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.6 mt -102.88 -50.04 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 121.03 2.415 . . . . 11.06 114.894 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.7 mm -112.92 131.91 22.56 Favored Pre-proline 0 CA--C 1.516 -0.328 0 N-CA-C 103.203 -2.888 . . . . 8.01 103.203 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.01 163.02 35.53 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.284 3.99 . . . . 6.52 112.918 171.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.34 144.48 71.81 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.563 2.175 . . . . 4.82 110.244 162.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.33 27.22 16.27 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 112.785 -2.007 . . . . 7.42 113.581 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.84 132.35 35.27 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 117.396 2.369 . . . . 2.22 117.396 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -80.51 132.43 35.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 121.722 2.055 . . . . 4.61 106.328 168.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.89 146.86 33.06 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.451 -1.406 . . . . 5.34 110.276 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.3 t -123.21 119.95 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 N-CA-C 103.743 -2.688 . . . . 3.97 103.743 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.6 m-85 -116.77 137.01 52.5 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.724 -1.235 . . . . 4.42 109.562 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.81 112.7 25.77 Favored 'General case' 0 C--N 1.314 -0.959 1 N-CA-C 98.91 -4.478 . . . . 2.09 98.91 173.972 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.4 t -126.8 132.33 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.12 -1.4 . . . . 3.53 110.82 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.44 121.84 39.39 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.524 -2.028 . . . . 14.21 105.524 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.09 109.01 19.92 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 123.618 1.675 . . . . 2.42 107.484 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.41 -43.34 13.72 Favored 'General case' 0 C--O 1.255 1.378 0 N-CA-C 115.175 1.546 . . . . 2.62 115.175 -171.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.405 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.5 tttt -161.79 153.59 19.05 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 113.559 -1.655 . . . . 11.71 109.229 -167.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.07 133.19 55.59 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 105.201 -2.148 . . . . 4.7 105.201 170.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.31 -1.138 0 CA-C-N 113.554 -1.657 . . . . 13.02 109.912 -179.795 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 106.073 -2.811 . . . . 6.33 106.073 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.34 142.55 43.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 101.741 -3.429 . . . . 6.35 101.741 176.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -117.05 130.13 56.46 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 102.734 -3.061 . . . . 16.98 102.734 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.9 t -109.53 117.04 53.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 103.741 -2.689 . . . . 5.58 103.741 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.62 124.72 47.01 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 118.957 -2.339 . . . . 12.8 104.824 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.4 m -75.68 140.02 42.28 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 119.292 -2.13 . . . . 3.24 115.635 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.41 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.3 mt -101.61 -52.02 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.832 -1.914 . . . . 4.79 105.832 171.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.6 m -138.95 139.03 22.27 Favored Pre-proline 0 C--O 1.241 0.652 0 O-C-N 119.5 -2.0 . . . . 11.59 106.301 177.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.7 Cg_exo -67.7 154.78 72.34 Favored 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.46 2.774 . . . . 4.55 112.201 -176.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.71 -161.17 28.86 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 109.135 -1.586 . . . . 2.0 109.135 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.49 -9.21 59.52 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 117.606 -3.291 . . . . 3.24 113.161 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.15 9.68 77.02 Favored Glycine 0 C--O 1.219 -0.8 0 CA-C-O 117.691 -1.616 . . . . 3.38 113.846 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.67 -26.58 0.96 Allowed 'General case' 0 C--O 1.24 0.587 0 CA-C-N 122.592 3.196 . . . . 26.59 114.214 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.57 94.0 4.96 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 119.057 -2.277 . . . . 3.02 109.45 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.13 142.53 24.81 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 125.01 1.444 . . . . 4.7 109.798 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.56 146.76 68.69 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.754 2.303 . . . . 2.94 110.627 -174.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.48 156.09 33.53 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.919 -1.491 . . . . 15.96 107.047 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.465 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.03 130.23 29.28 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 124.189 1.947 . . . . 11.69 112.721 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.36 -14.08 65.67 Favored Glycine 0 N--CA 1.423 -2.21 0 O-C-N 119.952 -1.717 . . . . 3.63 112.713 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.12 149.36 25.18 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.061 1.93 . . . . 5.9 112.326 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.92 120.36 31.08 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.176 1.548 . . . . 3.07 111.766 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.51 130.94 39.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 122.606 1.193 . . . . 4.11 109.874 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.3 t -111.89 111.39 35.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.638 -3.467 . . . . 2.16 101.638 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.54 154.39 40.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 121.817 0.817 . . . . 3.59 112.262 -172.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.04 145.49 30.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.173 -2.158 . . . . 3.13 105.173 164.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.1 p90 -145.89 156.11 43.33 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 120.048 1.294 . . . . 2.55 112.038 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.8 m -133.84 121.63 22.06 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 102.88 -3.007 . . . . 4.47 102.88 167.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.24 131.94 10.76 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 109.22 -1.552 . . . . 3.41 109.22 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.4 152.12 51.6 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 125.198 2.427 . . . . 18.22 110.405 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 164.62 22.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.741 -2.481 . . . . 5.93 106.447 172.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -58.04 -20.58 40.22 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.238 -3.414 . . . . 12.33 117.708 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.75 5.3 40.65 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.59 -1.943 . . . . 7.19 113.914 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.23 -10.33 69.62 Favored Glycine 0 C--N 1.357 1.697 0 CA-C-O 123.956 1.864 . . . . 6.47 113.646 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.59 124.22 22.23 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 116.622 -3.869 . . . . 21.86 110.583 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -77.77 130.83 37.21 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.457 -1.312 . . . . 16.18 107.457 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.71 -17.87 13.97 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.075 -1.05 . . . . 5.73 110.802 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -172.76 155.49 3.24 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 118.241 -0.885 . . . . 6.13 110.55 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.81 128.05 5.54 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.48 1.112 . . . . 2.93 110.371 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 40.3 p -75.89 -20.59 57.92 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.846 -0.741 . . . . 2.3 109.093 175.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.73 -36.69 84.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.696 -1.594 . . . . 10.55 106.696 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -67.62 -28.49 67.78 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.191 -1.568 . . . . 8.02 110.812 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.63 -10.1 49.81 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 120.854 -1.154 . . . . 10.21 112.341 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.51 34.28 24.05 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.346 1.546 . . . . 16.38 111.017 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.68 120.18 9.37 Favored Pre-proline 0 C--O 1.247 0.972 0 O-C-N 117.627 -3.171 . . . . 20.21 103.914 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -59.32 152.28 61.72 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 124.321 3.347 . . . . 8.75 110.32 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -95.84 138.13 33.92 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.534 -1.654 . . . . 4.65 106.534 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -111.61 136.89 50.2 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 120.572 1.533 . . . . 10.62 111.297 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.66 150.7 40.55 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.402 1.456 . . . . 4.31 107.373 169.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.51 126.67 37.7 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 120.311 1.414 . . . . 2.67 110.585 172.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 129.86 42.19 Favored 'General case' 0 N--CA 1.426 -1.643 0 O-C-N 125.251 1.594 . . . . 3.08 110.647 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.93 -4.12 84.8 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 123.841 0.734 . . . . 4.95 114.099 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.1 -3.12 57.86 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.797 -1.414 . . . . 10.26 114.561 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.51 39.62 6.69 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.106 -1.621 . . . . 10.24 113.784 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.38 -0.81 13.69 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 114.676 1.361 . . . . 10.56 114.676 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.37 172.63 9.33 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.118 -1.067 . . . . 2.45 108.118 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.2 pt -71.82 152.12 8.34 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.98 1.371 . . . . 5.57 109.785 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -56.22 -35.75 67.69 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.354 -1.294 . . . . 19.11 114.458 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.76 -23.31 72.38 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.423 2.828 . . . . 2.93 112.357 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.59 -54.68 7.0 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 118.621 1.21 . . . . 7.96 111.611 173.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -45.93 -44.45 14.74 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 124.015 1.864 . . . . 15.05 111.512 173.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.33 -35.31 47.77 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.517 -1.22 . . . . 20.27 114.084 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.05 -45.65 6.21 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.424 -1.37 . . . . 4.04 114.663 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.47 -27.25 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 121.317 -1.108 . . . . 5.35 109.456 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.95 -18.89 64.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.506 -2.621 . . . . 3.03 112.363 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.48 0.34 50.04 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.078 0.77 . . . . 3.49 113.078 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.9 mtp -107.88 143.08 36.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 120.765 1.62 . . . . 3.75 109.493 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -94.71 154.92 17.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.714 0.805 . . . . 2.3 109.877 174.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -57.58 130.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 119.965 1.257 . . . . 2.47 109.828 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.12 -12.54 52.26 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 113.366 -1.743 . . . . 2.61 113.124 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.444 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.7 tt0 -84.48 144.8 28.49 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.915 0.864 . . . . 6.53 112.605 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -124.01 123.99 41.57 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 102.578 -3.119 . . . . 12.36 102.578 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.82 45.01 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.467 2.354 . . . . 5.84 114.292 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.28 122.39 43.59 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.463 1.601 . . . . 16.57 108.651 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.59 28.82 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.847 -2.408 . . . . 5.86 106.709 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 86.2 m -98.79 120.47 39.28 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 105.822 -1.918 . . . . 5.76 105.822 176.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.73 122.55 69.01 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 108.616 -0.883 . . . . 3.36 108.616 -167.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.34 154.02 91.43 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-O 117.787 -1.101 . . . . 4.94 110.737 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.4 -35.08 91.11 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.312 2.675 . . . . 6.21 114.749 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.17 -13.83 62.36 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 113.777 1.029 . . . . 15.85 113.777 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.69 11.05 36.45 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 126.038 1.735 . . . . 11.52 111.693 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.79 -116.54 0.15 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 105.751 -1.944 . . . . 3.7 105.751 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.73 4.22 37.8 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 122.033 2.197 . . . . 6.84 115.452 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.36 -137.18 50.33 Favored Glycine 0 C--N 1.354 1.578 0 CA-C-O 123.708 1.727 . . . . 5.99 111.073 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.17 -18.75 41.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 111.661 -2.27 . . . . 10.11 111.047 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.25 -43.98 63.53 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 121.048 1.749 . . . . 13.76 112.575 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.4 -169.24 53.4 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 107.603 -2.199 . . . . 9.98 107.603 -170.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.87 114.9 35.23 Favored Pre-proline 0 C--O 1.246 0.913 0 O-C-N 118.097 -3.002 . . . . 15.88 103.151 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.13 122.43 7.4 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.667 3.578 . . . . 11.41 110.901 -166.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.17 -27.05 3.2 Favored Glycine 0 CA--C 1.545 1.935 0 CA-C-N 111.897 -2.41 . . . . 14.2 117.454 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.9 mt -102.85 -50.08 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.046 2.423 . . . . 11.06 114.972 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.84 131.93 22.52 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 103.124 -2.917 . . . . 8.01 103.124 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.09 163.08 35.43 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 125.218 3.945 . . . . 6.52 112.871 171.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.511 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.3 Cg_exo -55.4 144.54 72.21 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.428 2.085 . . . . 4.82 110.311 162.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.19 27.26 16.38 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 112.886 -1.961 . . . . 7.42 113.722 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.67 132.36 35.29 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 117.381 2.363 . . . . 2.22 117.381 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.47 132.46 35.71 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 121.796 2.089 . . . . 4.61 106.348 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -108.94 146.78 33.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 120.379 -1.45 . . . . 5.34 110.241 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.17 120.01 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 103.768 -2.679 . . . . 3.97 103.768 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.6 m-85 -116.76 136.95 52.55 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.724 -1.235 . . . . 4.42 109.591 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.8 t0 -103.75 112.7 25.77 Favored 'General case' 0 C--N 1.313 -1.0 1 N-CA-C 98.925 -4.472 . . . . 2.09 98.925 173.979 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.6 t -126.82 132.34 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.212 -1.358 . . . . 3.53 110.804 -172.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -120.47 121.9 39.5 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.464 -2.05 . . . . 14.21 105.464 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.6 tp -89.05 109.04 19.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 123.606 1.67 . . . . 2.42 107.516 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.46 -43.26 13.74 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.181 1.549 . . . . 2.62 115.181 -171.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.8 153.58 19.02 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 113.503 -1.68 . . . . 11.71 109.115 -167.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.04 133.24 55.59 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 105.206 -2.146 . . . . 4.7 105.206 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.582 -1.645 . . . . 13.02 109.912 -179.84 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 106.082 -2.807 . . . . 6.33 106.082 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.36 142.54 43.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 101.712 -3.44 . . . . 6.35 101.712 176.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -117.06 130.11 56.44 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 102.824 -3.028 . . . . 16.98 102.824 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.1 t -109.49 117.12 53.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 103.67 -2.715 . . . . 5.58 103.67 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.63 124.68 46.92 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 118.949 -2.345 . . . . 12.8 104.83 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.6 m -75.66 139.96 42.27 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.333 -2.105 . . . . 3.24 115.621 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.5 mt -101.66 -52.01 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 105.82 -1.919 . . . . 4.79 105.82 171.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.5 m -138.93 139.1 22.58 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 119.652 -1.905 . . . . 11.59 106.233 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.3 Cg_exo -67.66 154.76 72.49 Favored 'Trans proline' 0 C--N 1.33 -0.433 0 C-N-CA 123.568 2.846 . . . . 4.55 112.224 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.68 -161.08 28.88 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.106 -1.597 . . . . 2.0 109.106 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -82.55 -9.17 59.52 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 117.694 -3.239 . . . . 3.24 113.146 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.1 9.77 76.98 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.636 -1.647 . . . . 3.38 113.843 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.74 -26.66 0.95 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.592 3.196 . . . . 26.59 114.226 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 m -105.52 94.03 4.98 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 119.143 -2.223 . . . . 3.02 109.439 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.21 142.5 24.75 Favored Pre-proline 0 C--O 1.25 1.091 0 O-C-N 125.003 1.439 . . . . 4.7 109.77 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.53 146.59 68.31 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.789 2.326 . . . . 2.94 110.682 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.42 156.18 33.25 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.895 -1.502 . . . . 15.96 106.99 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.6 ttp180 -52.17 130.31 30.06 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 124.201 1.953 . . . . 11.69 112.828 174.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.28 -13.96 65.94 Favored Glycine 0 N--CA 1.424 -2.147 0 O-C-N 120.009 -1.682 . . . . 3.63 112.682 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.47 25.09 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 120.111 1.956 . . . . 5.9 112.356 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.9 m -89.89 120.31 31.01 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.308 1.63 . . . . 3.07 111.726 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.55 131.05 39.17 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.614 1.197 . . . . 4.11 109.851 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -112.0 111.41 36.04 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.643 -3.466 . . . . 2.16 101.643 -174.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.1 m -129.6 154.4 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.89 0.852 . . . . 3.59 112.249 -172.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.05 145.39 30.54 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.258 -2.127 . . . . 3.13 105.258 164.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.8 156.19 43.42 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 120.173 1.351 . . . . 2.55 111.923 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.4 m -133.86 121.54 21.91 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 102.99 -2.967 . . . . 4.47 102.99 167.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.2 131.95 10.77 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 109.3 -1.52 . . . . 3.41 109.3 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.39 152.19 51.56 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 125.263 2.459 . . . . 18.22 110.381 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.6 164.66 22.73 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.706 -2.497 . . . . 5.93 106.408 172.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -58.11 -20.64 41.69 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 117.28 -3.387 . . . . 12.33 117.67 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.57 5.21 40.45 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 119.536 -1.977 . . . . 7.19 113.927 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.22 -10.24 69.65 Favored Glycine 0 C--N 1.354 1.54 0 CA-C-O 123.973 1.874 . . . . 6.47 113.67 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.67 124.32 22.54 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 116.728 -3.807 . . . . 21.86 110.583 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.97 130.76 36.93 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.383 -1.34 . . . . 16.18 107.383 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.56 -17.9 13.98 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.142 -1.023 . . . . 5.73 110.845 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -172.71 155.44 3.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.064 -0.97 . . . . 6.13 110.614 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -158.82 128.17 5.58 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.421 1.088 . . . . 2.93 110.284 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.2 p -75.97 -20.74 57.66 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.841 -0.743 . . . . 2.3 109.006 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.63 -36.67 84.6 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.674 -1.602 . . . . 10.55 106.674 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.59 -28.47 67.79 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.191 -1.568 . . . . 8.02 110.881 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.67 -10.11 49.69 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 120.847 -1.158 . . . . 10.21 112.331 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.49 34.32 24.1 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-O 123.4 1.571 . . . . 16.38 110.989 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.69 120.2 9.36 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 117.703 -3.123 . . . . 20.21 103.926 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -59.24 152.26 61.35 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 124.209 3.273 . . . . 8.75 110.383 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -95.86 138.31 33.69 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.518 -1.66 . . . . 4.65 106.518 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.76 136.78 50.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.588 1.54 . . . . 10.62 111.326 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -142.56 150.59 40.57 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 120.437 1.472 . . . . 4.31 107.442 169.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.468 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.47 126.71 37.68 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.365 1.439 . . . . 2.67 110.634 172.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.87 129.83 42.14 Favored 'General case' 0 N--CA 1.428 -1.56 0 O-C-N 125.32 1.637 . . . . 3.08 110.654 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.87 -4.06 84.85 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 123.9 0.762 . . . . 4.95 114.093 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.11 -3.01 57.79 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.765 -1.432 . . . . 10.26 114.64 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.51 39.55 6.72 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.045 -1.659 . . . . 10.24 113.795 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.73 13.7 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 114.671 1.36 . . . . 10.56 114.671 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.46 172.68 9.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 N-CA-C 107.938 -1.134 . . . . 2.45 107.938 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 pt -71.77 152.12 8.37 Favored 'Isoleucine or valine' 0 C--O 1.259 1.604 0 CA-C-O 122.944 1.354 . . . . 5.57 109.765 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.34 -35.73 67.96 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 114.401 -1.272 . . . . 19.11 114.395 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.78 -23.34 72.42 Favored Glycine 0 CA--C 1.539 1.583 0 O-C-N 118.226 -2.796 . . . . 2.93 112.344 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.62 -54.55 7.23 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 118.556 1.178 . . . . 7.96 111.628 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.99 -44.45 15.03 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 124.015 1.864 . . . . 15.05 111.502 173.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.35 -35.25 47.71 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.544 -1.207 . . . . 20.27 114.101 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.04 -45.75 6.18 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.534 -1.317 . . . . 4.04 114.623 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.51 -27.22 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 121.338 -1.095 . . . . 5.35 109.425 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.97 -18.8 64.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 118.531 -2.606 . . . . 3.03 112.439 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.52 0.25 50.54 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.468 -0.777 . . . . 3.49 113.026 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.8 143.05 36.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 120.852 1.66 . . . . 3.75 109.577 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -94.77 154.96 17.03 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.693 0.797 . . . . 2.3 109.86 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.2 t -57.62 130.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 119.957 1.253 . . . . 2.47 109.763 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.15 -12.46 52.12 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 113.311 -1.768 . . . . 2.61 113.049 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.441 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.8 tt0 -84.48 144.77 28.51 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-O 121.854 0.835 . . . . 6.53 112.562 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.97 123.98 41.58 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 102.626 -3.102 . . . . 12.36 102.626 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.91 156.82 44.97 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.472 2.357 . . . . 5.84 114.221 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.36 122.42 43.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 123.443 1.592 . . . . 16.57 108.699 174.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.98 114.4 28.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 O-C-N 118.841 -2.412 . . . . 5.86 106.797 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.6 m -98.68 120.51 39.24 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 105.855 -1.905 . . . . 5.76 105.855 176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.63 122.61 69.25 Favored 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 108.714 -0.847 . . . . 3.36 108.714 -167.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.38 154.03 91.52 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.915 -1.04 . . . . 4.94 110.739 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.32 -35.19 90.99 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 123.268 2.645 . . . . 6.21 114.786 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -69.95 -13.96 62.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.927 1.084 . . . . 15.85 113.927 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.6 11.06 36.61 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 126.113 1.765 . . . . 11.52 111.757 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.79 -116.62 0.15 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 105.786 -1.931 . . . . 3.7 105.786 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -102.51 3.94 38.08 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 122.032 2.196 . . . . 6.84 115.545 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.58 -137.17 50.48 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-O 123.757 1.754 . . . . 5.99 111.011 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.64 41.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 111.622 -2.289 . . . . 10.11 110.983 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.26 -44.09 63.34 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 121.112 1.778 . . . . 13.76 112.529 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.4 -169.19 53.44 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.659 -2.177 . . . . 9.98 107.659 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.81 114.8 35.4 Favored Pre-proline 0 C--O 1.247 0.922 0 O-C-N 117.999 -3.06 . . . . 15.88 103.323 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -48.19 122.47 7.52 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 124.707 3.605 . . . . 11.41 110.89 -166.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.19 -26.97 3.23 Favored Glycine 0 CA--C 1.547 2.079 0 CA-C-N 111.87 -2.423 . . . . 14.2 117.361 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.1 mt -102.96 -50.04 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 121.074 2.437 . . . . 11.06 114.917 -175.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.95 131.92 22.57 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 103.17 -2.9 . . . . 8.01 103.17 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.0 163.07 35.32 Favored 'Trans proline' 0 C--O 1.24 0.592 1 C-N-CA 125.34 4.027 . . . . 6.52 112.853 171.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.34 144.45 71.94 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.534 2.156 . . . . 4.82 110.307 162.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.32 27.3 16.32 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 112.846 -1.979 . . . . 7.42 113.562 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.86 132.35 35.27 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 117.392 2.367 . . . . 2.22 117.392 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -80.57 132.45 35.65 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 121.696 2.043 . . . . 4.61 106.283 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.88 146.78 33.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.442 -1.411 . . . . 5.34 110.285 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.19 119.96 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 103.78 -2.674 . . . . 3.97 103.78 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.4 m-85 -116.81 137.09 52.45 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.77 -1.206 . . . . 4.42 109.541 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.81 112.73 25.81 Favored 'General case' 0 C--N 1.314 -0.975 1 N-CA-C 98.912 -4.477 . . . . 2.09 98.912 174.019 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.5 t -126.72 132.36 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.109 -1.405 . . . . 3.53 110.805 -172.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.49 121.82 39.29 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.57 -2.011 . . . . 14.21 105.57 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 tp -89.02 109.11 19.99 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.42 107.498 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.9 mt -85.47 -43.34 13.67 Favored 'General case' 0 C--O 1.254 1.34 0 N-CA-C 115.255 1.576 . . . . 2.62 115.255 -171.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.86 153.54 18.84 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.422 -1.717 . . . . 11.71 109.153 -167.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.0 133.28 55.59 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 105.155 -2.165 . . . . 4.7 105.155 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.313 -1.018 0 CA-C-N 113.548 -1.66 . . . . 13.02 109.8 -179.798 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 106.034 -2.826 . . . . 6.33 106.034 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.31 142.46 43.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 101.725 -3.435 . . . . 6.35 101.725 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -116.92 130.21 56.55 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 102.818 -3.03 . . . . 16.98 102.818 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.8 t -109.71 117.1 53.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 103.613 -2.736 . . . . 5.58 103.613 -175.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.61 124.65 46.85 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 118.919 -2.363 . . . . 12.8 104.82 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.7 m -75.57 139.97 42.41 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.183 -2.198 . . . . 3.24 115.598 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.7 mt -101.64 -52.07 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 105.844 -1.91 . . . . 4.79 105.844 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.7 m -138.9 139.03 22.4 Favored Pre-proline 0 C--O 1.243 0.723 0 O-C-N 119.684 -1.885 . . . . 11.59 106.358 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.7 Cg_exo -67.66 154.78 72.44 Favored 'Trans proline' 0 C--N 1.329 -0.48 0 C-N-CA 123.536 2.824 . . . . 4.55 112.15 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.63 -161.1 28.93 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 109.222 -1.551 . . . . 2.0 109.222 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.49 -9.21 59.52 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 117.65 -3.265 . . . . 3.24 113.163 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.14 9.69 76.98 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-O 117.585 -1.675 . . . . 3.38 113.806 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.63 -26.81 0.96 Allowed 'General case' 0 C--O 1.24 0.568 0 CA-C-N 122.669 3.234 . . . . 26.59 114.208 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.38 93.92 4.93 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 119.101 -2.249 . . . . 3.02 109.602 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -104.22 142.46 24.65 Favored Pre-proline 0 C--O 1.25 1.08 0 O-C-N 125.005 1.441 . . . . 4.7 109.82 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.48 146.67 68.91 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.704 2.27 . . . . 2.94 110.657 -174.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.46 156.29 33.08 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.836 -1.529 . . . . 15.96 106.962 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.24 130.27 30.21 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 124.253 1.977 . . . . 11.69 112.764 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.3 -14.08 65.72 Favored Glycine 0 N--CA 1.424 -2.159 0 O-C-N 119.999 -1.688 . . . . 3.63 112.766 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -86.18 149.43 25.11 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.095 1.948 . . . . 5.9 112.333 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.95 120.29 31.04 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 125.308 1.63 . . . . 3.07 111.729 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.3 m -93.57 131.09 39.17 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 122.616 1.198 . . . . 4.11 109.827 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -111.99 111.5 36.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 N-CA-C 101.625 -3.472 . . . . 2.16 101.625 -174.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.58 154.42 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.82 0.819 . . . . 3.59 112.3 -172.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.46 30.52 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.215 -2.143 . . . . 3.13 105.215 164.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.82 156.17 43.4 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 120.04 1.291 . . . . 2.55 111.927 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.79 121.57 22.03 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 102.929 -2.989 . . . . 4.47 102.929 167.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.22 131.93 10.76 Favored Glycine 0 N--CA 1.471 1.013 0 N-CA-C 109.192 -1.563 . . . . 3.41 109.192 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.38 152.13 51.58 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 125.142 2.401 . . . . 18.22 110.435 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 164.56 22.85 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 111.797 -2.456 . . . . 5.93 106.384 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.08 -20.54 40.39 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.242 -3.411 . . . . 12.33 117.684 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -87.75 5.29 40.67 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 119.659 -1.901 . . . . 7.19 113.885 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.22 69.72 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-O 123.966 1.87 . . . . 6.47 113.684 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.65 124.2 22.2 Favored 'General case' 0 N--CA 1.438 -1.045 0 O-C-N 116.678 -3.836 . . . . 21.86 110.593 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.81 130.81 37.14 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 107.477 -1.305 . . . . 16.18 107.477 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -107.62 -17.88 13.98 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.041 -1.064 . . . . 5.73 110.913 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.68 155.5 3.3 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 118.16 -0.924 . . . . 6.13 110.504 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.85 128.16 5.55 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.451 1.101 . . . . 2.93 110.328 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 38.6 p -75.97 -20.59 57.77 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.827 -0.749 . . . . 2.3 109.052 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.86 -36.54 84.25 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.639 -1.615 . . . . 10.55 106.639 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -67.74 -28.4 67.6 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.219 -1.551 . . . . 8.02 110.819 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.57 -10.22 49.56 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 120.767 -1.208 . . . . 10.21 112.436 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.63 34.21 24.1 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 123.286 1.517 . . . . 16.38 110.908 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.4 tttm -139.71 120.18 9.34 Favored Pre-proline 0 C--N 1.315 -0.931 0 O-C-N 117.632 -3.168 . . . . 20.21 103.894 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.3 152.4 60.74 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 124.23 3.287 . . . . 8.75 110.318 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -96.05 138.09 34.17 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.505 -1.665 . . . . 4.65 106.505 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -111.51 136.85 50.12 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 120.521 1.51 . . . . 10.62 111.367 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -142.57 150.62 40.6 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 120.513 1.506 . . . . 4.31 107.457 169.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.46 126.69 37.65 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.348 1.431 . . . . 2.67 110.613 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.96 129.91 42.44 Favored 'General case' 0 N--CA 1.428 -1.536 0 O-C-N 125.265 1.603 . . . . 3.08 110.624 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.04 -4.27 84.69 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 115.603 -0.726 . . . . 4.95 114.035 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.4 tttt -83.99 -3.13 57.78 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.735 -1.45 . . . . 10.26 114.566 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.52 39.53 6.73 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.156 -1.59 . . . . 10.24 113.836 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.76 13.69 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.69 1.367 . . . . 10.56 114.69 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.34 172.65 9.25 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 108.173 -1.047 . . . . 2.45 108.173 171.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.82 152.1 8.35 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.987 1.375 . . . . 5.57 109.803 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.27 -35.77 67.81 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.362 -1.29 . . . . 19.11 114.473 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.71 -23.34 72.3 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 123.254 2.752 . . . . 2.93 112.373 177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -74.52 -54.63 7.15 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.552 1.176 . . . . 7.96 111.628 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.03 -44.4 15.19 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 124.007 1.86 . . . . 15.05 111.453 173.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.38 -35.4 47.36 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.637 -1.165 . . . . 20.27 114.001 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.02 -45.64 6.22 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 119.451 -1.357 . . . . 4.04 114.668 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.53 -27.23 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 119.125 -1.03 . . . . 5.35 109.414 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.589 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.93 -18.88 64.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.498 -2.626 . . . . 3.03 112.386 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.4 0.2 50.34 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 118.401 -0.809 . . . . 3.49 113.083 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.72 143.07 36.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 120.81 1.641 . . . . 3.75 109.557 -171.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 p -94.78 155.05 16.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.706 0.802 . . . . 2.3 109.771 174.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.3 t -57.66 130.1 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 119.835 1.198 . . . . 2.47 109.795 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.41 52.01 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 113.309 -1.769 . . . . 2.61 113.041 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.44 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.5 tt0 -84.4 144.74 28.6 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 121.874 0.845 . . . . 6.53 112.608 -171.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.97 123.98 41.58 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 102.671 -3.085 . . . . 12.36 102.671 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.71 44.99 Favored 'General case' 0 C--O 1.243 0.726 0 O-C-N 126.408 2.318 . . . . 5.84 114.261 -176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.35 122.52 43.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.564 1.649 . . . . 16.57 108.584 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.07 114.56 28.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 118.825 -2.422 . . . . 5.86 106.76 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 86.3 m -98.69 120.39 39.04 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 105.814 -1.921 . . . . 5.76 105.814 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.55 122.63 69.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.733 -0.84 . . . . 3.36 108.733 -167.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.36 153.97 91.59 Favored Pre-proline 0 C--O 1.243 0.738 0 CA-C-O 117.958 -1.02 . . . . 4.94 110.632 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.33 -35.09 90.82 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.263 2.642 . . . . 6.21 114.85 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.13 -13.76 62.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.784 1.031 . . . . 15.85 113.784 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.67 10.84 36.62 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 126.145 1.778 . . . . 11.52 111.809 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.64 -116.52 0.16 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 105.763 -1.94 . . . . 3.7 105.763 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -102.51 3.91 38.04 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 122.045 2.202 . . . . 6.84 115.502 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.48 -137.08 50.51 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-O 123.679 1.711 . . . . 5.99 111.101 172.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.2 -18.8 41.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 111.708 -2.246 . . . . 10.11 111.071 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.26 -43.93 63.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.048 1.749 . . . . 13.76 112.61 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.22 -169.2 53.29 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 107.746 -2.141 . . . . 9.98 107.746 -170.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.82 114.81 35.39 Favored Pre-proline 0 C--O 1.246 0.913 0 O-C-N 118.048 -3.031 . . . . 15.88 103.252 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -48.17 122.44 7.47 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 124.682 3.588 . . . . 11.41 110.933 -166.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.15 -26.95 3.21 Favored Glycine 0 CA--C 1.547 2.044 0 CA-C-N 111.865 -2.425 . . . . 14.2 117.389 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.88 -50.04 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 121.14 2.47 . . . . 11.06 115.045 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.6 mm -112.87 131.89 22.55 Favored Pre-proline 0 CA--C 1.516 -0.334 0 N-CA-C 103.19 -2.893 . . . . 8.01 103.19 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.0 163.04 35.44 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.268 3.978 . . . . 6.52 112.969 171.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.518 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 12.9 Cg_exo -55.28 144.5 71.1 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.578 2.185 . . . . 4.82 110.31 162.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.13 27.34 16.47 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 112.9 -1.954 . . . . 7.42 113.692 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.78 132.42 35.28 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 117.409 2.374 . . . . 2.22 117.409 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.53 132.36 35.66 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 121.698 2.045 . . . . 4.61 106.382 168.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -108.84 146.72 33.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 120.423 -1.423 . . . . 5.34 110.318 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.1 120.11 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 103.729 -2.693 . . . . 3.97 103.729 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.485 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.9 m-85 -116.83 136.91 52.58 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.768 -1.208 . . . . 4.42 109.539 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 33.0 t0 -103.74 112.73 25.81 Favored 'General case' 0 C--N 1.315 -0.917 1 N-CA-C 98.96 -4.459 . . . . 2.09 98.96 173.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.9 t -126.78 132.29 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.045 -1.434 . . . . 3.53 110.844 -172.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -120.47 121.91 39.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.485 -2.043 . . . . 14.21 105.485 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 tp -89.09 109.2 20.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 123.659 1.695 . . . . 2.42 107.434 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.4 mt -85.65 -43.24 13.61 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 115.128 1.529 . . . . 2.62 115.128 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.3 tttt -161.9 153.56 18.79 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 113.565 -1.652 . . . . 11.71 109.151 -167.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.8 mt -120.06 133.26 55.58 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 105.153 -2.166 . . . . 4.7 105.153 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 113.505 -1.679 . . . . 13.02 109.711 -179.726 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 105.992 -2.843 . . . . 6.33 105.992 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.42 142.51 43.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 101.754 -3.424 . . . . 6.35 101.754 176.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -116.94 130.14 56.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 102.844 -3.021 . . . . 16.98 102.844 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.56 117.02 53.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 N-CA-C 103.692 -2.707 . . . . 5.58 103.692 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.66 124.68 46.87 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 118.946 -2.346 . . . . 12.8 104.824 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.9 m -75.66 139.83 42.21 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.234 -2.166 . . . . 3.24 115.624 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.42 -52.09 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 105.935 -1.876 . . . . 4.79 105.935 171.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.6 m -138.89 139.02 22.42 Favored Pre-proline 0 C--O 1.243 0.737 0 O-C-N 119.622 -1.924 . . . . 11.59 106.275 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.4 Cg_exo -67.69 154.77 72.41 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 123.538 2.825 . . . . 4.55 112.194 -176.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.63 -161.16 28.94 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.169 -1.573 . . . . 2.0 109.169 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -82.41 -9.2 59.54 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 117.645 -3.268 . . . . 3.24 113.188 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.01 9.78 76.67 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.654 -1.637 . . . . 3.38 113.886 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.72 -26.57 0.96 Allowed 'General case' 0 C--O 1.241 0.631 0 CA-C-N 122.567 3.183 . . . . 26.59 114.251 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.54 93.96 4.95 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 119.08 -2.262 . . . . 3.02 109.544 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -104.22 142.52 24.78 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 124.969 1.418 . . . . 4.7 109.84 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.59 146.75 68.48 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.738 2.292 . . . . 2.94 110.636 -173.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.49 156.13 33.46 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.918 -1.492 . . . . 15.96 107.053 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.07 130.25 29.49 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 124.169 1.938 . . . . 11.69 112.819 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.24 -14.01 65.88 Favored Glycine 0 N--CA 1.421 -2.307 0 O-C-N 120.021 -1.674 . . . . 3.63 112.845 -178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.4 25.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 120.047 1.924 . . . . 5.9 112.396 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.94 120.37 31.1 Favored 'General case' 0 C--O 1.25 1.101 0 O-C-N 125.305 1.628 . . . . 3.07 111.734 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.9 m -93.5 131.04 39.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.649 1.214 . . . . 4.11 109.856 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -112.02 111.38 35.92 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 N-CA-C 101.607 -3.479 . . . . 2.16 101.607 -174.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.53 154.44 40.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.842 0.829 . . . . 3.59 112.242 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.14 145.44 30.56 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.259 -2.126 . . . . 3.13 105.259 164.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.2 p90 -145.85 156.06 43.31 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 120.177 1.353 . . . . 2.55 111.928 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.77 121.55 22.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 102.968 -2.975 . . . . 4.47 102.968 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.24 131.96 10.77 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 109.198 -1.561 . . . . 3.41 109.198 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.43 152.18 51.59 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 125.238 2.447 . . . . 18.22 110.391 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.56 164.58 22.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.694 -2.503 . . . . 5.93 106.444 172.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.03 -20.64 40.5 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.16 -3.462 . . . . 12.33 117.624 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -87.7 5.34 40.29 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 119.634 -1.916 . . . . 7.19 113.918 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.15 -10.23 69.82 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-O 124.009 1.894 . . . . 6.47 113.719 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.56 124.19 22.13 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 116.616 -3.873 . . . . 21.86 110.554 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.89 130.77 37.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.415 -1.328 . . . . 16.18 107.415 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -107.67 -17.77 14.0 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.076 -1.05 . . . . 5.73 110.811 173.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.77 155.36 3.19 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 118.121 -0.942 . . . . 6.13 110.564 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.6 t -158.74 128.14 5.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.462 1.105 . . . . 2.93 110.341 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.3 p -75.94 -20.65 57.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.006 -0.738 . . . . 2.3 109.006 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.71 -36.65 84.57 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.698 -1.593 . . . . 10.55 106.698 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -67.64 -28.42 67.7 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.205 -1.559 . . . . 8.02 110.906 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtm-85 -88.65 -10.03 50.03 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.859 -1.15 . . . . 10.21 112.411 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.46 34.29 24.02 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 123.329 1.538 . . . . 16.38 110.996 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.73 120.27 9.35 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 117.722 -3.111 . . . . 20.21 103.806 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -59.39 152.35 61.7 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 124.204 3.27 . . . . 8.75 110.294 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -95.99 138.15 34.03 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.47 -1.678 . . . . 4.65 106.47 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.62 136.86 50.27 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.49 1.495 . . . . 10.62 111.316 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.6 150.62 40.56 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 120.424 1.465 . . . . 4.31 107.372 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.48 126.63 37.65 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 120.31 1.414 . . . . 2.67 110.583 172.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.83 129.77 41.91 Favored 'General case' 0 N--CA 1.427 -1.576 0 O-C-N 125.198 1.561 . . . . 3.08 110.742 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.96 -4.04 84.75 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 123.874 0.75 . . . . 4.95 113.968 176.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.12 -3.11 57.88 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 120.707 -1.467 . . . . 10.26 114.62 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.59 39.53 6.56 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.129 -1.607 . . . . 10.24 113.8 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.36 -0.84 13.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 114.701 1.371 . . . . 10.56 114.701 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.39 172.65 9.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 N-CA-C 108.078 -1.082 . . . . 2.45 108.078 171.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.75 152.07 8.39 Favored 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.946 1.355 . . . . 5.57 109.782 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.25 -35.85 67.87 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 114.327 -1.306 . . . . 19.11 114.393 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.65 -23.33 72.21 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-N 123.338 2.79 . . . . 2.93 112.496 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.57 -54.62 7.13 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 118.49 1.145 . . . . 7.96 111.665 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.01 -44.45 15.12 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 123.982 1.848 . . . . 15.05 111.431 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.35 -35.31 47.65 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.531 -1.213 . . . . 20.27 114.06 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.98 -45.68 6.22 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 119.547 -1.311 . . . . 4.04 114.67 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.62 -27.15 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 O-C-N 121.382 -1.07 . . . . 5.35 109.419 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.83 64.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.57 -2.581 . . . . 3.03 112.35 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.49 0.36 50.02 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.107 0.78 . . . . 3.49 113.107 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.7 mtp -107.9 143.08 37.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 120.786 1.63 . . . . 3.75 109.492 -171.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 p -94.82 155.04 16.97 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.604 0.762 . . . . 2.3 109.786 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.72 130.27 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 119.917 1.235 . . . . 2.47 109.757 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 -12.63 52.12 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 113.289 -1.778 . . . . 2.61 113.056 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.44 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.6 tt0 -84.42 144.79 28.55 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.915 0.864 . . . . 6.53 112.558 -171.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -124.02 123.96 41.52 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 102.619 -3.104 . . . . 12.36 102.619 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.86 156.81 45.0 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.518 2.386 . . . . 5.84 114.307 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.3 122.5 43.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.516 1.627 . . . . 16.57 108.587 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.1 114.48 28.65 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 118.822 -2.424 . . . . 5.86 106.737 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.4 m -98.8 120.42 39.2 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 105.853 -1.906 . . . . 5.76 105.853 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.63 122.58 69.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 108.683 -0.858 . . . . 3.36 108.683 -167.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.38 153.95 91.7 Favored Pre-proline 0 C--O 1.244 0.777 0 CA-C-O 117.826 -1.083 . . . . 4.94 110.731 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.3 -35.14 90.75 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.328 2.685 . . . . 6.21 114.754 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.06 -13.9 62.43 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.883 1.068 . . . . 15.85 113.883 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.67 11.04 36.51 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 126.088 1.755 . . . . 11.52 111.74 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.76 -116.51 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.765 -1.939 . . . . 3.7 105.765 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.64 4.15 37.96 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-N 121.99 2.177 . . . . 6.84 115.48 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.44 -137.13 50.43 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-O 123.745 1.747 . . . . 5.99 111.038 171.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.66 41.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 111.624 -2.288 . . . . 10.11 110.972 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.37 -43.89 63.36 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 121.093 1.77 . . . . 13.76 112.581 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.32 -169.27 53.3 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 107.607 -2.197 . . . . 9.98 107.607 -170.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.8 114.85 35.39 Favored Pre-proline 0 C--O 1.246 0.882 0 O-C-N 118.04 -3.036 . . . . 15.88 103.292 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -48.16 122.43 7.43 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 124.61 3.54 . . . . 11.41 110.909 -166.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.19 -26.94 3.23 Favored Glycine 0 CA--C 1.547 2.038 0 CA-C-N 111.881 -2.418 . . . . 14.2 117.4 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.2 mt -102.84 -50.1 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.05 2.425 . . . . 11.06 114.992 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.7 mm -112.83 131.99 22.5 Favored Pre-proline 0 CA--C 1.516 -0.343 0 N-CA-C 103.159 -2.904 . . . . 8.01 103.159 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.09 163.08 35.44 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 125.218 3.945 . . . . 6.52 112.871 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.3 144.47 71.37 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.518 2.146 . . . . 4.82 110.307 162.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.31 27.24 16.29 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 112.886 -1.961 . . . . 7.42 113.609 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.8 132.29 35.28 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 117.36 2.356 . . . . 2.22 117.36 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.44 132.34 35.71 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 121.686 2.039 . . . . 4.61 106.347 168.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.7 mt -108.81 146.87 32.94 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 120.451 -1.405 . . . . 5.34 110.274 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.19 119.97 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 103.779 -2.674 . . . . 3.97 103.779 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.485 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.2 m-85 -116.79 137.05 52.48 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.734 -1.229 . . . . 4.42 109.519 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.6 t0 -103.92 112.74 25.84 Favored 'General case' 0 C--N 1.315 -0.928 1 N-CA-C 98.875 -4.491 . . . . 2.09 98.875 174.001 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.9 t -126.79 132.37 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.077 -1.42 . . . . 3.53 110.794 -172.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.52 121.84 39.32 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.509 -2.034 . . . . 14.21 105.509 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 tp -88.95 109.06 19.92 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.42 107.536 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.46 -43.31 13.7 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.193 1.553 . . . . 2.62 115.193 -171.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.85 153.56 18.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 113.534 -1.666 . . . . 11.71 109.131 -167.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.2 mt -119.98 133.19 55.63 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 105.19 -2.152 . . . . 4.7 105.19 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.589 -1.642 . . . . 13.02 109.884 -179.828 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 N-CA-C 106.07 -2.812 . . . . 6.33 106.07 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.26 142.58 43.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 101.723 -3.436 . . . . 6.35 101.723 176.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -117.11 130.01 56.35 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.776 -3.046 . . . . 16.98 102.776 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.3 t -109.44 117.07 53.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 103.771 -2.677 . . . . 5.58 103.771 -175.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.61 124.69 46.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 118.863 -2.398 . . . . 12.8 104.83 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.8 m -75.72 139.97 42.19 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 119.313 -2.117 . . . . 3.24 115.643 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.407 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.58 -52.05 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 105.84 -1.911 . . . . 4.79 105.84 171.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.4 m -138.85 139.11 22.82 Favored Pre-proline 0 C--O 1.244 0.77 0 O-C-N 119.647 -1.908 . . . . 11.59 106.305 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.3 Cg_exo -67.71 154.75 72.41 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 123.634 2.889 . . . . 4.55 112.174 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.7 -161.22 28.88 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.09 -1.604 . . . . 2.0 109.09 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.43 -9.15 59.55 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 117.708 -3.231 . . . . 3.24 113.205 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.09 9.73 76.87 Favored Glycine 0 C--O 1.218 -0.851 0 CA-C-O 117.647 -1.641 . . . . 3.38 113.884 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.72 -26.62 0.96 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.576 3.188 . . . . 26.59 114.251 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.52 94.04 4.99 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 119.111 -2.243 . . . . 3.02 109.503 -175.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.18 142.53 24.8 Favored Pre-proline 0 C--O 1.252 1.204 0 O-C-N 125.016 1.448 . . . . 4.7 109.867 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.5 Cg_endo -68.67 146.78 68.13 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.715 2.277 . . . . 2.94 110.588 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.52 156.16 33.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.866 -1.516 . . . . 15.96 107.026 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.4 ttp180 -52.07 130.25 29.49 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 124.169 1.938 . . . . 11.69 112.819 174.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.33 -14.14 65.6 Favored Glycine 0 N--CA 1.422 -2.246 0 O-C-N 120.021 -1.674 . . . . 3.63 112.755 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.37 25.17 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 120.066 1.933 . . . . 5.9 112.357 174.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.85 120.31 30.98 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.249 1.593 . . . . 3.07 111.684 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.53 130.99 39.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 122.65 1.214 . . . . 4.11 109.86 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.5 t -111.92 111.39 35.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 N-CA-C 101.643 -3.465 . . . . 2.16 101.643 -174.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.9 m -129.5 154.39 40.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-O 121.822 0.82 . . . . 3.59 112.242 -172.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.06 145.43 30.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.22 -2.141 . . . . 3.13 105.22 164.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.1 p90 -145.81 156.1 43.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 120.18 1.355 . . . . 2.55 111.967 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.76 121.49 21.95 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 103.024 -2.954 . . . . 4.47 103.024 167.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.13 131.87 10.74 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 109.251 -1.54 . . . . 3.41 109.251 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.4 152.12 51.6 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 125.242 2.449 . . . . 18.22 110.391 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 164.59 22.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.707 -2.497 . . . . 5.93 106.444 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -57.97 -20.65 39.72 Favored 'General case' 0 C--O 1.22 -0.469 0 O-C-N 117.197 -3.439 . . . . 12.33 117.737 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.75 5.44 39.95 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 119.642 -1.911 . . . . 7.19 113.894 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.03 -10.26 70.07 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 123.956 1.864 . . . . 6.47 113.807 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.53 124.23 22.24 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 116.803 -3.763 . . . . 21.86 110.556 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.89 130.84 37.11 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.403 -1.332 . . . . 16.18 107.403 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.67 -17.84 13.99 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.07 -1.052 . . . . 5.73 110.809 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.77 155.43 3.22 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.153 -0.927 . . . . 6.13 110.567 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -158.81 128.13 5.57 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.527 1.131 . . . . 2.93 110.345 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.4 p -75.97 -20.65 57.73 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.977 -0.749 . . . . 2.3 108.977 175.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.68 84.65 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.685 -1.598 . . . . 10.55 106.685 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -67.58 -28.57 67.87 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.215 -1.553 . . . . 8.02 110.809 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.6 -10.12 49.81 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.9 -1.125 . . . . 10.21 112.368 176.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.62 34.22 24.11 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.349 1.547 . . . . 16.38 110.95 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.73 120.18 9.32 Favored Pre-proline 0 C--N 1.315 -0.934 0 O-C-N 117.627 -3.171 . . . . 20.21 103.882 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -59.24 152.27 61.32 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 124.274 3.316 . . . . 8.75 110.326 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -95.93 138.22 33.88 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.566 -1.642 . . . . 4.65 106.566 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.72 136.87 50.38 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 120.584 1.538 . . . . 10.62 111.244 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.63 150.71 40.62 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 120.397 1.453 . . . . 4.31 107.28 169.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.41 126.64 37.58 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 120.243 1.383 . . . . 2.67 110.584 172.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 129.81 42.03 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.288 1.617 . . . . 3.08 110.719 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.0 -4.12 84.73 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 123.865 0.745 . . . . 4.95 114.009 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.1 -3.09 57.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.752 -1.44 . . . . 10.26 114.561 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 64.52 39.57 6.7 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 120.081 -1.637 . . . . 10.24 113.808 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.37 -0.82 13.69 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 114.684 1.365 . . . . 10.56 114.684 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.35 172.65 9.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 108.09 -1.078 . . . . 2.45 108.09 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.79 152.04 8.38 Favored 'Isoleucine or valine' 0 C--O 1.259 1.567 0 CA-C-O 122.974 1.368 . . . . 5.57 109.855 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.22 -35.8 67.74 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 114.442 1.275 . . . . 19.11 114.442 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.67 -23.35 72.24 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.351 2.796 . . . . 2.93 112.415 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.58 -54.58 7.19 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 118.574 1.187 . . . . 7.96 111.643 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.0 -44.43 15.09 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 124.02 1.867 . . . . 15.05 111.514 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.36 -35.29 47.63 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.495 -1.23 . . . . 20.27 114.037 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.06 -45.73 6.17 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.571 -1.299 . . . . 4.04 114.6 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.6 t -67.46 -27.23 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 121.378 -1.072 . . . . 5.35 109.495 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.83 64.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.506 -2.621 . . . . 3.03 112.35 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.48 0.28 50.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.489 -0.767 . . . . 3.49 113.057 175.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.83 143.03 36.97 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 120.831 1.65 . . . . 3.75 109.555 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -94.73 155.06 17.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.692 0.797 . . . . 2.3 109.822 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.7 130.19 20.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 119.91 1.232 . . . . 2.47 109.734 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.54 52.07 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.333 -1.758 . . . . 2.61 112.989 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.44 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.6 tt0 -84.39 144.69 28.63 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-O 121.874 0.845 . . . . 6.53 112.601 -171.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.9 ttt180 -123.93 123.9 41.43 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 102.677 -3.083 . . . . 12.36 102.677 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.78 45.0 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 126.442 2.339 . . . . 5.84 114.322 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.21 122.45 43.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 123.465 1.602 . . . . 16.57 108.59 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.07 114.49 28.66 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 118.787 -2.445 . . . . 5.86 106.775 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.7 m -98.78 120.42 39.19 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 105.772 -1.936 . . . . 5.76 105.772 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.63 122.55 69.09 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 108.71 -0.848 . . . . 3.36 108.71 -167.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.37 153.99 91.57 Favored Pre-proline 0 C--O 1.243 0.723 0 CA-C-O 117.934 -1.031 . . . . 4.94 110.712 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.21 -35.26 90.61 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.374 2.716 . . . . 6.21 114.803 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.03 -13.87 62.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.883 1.068 . . . . 15.85 113.883 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.73 11.09 36.32 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 125.959 1.703 . . . . 11.52 111.671 175.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.82 -116.53 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.754 -1.943 . . . . 3.7 105.754 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.61 4.1 37.98 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 122.025 2.193 . . . . 6.84 115.511 -173.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.53 -137.12 50.5 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 123.728 1.738 . . . . 5.99 111.048 171.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.22 -18.71 41.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 111.705 -2.247 . . . . 10.11 111.036 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.38 -43.97 63.22 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.076 1.762 . . . . 13.76 112.458 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.34 -169.19 53.39 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.693 -2.163 . . . . 9.98 107.693 -170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.87 114.77 35.3 Favored Pre-proline 0 C--O 1.247 0.962 0 O-C-N 118.014 -3.05 . . . . 15.88 103.215 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -48.03 122.3 7.13 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 124.72 3.613 . . . . 11.41 110.928 -166.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.3 -27.05 3.26 Favored Glycine 0 CA--C 1.546 2.022 0 CA-C-N 111.961 -2.382 . . . . 14.2 117.388 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.1 mt -102.89 -50.04 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 121.022 2.411 . . . . 11.06 114.971 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.88 131.97 22.52 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 103.178 -2.897 . . . . 8.01 103.178 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.18 163.11 35.49 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.198 3.932 . . . . 6.52 112.859 171.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.27 144.51 70.91 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.476 2.117 . . . . 4.82 110.357 162.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.28 27.21 16.3 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 112.969 -1.923 . . . . 7.42 113.618 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.8 132.4 35.28 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 117.358 2.355 . . . . 2.22 117.358 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.47 132.41 35.7 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 121.667 2.031 . . . . 4.61 106.347 168.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.8 mt -108.94 146.76 33.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.414 -1.429 . . . . 5.34 110.239 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.1 t -123.08 120.02 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 103.764 -2.68 . . . . 3.97 103.764 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.9 m-85 -116.79 136.96 52.55 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.705 -1.247 . . . . 4.42 109.553 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.7 t0 -103.81 112.69 25.75 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.853 -4.499 . . . . 2.09 98.853 174.041 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.5 t -126.79 132.28 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.092 -1.413 . . . . 3.53 110.836 -172.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.38 121.89 39.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 105.563 -2.014 . . . . 14.21 105.563 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.08 109.02 19.92 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 123.653 1.692 . . . . 2.42 107.494 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.46 -43.25 13.76 Favored 'General case' 0 C--O 1.254 1.293 0 N-CA-C 115.26 1.578 . . . . 2.62 115.26 -171.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.8 153.62 19.08 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 113.501 -1.681 . . . . 11.71 109.248 -167.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.08 133.21 55.58 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 105.204 -2.147 . . . . 4.7 105.204 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.568 -1.651 . . . . 13.02 109.761 -179.719 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 106.08 -2.808 . . . . 6.33 106.08 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.33 142.58 43.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 101.707 -3.442 . . . . 6.35 101.707 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -117.16 130.05 56.36 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 102.802 -3.036 . . . . 16.98 102.802 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.9 t -109.53 117.12 53.85 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 103.663 -2.717 . . . . 5.58 103.663 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.66 124.65 46.81 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 118.871 -2.393 . . . . 12.8 104.839 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.8 m -75.66 139.9 42.24 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.28 -2.138 . . . . 3.24 115.656 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.5 mt -101.51 -52.02 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.86 -1.904 . . . . 4.79 105.86 171.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.5 m -138.89 139.13 22.76 Favored Pre-proline 0 C--O 1.244 0.783 0 O-C-N 119.548 -1.97 . . . . 11.59 106.27 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.8 Cg_exo -67.86 154.84 71.93 Favored 'Trans proline' 0 C--N 1.329 -0.454 0 C-N-CA 123.546 2.83 . . . . 4.55 112.196 -176.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.72 -161.14 28.85 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.102 -1.599 . . . . 2.0 109.102 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -82.43 -9.27 59.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 117.659 -3.26 . . . . 3.24 113.165 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.07 9.77 76.86 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-O 117.71 -1.606 . . . . 3.38 113.87 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.66 -26.66 0.96 Allowed 'General case' 0 C--O 1.241 0.608 0 CA-C-N 122.593 3.196 . . . . 26.59 114.305 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.59 94.04 4.99 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 119.039 -2.288 . . . . 3.02 109.435 -175.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.2 142.52 24.78 Favored Pre-proline 0 C--O 1.252 1.211 0 O-C-N 125.007 1.442 . . . . 4.7 109.761 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.59 146.73 68.4 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.728 2.285 . . . . 2.94 110.688 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.49 156.2 33.31 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.932 -1.485 . . . . 15.96 107.121 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.6 ttp180 -52.17 130.36 30.18 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 124.263 1.982 . . . . 11.69 112.765 174.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.21 -13.97 65.97 Favored Glycine 0 N--CA 1.424 -2.122 0 O-C-N 119.919 -1.738 . . . . 3.63 112.734 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.24 149.42 25.09 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-N 120.123 1.961 . . . . 5.9 112.381 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.85 120.28 30.95 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.146 1.529 . . . . 3.07 111.799 174.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.9 m -93.43 131.02 39.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.485 1.136 . . . . 4.11 109.878 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.5 t -112.03 111.47 36.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 101.624 -3.473 . . . . 2.16 101.624 -174.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.3 m -129.63 154.39 40.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.866 0.841 . . . . 3.59 112.193 -172.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 145.45 30.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.264 -2.124 . . . . 3.13 105.264 164.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.84 156.09 43.34 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 120.128 1.331 . . . . 2.55 111.9 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.6 m -133.83 121.63 22.07 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 102.88 -3.007 . . . . 4.47 102.88 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.21 131.84 10.73 Favored Glycine 0 N--CA 1.471 0.999 0 N-CA-C 109.237 -1.545 . . . . 3.41 109.237 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.31 152.2 51.5 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 125.277 2.465 . . . . 18.22 110.421 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.56 164.59 22.82 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.694 -2.503 . . . . 5.93 106.444 172.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.08 -20.56 40.59 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 117.19 -3.444 . . . . 12.33 117.684 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -87.64 5.31 40.24 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 119.603 -1.936 . . . . 7.19 113.956 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.17 -10.42 69.74 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-O 123.896 1.831 . . . . 6.47 113.661 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.64 124.26 22.37 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 116.724 -3.809 . . . . 21.86 110.529 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.82 130.86 37.2 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 107.349 -1.352 . . . . 16.18 107.349 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.7 -17.84 13.98 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.099 -1.04 . . . . 5.73 110.809 173.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.71 155.37 3.24 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 118.08 -0.962 . . . . 6.13 110.605 176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -158.78 128.19 5.61 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.518 1.127 . . . . 2.93 110.38 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.6 p -76.1 -20.51 57.61 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.757 -0.777 . . . . 2.3 109.043 175.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.72 84.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.637 -1.616 . . . . 10.55 106.637 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.58 -28.56 67.87 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.247 -1.533 . . . . 8.02 110.827 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.6 -10.12 49.81 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 120.906 -1.121 . . . . 10.21 112.368 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.56 34.2 23.98 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 123.382 1.563 . . . . 16.38 111.007 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.3 tttm -139.65 120.21 9.39 Favored Pre-proline 0 C--O 1.247 0.928 0 O-C-N 117.698 -3.126 . . . . 20.21 103.882 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.24 152.34 60.79 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 124.234 3.29 . . . . 8.75 110.43 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.468 ' CZ ' ' H32' ' A' ' 108' ' ' GPI . 84.9 t80 -95.95 138.17 33.97 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.518 -1.66 . . . . 4.65 106.518 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.61 136.9 50.18 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 120.541 1.518 . . . . 10.62 111.313 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.67 150.71 40.55 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.458 1.481 . . . . 4.31 107.308 169.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.5 126.68 37.69 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.304 1.411 . . . . 2.67 110.549 172.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 129.84 42.14 Favored 'General case' 0 N--CA 1.426 -1.643 0 O-C-N 125.228 1.58 . . . . 3.08 110.647 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.01 -4.19 84.73 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 123.806 0.717 . . . . 4.95 114.035 176.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.7 tttt -84.13 -3.05 57.85 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.752 -1.44 . . . . 10.26 114.561 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.55 39.56 6.64 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 120.132 -1.605 . . . . 10.24 113.778 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.74 13.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 114.75 1.389 . . . . 10.56 114.75 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG12 ' O1 ' ' A' ' 108' ' ' GPI . 5.4 m -122.42 172.67 9.31 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.057 -1.09 . . . . 2.45 108.057 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.81 152.1 8.35 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.98 1.371 . . . . 5.57 109.768 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.24 -35.88 67.88 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 114.343 -1.298 . . . . 19.11 114.386 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.62 -23.37 72.17 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-N 123.392 2.814 . . . . 2.93 112.384 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.55 -54.65 7.09 Favored 'General case' 0 C--O 1.249 1.071 0 CA-C-N 118.559 1.179 . . . . 7.96 111.575 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.04 -44.39 15.26 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 124.026 1.87 . . . . 15.05 111.467 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.37 -35.29 47.54 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.544 -1.207 . . . . 20.27 114.065 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.06 -45.72 6.18 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.502 -1.332 . . . . 4.04 114.612 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.55 -27.09 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 O-C-N 121.383 -1.069 . . . . 5.35 109.486 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.86 64.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.537 -2.602 . . . . 3.03 112.398 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.54 0.41 49.98 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 118.456 -0.783 . . . . 3.49 113.025 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.9 mtp -107.95 143.02 37.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 120.812 1.642 . . . . 3.75 109.436 -171.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.0 p -94.66 155.01 17.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.678 0.791 . . . . 2.3 109.852 174.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.68 130.19 20.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 119.88 1.218 . . . . 2.47 109.796 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.11 -12.53 52.28 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 113.35 -1.75 . . . . 2.61 113.133 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.44 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.6 tt0 -84.4 144.75 28.59 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.95 0.881 . . . . 6.53 112.567 -171.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.406 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.99 123.92 41.44 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 102.576 -3.12 . . . . 12.36 102.576 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.8 156.73 45.01 Favored 'General case' 0 C--O 1.244 0.806 0 O-C-N 126.393 2.308 . . . . 5.84 114.283 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.26 122.55 43.87 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 123.429 1.585 . . . . 16.57 108.671 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.15 114.49 28.65 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.859 -2.401 . . . . 5.86 106.745 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.4 m -98.73 120.42 39.13 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 105.766 -1.939 . . . . 5.76 105.766 176.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.5 mt -119.55 122.57 69.21 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 N-CA-C 108.712 -0.847 . . . . 3.36 108.712 -167.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.43 153.93 91.85 Favored Pre-proline 0 C--O 1.244 0.807 0 CA-C-O 117.878 -1.058 . . . . 4.94 110.676 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -55.16 -35.26 90.4 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.328 2.686 . . . . 6.21 114.829 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -69.99 -13.92 62.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.869 1.062 . . . . 15.85 113.869 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -103.69 11.05 36.44 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 126.051 1.74 . . . . 11.52 111.751 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.74 -116.39 0.16 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 105.808 -1.923 . . . . 3.7 105.808 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.68 4.16 37.85 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 122.067 2.212 . . . . 6.84 115.447 -173.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.42 -137.11 50.45 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 123.686 1.714 . . . . 5.99 111.096 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.28 -18.8 41.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 111.738 -2.231 . . . . 10.11 110.932 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.26 -43.93 63.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.129 1.786 . . . . 13.76 112.547 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.23 -169.28 53.23 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 107.76 -2.136 . . . . 9.98 107.76 -170.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.736 ' CE1' H111 ' A' ' 108' ' ' GPI . 65.3 t-80 -118.78 114.9 35.41 Favored Pre-proline 0 C--O 1.246 0.873 0 O-C-N 118.003 -3.057 . . . . 15.88 103.262 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -48.24 122.36 7.42 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.638 3.559 . . . . 11.41 110.939 -166.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.35 -27.07 3.28 Favored Glycine 0 CA--C 1.547 2.073 0 CA-C-N 111.788 -2.46 . . . . 14.2 117.374 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.8 mt -102.87 -50.05 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.041 2.421 . . . . 11.06 114.942 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.6 mm -112.9 131.83 22.6 Favored Pre-proline 0 CA--C 1.516 -0.334 0 N-CA-C 103.174 -2.899 . . . . 8.01 103.174 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.07 163.03 35.6 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.259 3.973 . . . . 6.52 112.865 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.33 144.55 71.39 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.392 2.061 . . . . 4.82 110.321 162.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.35 27.21 16.25 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 112.878 -1.965 . . . . 7.42 113.579 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.87 132.42 35.27 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 117.345 2.35 . . . . 2.22 117.345 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -80.56 132.45 35.65 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 121.695 2.043 . . . . 4.61 106.31 168.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.5 mt -108.82 146.79 33.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.321 -1.487 . . . . 5.34 110.281 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.27 119.93 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 103.743 -2.688 . . . . 3.97 103.743 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.0 m-85 -116.7 136.96 52.55 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.796 -1.19 . . . . 4.42 109.596 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.76 112.67 25.72 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.874 -4.491 . . . . 2.09 98.874 174.017 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.5 t -126.72 132.3 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 114.206 -1.361 . . . . 3.53 110.841 -172.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.44 121.91 39.56 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.578 -2.008 . . . . 14.21 105.578 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.02 109.07 19.95 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.42 107.498 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.5 -43.27 13.7 Favored 'General case' 0 C--O 1.253 1.28 0 N-CA-C 115.203 1.557 . . . . 2.62 115.203 -171.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.82 153.63 19.03 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 113.509 -1.678 . . . . 11.71 109.167 -167.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.7 mt -120.04 133.17 55.61 Favored 'General case' 0 C--O 1.251 1.165 0 N-CA-C 105.25 -2.13 . . . . 4.7 105.25 170.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.697 -1.592 . . . . 13.02 109.805 -179.746 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GPI . . . . . 0.736 H111 ' CE1' ' A' ' 87' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.695 0 N-CA-C 106.067 -2.813 . . . . 6.33 106.067 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.41 142.56 43.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 101.672 -3.455 . . . . 6.35 101.672 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -117.13 130.16 56.44 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 102.682 -3.081 . . . . 16.98 102.682 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.4 t -109.51 117.01 53.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 103.737 -2.69 . . . . 5.58 103.737 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.58 124.72 47.05 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 118.893 -2.379 . . . . 12.8 104.872 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.4 m -75.77 140.1 42.17 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 119.226 -2.171 . . . . 3.24 115.55 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.67 -52.05 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 105.832 -1.914 . . . . 4.79 105.832 171.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.8 m -138.97 139.0 22.13 Favored Pre-proline 0 C--O 1.241 0.652 0 O-C-N 119.53 -1.981 . . . . 11.59 106.331 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 30.2 Cg_exo -67.67 154.85 72.22 Favored 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.501 2.801 . . . . 4.55 112.125 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.84 -161.24 28.74 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 109.071 -1.611 . . . . 2.0 109.071 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.43 -9.1 59.57 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 117.674 -3.251 . . . . 3.24 113.258 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.07 9.78 76.86 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.639 -1.645 . . . . 3.38 113.793 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.7 -26.69 0.95 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-N 122.583 3.191 . . . . 26.59 114.244 -178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.44 94.08 5.02 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 119.049 -2.282 . . . . 3.02 109.503 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.24 142.55 24.85 Favored Pre-proline 0 C--O 1.252 1.211 0 O-C-N 124.963 1.414 . . . . 4.7 109.799 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.592 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.6 146.74 68.41 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.754 2.303 . . . . 2.94 110.6 -174.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.57 156.14 33.55 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.889 -1.505 . . . . 15.96 106.988 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.4 ttp180 -52.04 130.24 29.34 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 124.134 1.921 . . . . 11.69 112.709 174.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.36 -14.13 65.58 Favored Glycine 0 N--CA 1.423 -2.184 0 O-C-N 120.009 -1.682 . . . . 3.63 112.762 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.16 149.32 25.2 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 120.085 1.943 . . . . 5.9 112.242 174.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.8 m -89.83 120.25 30.91 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.283 1.614 . . . . 3.07 111.806 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.2 m -93.55 131.04 39.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 122.716 1.246 . . . . 4.11 109.813 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.5 t -112.0 111.41 36.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 101.593 -3.484 . . . . 2.16 101.593 -174.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.57 154.34 40.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-O 121.795 0.807 . . . . 3.59 112.243 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.42 30.57 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.129 -2.174 . . . . 3.13 105.129 164.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.0 p90 -145.74 156.11 43.4 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 120.003 1.274 . . . . 2.55 112.02 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -133.81 121.53 21.94 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 102.968 -2.975 . . . . 4.47 102.968 167.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.19 131.94 10.76 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 109.28 -1.528 . . . . 3.41 109.28 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.4 152.18 51.57 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 125.259 2.457 . . . . 18.22 110.435 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 164.59 22.9 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 111.746 -2.479 . . . . 5.93 106.38 172.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.16 -20.55 41.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 117.283 -3.385 . . . . 12.33 117.639 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.67 5.29 40.44 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.56 -1.962 . . . . 7.19 113.906 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.16 -10.34 69.77 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-O 124.04 1.911 . . . . 6.47 113.785 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.62 124.23 22.26 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 116.632 -3.864 . . . . 21.86 110.58 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.81 130.83 37.17 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.359 -1.348 . . . . 16.18 107.359 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -107.76 -17.76 14.0 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 118.998 -1.081 . . . . 5.73 110.799 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -172.71 155.5 3.28 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 118.093 -0.956 . . . . 6.13 110.652 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.87 128.08 5.51 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.428 1.091 . . . . 2.93 110.314 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 41.2 p -75.83 -20.75 57.91 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 119.866 -0.733 . . . . 2.3 109.117 175.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.63 -36.65 84.53 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.754 -1.573 . . . . 10.55 106.754 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.61 -28.5 67.8 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.253 -1.529 . . . . 8.02 110.807 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.6 mtm-85 -88.72 -9.98 50.02 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 120.914 -1.116 . . . . 10.21 112.403 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.54 34.21 23.98 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 123.316 1.531 . . . . 16.38 111.034 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.3 tttm -139.7 120.24 9.37 Favored Pre-proline 0 C--N 1.315 -0.934 0 O-C-N 117.645 -3.16 . . . . 20.21 103.879 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.27 152.3 61.28 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.269 3.313 . . . . 8.75 110.402 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.432 ' CE2' ' H32' ' A' ' 108' ' ' GPI . 85.1 t80 -95.89 138.12 33.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.534 -1.654 . . . . 4.65 106.534 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -111.64 136.87 50.27 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.496 1.498 . . . . 10.62 111.285 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.67 150.69 40.53 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 120.397 1.453 . . . . 4.31 107.366 169.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.466 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.39 126.62 37.56 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-N 120.244 1.384 . . . . 2.67 110.617 172.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.89 129.81 42.05 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 125.217 1.573 . . . . 3.08 110.68 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.98 -4.13 84.76 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.605 -0.725 . . . . 4.95 114.044 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.09 -3.06 57.81 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 120.823 -1.398 . . . . 10.26 114.679 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.48 39.6 6.75 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.117 -1.615 . . . . 10.24 113.775 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.31 -0.88 13.71 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 114.725 1.38 . . . . 10.56 114.725 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.403 ' HA ' ' O2 ' ' A' ' 108' ' ' GPI . 5.5 m -122.37 172.62 9.32 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.085 -1.08 . . . . 2.45 108.085 171.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.73 152.07 8.41 Favored 'Isoleucine or valine' 0 C--O 1.257 1.496 0 CA-C-O 122.937 1.351 . . . . 5.57 109.851 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.25 -35.73 67.74 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.361 -1.29 . . . . 19.11 114.466 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.73 -23.34 72.35 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-N 123.383 2.81 . . . . 2.93 112.389 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.53 -54.67 7.07 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.51 1.155 . . . . 7.96 111.633 173.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.0 -44.43 15.06 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.951 1.834 . . . . 15.05 111.461 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.36 -35.3 47.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.485 -1.234 . . . . 20.27 114.084 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.11 -45.63 6.19 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 119.471 -1.347 . . . . 4.04 114.615 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.53 -27.17 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 121.348 -1.089 . . . . 5.35 109.425 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.592 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.06 -18.83 64.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 118.538 -2.601 . . . . 3.03 112.378 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.5 0.31 50.24 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 118.439 -0.791 . . . . 3.49 113.016 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.7 mtp -107.82 143.18 36.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 120.821 1.646 . . . . 3.75 109.524 -171.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -94.79 154.93 17.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.695 0.798 . . . . 2.3 109.842 174.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.3 t -57.53 130.09 20.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 119.965 1.257 . . . . 2.47 109.868 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.21 -12.44 51.93 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 113.422 -1.717 . . . . 2.61 113.069 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.7 tt0 -84.4 144.8 28.55 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.883 0.849 . . . . 6.53 112.623 -171.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.9 ttt180 -124.05 124.02 41.63 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 102.588 -3.116 . . . . 12.36 102.588 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.81 44.99 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.421 2.326 . . . . 5.84 114.303 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.28 122.45 43.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.47 1.605 . . . . 16.57 108.556 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.02 114.51 28.69 Favored 'General case' 0 N--CA 1.44 -0.975 0 O-C-N 118.864 -2.398 . . . . 5.86 106.786 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.5 m -98.81 120.49 39.34 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 105.801 -1.925 . . . . 5.76 105.801 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.6 mt -119.65 122.55 69.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 108.671 -0.862 . . . . 3.36 108.671 -167.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.38 154.03 91.52 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-O 117.802 -1.094 . . . . 4.94 110.655 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.4 -35.07 91.09 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.333 2.689 . . . . 6.21 114.761 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.13 -13.88 62.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.795 1.035 . . . . 15.85 113.795 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.68 11.03 36.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 126.004 1.722 . . . . 11.52 111.734 175.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.86 -116.55 0.15 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 105.72 -1.955 . . . . 3.7 105.72 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.61 4.16 38.05 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 122.025 2.193 . . . . 6.84 115.511 -173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.45 -137.16 50.41 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-O 123.769 1.761 . . . . 5.99 111.131 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.33 -18.64 41.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 111.603 -2.299 . . . . 10.11 111.024 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.36 -43.9 63.35 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.04 1.745 . . . . 13.76 112.497 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.28 -169.16 53.38 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 107.641 -2.184 . . . . 9.98 107.641 -170.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.89 114.83 35.23 Favored Pre-proline 0 C--O 1.246 0.899 0 O-C-N 118.128 -2.984 . . . . 15.88 103.198 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -48.14 122.43 7.41 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 124.622 3.548 . . . . 11.41 110.975 -166.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.18 -26.96 3.22 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.979 -2.373 . . . . 14.2 117.412 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.718 HD13 ' C11' ' A' ' 108' ' ' GPI . 60.0 mt -102.93 -50.02 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 121.102 2.451 . . . . 11.06 114.943 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.86 131.82 22.59 Favored Pre-proline 0 CA--C 1.516 -0.328 0 N-CA-C 103.233 -2.877 . . . . 8.01 103.233 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.08 163.01 35.7 Favored 'Trans proline' 0 C--O 1.24 0.619 0 C-N-CA 125.229 3.953 . . . . 6.52 112.909 171.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.27 144.49 71.08 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.547 2.165 . . . . 4.82 110.275 162.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.26 27.26 16.34 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 112.886 -1.961 . . . . 7.42 113.607 172.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.73 132.45 35.29 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.446 2.387 . . . . 2.22 117.446 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -80.53 132.47 35.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.737 2.062 . . . . 4.61 106.298 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.1 mt -108.99 146.69 33.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.469 -1.394 . . . . 5.34 110.24 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.0 t -123.12 120.08 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 N-CA-C 103.657 -2.72 . . . . 3.97 103.657 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.2 m-85 -116.75 136.97 52.54 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.594 -1.316 . . . . 4.42 109.608 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.5 t0 -103.8 112.65 25.7 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.911 -4.477 . . . . 2.09 98.911 174.018 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 88.0 t -126.77 132.4 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 114.194 -1.367 . . . . 3.53 110.763 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.47 121.92 39.53 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.449 -2.056 . . . . 14.21 105.449 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.13 109.06 19.97 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 123.636 1.684 . . . . 2.42 107.492 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.43 -43.33 13.71 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 115.193 1.553 . . . . 2.62 115.193 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.2 tttt -161.78 153.59 19.06 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 113.475 -1.693 . . . . 11.71 109.153 -167.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.8 mt -120.01 133.24 55.6 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 105.186 -2.153 . . . . 4.7 105.186 170.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.31 -1.141 0 CA-C-N 113.64 -1.618 . . . . 13.02 109.94 -179.848 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GPI . . . . . 0.718 ' C11' HD13 ' A' ' 90' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 106.096 -2.802 . . . . 6.33 106.096 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.31 142.62 43.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 101.693 -3.447 . . . . 6.35 101.693 176.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -117.13 130.12 56.42 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.736 -3.061 . . . . 16.98 102.736 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.57 117.2 54.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 103.58 -2.748 . . . . 5.58 103.58 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.75 124.78 47.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 118.863 -2.398 . . . . 12.8 104.757 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.3 m -75.74 139.95 42.15 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 119.3 -2.125 . . . . 3.24 115.646 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.2 mt -101.62 -51.94 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 105.837 -1.912 . . . . 4.79 105.837 171.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.4 m -138.94 138.9 22.03 Favored Pre-proline 0 C--O 1.242 0.684 0 O-C-N 119.603 -1.936 . . . . 11.59 106.347 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.9 Cg_exo -67.57 154.73 72.73 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.636 2.891 . . . . 4.55 112.191 -176.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.7 -161.13 28.86 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 109.075 -1.61 . . . . 2.0 109.075 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -82.49 -9.22 59.52 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 117.618 -3.284 . . . . 3.24 113.167 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.17 9.6 76.94 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-O 117.625 -1.653 . . . . 3.38 113.81 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.63 -26.66 0.96 Allowed 'General case' 0 C--O 1.241 0.655 0 CA-C-N 122.703 3.252 . . . . 26.59 114.189 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.45 93.95 4.95 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 119.121 -2.237 . . . . 3.02 109.496 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.22 142.49 24.72 Favored Pre-proline 0 C--O 1.25 1.122 0 O-C-N 124.975 1.422 . . . . 4.7 109.8 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.58 146.65 68.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.748 2.298 . . . . 2.94 110.674 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.44 156.09 33.48 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.899 -1.5 . . . . 15.96 107.015 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.03 130.25 29.31 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 124.118 1.913 . . . . 11.69 112.797 174.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.22 -13.88 66.11 Favored Glycine 0 N--CA 1.422 -2.296 0 O-C-N 119.978 -1.701 . . . . 3.63 112.694 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -86.24 149.41 25.1 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 120.094 1.947 . . . . 5.9 112.253 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.92 120.21 30.94 Favored 'General case' 0 C--O 1.25 1.12 0 O-C-N 125.248 1.593 . . . . 3.07 111.729 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.45 131.02 39.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.654 1.216 . . . . 4.11 109.859 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.3 t -111.92 111.31 35.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 101.67 -3.456 . . . . 2.16 101.67 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.53 154.5 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 121.885 0.85 . . . . 3.59 112.263 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.15 145.46 30.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 105.178 -2.156 . . . . 3.13 105.178 164.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.2 p90 -145.8 156.11 43.37 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 120.124 1.329 . . . . 2.55 111.988 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -133.77 121.64 22.16 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 102.948 -2.982 . . . . 4.47 102.948 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.22 131.99 10.78 Favored Glycine 0 N--CA 1.472 1.041 0 N-CA-C 109.184 -1.566 . . . . 3.41 109.184 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.5 152.09 51.68 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 125.269 2.462 . . . . 18.22 110.383 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.49 164.63 22.85 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.664 -2.516 . . . . 5.93 106.454 172.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.07 -20.64 41.06 Favored 'General case' 0 C--O 1.219 -0.512 0 O-C-N 117.262 -3.399 . . . . 12.33 117.708 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.73 5.38 40.17 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.663 -1.898 . . . . 7.19 113.893 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.24 -10.39 69.58 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-O 123.976 1.876 . . . . 6.47 113.678 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.58 124.24 22.28 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 116.628 -3.866 . . . . 21.86 110.532 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.9 130.78 37.02 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.381 -1.341 . . . . 16.18 107.381 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -107.67 -17.89 13.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.021 -1.072 . . . . 5.73 110.693 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -172.68 155.49 3.29 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 118.181 -0.914 . . . . 6.13 110.509 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.82 128.15 5.57 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.451 1.101 . . . . 2.93 110.361 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 38.1 p -76.0 -20.66 57.66 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.982 -0.748 . . . . 2.3 108.982 175.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.7 -36.61 84.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.722 -1.585 . . . . 10.55 106.722 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.71 -28.42 67.65 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.197 -1.565 . . . . 8.02 110.833 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.68 -10.08 49.75 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.89 -1.131 . . . . 10.21 112.361 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.48 34.31 24.07 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-O 123.4 1.571 . . . . 16.38 111.007 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.66 120.16 9.38 Favored Pre-proline 0 C--O 1.248 1.017 0 O-C-N 117.693 -3.129 . . . . 20.21 103.897 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -59.24 152.31 61.02 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 124.277 3.318 . . . . 8.75 110.383 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.41 ' CE2' ' H32' ' A' ' 108' ' ' GPI . 84.9 t80 -96.0 138.11 34.1 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.541 -1.652 . . . . 4.65 106.541 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.62 136.87 50.24 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 120.539 1.518 . . . . 10.62 111.372 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.66 150.61 40.44 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.415 1.461 . . . . 4.31 107.377 169.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.47 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.44 126.68 37.63 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.297 1.408 . . . . 2.67 110.48 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.92 129.7 41.54 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 125.286 1.616 . . . . 3.08 110.723 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.11 -4.22 84.56 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.879 0.752 . . . . 4.95 113.989 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.05 -3.01 57.74 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.648 -1.501 . . . . 10.26 114.603 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.47 39.58 6.79 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.017 -1.677 . . . . 10.24 113.841 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.33 -0.84 13.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 114.736 1.384 . . . . 10.56 114.736 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.32 172.58 9.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 108.099 -1.074 . . . . 2.45 108.099 171.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.71 152.07 8.42 Favored 'Isoleucine or valine' 0 C--O 1.259 1.567 0 CA-C-O 123.026 1.393 . . . . 5.57 109.757 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.27 -35.73 67.79 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 114.391 -1.277 . . . . 19.11 114.432 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.86 -23.31 72.55 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.33 2.786 . . . . 2.93 112.304 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.62 -54.61 7.13 Favored 'General case' 0 C--O 1.249 1.071 0 CA-C-N 118.616 1.208 . . . . 7.96 111.572 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.05 -44.35 15.27 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 123.983 1.849 . . . . 15.05 111.447 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.3 -35.42 47.91 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.541 -1.208 . . . . 20.27 114.093 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.03 -45.65 6.22 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 119.497 -1.335 . . . . 4.04 114.596 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.51 -27.28 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 O-C-N 121.37 -1.076 . . . . 5.35 109.382 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.93 -18.88 64.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.688 -2.508 . . . . 3.03 112.403 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.55 0.33 50.34 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 118.448 -0.787 . . . . 3.49 112.985 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.9 mtp -107.89 143.02 37.09 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 120.791 1.632 . . . . 3.75 109.464 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 p -94.78 155.01 17.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.625 0.77 . . . . 2.3 109.762 174.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.62 130.17 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 119.841 1.2 . . . . 2.47 109.858 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.58 52.07 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 113.272 -1.785 . . . . 2.61 113.064 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.6 tt0 -84.43 144.75 28.56 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 121.907 0.86 . . . . 6.53 112.57 -171.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.97 123.93 41.47 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 102.671 -3.085 . . . . 12.36 102.671 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.8 44.99 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 126.4 2.313 . . . . 5.84 114.273 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.23 122.53 43.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.516 1.627 . . . . 16.57 108.62 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.12 114.47 28.63 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 118.854 -2.404 . . . . 5.86 106.728 -176.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 86.3 m -98.77 120.47 39.25 Favored 'General case' 0 C--O 1.247 0.925 0 N-CA-C 105.858 -1.905 . . . . 5.76 105.858 176.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.72 122.62 69.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.653 -0.869 . . . . 3.36 108.653 -167.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.36 154.08 91.34 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.861 -1.066 . . . . 4.94 110.682 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -55.48 -35.12 91.59 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.298 2.665 . . . . 6.21 114.752 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.03 -13.84 62.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.922 1.082 . . . . 15.85 113.922 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.64 11.07 36.54 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 126.009 1.723 . . . . 11.52 111.674 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.9 -116.6 0.15 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 105.739 -1.949 . . . . 3.7 105.739 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -102.59 4.11 38.04 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 122.07 2.214 . . . . 6.84 115.498 -173.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.47 -137.09 50.49 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-O 123.739 1.744 . . . . 5.99 111.136 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.69 41.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 111.686 -2.257 . . . . 10.11 111.009 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.47 -43.89 63.08 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 121.039 1.745 . . . . 13.76 112.464 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.39 -169.16 53.46 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 107.606 -2.197 . . . . 9.98 107.606 -170.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.85 114.76 35.34 Favored Pre-proline 0 C--O 1.246 0.896 0 O-C-N 117.924 -3.103 . . . . 15.88 103.253 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.14 122.35 7.3 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 124.679 3.586 . . . . 11.41 110.936 -166.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.15 -26.85 3.24 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-N 111.933 -2.394 . . . . 14.2 117.385 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.531 HG21 ' C11' ' A' ' 108' ' ' GPI . 60.0 mt -102.99 -49.97 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 121.107 2.454 . . . . 11.06 114.938 -175.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.4 mm -112.84 131.87 22.56 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 103.118 -2.919 . . . . 8.01 103.118 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.95 163.02 35.38 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 125.236 3.957 . . . . 6.52 112.945 171.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.31 144.41 71.84 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.571 2.181 . . . . 4.82 110.331 162.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.31 27.33 16.34 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 112.938 -1.937 . . . . 7.42 113.577 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.79 132.31 35.28 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.388 2.366 . . . . 2.22 117.388 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.37 132.42 35.77 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 121.799 2.091 . . . . 4.61 106.349 168.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -109.0 146.79 33.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.379 -1.45 . . . . 5.34 110.284 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.9 t -123.16 120.03 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 103.679 -2.711 . . . . 3.97 103.679 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.0 m-85 -116.8 137.02 52.5 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.701 -1.25 . . . . 4.42 109.577 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.8 t0 -103.8 112.72 25.79 Favored 'General case' 0 C--N 1.314 -0.95 1 N-CA-C 98.876 -4.49 . . . . 2.09 98.876 174.026 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.7 t -126.75 132.43 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.153 -1.385 . . . . 3.53 110.821 -172.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.48 121.93 39.56 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.466 -2.05 . . . . 14.21 105.466 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 tp -89.06 109.11 20.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 123.57 1.652 . . . . 2.42 107.405 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.58 -43.25 13.66 Favored 'General case' 0 C--O 1.255 1.344 0 N-CA-C 115.19 1.552 . . . . 2.62 115.19 -171.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.3 tttt -161.87 153.64 18.94 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 113.612 -1.631 . . . . 11.71 109.154 -167.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.9 mt -120.12 133.28 55.55 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 105.097 -2.186 . . . . 4.7 105.097 170.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.311 -1.082 0 CA-C-N 113.552 -1.658 . . . . 13.02 109.82 -179.812 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GPI . . . . . 0.531 ' C11' HG21 ' A' ' 90' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 106.038 -2.825 . . . . 6.33 106.038 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.28 142.6 43.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 101.745 -3.428 . . . . 6.35 101.745 176.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -117.12 130.07 56.39 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.726 -3.065 . . . . 16.98 102.726 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.57 117.11 53.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 N-CA-C 103.674 -2.713 . . . . 5.58 103.674 -175.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.68 124.72 46.96 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 118.877 -2.389 . . . . 12.8 104.759 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.6 m -75.82 140.0 42.05 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.279 -2.138 . . . . 3.24 115.603 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.407 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.54 -52.03 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 105.899 -1.889 . . . . 4.79 105.899 171.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.8 m -138.86 139.01 22.45 Favored Pre-proline 0 C--O 1.243 0.737 0 O-C-N 119.518 -1.989 . . . . 11.59 106.357 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.3 Cg_exo -67.69 154.73 72.51 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 123.627 2.885 . . . . 4.55 112.23 -176.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.68 -161.22 28.9 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.09 -1.604 . . . . 2.0 109.09 175.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.54 -9.04 59.58 Favored 'General case' 0 C--O 1.241 0.628 0 O-C-N 117.639 -3.271 . . . . 3.24 113.18 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.12 9.65 76.86 Favored Glycine 0 C--O 1.218 -0.887 0 CA-C-O 117.637 -1.646 . . . . 3.38 113.874 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.62 -26.73 0.96 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 122.508 3.154 . . . . 26.59 114.241 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.4 93.98 4.97 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.072 -2.268 . . . . 3.02 109.579 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.21 142.54 24.82 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 125.023 1.452 . . . . 4.7 109.79 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.58 146.75 68.59 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.704 2.269 . . . . 2.94 110.702 -174.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.46 156.15 33.37 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.913 -1.494 . . . . 15.96 107.073 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.3 ttp180 -52.07 130.27 29.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 124.24 1.972 . . . . 11.69 112.804 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.29 -14.02 65.83 Favored Glycine 0 N--CA 1.422 -2.246 0 O-C-N 119.929 -1.732 . . . . 3.63 112.757 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -86.24 149.47 25.05 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 120.029 1.915 . . . . 5.9 112.243 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.2 m -89.97 120.29 31.05 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.312 1.633 . . . . 3.07 111.746 174.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.46 131.0 39.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 122.55 1.167 . . . . 4.11 109.891 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -111.96 111.39 35.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 101.624 -3.473 . . . . 2.16 101.624 -174.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 m -129.48 154.42 40.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.806 0.812 . . . . 3.59 112.282 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.4 30.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.187 -2.153 . . . . 3.13 105.187 164.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.0 p90 -145.79 156.1 43.36 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 120.126 1.33 . . . . 2.55 112.055 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -133.83 121.47 21.85 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 102.952 -2.981 . . . . 4.47 102.952 167.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.11 131.87 10.73 Favored Glycine 0 N--CA 1.471 0.999 0 N-CA-C 109.248 -1.541 . . . . 3.41 109.248 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.37 152.11 51.58 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 125.16 2.41 . . . . 18.22 110.481 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 164.64 22.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.745 -2.48 . . . . 5.93 106.447 172.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -58.03 -20.62 40.37 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 117.17 -3.457 . . . . 12.33 117.699 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -87.74 5.32 40.52 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 119.545 -1.972 . . . . 7.19 113.851 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.08 -10.2 69.96 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 124.013 1.896 . . . . 6.47 113.789 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.7 124.27 22.41 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 116.688 -3.831 . . . . 21.86 110.564 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.84 130.78 37.07 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.404 -1.332 . . . . 16.18 107.404 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -107.67 -17.9 13.97 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.124 -1.03 . . . . 5.73 110.667 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -172.76 155.4 3.21 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 118.087 -0.959 . . . . 6.13 110.587 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -158.76 128.12 5.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.47 1.108 . . . . 2.93 110.385 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 37.4 p -76.01 -20.67 57.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.937 -0.764 . . . . 2.3 108.937 175.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.61 -36.74 84.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.742 -1.577 . . . . 10.55 106.742 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -67.55 -28.53 67.87 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.172 -1.58 . . . . 8.02 110.807 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.68 -10.01 50.02 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 120.859 -1.15 . . . . 10.21 112.366 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.47 34.32 24.07 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-O 123.33 1.538 . . . . 16.38 110.945 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.76 120.14 9.29 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 117.594 -3.191 . . . . 20.21 103.887 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -59.22 152.27 61.14 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 124.231 3.288 . . . . 8.75 110.378 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CE2' ' H32' ' A' ' 108' ' ' GPI . 84.9 t80 -95.91 138.24 33.83 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.58 -1.637 . . . . 4.65 106.58 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.7 136.84 50.39 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 120.622 1.555 . . . . 10.62 111.311 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.61 150.71 40.66 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 120.466 1.485 . . . . 4.31 107.337 169.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.47 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.51 126.72 37.72 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 120.313 1.415 . . . . 2.67 110.563 172.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 129.8 41.92 Favored 'General case' 0 N--CA 1.426 -1.627 0 O-C-N 125.285 1.616 . . . . 3.08 110.639 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.97 -4.18 84.77 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.901 0.762 . . . . 4.95 114.009 176.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.03 -3.09 57.78 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.788 -1.419 . . . . 10.26 114.647 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 64.57 39.48 6.63 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.046 -1.659 . . . . 10.24 113.756 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.23 -0.79 13.8 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 114.767 1.395 . . . . 10.56 114.767 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.42 172.7 9.25 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 107.978 -1.119 . . . . 2.45 107.978 171.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.76 152.13 8.37 Favored 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.91 1.338 . . . . 5.57 109.851 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.42 -35.68 68.08 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.381 -1.282 . . . . 19.11 114.386 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.62 -23.5 72.23 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 123.333 2.788 . . . . 2.93 112.363 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.47 -54.67 7.1 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 118.535 1.168 . . . . 7.96 111.633 173.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.06 -44.43 15.37 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 124.028 1.871 . . . . 15.05 111.449 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.18 -35.49 48.63 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.639 -1.164 . . . . 20.27 114.111 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.95 -45.75 6.21 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 119.572 -1.299 . . . . 4.04 114.64 -175.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.49 -27.21 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 O-C-N 121.404 -1.056 . . . . 5.35 109.454 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.92 -18.93 64.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 118.625 -2.547 . . . . 3.03 112.343 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.49 0.27 50.35 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.454 -0.784 . . . . 3.49 113.026 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.76 143.09 36.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 120.831 1.65 . . . . 3.75 109.476 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.7 p -94.86 155.02 16.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.66 0.784 . . . . 2.3 109.8 174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.1 t -57.63 130.2 20.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 119.954 1.252 . . . . 2.47 109.711 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.7 52.05 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.381 -1.736 . . . . 2.61 113.077 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.5 tt0 -84.37 144.73 28.63 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.998 0.904 . . . . 6.53 112.566 -171.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.96 123.87 41.35 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 102.65 -3.092 . . . . 12.36 102.65 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.82 156.79 45.01 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 126.501 2.376 . . . . 5.84 114.323 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.28 122.38 43.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 123.449 1.595 . . . . 16.57 108.617 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.39 28.5 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 118.85 -2.406 . . . . 5.86 106.793 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.6 m -98.69 120.47 39.17 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 105.822 -1.918 . . . . 5.76 105.822 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.72 122.68 69.34 Favored 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 108.589 -0.893 . . . . 3.36 108.589 -167.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.1 p -66.41 153.99 91.67 Favored Pre-proline 0 C--O 1.243 0.721 0 CA-C-O 117.838 -1.077 . . . . 4.94 110.77 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -55.26 -35.11 90.53 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 123.285 2.656 . . . . 6.21 114.899 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.12 -13.85 62.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.792 1.034 . . . . 15.85 113.792 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -103.67 11.0 36.55 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 126.105 1.762 . . . . 11.52 111.737 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.83 -116.58 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.693 -1.965 . . . . 3.7 105.693 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.54 4.04 38.1 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 122.036 2.198 . . . . 6.84 115.453 -173.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.49 -137.15 50.44 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-O 123.733 1.74 . . . . 5.99 111.078 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.22 -18.78 41.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 111.725 -2.238 . . . . 10.11 110.993 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.1 m -72.28 -43.98 63.46 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 121.064 1.756 . . . . 13.76 112.529 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.39 -169.25 53.39 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 107.715 -2.154 . . . . 9.98 107.715 -170.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.85 114.93 35.27 Favored Pre-proline 0 C--O 1.247 0.962 0 O-C-N 118.012 -3.052 . . . . 15.88 103.164 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -48.14 122.36 7.32 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 124.781 3.654 . . . . 11.41 110.876 -166.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.17 -26.94 3.23 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.94 -2.391 . . . . 14.2 117.416 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.588 HD13 ' C11' ' A' ' 108' ' ' GPI . 59.6 mt -102.87 -50.16 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 121.056 2.428 . . . . 11.06 114.918 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.5 mm -112.85 131.88 22.55 Favored Pre-proline 0 CA--C 1.516 -0.337 0 N-CA-C 103.209 -2.885 . . . . 8.01 103.209 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.03 163.05 35.45 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.282 3.988 . . . . 6.52 112.915 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.2 Cg_exo -55.3 144.48 71.42 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.521 2.147 . . . . 4.82 110.232 162.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.14 27.46 16.53 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 112.924 -1.943 . . . . 7.42 113.622 172.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.91 132.42 35.27 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 117.382 2.364 . . . . 2.22 117.382 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.55 132.37 35.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 121.695 2.043 . . . . 4.61 106.359 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.82 146.84 32.99 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.457 -1.402 . . . . 5.34 110.308 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.18 120.01 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 103.74 -2.689 . . . . 3.97 103.74 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.7 m-85 -116.79 136.93 52.56 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.734 -1.229 . . . . 4.42 109.553 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.6 t0 -103.78 112.77 25.86 Favored 'General case' 0 C--N 1.315 -0.933 1 N-CA-C 98.863 -4.495 . . . . 2.09 98.863 174.014 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.2 t -126.86 132.31 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 114.143 -1.39 . . . . 3.53 110.765 -172.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.42 121.99 39.74 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.45 -2.055 . . . . 14.21 105.45 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 tp -89.14 109.07 19.98 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 123.643 1.687 . . . . 2.42 107.496 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.6 mt -85.53 -43.25 13.7 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.203 1.557 . . . . 2.62 115.203 -171.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.85 153.57 18.9 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.509 -1.678 . . . . 11.71 109.189 -167.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.1 mt -120.01 133.21 55.61 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 105.177 -2.157 . . . . 4.7 105.177 170.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 . . . . . 0 C--N 1.312 -1.049 0 CA-C-N 113.591 -1.641 . . . . 13.02 109.823 -179.805 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GPI . . . . . 0.588 ' C11' HD13 ' A' ' 90' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 106.024 -2.83 . . . . 6.33 106.024 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.33 142.48 43.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 101.784 -3.413 . . . . 6.35 101.784 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -116.98 130.16 56.51 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 102.807 -3.034 . . . . 16.98 102.807 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.5 t -109.54 117.04 53.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 103.718 -2.697 . . . . 5.58 103.718 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.65 124.7 46.94 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 118.927 -2.358 . . . . 12.8 104.834 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.3 m -75.7 140.03 42.25 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 119.365 -2.084 . . . . 3.24 115.68 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.9 mt -101.63 -51.92 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 105.874 -1.899 . . . . 4.79 105.874 171.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.3 m -138.93 139.06 22.45 Favored Pre-proline 0 C--O 1.242 0.704 0 O-C-N 119.572 -1.955 . . . . 11.59 106.299 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.7 Cg_exo -67.73 154.71 72.49 Favored 'Trans proline' 0 C--N 1.328 -0.522 0 C-N-CA 123.626 2.884 . . . . 4.55 112.166 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.71 -161.29 28.88 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 109.15 -1.58 . . . . 2.0 109.15 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -82.33 -9.21 59.56 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 117.677 -3.249 . . . . 3.24 113.21 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.17 9.67 77.07 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-O 117.585 -1.675 . . . . 3.38 113.799 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.62 -26.79 0.96 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.669 3.234 . . . . 26.59 114.225 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.47 94.04 4.99 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 119.111 -2.243 . . . . 3.02 109.525 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.27 142.53 24.8 Favored Pre-proline 0 C--O 1.251 1.14 0 O-C-N 124.95 1.406 . . . . 4.7 109.769 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.62 146.71 68.18 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.743 2.295 . . . . 2.94 110.671 -174.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -121.47 156.25 33.16 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.925 -1.489 . . . . 15.96 106.994 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.3 ttp180 -52.1 130.27 29.67 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 124.121 1.915 . . . . 11.69 112.831 174.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.21 -14.05 65.84 Favored Glycine 0 N--CA 1.421 -2.307 0 O-C-N 119.971 -1.706 . . . . 3.63 112.763 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.15 149.41 25.13 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.098 1.949 . . . . 5.9 112.311 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.6 m -89.97 120.42 31.16 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 125.257 1.598 . . . . 3.07 111.689 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.52 131.06 39.12 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.592 1.187 . . . . 4.11 109.799 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.4 t -112.06 111.33 35.69 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.649 -3.463 . . . . 2.16 101.649 -174.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.9 m -129.43 154.43 40.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.77 0.795 . . . . 3.59 112.313 -172.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.12 145.41 30.58 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.274 -2.121 . . . . 3.13 105.274 164.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.86 156.13 43.35 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 120.172 1.351 . . . . 2.55 111.87 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -133.86 121.48 21.82 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 102.924 -2.991 . . . . 4.47 102.924 167.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.27 131.93 10.76 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 109.173 -1.571 . . . . 3.41 109.173 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.46 152.18 51.61 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 125.291 2.472 . . . . 18.22 110.374 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 164.55 22.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 111.65 -2.523 . . . . 5.93 106.435 172.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -57.96 -20.69 39.78 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 117.263 -3.398 . . . . 12.33 117.705 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.75 5.4 40.18 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.564 -1.96 . . . . 7.19 113.874 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.36 69.71 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-O 124.113 1.952 . . . . 6.47 113.754 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.42 124.18 22.04 Favored 'General case' 0 N--CA 1.438 -1.037 0 O-C-N 116.601 -3.882 . . . . 21.86 110.686 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.91 130.79 37.01 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.37 -1.344 . . . . 16.18 107.37 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.61 -17.93 13.97 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.095 -1.042 . . . . 5.73 110.74 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.68 155.44 3.28 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 118.041 -0.98 . . . . 6.13 110.665 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -158.77 128.2 5.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.484 1.113 . . . . 2.93 110.312 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 38.9 p -76.03 -20.61 57.64 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.001 -0.74 . . . . 2.3 109.001 175.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.63 84.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.685 -1.598 . . . . 10.55 106.685 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -67.64 -28.56 67.83 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.143 -1.598 . . . . 8.02 110.827 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.3 mtm-85 -88.58 -10.04 50.14 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.861 -1.149 . . . . 10.21 112.427 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.5 34.26 24.0 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.311 1.529 . . . . 16.38 110.951 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.7 120.2 9.36 Favored Pre-proline 0 C--O 1.247 0.972 0 O-C-N 117.571 -3.206 . . . . 20.21 103.921 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -59.33 152.29 61.77 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.292 3.328 . . . . 8.75 110.276 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CE2' ' H32' ' A' ' 108' ' ' GPI . 85.1 t80 -95.85 138.18 33.86 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.572 -1.64 . . . . 4.65 106.572 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.67 136.88 50.3 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 120.525 1.512 . . . . 10.62 111.253 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.6 150.7 40.67 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 120.475 1.489 . . . . 4.31 107.368 169.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.466 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.46 126.61 37.62 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.324 1.42 . . . . 2.67 110.542 172.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.87 129.9 42.45 Favored 'General case' 0 N--CA 1.427 -1.576 0 O-C-N 125.33 1.644 . . . . 3.08 110.699 176.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.79 -4.02 84.92 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 123.862 0.744 . . . . 4.95 114.043 176.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.08 -3.13 57.86 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.686 -1.479 . . . . 10.26 114.633 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 64.56 39.52 6.65 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 120.012 -1.68 . . . . 10.24 113.858 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.34 -0.89 13.69 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 114.722 1.378 . . . . 10.56 114.722 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.4 172.67 9.28 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 N-CA-C 108.085 -1.08 . . . . 2.45 108.085 171.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 pt -71.82 152.17 8.32 Favored 'Isoleucine or valine' 0 C--O 1.256 1.445 0 CA-C-O 123.029 1.395 . . . . 5.57 109.725 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -56.26 -35.71 67.75 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 114.316 -1.311 . . . . 19.11 114.471 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.86 -23.22 72.53 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 123.4 2.818 . . . . 2.93 112.432 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.52 -54.76 6.89 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 118.555 1.178 . . . . 7.96 111.583 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.86 -44.43 14.36 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 124.045 1.878 . . . . 15.05 111.503 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.44 -35.35 46.98 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.564 -1.198 . . . . 20.27 114.007 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.94 -45.7 6.23 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 119.615 -1.279 . . . . 4.04 114.724 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.58 -27.18 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 119.09 -1.044 . . . . 5.35 109.425 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.85 64.71 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.541 -2.6 . . . . 3.03 112.35 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.42 0.18 50.46 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 118.425 -0.798 . . . . 3.49 113.068 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.6 mtp -107.7 143.1 36.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 120.81 1.641 . . . . 3.75 109.572 -171.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -94.84 154.96 17.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.715 0.806 . . . . 2.3 109.806 174.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.2 t -57.62 130.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 119.867 1.212 . . . . 2.47 109.783 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 -12.53 52.08 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 113.35 -1.75 . . . . 2.61 112.995 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.7 tt0 -84.46 144.76 28.52 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.919 0.866 . . . . 6.53 112.575 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.95 123.89 41.4 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 102.632 -3.099 . . . . 12.36 102.632 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.91 156.64 44.94 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 126.471 2.357 . . . . 5.84 114.285 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.15 122.45 43.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 123.551 1.643 . . . . 16.57 108.638 174.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.05 114.59 28.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 118.741 -2.474 . . . . 5.86 106.76 -176.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.9 m -98.74 120.44 39.18 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 105.77 -1.937 . . . . 5.76 105.77 176.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.66 122.59 69.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 108.687 -0.857 . . . . 3.36 108.687 -167.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.35 154.03 91.41 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.907 -1.044 . . . . 4.94 110.683 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -55.45 -35.09 91.39 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.355 2.704 . . . . 6.21 114.738 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.07 -13.84 62.4 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.897 1.073 . . . . 15.85 113.897 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.61 10.99 36.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 126.106 1.762 . . . . 11.52 111.692 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.86 -116.6 0.15 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 105.712 -1.958 . . . . 3.7 105.712 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.59 4.0 37.92 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-N 121.991 2.178 . . . . 6.84 115.444 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.49 -137.15 50.44 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-O 123.739 1.744 . . . . 5.99 111.032 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.29 -18.73 41.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 111.674 -2.263 . . . . 10.11 110.982 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.1 m -72.19 -43.98 63.69 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 121.131 1.787 . . . . 13.76 112.608 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.3 -169.17 53.38 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 107.652 -2.179 . . . . 9.98 107.652 -170.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -118.83 114.9 35.32 Favored Pre-proline 0 C--O 1.247 0.959 0 O-C-N 117.982 -3.069 . . . . 15.88 103.268 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.21 122.44 7.5 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.622 3.548 . . . . 11.41 110.903 -166.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.21 -26.98 3.23 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.863 -2.426 . . . . 14.2 117.416 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.6 mt -102.88 -50.04 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 121.03 2.415 . . . . 11.06 114.894 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.7 mm -112.92 131.91 22.56 Favored Pre-proline 0 CA--C 1.516 -0.328 0 N-CA-C 103.203 -2.888 . . . . 8.01 103.203 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.01 163.02 35.53 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.284 3.99 . . . . 6.52 112.918 171.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.34 144.48 71.81 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.563 2.175 . . . . 4.82 110.244 162.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.33 27.22 16.27 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 112.785 -2.007 . . . . 7.42 113.581 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.84 132.35 35.27 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 117.396 2.369 . . . . 2.22 117.396 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -80.51 132.43 35.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 121.722 2.055 . . . . 4.61 106.328 168.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.89 146.86 33.06 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.451 -1.406 . . . . 5.34 110.276 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.3 t -123.21 119.95 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 N-CA-C 103.743 -2.688 . . . . 3.97 103.743 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.6 m-85 -116.77 137.01 52.5 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.724 -1.235 . . . . 4.42 109.562 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.81 112.7 25.77 Favored 'General case' 0 C--N 1.314 -0.959 1 N-CA-C 98.91 -4.478 . . . . 2.09 98.91 173.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.4 t -126.8 132.33 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.12 -1.4 . . . . 3.53 110.82 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.44 121.84 39.39 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.524 -2.028 . . . . 14.21 105.524 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.09 109.01 19.92 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 123.618 1.675 . . . . 2.42 107.484 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.41 -43.34 13.72 Favored 'General case' 0 C--O 1.255 1.378 0 N-CA-C 115.175 1.546 . . . . 2.62 115.175 -171.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.405 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.5 tttt -161.79 153.59 19.05 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 113.559 -1.655 . . . . 11.71 109.229 -167.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.07 133.19 55.59 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 105.201 -2.148 . . . . 4.7 105.201 170.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.31 -1.138 0 CA-C-N 113.554 -1.657 . . . . 13.02 109.912 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GPI . . . . . 0.533 H151 H132 ' A' ' 108' ' ' GPI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 106.073 -2.811 . . . . 6.33 106.073 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.34 142.55 43.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 101.741 -3.429 . . . . 6.35 101.741 176.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -117.05 130.13 56.46 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 102.734 -3.061 . . . . 16.98 102.734 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.9 t -109.53 117.04 53.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 103.741 -2.689 . . . . 5.58 103.741 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.62 124.72 47.01 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 118.957 -2.339 . . . . 12.8 104.824 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.4 m -75.68 140.02 42.28 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 119.292 -2.13 . . . . 3.24 115.635 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.41 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.3 mt -101.61 -52.02 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.832 -1.914 . . . . 4.79 105.832 171.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.6 m -138.95 139.03 22.27 Favored Pre-proline 0 C--O 1.241 0.652 0 O-C-N 119.5 -2.0 . . . . 11.59 106.301 177.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.7 Cg_exo -67.7 154.78 72.34 Favored 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.46 2.774 . . . . 4.55 112.201 -176.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.71 -161.17 28.86 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 109.135 -1.586 . . . . 2.0 109.135 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.49 -9.21 59.52 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 117.606 -3.291 . . . . 3.24 113.161 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.15 9.68 77.02 Favored Glycine 0 C--O 1.219 -0.8 0 CA-C-O 117.691 -1.616 . . . . 3.38 113.846 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.67 -26.58 0.96 Allowed 'General case' 0 C--O 1.24 0.587 0 CA-C-N 122.592 3.196 . . . . 26.59 114.214 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.57 94.0 4.96 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 119.057 -2.277 . . . . 3.02 109.45 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.13 142.53 24.81 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 125.01 1.444 . . . . 4.7 109.798 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.56 146.76 68.69 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.754 2.303 . . . . 2.94 110.627 -174.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.48 156.09 33.53 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.919 -1.491 . . . . 15.96 107.047 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.465 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.03 130.23 29.28 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 124.189 1.947 . . . . 11.69 112.721 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.36 -14.08 65.67 Favored Glycine 0 N--CA 1.423 -2.21 0 O-C-N 119.952 -1.717 . . . . 3.63 112.713 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.12 149.36 25.18 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.061 1.93 . . . . 5.9 112.326 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.92 120.36 31.08 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.176 1.548 . . . . 3.07 111.766 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.51 130.94 39.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 122.606 1.193 . . . . 4.11 109.874 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.3 t -111.89 111.39 35.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.638 -3.467 . . . . 2.16 101.638 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.54 154.39 40.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 121.817 0.817 . . . . 3.59 112.262 -172.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.04 145.49 30.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.173 -2.158 . . . . 3.13 105.173 164.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.496 ' CZ ' ' H52' ' A' ' 108' ' ' GPI . 33.1 p90 -145.89 156.11 43.33 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 120.048 1.294 . . . . 2.55 112.038 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.8 m -133.84 121.63 22.06 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 102.88 -3.007 . . . . 4.47 102.88 167.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.24 131.94 10.76 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 109.22 -1.552 . . . . 3.41 109.22 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.4 152.12 51.6 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 125.198 2.427 . . . . 18.22 110.405 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 164.62 22.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.741 -2.481 . . . . 5.93 106.447 172.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -58.04 -20.58 40.22 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.238 -3.414 . . . . 12.33 117.708 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.75 5.3 40.65 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.59 -1.943 . . . . 7.19 113.914 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.23 -10.33 69.62 Favored Glycine 0 C--N 1.357 1.697 0 CA-C-O 123.956 1.864 . . . . 6.47 113.646 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.59 124.22 22.23 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 116.622 -3.869 . . . . 21.86 110.583 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -77.77 130.83 37.21 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.457 -1.312 . . . . 16.18 107.457 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.71 -17.87 13.97 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.075 -1.05 . . . . 5.73 110.802 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -172.76 155.49 3.24 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 118.241 -0.885 . . . . 6.13 110.55 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.81 128.05 5.54 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.48 1.112 . . . . 2.93 110.371 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 40.3 p -75.89 -20.59 57.92 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.846 -0.741 . . . . 2.3 109.093 175.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.73 -36.69 84.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.696 -1.594 . . . . 10.55 106.696 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -67.62 -28.49 67.78 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.191 -1.568 . . . . 8.02 110.812 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.63 -10.1 49.81 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 120.854 -1.154 . . . . 10.21 112.341 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.51 34.28 24.05 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.346 1.546 . . . . 16.38 111.017 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.68 120.18 9.37 Favored Pre-proline 0 C--O 1.247 0.972 0 O-C-N 117.627 -3.171 . . . . 20.21 103.914 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -59.32 152.28 61.72 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 124.321 3.347 . . . . 8.75 110.32 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.486 ' CZ ' ' H41' ' A' ' 108' ' ' GPI . 85.1 t80 -95.84 138.13 33.92 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.534 -1.654 . . . . 4.65 106.534 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -111.61 136.89 50.2 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 120.572 1.533 . . . . 10.62 111.297 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.66 150.7 40.55 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.402 1.456 . . . . 4.31 107.373 169.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.51 126.67 37.7 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 120.311 1.414 . . . . 2.67 110.585 172.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 129.86 42.19 Favored 'General case' 0 N--CA 1.426 -1.643 0 O-C-N 125.251 1.594 . . . . 3.08 110.647 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.93 -4.12 84.8 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 123.841 0.734 . . . . 4.95 114.099 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.1 -3.12 57.86 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.797 -1.414 . . . . 10.26 114.561 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.51 39.62 6.69 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.106 -1.621 . . . . 10.24 113.784 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.38 -0.81 13.69 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 114.676 1.361 . . . . 10.56 114.676 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.37 172.63 9.33 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.118 -1.067 . . . . 2.45 108.118 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.2 pt -71.82 152.12 8.34 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.98 1.371 . . . . 5.57 109.785 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -56.22 -35.75 67.69 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.354 -1.294 . . . . 19.11 114.458 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.76 -23.31 72.38 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.423 2.828 . . . . 2.93 112.357 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.59 -54.68 7.0 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 118.621 1.21 . . . . 7.96 111.611 173.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -45.93 -44.45 14.74 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 124.015 1.864 . . . . 15.05 111.512 173.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.33 -35.31 47.77 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.517 -1.22 . . . . 20.27 114.084 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.05 -45.65 6.21 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.424 -1.37 . . . . 4.04 114.663 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.47 -27.25 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 121.317 -1.108 . . . . 5.35 109.456 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.95 -18.89 64.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.506 -2.621 . . . . 3.03 112.363 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.48 0.34 50.04 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.078 0.77 . . . . 3.49 113.078 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.9 mtp -107.88 143.08 36.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 120.765 1.62 . . . . 3.75 109.493 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -94.71 154.92 17.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.714 0.805 . . . . 2.3 109.877 174.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -57.58 130.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 119.965 1.257 . . . . 2.47 109.828 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.12 -12.54 52.26 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 113.366 -1.743 . . . . 2.61 113.124 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.444 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.7 tt0 -84.48 144.8 28.49 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.915 0.864 . . . . 6.53 112.605 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -124.01 123.99 41.57 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 102.578 -3.119 . . . . 12.36 102.578 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.82 45.01 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.467 2.354 . . . . 5.84 114.292 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.28 122.39 43.59 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.463 1.601 . . . . 16.57 108.651 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.59 28.82 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.847 -2.408 . . . . 5.86 106.709 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 86.2 m -98.79 120.47 39.28 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 105.822 -1.918 . . . . 5.76 105.822 176.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.73 122.55 69.01 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 108.616 -0.883 . . . . 3.36 108.616 -167.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.34 154.02 91.43 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-O 117.787 -1.101 . . . . 4.94 110.737 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.4 -35.08 91.11 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.312 2.675 . . . . 6.21 114.749 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.17 -13.83 62.36 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 113.777 1.029 . . . . 15.85 113.777 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.69 11.05 36.45 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 126.038 1.735 . . . . 11.52 111.693 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.79 -116.54 0.15 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 105.751 -1.944 . . . . 3.7 105.751 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.73 4.22 37.8 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 122.033 2.197 . . . . 6.84 115.452 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.36 -137.18 50.33 Favored Glycine 0 C--N 1.354 1.578 0 CA-C-O 123.708 1.727 . . . . 5.99 111.073 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.17 -18.75 41.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 111.661 -2.27 . . . . 10.11 111.047 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.25 -43.98 63.53 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 121.048 1.749 . . . . 13.76 112.575 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.4 -169.24 53.4 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 107.603 -2.199 . . . . 9.98 107.603 -170.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.87 114.9 35.23 Favored Pre-proline 0 C--O 1.246 0.913 0 O-C-N 118.097 -3.002 . . . . 15.88 103.151 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.13 122.43 7.4 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.667 3.578 . . . . 11.41 110.901 -166.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.17 -27.05 3.2 Favored Glycine 0 CA--C 1.545 1.935 0 CA-C-N 111.897 -2.41 . . . . 14.2 117.454 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.9 mt -102.85 -50.08 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.046 2.423 . . . . 11.06 114.972 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.84 131.93 22.52 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 103.124 -2.917 . . . . 8.01 103.124 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.09 163.08 35.43 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 125.218 3.945 . . . . 6.52 112.871 171.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.511 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.3 Cg_exo -55.4 144.54 72.21 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.428 2.085 . . . . 4.82 110.311 162.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.19 27.26 16.38 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 112.886 -1.961 . . . . 7.42 113.722 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.67 132.36 35.29 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 117.381 2.363 . . . . 2.22 117.381 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.47 132.46 35.71 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 121.796 2.089 . . . . 4.61 106.348 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -108.94 146.78 33.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 120.379 -1.45 . . . . 5.34 110.241 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.17 120.01 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 103.768 -2.679 . . . . 3.97 103.768 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.6 m-85 -116.76 136.95 52.55 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.724 -1.235 . . . . 4.42 109.591 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.8 t0 -103.75 112.7 25.77 Favored 'General case' 0 C--N 1.313 -1.0 1 N-CA-C 98.925 -4.472 . . . . 2.09 98.925 173.979 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.6 t -126.82 132.34 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.212 -1.358 . . . . 3.53 110.804 -172.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -120.47 121.9 39.5 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.464 -2.05 . . . . 14.21 105.464 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.6 tp -89.05 109.04 19.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 123.606 1.67 . . . . 2.42 107.516 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.46 -43.26 13.74 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.181 1.549 . . . . 2.62 115.181 -171.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.8 153.58 19.02 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 113.503 -1.68 . . . . 11.71 109.115 -167.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.04 133.24 55.59 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 105.206 -2.146 . . . . 4.7 105.206 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.582 -1.645 . . . . 13.02 109.912 -179.84 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GPI . . . . . 0.496 ' H52' ' CZ ' ' A' ' 26' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 106.082 -2.807 . . . . 6.33 106.082 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.36 142.54 43.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 101.712 -3.44 . . . . 6.35 101.712 176.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -117.06 130.11 56.44 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 102.824 -3.028 . . . . 16.98 102.824 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.1 t -109.49 117.12 53.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 103.67 -2.715 . . . . 5.58 103.67 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.63 124.68 46.92 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 118.949 -2.345 . . . . 12.8 104.83 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.6 m -75.66 139.96 42.27 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.333 -2.105 . . . . 3.24 115.621 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.5 mt -101.66 -52.01 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 105.82 -1.919 . . . . 4.79 105.82 171.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.5 m -138.93 139.1 22.58 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 119.652 -1.905 . . . . 11.59 106.233 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.3 Cg_exo -67.66 154.76 72.49 Favored 'Trans proline' 0 C--N 1.33 -0.433 0 C-N-CA 123.568 2.846 . . . . 4.55 112.224 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.68 -161.08 28.88 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.106 -1.597 . . . . 2.0 109.106 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -82.55 -9.17 59.52 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 117.694 -3.239 . . . . 3.24 113.146 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.1 9.77 76.98 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.636 -1.647 . . . . 3.38 113.843 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.74 -26.66 0.95 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.592 3.196 . . . . 26.59 114.226 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 m -105.52 94.03 4.98 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 119.143 -2.223 . . . . 3.02 109.439 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.21 142.5 24.75 Favored Pre-proline 0 C--O 1.25 1.091 0 O-C-N 125.003 1.439 . . . . 4.7 109.77 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.53 146.59 68.31 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.789 2.326 . . . . 2.94 110.682 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.42 156.18 33.25 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.895 -1.502 . . . . 15.96 106.99 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.6 ttp180 -52.17 130.31 30.06 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 124.201 1.953 . . . . 11.69 112.828 174.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.28 -13.96 65.94 Favored Glycine 0 N--CA 1.424 -2.147 0 O-C-N 120.009 -1.682 . . . . 3.63 112.682 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.47 25.09 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 120.111 1.956 . . . . 5.9 112.356 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.9 m -89.89 120.31 31.01 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.308 1.63 . . . . 3.07 111.726 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.55 131.05 39.17 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.614 1.197 . . . . 4.11 109.851 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -112.0 111.41 36.04 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.643 -3.466 . . . . 2.16 101.643 -174.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.1 m -129.6 154.4 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.89 0.852 . . . . 3.59 112.249 -172.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.05 145.39 30.54 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.258 -2.127 . . . . 3.13 105.258 164.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.8 156.19 43.42 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 120.173 1.351 . . . . 2.55 111.923 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.4 m -133.86 121.54 21.91 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 102.99 -2.967 . . . . 4.47 102.99 167.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.2 131.95 10.77 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 109.3 -1.52 . . . . 3.41 109.3 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.39 152.19 51.56 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 125.263 2.459 . . . . 18.22 110.381 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.6 164.66 22.73 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.706 -2.497 . . . . 5.93 106.408 172.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -58.11 -20.64 41.69 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 117.28 -3.387 . . . . 12.33 117.67 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.57 5.21 40.45 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 119.536 -1.977 . . . . 7.19 113.927 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.22 -10.24 69.65 Favored Glycine 0 C--N 1.354 1.54 0 CA-C-O 123.973 1.874 . . . . 6.47 113.67 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.67 124.32 22.54 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 116.728 -3.807 . . . . 21.86 110.583 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.97 130.76 36.93 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.383 -1.34 . . . . 16.18 107.383 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.56 -17.9 13.98 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.142 -1.023 . . . . 5.73 110.845 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -172.71 155.44 3.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.064 -0.97 . . . . 6.13 110.614 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -158.82 128.17 5.58 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.421 1.088 . . . . 2.93 110.284 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.2 p -75.97 -20.74 57.66 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.841 -0.743 . . . . 2.3 109.006 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.63 -36.67 84.6 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.674 -1.602 . . . . 10.55 106.674 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.59 -28.47 67.79 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.191 -1.568 . . . . 8.02 110.881 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.67 -10.11 49.69 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 120.847 -1.158 . . . . 10.21 112.331 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.49 34.32 24.1 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-O 123.4 1.571 . . . . 16.38 110.989 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.69 120.2 9.36 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 117.703 -3.123 . . . . 20.21 103.926 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -59.24 152.26 61.35 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 124.209 3.273 . . . . 8.75 110.383 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -95.86 138.31 33.69 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.518 -1.66 . . . . 4.65 106.518 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.76 136.78 50.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.588 1.54 . . . . 10.62 111.326 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -142.56 150.59 40.57 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 120.437 1.472 . . . . 4.31 107.442 169.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.468 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.47 126.71 37.68 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.365 1.439 . . . . 2.67 110.634 172.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.87 129.83 42.14 Favored 'General case' 0 N--CA 1.428 -1.56 0 O-C-N 125.32 1.637 . . . . 3.08 110.654 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.87 -4.06 84.85 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 123.9 0.762 . . . . 4.95 114.093 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.11 -3.01 57.79 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.765 -1.432 . . . . 10.26 114.64 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.51 39.55 6.72 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.045 -1.659 . . . . 10.24 113.795 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.73 13.7 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 114.671 1.36 . . . . 10.56 114.671 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.46 172.68 9.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 N-CA-C 107.938 -1.134 . . . . 2.45 107.938 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 pt -71.77 152.12 8.37 Favored 'Isoleucine or valine' 0 C--O 1.259 1.604 0 CA-C-O 122.944 1.354 . . . . 5.57 109.765 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.34 -35.73 67.96 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 114.401 -1.272 . . . . 19.11 114.395 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.78 -23.34 72.42 Favored Glycine 0 CA--C 1.539 1.583 0 O-C-N 118.226 -2.796 . . . . 2.93 112.344 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.62 -54.55 7.23 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 118.556 1.178 . . . . 7.96 111.628 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.99 -44.45 15.03 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 124.015 1.864 . . . . 15.05 111.502 173.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.35 -35.25 47.71 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.544 -1.207 . . . . 20.27 114.101 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.04 -45.75 6.18 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.534 -1.317 . . . . 4.04 114.623 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.51 -27.22 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 121.338 -1.095 . . . . 5.35 109.425 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.97 -18.8 64.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 118.531 -2.606 . . . . 3.03 112.439 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.52 0.25 50.54 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.468 -0.777 . . . . 3.49 113.026 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.8 143.05 36.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 120.852 1.66 . . . . 3.75 109.577 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -94.77 154.96 17.03 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.693 0.797 . . . . 2.3 109.86 174.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.2 t -57.62 130.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 119.957 1.253 . . . . 2.47 109.763 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.15 -12.46 52.12 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 113.311 -1.768 . . . . 2.61 113.049 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.441 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.8 tt0 -84.48 144.77 28.51 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-O 121.854 0.835 . . . . 6.53 112.562 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.97 123.98 41.58 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 102.626 -3.102 . . . . 12.36 102.626 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.91 156.82 44.97 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.472 2.357 . . . . 5.84 114.221 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.36 122.42 43.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 123.443 1.592 . . . . 16.57 108.699 174.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.98 114.4 28.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 O-C-N 118.841 -2.412 . . . . 5.86 106.797 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.6 m -98.68 120.51 39.24 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 105.855 -1.905 . . . . 5.76 105.855 176.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.63 122.61 69.25 Favored 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 108.714 -0.847 . . . . 3.36 108.714 -167.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.38 154.03 91.52 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.915 -1.04 . . . . 4.94 110.739 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.32 -35.19 90.99 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 123.268 2.645 . . . . 6.21 114.786 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -69.95 -13.96 62.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.927 1.084 . . . . 15.85 113.927 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.6 11.06 36.61 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 126.113 1.765 . . . . 11.52 111.757 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.79 -116.62 0.15 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 105.786 -1.931 . . . . 3.7 105.786 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -102.51 3.94 38.08 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 122.032 2.196 . . . . 6.84 115.545 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.58 -137.17 50.48 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-O 123.757 1.754 . . . . 5.99 111.011 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.64 41.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 111.622 -2.289 . . . . 10.11 110.983 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.26 -44.09 63.34 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 121.112 1.778 . . . . 13.76 112.529 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.4 -169.19 53.44 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.659 -2.177 . . . . 9.98 107.659 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.81 114.8 35.4 Favored Pre-proline 0 C--O 1.247 0.922 0 O-C-N 117.999 -3.06 . . . . 15.88 103.323 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -48.19 122.47 7.52 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 124.707 3.605 . . . . 11.41 110.89 -166.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.19 -26.97 3.23 Favored Glycine 0 CA--C 1.547 2.079 0 CA-C-N 111.87 -2.423 . . . . 14.2 117.361 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.606 HD13 ' C11' ' A' ' 108' ' ' GPI . 60.1 mt -102.96 -50.04 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 121.074 2.437 . . . . 11.06 114.917 -175.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.95 131.92 22.57 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 103.17 -2.9 . . . . 8.01 103.17 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.0 163.07 35.32 Favored 'Trans proline' 0 C--O 1.24 0.592 1 C-N-CA 125.34 4.027 . . . . 6.52 112.853 171.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.34 144.45 71.94 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.534 2.156 . . . . 4.82 110.307 162.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.32 27.3 16.32 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 112.846 -1.979 . . . . 7.42 113.562 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.86 132.35 35.27 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 117.392 2.367 . . . . 2.22 117.392 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -80.57 132.45 35.65 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 121.696 2.043 . . . . 4.61 106.283 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.88 146.78 33.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.442 -1.411 . . . . 5.34 110.285 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.19 119.96 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 103.78 -2.674 . . . . 3.97 103.78 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.4 m-85 -116.81 137.09 52.45 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.77 -1.206 . . . . 4.42 109.541 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.81 112.73 25.81 Favored 'General case' 0 C--N 1.314 -0.975 1 N-CA-C 98.912 -4.477 . . . . 2.09 98.912 174.019 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.5 t -126.72 132.36 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.109 -1.405 . . . . 3.53 110.805 -172.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.49 121.82 39.29 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.57 -2.011 . . . . 14.21 105.57 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 tp -89.02 109.11 19.99 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.42 107.498 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.9 mt -85.47 -43.34 13.67 Favored 'General case' 0 C--O 1.254 1.34 0 N-CA-C 115.255 1.576 . . . . 2.62 115.255 -171.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.86 153.54 18.84 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.422 -1.717 . . . . 11.71 109.153 -167.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.0 133.28 55.59 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 105.155 -2.165 . . . . 4.7 105.155 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.313 -1.018 0 CA-C-N 113.548 -1.66 . . . . 13.02 109.8 -179.798 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GPI . . . . . 0.606 ' C11' HD13 ' A' ' 90' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 106.034 -2.826 . . . . 6.33 106.034 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.31 142.46 43.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 101.725 -3.435 . . . . 6.35 101.725 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -116.92 130.21 56.55 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 102.818 -3.03 . . . . 16.98 102.818 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.8 t -109.71 117.1 53.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 103.613 -2.736 . . . . 5.58 103.613 -175.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.61 124.65 46.85 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 118.919 -2.363 . . . . 12.8 104.82 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.7 m -75.57 139.97 42.41 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.183 -2.198 . . . . 3.24 115.598 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.7 mt -101.64 -52.07 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 105.844 -1.91 . . . . 4.79 105.844 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.7 m -138.9 139.03 22.4 Favored Pre-proline 0 C--O 1.243 0.723 0 O-C-N 119.684 -1.885 . . . . 11.59 106.358 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.7 Cg_exo -67.66 154.78 72.44 Favored 'Trans proline' 0 C--N 1.329 -0.48 0 C-N-CA 123.536 2.824 . . . . 4.55 112.15 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.63 -161.1 28.93 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 109.222 -1.551 . . . . 2.0 109.222 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.49 -9.21 59.52 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 117.65 -3.265 . . . . 3.24 113.163 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.14 9.69 76.98 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-O 117.585 -1.675 . . . . 3.38 113.806 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.63 -26.81 0.96 Allowed 'General case' 0 C--O 1.24 0.568 0 CA-C-N 122.669 3.234 . . . . 26.59 114.208 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.38 93.92 4.93 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 119.101 -2.249 . . . . 3.02 109.602 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -104.22 142.46 24.65 Favored Pre-proline 0 C--O 1.25 1.08 0 O-C-N 125.005 1.441 . . . . 4.7 109.82 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.48 146.67 68.91 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.704 2.27 . . . . 2.94 110.657 -174.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.46 156.29 33.08 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.836 -1.529 . . . . 15.96 106.962 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.24 130.27 30.21 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 124.253 1.977 . . . . 11.69 112.764 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.3 -14.08 65.72 Favored Glycine 0 N--CA 1.424 -2.159 0 O-C-N 119.999 -1.688 . . . . 3.63 112.766 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -86.18 149.43 25.11 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.095 1.948 . . . . 5.9 112.333 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.95 120.29 31.04 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 125.308 1.63 . . . . 3.07 111.729 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.3 m -93.57 131.09 39.17 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 122.616 1.198 . . . . 4.11 109.827 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -111.99 111.5 36.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 N-CA-C 101.625 -3.472 . . . . 2.16 101.625 -174.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.58 154.42 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.82 0.819 . . . . 3.59 112.3 -172.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.46 30.52 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.215 -2.143 . . . . 3.13 105.215 164.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.82 156.17 43.4 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 120.04 1.291 . . . . 2.55 111.927 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.79 121.57 22.03 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 102.929 -2.989 . . . . 4.47 102.929 167.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.22 131.93 10.76 Favored Glycine 0 N--CA 1.471 1.013 0 N-CA-C 109.192 -1.563 . . . . 3.41 109.192 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.38 152.13 51.58 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 125.142 2.401 . . . . 18.22 110.435 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 164.56 22.85 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 111.797 -2.456 . . . . 5.93 106.384 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.08 -20.54 40.39 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.242 -3.411 . . . . 12.33 117.684 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -87.75 5.29 40.67 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 119.659 -1.901 . . . . 7.19 113.885 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.22 69.72 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-O 123.966 1.87 . . . . 6.47 113.684 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.65 124.2 22.2 Favored 'General case' 0 N--CA 1.438 -1.045 0 O-C-N 116.678 -3.836 . . . . 21.86 110.593 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.81 130.81 37.14 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 107.477 -1.305 . . . . 16.18 107.477 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -107.62 -17.88 13.98 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.041 -1.064 . . . . 5.73 110.913 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.68 155.5 3.3 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 118.16 -0.924 . . . . 6.13 110.504 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.85 128.16 5.55 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.451 1.101 . . . . 2.93 110.328 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 38.6 p -75.97 -20.59 57.77 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.827 -0.749 . . . . 2.3 109.052 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.86 -36.54 84.25 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.639 -1.615 . . . . 10.55 106.639 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -67.74 -28.4 67.6 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.219 -1.551 . . . . 8.02 110.819 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.57 -10.22 49.56 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 120.767 -1.208 . . . . 10.21 112.436 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.63 34.21 24.1 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 123.286 1.517 . . . . 16.38 110.908 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.4 tttm -139.71 120.18 9.34 Favored Pre-proline 0 C--N 1.315 -0.931 0 O-C-N 117.632 -3.168 . . . . 20.21 103.894 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.3 152.4 60.74 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 124.23 3.287 . . . . 8.75 110.318 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.486 ' CZ ' ' H32' ' A' ' 108' ' ' GPI . 84.8 t80 -96.05 138.09 34.17 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.505 -1.665 . . . . 4.65 106.505 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -111.51 136.85 50.12 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 120.521 1.51 . . . . 10.62 111.367 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -142.57 150.62 40.6 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 120.513 1.506 . . . . 4.31 107.457 169.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.46 126.69 37.65 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.348 1.431 . . . . 2.67 110.613 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.96 129.91 42.44 Favored 'General case' 0 N--CA 1.428 -1.536 0 O-C-N 125.265 1.603 . . . . 3.08 110.624 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.04 -4.27 84.69 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 115.603 -0.726 . . . . 4.95 114.035 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.4 tttt -83.99 -3.13 57.78 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.735 -1.45 . . . . 10.26 114.566 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.52 39.53 6.73 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.156 -1.59 . . . . 10.24 113.836 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.76 13.69 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.69 1.367 . . . . 10.56 114.69 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.34 172.65 9.25 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 108.173 -1.047 . . . . 2.45 108.173 171.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.82 152.1 8.35 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.987 1.375 . . . . 5.57 109.803 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.27 -35.77 67.81 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.362 -1.29 . . . . 19.11 114.473 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.71 -23.34 72.3 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 123.254 2.752 . . . . 2.93 112.373 177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -74.52 -54.63 7.15 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.552 1.176 . . . . 7.96 111.628 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.03 -44.4 15.19 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 124.007 1.86 . . . . 15.05 111.453 173.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.38 -35.4 47.36 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.637 -1.165 . . . . 20.27 114.001 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.02 -45.64 6.22 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 119.451 -1.357 . . . . 4.04 114.668 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.53 -27.23 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 119.125 -1.03 . . . . 5.35 109.414 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.589 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.93 -18.88 64.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.498 -2.626 . . . . 3.03 112.386 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.4 0.2 50.34 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 118.401 -0.809 . . . . 3.49 113.083 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.72 143.07 36.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 120.81 1.641 . . . . 3.75 109.557 -171.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 p -94.78 155.05 16.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.706 0.802 . . . . 2.3 109.771 174.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.3 t -57.66 130.1 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 119.835 1.198 . . . . 2.47 109.795 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.41 52.01 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 113.309 -1.769 . . . . 2.61 113.041 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.44 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.5 tt0 -84.4 144.74 28.6 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 121.874 0.845 . . . . 6.53 112.608 -171.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.97 123.98 41.58 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 102.671 -3.085 . . . . 12.36 102.671 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.71 44.99 Favored 'General case' 0 C--O 1.243 0.726 0 O-C-N 126.408 2.318 . . . . 5.84 114.261 -176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.35 122.52 43.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.564 1.649 . . . . 16.57 108.584 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.07 114.56 28.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 118.825 -2.422 . . . . 5.86 106.76 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 86.3 m -98.69 120.39 39.04 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 105.814 -1.921 . . . . 5.76 105.814 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.55 122.63 69.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.733 -0.84 . . . . 3.36 108.733 -167.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.36 153.97 91.59 Favored Pre-proline 0 C--O 1.243 0.738 0 CA-C-O 117.958 -1.02 . . . . 4.94 110.632 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.33 -35.09 90.82 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.263 2.642 . . . . 6.21 114.85 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.13 -13.76 62.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.784 1.031 . . . . 15.85 113.784 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.67 10.84 36.62 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 126.145 1.778 . . . . 11.52 111.809 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.64 -116.52 0.16 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 105.763 -1.94 . . . . 3.7 105.763 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -102.51 3.91 38.04 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 122.045 2.202 . . . . 6.84 115.502 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.48 -137.08 50.51 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-O 123.679 1.711 . . . . 5.99 111.101 172.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.2 -18.8 41.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 111.708 -2.246 . . . . 10.11 111.071 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.26 -43.93 63.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.048 1.749 . . . . 13.76 112.61 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.22 -169.2 53.29 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 107.746 -2.141 . . . . 9.98 107.746 -170.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.82 114.81 35.39 Favored Pre-proline 0 C--O 1.246 0.913 0 O-C-N 118.048 -3.031 . . . . 15.88 103.252 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -48.17 122.44 7.47 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 124.682 3.588 . . . . 11.41 110.933 -166.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.15 -26.95 3.21 Favored Glycine 0 CA--C 1.547 2.044 0 CA-C-N 111.865 -2.425 . . . . 14.2 117.389 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.88 -50.04 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 121.14 2.47 . . . . 11.06 115.045 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.6 mm -112.87 131.89 22.55 Favored Pre-proline 0 CA--C 1.516 -0.334 0 N-CA-C 103.19 -2.893 . . . . 8.01 103.19 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.0 163.04 35.44 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.268 3.978 . . . . 6.52 112.969 171.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.518 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 12.9 Cg_exo -55.28 144.5 71.1 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.578 2.185 . . . . 4.82 110.31 162.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.13 27.34 16.47 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 112.9 -1.954 . . . . 7.42 113.692 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.78 132.42 35.28 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 117.409 2.374 . . . . 2.22 117.409 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.53 132.36 35.66 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 121.698 2.045 . . . . 4.61 106.382 168.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -108.84 146.72 33.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 120.423 -1.423 . . . . 5.34 110.318 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.1 120.11 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 103.729 -2.693 . . . . 3.97 103.729 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.485 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.9 m-85 -116.83 136.91 52.58 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.768 -1.208 . . . . 4.42 109.539 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 33.0 t0 -103.74 112.73 25.81 Favored 'General case' 0 C--N 1.315 -0.917 1 N-CA-C 98.96 -4.459 . . . . 2.09 98.96 173.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.9 t -126.78 132.29 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.045 -1.434 . . . . 3.53 110.844 -172.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -120.47 121.91 39.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.485 -2.043 . . . . 14.21 105.485 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 tp -89.09 109.2 20.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 123.659 1.695 . . . . 2.42 107.434 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.4 mt -85.65 -43.24 13.61 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 115.128 1.529 . . . . 2.62 115.128 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.3 tttt -161.9 153.56 18.79 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 113.565 -1.652 . . . . 11.71 109.151 -167.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.8 mt -120.06 133.26 55.58 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 105.153 -2.166 . . . . 4.7 105.153 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 113.505 -1.679 . . . . 13.02 109.711 -179.726 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GPI . . . . . 0.486 ' H32' ' CZ ' ' A' ' 46' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 105.992 -2.843 . . . . 6.33 105.992 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.42 142.51 43.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 101.754 -3.424 . . . . 6.35 101.754 176.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -116.94 130.14 56.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 102.844 -3.021 . . . . 16.98 102.844 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.56 117.02 53.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 N-CA-C 103.692 -2.707 . . . . 5.58 103.692 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.66 124.68 46.87 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 118.946 -2.346 . . . . 12.8 104.824 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.9 m -75.66 139.83 42.21 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.234 -2.166 . . . . 3.24 115.624 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.42 -52.09 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 105.935 -1.876 . . . . 4.79 105.935 171.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.6 m -138.89 139.02 22.42 Favored Pre-proline 0 C--O 1.243 0.737 0 O-C-N 119.622 -1.924 . . . . 11.59 106.275 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.4 Cg_exo -67.69 154.77 72.41 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 123.538 2.825 . . . . 4.55 112.194 -176.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.63 -161.16 28.94 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.169 -1.573 . . . . 2.0 109.169 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -82.41 -9.2 59.54 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 117.645 -3.268 . . . . 3.24 113.188 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.01 9.78 76.67 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.654 -1.637 . . . . 3.38 113.886 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.72 -26.57 0.96 Allowed 'General case' 0 C--O 1.241 0.631 0 CA-C-N 122.567 3.183 . . . . 26.59 114.251 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.54 93.96 4.95 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 119.08 -2.262 . . . . 3.02 109.544 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -104.22 142.52 24.78 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 124.969 1.418 . . . . 4.7 109.84 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.59 146.75 68.48 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.738 2.292 . . . . 2.94 110.636 -173.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.49 156.13 33.46 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.918 -1.492 . . . . 15.96 107.053 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.07 130.25 29.49 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 124.169 1.938 . . . . 11.69 112.819 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.24 -14.01 65.88 Favored Glycine 0 N--CA 1.421 -2.307 0 O-C-N 120.021 -1.674 . . . . 3.63 112.845 -178.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.4 25.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 120.047 1.924 . . . . 5.9 112.396 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.94 120.37 31.1 Favored 'General case' 0 C--O 1.25 1.101 0 O-C-N 125.305 1.628 . . . . 3.07 111.734 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.9 m -93.5 131.04 39.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.649 1.214 . . . . 4.11 109.856 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -112.02 111.38 35.92 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 N-CA-C 101.607 -3.479 . . . . 2.16 101.607 -174.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.53 154.44 40.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.842 0.829 . . . . 3.59 112.242 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.14 145.44 30.56 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.259 -2.126 . . . . 3.13 105.259 164.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.2 p90 -145.85 156.06 43.31 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 120.177 1.353 . . . . 2.55 111.928 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.77 121.55 22.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 102.968 -2.975 . . . . 4.47 102.968 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.24 131.96 10.77 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 109.198 -1.561 . . . . 3.41 109.198 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.43 152.18 51.59 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 125.238 2.447 . . . . 18.22 110.391 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.56 164.58 22.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.694 -2.503 . . . . 5.93 106.444 172.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.03 -20.64 40.5 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.16 -3.462 . . . . 12.33 117.624 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -87.7 5.34 40.29 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 119.634 -1.916 . . . . 7.19 113.918 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.15 -10.23 69.82 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-O 124.009 1.894 . . . . 6.47 113.719 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.56 124.19 22.13 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 116.616 -3.873 . . . . 21.86 110.554 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.89 130.77 37.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.415 -1.328 . . . . 16.18 107.415 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -107.67 -17.77 14.0 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.076 -1.05 . . . . 5.73 110.811 173.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.77 155.36 3.19 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 118.121 -0.942 . . . . 6.13 110.564 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.6 t -158.74 128.14 5.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.462 1.105 . . . . 2.93 110.341 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.3 p -75.94 -20.65 57.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.006 -0.738 . . . . 2.3 109.006 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.71 -36.65 84.57 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.698 -1.593 . . . . 10.55 106.698 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -67.64 -28.42 67.7 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.205 -1.559 . . . . 8.02 110.906 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtm-85 -88.65 -10.03 50.03 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.859 -1.15 . . . . 10.21 112.411 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.46 34.29 24.02 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 123.329 1.538 . . . . 16.38 110.996 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.73 120.27 9.35 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 117.722 -3.111 . . . . 20.21 103.806 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -59.39 152.35 61.7 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 124.204 3.27 . . . . 8.75 110.294 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.402 ' CZ ' ' H32' ' A' ' 108' ' ' GPI . 84.8 t80 -95.99 138.15 34.03 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.47 -1.678 . . . . 4.65 106.47 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.62 136.86 50.27 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.49 1.495 . . . . 10.62 111.316 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.6 150.62 40.56 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 120.424 1.465 . . . . 4.31 107.372 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.48 126.63 37.65 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 120.31 1.414 . . . . 2.67 110.583 172.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.83 129.77 41.91 Favored 'General case' 0 N--CA 1.427 -1.576 0 O-C-N 125.198 1.561 . . . . 3.08 110.742 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.96 -4.04 84.75 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 123.874 0.75 . . . . 4.95 113.968 176.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.12 -3.11 57.88 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 120.707 -1.467 . . . . 10.26 114.62 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.59 39.53 6.56 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.129 -1.607 . . . . 10.24 113.8 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.36 -0.84 13.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 114.701 1.371 . . . . 10.56 114.701 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.39 172.65 9.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 N-CA-C 108.078 -1.082 . . . . 2.45 108.078 171.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.75 152.07 8.39 Favored 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.946 1.355 . . . . 5.57 109.782 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.25 -35.85 67.87 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 114.327 -1.306 . . . . 19.11 114.393 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.65 -23.33 72.21 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-N 123.338 2.79 . . . . 2.93 112.496 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.57 -54.62 7.13 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 118.49 1.145 . . . . 7.96 111.665 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.01 -44.45 15.12 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 123.982 1.848 . . . . 15.05 111.431 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.35 -35.31 47.65 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.531 -1.213 . . . . 20.27 114.06 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.98 -45.68 6.22 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 119.547 -1.311 . . . . 4.04 114.67 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.62 -27.15 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 O-C-N 121.382 -1.07 . . . . 5.35 109.419 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.83 64.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.57 -2.581 . . . . 3.03 112.35 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.49 0.36 50.02 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.107 0.78 . . . . 3.49 113.107 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.7 mtp -107.9 143.08 37.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 120.786 1.63 . . . . 3.75 109.492 -171.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 p -94.82 155.04 16.97 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.604 0.762 . . . . 2.3 109.786 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.72 130.27 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 119.917 1.235 . . . . 2.47 109.757 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 -12.63 52.12 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 113.289 -1.778 . . . . 2.61 113.056 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.44 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.6 tt0 -84.42 144.79 28.55 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.915 0.864 . . . . 6.53 112.558 -171.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -124.02 123.96 41.52 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 102.619 -3.104 . . . . 12.36 102.619 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.86 156.81 45.0 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.518 2.386 . . . . 5.84 114.307 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.3 122.5 43.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.516 1.627 . . . . 16.57 108.587 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.1 114.48 28.65 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 118.822 -2.424 . . . . 5.86 106.737 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.4 m -98.8 120.42 39.2 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 105.853 -1.906 . . . . 5.76 105.853 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.63 122.58 69.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 108.683 -0.858 . . . . 3.36 108.683 -167.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.38 153.95 91.7 Favored Pre-proline 0 C--O 1.244 0.777 0 CA-C-O 117.826 -1.083 . . . . 4.94 110.731 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.3 -35.14 90.75 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.328 2.685 . . . . 6.21 114.754 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.06 -13.9 62.43 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.883 1.068 . . . . 15.85 113.883 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.67 11.04 36.51 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 126.088 1.755 . . . . 11.52 111.74 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.76 -116.51 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.765 -1.939 . . . . 3.7 105.765 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.64 4.15 37.96 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-N 121.99 2.177 . . . . 6.84 115.48 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.44 -137.13 50.43 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-O 123.745 1.747 . . . . 5.99 111.038 171.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.66 41.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 111.624 -2.288 . . . . 10.11 110.972 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.37 -43.89 63.36 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 121.093 1.77 . . . . 13.76 112.581 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.32 -169.27 53.3 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 107.607 -2.197 . . . . 9.98 107.607 -170.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.8 114.85 35.39 Favored Pre-proline 0 C--O 1.246 0.882 0 O-C-N 118.04 -3.036 . . . . 15.88 103.292 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -48.16 122.43 7.43 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 124.61 3.54 . . . . 11.41 110.909 -166.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.19 -26.94 3.23 Favored Glycine 0 CA--C 1.547 2.038 0 CA-C-N 111.881 -2.418 . . . . 14.2 117.4 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.2 mt -102.84 -50.1 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.05 2.425 . . . . 11.06 114.992 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.7 mm -112.83 131.99 22.5 Favored Pre-proline 0 CA--C 1.516 -0.343 0 N-CA-C 103.159 -2.904 . . . . 8.01 103.159 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.09 163.08 35.44 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 125.218 3.945 . . . . 6.52 112.871 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.3 144.47 71.37 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.518 2.146 . . . . 4.82 110.307 162.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.31 27.24 16.29 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 112.886 -1.961 . . . . 7.42 113.609 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.8 132.29 35.28 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 117.36 2.356 . . . . 2.22 117.36 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.44 132.34 35.71 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 121.686 2.039 . . . . 4.61 106.347 168.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.7 mt -108.81 146.87 32.94 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 120.451 -1.405 . . . . 5.34 110.274 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.19 119.97 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 103.779 -2.674 . . . . 3.97 103.779 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.485 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.2 m-85 -116.79 137.05 52.48 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.734 -1.229 . . . . 4.42 109.519 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.6 t0 -103.92 112.74 25.84 Favored 'General case' 0 C--N 1.315 -0.928 1 N-CA-C 98.875 -4.491 . . . . 2.09 98.875 174.001 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.9 t -126.79 132.37 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.077 -1.42 . . . . 3.53 110.794 -172.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.52 121.84 39.32 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.509 -2.034 . . . . 14.21 105.509 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 tp -88.95 109.06 19.92 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.42 107.536 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.46 -43.31 13.7 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.193 1.553 . . . . 2.62 115.193 -171.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.85 153.56 18.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 113.534 -1.666 . . . . 11.71 109.131 -167.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.2 mt -119.98 133.19 55.63 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 105.19 -2.152 . . . . 4.7 105.19 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.589 -1.642 . . . . 13.02 109.884 -179.828 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GPI . . . . . 0.444 ' O8 ' H113 ' A' ' 108' ' ' GPI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 N-CA-C 106.07 -2.812 . . . . 6.33 106.07 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.26 142.58 43.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 101.723 -3.436 . . . . 6.35 101.723 176.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -117.11 130.01 56.35 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.776 -3.046 . . . . 16.98 102.776 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.3 t -109.44 117.07 53.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 103.771 -2.677 . . . . 5.58 103.771 -175.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.61 124.69 46.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 118.863 -2.398 . . . . 12.8 104.83 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.8 m -75.72 139.97 42.19 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 119.313 -2.117 . . . . 3.24 115.643 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.407 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.58 -52.05 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 105.84 -1.911 . . . . 4.79 105.84 171.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.4 m -138.85 139.11 22.82 Favored Pre-proline 0 C--O 1.244 0.77 0 O-C-N 119.647 -1.908 . . . . 11.59 106.305 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.3 Cg_exo -67.71 154.75 72.41 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 123.634 2.889 . . . . 4.55 112.174 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.7 -161.22 28.88 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.09 -1.604 . . . . 2.0 109.09 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.43 -9.15 59.55 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 117.708 -3.231 . . . . 3.24 113.205 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.09 9.73 76.87 Favored Glycine 0 C--O 1.218 -0.851 0 CA-C-O 117.647 -1.641 . . . . 3.38 113.884 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.72 -26.62 0.96 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.576 3.188 . . . . 26.59 114.251 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.52 94.04 4.99 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 119.111 -2.243 . . . . 3.02 109.503 -175.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.18 142.53 24.8 Favored Pre-proline 0 C--O 1.252 1.204 0 O-C-N 125.016 1.448 . . . . 4.7 109.867 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.5 Cg_endo -68.67 146.78 68.13 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.715 2.277 . . . . 2.94 110.588 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.52 156.16 33.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.866 -1.516 . . . . 15.96 107.026 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.4 ttp180 -52.07 130.25 29.49 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 124.169 1.938 . . . . 11.69 112.819 174.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.33 -14.14 65.6 Favored Glycine 0 N--CA 1.422 -2.246 0 O-C-N 120.021 -1.674 . . . . 3.63 112.755 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.37 25.17 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 120.066 1.933 . . . . 5.9 112.357 174.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.85 120.31 30.98 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.249 1.593 . . . . 3.07 111.684 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.53 130.99 39.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 122.65 1.214 . . . . 4.11 109.86 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.5 t -111.92 111.39 35.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 N-CA-C 101.643 -3.465 . . . . 2.16 101.643 -174.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.9 m -129.5 154.39 40.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-O 121.822 0.82 . . . . 3.59 112.242 -172.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.06 145.43 30.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.22 -2.141 . . . . 3.13 105.22 164.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.1 p90 -145.81 156.1 43.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 120.18 1.355 . . . . 2.55 111.967 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.76 121.49 21.95 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 103.024 -2.954 . . . . 4.47 103.024 167.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.13 131.87 10.74 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 109.251 -1.54 . . . . 3.41 109.251 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.4 152.12 51.6 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 125.242 2.449 . . . . 18.22 110.391 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 164.59 22.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.707 -2.497 . . . . 5.93 106.444 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -57.97 -20.65 39.72 Favored 'General case' 0 C--O 1.22 -0.469 0 O-C-N 117.197 -3.439 . . . . 12.33 117.737 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.75 5.44 39.95 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 119.642 -1.911 . . . . 7.19 113.894 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.03 -10.26 70.07 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 123.956 1.864 . . . . 6.47 113.807 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.53 124.23 22.24 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 116.803 -3.763 . . . . 21.86 110.556 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.89 130.84 37.11 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.403 -1.332 . . . . 16.18 107.403 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.67 -17.84 13.99 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.07 -1.052 . . . . 5.73 110.809 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.77 155.43 3.22 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.153 -0.927 . . . . 6.13 110.567 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -158.81 128.13 5.57 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.527 1.131 . . . . 2.93 110.345 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.4 p -75.97 -20.65 57.73 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.977 -0.749 . . . . 2.3 108.977 175.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.68 84.65 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.685 -1.598 . . . . 10.55 106.685 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -67.58 -28.57 67.87 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.215 -1.553 . . . . 8.02 110.809 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.6 -10.12 49.81 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.9 -1.125 . . . . 10.21 112.368 176.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.62 34.22 24.11 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.349 1.547 . . . . 16.38 110.95 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.73 120.18 9.32 Favored Pre-proline 0 C--N 1.315 -0.934 0 O-C-N 117.627 -3.171 . . . . 20.21 103.882 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -59.24 152.27 61.32 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 124.274 3.316 . . . . 8.75 110.326 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -95.93 138.22 33.88 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.566 -1.642 . . . . 4.65 106.566 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.72 136.87 50.38 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 120.584 1.538 . . . . 10.62 111.244 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.63 150.71 40.62 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 120.397 1.453 . . . . 4.31 107.28 169.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.41 126.64 37.58 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 120.243 1.383 . . . . 2.67 110.584 172.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 129.81 42.03 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.288 1.617 . . . . 3.08 110.719 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.0 -4.12 84.73 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 123.865 0.745 . . . . 4.95 114.009 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.1 -3.09 57.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.752 -1.44 . . . . 10.26 114.561 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 64.52 39.57 6.7 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 120.081 -1.637 . . . . 10.24 113.808 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.37 -0.82 13.69 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 114.684 1.365 . . . . 10.56 114.684 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.35 172.65 9.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 108.09 -1.078 . . . . 2.45 108.09 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.79 152.04 8.38 Favored 'Isoleucine or valine' 0 C--O 1.259 1.567 0 CA-C-O 122.974 1.368 . . . . 5.57 109.855 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.22 -35.8 67.74 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 114.442 1.275 . . . . 19.11 114.442 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.67 -23.35 72.24 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.351 2.796 . . . . 2.93 112.415 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.58 -54.58 7.19 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 118.574 1.187 . . . . 7.96 111.643 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.0 -44.43 15.09 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 124.02 1.867 . . . . 15.05 111.514 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.36 -35.29 47.63 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.495 -1.23 . . . . 20.27 114.037 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.06 -45.73 6.17 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.571 -1.299 . . . . 4.04 114.6 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.6 t -67.46 -27.23 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 121.378 -1.072 . . . . 5.35 109.495 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.83 64.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.506 -2.621 . . . . 3.03 112.35 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.48 0.28 50.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.489 -0.767 . . . . 3.49 113.057 175.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.83 143.03 36.97 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 120.831 1.65 . . . . 3.75 109.555 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -94.73 155.06 17.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.692 0.797 . . . . 2.3 109.822 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.7 130.19 20.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 119.91 1.232 . . . . 2.47 109.734 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.54 52.07 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.333 -1.758 . . . . 2.61 112.989 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.44 ' HB2' ' HA3' ' A' ' 10' ' ' GLY . 44.6 tt0 -84.39 144.69 28.63 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-O 121.874 0.845 . . . . 6.53 112.601 -171.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.9 ttt180 -123.93 123.9 41.43 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 102.677 -3.083 . . . . 12.36 102.677 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.78 45.0 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 126.442 2.339 . . . . 5.84 114.322 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.21 122.45 43.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 123.465 1.602 . . . . 16.57 108.59 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.07 114.49 28.66 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 118.787 -2.445 . . . . 5.86 106.775 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.7 m -98.78 120.42 39.19 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 105.772 -1.936 . . . . 5.76 105.772 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.63 122.55 69.09 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 108.71 -0.848 . . . . 3.36 108.71 -167.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.37 153.99 91.57 Favored Pre-proline 0 C--O 1.243 0.723 0 CA-C-O 117.934 -1.031 . . . . 4.94 110.712 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.21 -35.26 90.61 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.374 2.716 . . . . 6.21 114.803 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.03 -13.87 62.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.883 1.068 . . . . 15.85 113.883 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.73 11.09 36.32 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 125.959 1.703 . . . . 11.52 111.671 175.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.82 -116.53 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.754 -1.943 . . . . 3.7 105.754 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.61 4.1 37.98 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 122.025 2.193 . . . . 6.84 115.511 -173.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.53 -137.12 50.5 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 123.728 1.738 . . . . 5.99 111.048 171.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.22 -18.71 41.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 111.705 -2.247 . . . . 10.11 111.036 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.38 -43.97 63.22 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.076 1.762 . . . . 13.76 112.458 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.34 -169.19 53.39 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.693 -2.163 . . . . 9.98 107.693 -170.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.87 114.77 35.3 Favored Pre-proline 0 C--O 1.247 0.962 0 O-C-N 118.014 -3.05 . . . . 15.88 103.215 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -48.03 122.3 7.13 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 124.72 3.613 . . . . 11.41 110.928 -166.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.3 -27.05 3.26 Favored Glycine 0 CA--C 1.546 2.022 0 CA-C-N 111.961 -2.382 . . . . 14.2 117.388 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.1 mt -102.89 -50.04 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 121.022 2.411 . . . . 11.06 114.971 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.88 131.97 22.52 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 103.178 -2.897 . . . . 8.01 103.178 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.18 163.11 35.49 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.198 3.932 . . . . 6.52 112.859 171.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.27 144.51 70.91 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.476 2.117 . . . . 4.82 110.357 162.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.28 27.21 16.3 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 112.969 -1.923 . . . . 7.42 113.618 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.8 132.4 35.28 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 117.358 2.355 . . . . 2.22 117.358 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.47 132.41 35.7 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 121.667 2.031 . . . . 4.61 106.347 168.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.8 mt -108.94 146.76 33.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.414 -1.429 . . . . 5.34 110.239 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.1 t -123.08 120.02 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 103.764 -2.68 . . . . 3.97 103.764 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.9 m-85 -116.79 136.96 52.55 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.705 -1.247 . . . . 4.42 109.553 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.7 t0 -103.81 112.69 25.75 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.853 -4.499 . . . . 2.09 98.853 174.041 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.5 t -126.79 132.28 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.092 -1.413 . . . . 3.53 110.836 -172.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.38 121.89 39.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 105.563 -2.014 . . . . 14.21 105.563 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.08 109.02 19.92 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 123.653 1.692 . . . . 2.42 107.494 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.46 -43.25 13.76 Favored 'General case' 0 C--O 1.254 1.293 0 N-CA-C 115.26 1.578 . . . . 2.62 115.26 -171.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.8 153.62 19.08 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 113.501 -1.681 . . . . 11.71 109.248 -167.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.08 133.21 55.58 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 105.204 -2.147 . . . . 4.7 105.204 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.568 -1.651 . . . . 13.02 109.761 -179.719 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GPI . . . . . 0.62 H151 H132 ' A' ' 108' ' ' GPI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 106.08 -2.808 . . . . 6.3300000000000001 106.08 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.33 142.58 43.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 101.707 -3.442 . . . . 6.3499999999999996 101.707 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -117.16 130.05 56.36 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 102.802 -3.036 . . . . 16.98 102.802 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.9 t -109.53 117.12 53.85 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 103.663 -2.717 . . . . 5.5800000000000001 103.663 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.66 124.65 46.81 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 118.871 -2.393 . . . . 12.800000000000001 104.839 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.8 m -75.66 139.9 42.24 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.28 -2.138 . . . . 3.2400000000000002 115.656 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.5 mt -101.51 -52.02 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.86 -1.904 . . . . 4.79 105.86 171.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.5 m -138.89 139.13 22.76 Favored Pre-proline 0 C--O 1.244 0.783 0 O-C-N 119.548 -1.97 . . . . 11.59 106.27 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.8 Cg_exo -67.86 154.84 71.93 Favored 'Trans proline' 0 C--N 1.329 -0.454 0 C-N-CA 123.546 2.83 . . . . 4.5499999999999998 112.196 -176.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.72 -161.14 28.85 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.102 -1.599 . . . . 2.0 109.102 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -82.43 -9.27 59.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 117.659 -3.26 . . . . 3.2400000000000002 113.165 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.07 9.77 76.86 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-O 117.71 -1.606 . . . . 3.3799999999999999 113.87 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.66 -26.66 0.96 Allowed 'General case' 0 C--O 1.241 0.608 0 CA-C-N 122.593 3.196 . . . . 26.59 114.305 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.59 94.04 4.99 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 119.039 -2.288 . . . . 3.02 109.435 -175.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.2 142.52 24.78 Favored Pre-proline 0 C--O 1.252 1.211 0 O-C-N 125.007 1.442 . . . . 4.7000000000000002 109.761 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.59 146.73 68.4 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.728 2.285 . . . . 2.9399999999999999 110.688 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.49 156.2 33.31 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.932 -1.485 . . . . 15.960000000000001 107.121 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.6 ttp180 -52.17 130.36 30.18 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 124.263 1.982 . . . . 11.69 112.765 174.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.21 -13.97 65.97 Favored Glycine 0 N--CA 1.424 -2.122 0 O-C-N 119.919 -1.738 . . . . 3.6299999999999999 112.734 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.24 149.42 25.09 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-N 120.123 1.961 . . . . 5.9000000000000004 112.381 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.85 120.28 30.95 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.146 1.529 . . . . 3.0699999999999998 111.799 174.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.9 m -93.43 131.02 39.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.485 1.136 . . . . 4.1100000000000003 109.878 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.5 t -112.03 111.47 36.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 101.624 -3.473 . . . . 2.1600000000000001 101.624 -174.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.3 m -129.63 154.39 40.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.866 0.841 . . . . 3.5899999999999999 112.193 -172.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 145.45 30.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.264 -2.124 . . . . 3.1299999999999999 105.264 164.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.84 156.09 43.34 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 120.128 1.331 . . . . 2.5499999999999998 111.9 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.6 m -133.83 121.63 22.07 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 102.88 -3.007 . . . . 4.4699999999999998 102.88 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.21 131.84 10.73 Favored Glycine 0 N--CA 1.471 0.999 0 N-CA-C 109.237 -1.545 . . . . 3.4100000000000001 109.237 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.31 152.2 51.5 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 125.277 2.465 . . . . 18.219999999999999 110.421 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.56 164.59 22.82 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.694 -2.503 . . . . 5.9299999999999997 106.444 172.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.08 -20.56 40.59 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 117.19 -3.444 . . . . 12.33 117.684 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -87.64 5.31 40.24 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 119.603 -1.936 . . . . 7.1900000000000004 113.956 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.17 -10.42 69.74 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-O 123.896 1.831 . . . . 6.4699999999999998 113.661 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.64 124.26 22.37 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 116.724 -3.809 . . . . 21.859999999999999 110.529 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.82 130.86 37.2 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 107.349 -1.352 . . . . 16.18 107.349 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.7 -17.84 13.98 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.099 -1.04 . . . . 5.7300000000000004 110.809 173.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.71 155.37 3.24 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 118.08 -0.962 . . . . 6.1299999999999999 110.605 176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -158.78 128.19 5.61 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.518 1.127 . . . . 2.9300000000000002 110.38 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.6 p -76.1 -20.51 57.61 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.757 -0.777 . . . . 2.2999999999999998 109.043 175.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.72 84.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.637 -1.616 . . . . 10.550000000000001 106.637 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.58 -28.56 67.87 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.247 -1.533 . . . . 8.0199999999999996 110.827 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.6 -10.12 49.81 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 120.906 -1.121 . . . . 10.210000000000001 112.368 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.56 34.2 23.98 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 123.382 1.563 . . . . 16.379999999999999 111.007 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.3 tttm -139.65 120.21 9.39 Favored Pre-proline 0 C--O 1.247 0.928 0 O-C-N 117.698 -3.126 . . . . 20.210000000000001 103.882 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.24 152.34 60.79 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 124.234 3.29 . . . . 8.75 110.43 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -95.95 138.17 33.97 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.518 -1.66 . . . . 4.6500000000000004 106.518 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.61 136.9 50.18 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 120.541 1.518 . . . . 10.619999999999999 111.313 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.67 150.71 40.55 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.458 1.481 . . . . 4.3099999999999996 107.308 169.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.5 126.68 37.69 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.304 1.411 . . . . 2.6699999999999999 110.549 172.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 129.84 42.14 Favored 'General case' 0 N--CA 1.426 -1.643 0 O-C-N 125.228 1.58 . . . . 3.0800000000000001 110.647 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.01 -4.19 84.73 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 123.806 0.717 . . . . 4.9500000000000002 114.035 176.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.7 tttt -84.13 -3.05 57.85 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.752 -1.44 . . . . 10.26 114.561 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.55 39.56 6.64 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 120.132 -1.605 . . . . 10.24 113.778 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.74 13.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 114.75 1.389 . . . . 10.56 114.75 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.42 172.67 9.31 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.057 -1.09 . . . . 2.4500000000000002 108.057 171.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.81 152.1 8.35 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.98 1.371 . . . . 5.5700000000000003 109.768 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.24 -35.88 67.88 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 114.343 -1.298 . . . . 19.109999999999999 114.386 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.62 -23.37 72.17 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-N 123.392 2.814 . . . . 2.9300000000000002 112.384 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.55 -54.65 7.09 Favored 'General case' 0 C--O 1.249 1.071 0 CA-C-N 118.559 1.179 . . . . 7.96 111.575 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.04 -44.39 15.26 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 124.026 1.87 . . . . 15.050000000000001 111.467 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.37 -35.29 47.54 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.544 -1.207 . . . . 20.27 114.065 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.06 -45.72 6.18 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.502 -1.332 . . . . 4.04 114.612 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.55 -27.09 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 O-C-N 121.383 -1.069 . . . . 5.3499999999999996 109.486 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.86 64.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.537 -2.602 . . . . 3.0299999999999998 112.398 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.54 0.41 49.98 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 118.456 -0.783 . . . . 3.4900000000000002 113.025 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.9 mtp -107.95 143.02 37.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 120.812 1.642 . . . . 3.75 109.436 -171.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.521 ' H ' HE21 ' A' ' 70' ' ' GLN . 11.0 p -94.66 155.01 17.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.678 0.791 . . . . 2.2999999999999998 109.852 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.68 130.19 20.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 119.88 1.218 . . . . 2.4700000000000002 109.796 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.11 -12.53 52.28 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 113.35 -1.75 . . . . 2.6099999999999999 113.133 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.521 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.4 144.75 28.59 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.95 0.881 . . . . 6.5300000000000002 112.567 -171.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.406 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.99 123.92 41.44 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 102.576 -3.12 . . . . 12.359999999999999 102.576 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.8 156.73 45.01 Favored 'General case' 0 C--O 1.244 0.806 0 O-C-N 126.393 2.308 . . . . 5.8399999999999999 114.283 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.26 122.55 43.87 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 123.429 1.585 . . . . 16.57 108.671 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.15 114.49 28.65 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.859 -2.401 . . . . 5.8600000000000003 106.745 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.4 m -98.73 120.42 39.13 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 105.766 -1.939 . . . . 5.7599999999999998 105.766 176.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.5 mt -119.55 122.57 69.21 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 N-CA-C 108.712 -0.847 . . . . 3.3599999999999999 108.712 -167.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.43 153.93 91.85 Favored Pre-proline 0 C--O 1.244 0.807 0 CA-C-O 117.878 -1.058 . . . . 4.9400000000000004 110.676 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -55.16 -35.26 90.4 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.328 2.686 . . . . 6.21 114.829 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -69.99 -13.92 62.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.869 1.062 . . . . 15.85 113.869 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -103.69 11.05 36.44 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 126.051 1.74 . . . . 11.52 111.751 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.74 -116.39 0.16 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 105.808 -1.923 . . . . 3.7000000000000002 105.808 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.68 4.16 37.85 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 122.067 2.212 . . . . 6.8399999999999999 115.447 -173.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.42 -137.11 50.45 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 123.686 1.714 . . . . 5.9900000000000002 111.096 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.28 -18.8 41.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 111.738 -2.231 . . . . 10.109999999999999 110.932 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.26 -43.93 63.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.129 1.786 . . . . 13.76 112.547 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.23 -169.28 53.23 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 107.76 -2.136 . . . . 9.9800000000000004 107.76 -170.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.78 114.9 35.41 Favored Pre-proline 0 C--O 1.246 0.873 0 O-C-N 118.003 -3.057 . . . . 15.880000000000001 103.262 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -48.24 122.36 7.42 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.638 3.559 . . . . 11.41 110.939 -166.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.35 -27.07 3.28 Favored Glycine 0 CA--C 1.547 2.073 0 CA-C-N 111.788 -2.46 . . . . 14.199999999999999 117.374 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.8 mt -102.87 -50.05 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.041 2.421 . . . . 11.06 114.942 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.6 mm -112.9 131.83 22.6 Favored Pre-proline 0 CA--C 1.516 -0.334 0 N-CA-C 103.174 -2.899 . . . . 8.0099999999999998 103.174 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.07 163.03 35.6 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.259 3.973 . . . . 6.5199999999999996 112.865 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.33 144.55 71.39 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.392 2.061 . . . . 4.8200000000000003 110.321 162.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.35 27.21 16.25 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 112.878 -1.965 . . . . 7.4199999999999999 113.579 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.87 132.42 35.27 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 117.345 2.35 . . . . 2.2200000000000002 117.345 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -80.56 132.45 35.65 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 121.695 2.043 . . . . 4.6100000000000003 106.31 168.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.5 mt -108.82 146.79 33.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.321 -1.487 . . . . 5.3399999999999999 110.281 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.27 119.93 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 103.743 -2.688 . . . . 3.9700000000000002 103.743 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.0 m-85 -116.7 136.96 52.55 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.796 -1.19 . . . . 4.4199999999999999 109.596 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.76 112.67 25.72 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.874 -4.491 . . . . 2.0899999999999999 98.874 174.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.5 t -126.72 132.3 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 114.206 -1.361 . . . . 3.5299999999999998 110.841 -172.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.44 121.91 39.56 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.578 -2.008 . . . . 14.210000000000001 105.578 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.02 109.07 19.95 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.498 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.5 -43.27 13.7 Favored 'General case' 0 C--O 1.253 1.28 0 N-CA-C 115.203 1.557 . . . . 2.6200000000000001 115.203 -171.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.82 153.63 19.03 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 113.509 -1.678 . . . . 11.710000000000001 109.167 -167.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.7 mt -120.04 133.17 55.61 Favored 'General case' 0 C--O 1.251 1.165 0 N-CA-C 105.25 -2.13 . . . . 4.7000000000000002 105.25 170.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.697 -1.592 . . . . 13.02 109.805 -179.746 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.695 0 N-CA-C 106.067 -2.813 . . . . 6.3300000000000001 106.067 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.41 142.56 43.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 101.672 -3.455 . . . . 6.3499999999999996 101.672 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -117.13 130.16 56.44 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 102.682 -3.081 . . . . 16.98 102.682 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.4 t -109.51 117.01 53.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 103.737 -2.69 . . . . 5.5800000000000001 103.737 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.58 124.72 47.05 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 118.893 -2.379 . . . . 12.800000000000001 104.872 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.4 m -75.77 140.1 42.17 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 119.226 -2.171 . . . . 3.2400000000000002 115.55 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.67 -52.05 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 105.832 -1.914 . . . . 4.79 105.832 171.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.8 m -138.97 139.0 22.13 Favored Pre-proline 0 C--O 1.241 0.652 0 O-C-N 119.53 -1.981 . . . . 11.59 106.331 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 30.2 Cg_exo -67.67 154.85 72.22 Favored 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.501 2.801 . . . . 4.5499999999999998 112.125 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.84 -161.24 28.74 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 109.071 -1.611 . . . . 2.0 109.071 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.43 -9.1 59.57 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 117.674 -3.251 . . . . 3.2400000000000002 113.258 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.07 9.78 76.86 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.639 -1.645 . . . . 3.3799999999999999 113.793 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.7 -26.69 0.95 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-N 122.583 3.191 . . . . 26.59 114.244 -178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.44 94.08 5.02 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 119.049 -2.282 . . . . 3.02 109.503 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.24 142.55 24.85 Favored Pre-proline 0 C--O 1.252 1.211 0 O-C-N 124.963 1.414 . . . . 4.7000000000000002 109.799 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.592 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.6 146.74 68.41 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.754 2.303 . . . . 2.9399999999999999 110.6 -174.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.57 156.14 33.55 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.889 -1.505 . . . . 15.960000000000001 106.988 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.4 ttp180 -52.04 130.24 29.34 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 124.134 1.921 . . . . 11.69 112.709 174.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.36 -14.13 65.58 Favored Glycine 0 N--CA 1.423 -2.184 0 O-C-N 120.009 -1.682 . . . . 3.6299999999999999 112.762 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.16 149.32 25.2 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 120.085 1.943 . . . . 5.9000000000000004 112.242 174.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.8 m -89.83 120.25 30.91 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.283 1.614 . . . . 3.0699999999999998 111.806 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.2 m -93.55 131.04 39.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 122.716 1.246 . . . . 4.1100000000000003 109.813 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.5 t -112.0 111.41 36.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 101.593 -3.484 . . . . 2.1600000000000001 101.593 -174.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.57 154.34 40.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-O 121.795 0.807 . . . . 3.5899999999999999 112.243 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.42 30.57 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.129 -2.174 . . . . 3.1299999999999999 105.129 164.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.0 p90 -145.74 156.11 43.4 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 120.003 1.274 . . . . 2.5499999999999998 112.02 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -133.81 121.53 21.94 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 102.968 -2.975 . . . . 4.4699999999999998 102.968 167.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.19 131.94 10.76 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 109.28 -1.528 . . . . 3.4100000000000001 109.28 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.4 152.18 51.57 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 125.259 2.457 . . . . 18.219999999999999 110.435 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 164.59 22.9 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 111.746 -2.479 . . . . 5.9299999999999997 106.38 172.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.16 -20.55 41.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 117.283 -3.385 . . . . 12.33 117.639 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.67 5.29 40.44 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.56 -1.962 . . . . 7.1900000000000004 113.906 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.16 -10.34 69.77 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-O 124.04 1.911 . . . . 6.4699999999999998 113.785 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.62 124.23 22.26 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 116.632 -3.864 . . . . 21.859999999999999 110.58 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.81 130.83 37.17 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.359 -1.348 . . . . 16.18 107.359 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -107.76 -17.76 14.0 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 118.998 -1.081 . . . . 5.7300000000000004 110.799 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -172.71 155.5 3.28 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 118.093 -0.956 . . . . 6.1299999999999999 110.652 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.87 128.08 5.51 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.428 1.091 . . . . 2.9300000000000002 110.314 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 41.2 p -75.83 -20.75 57.91 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 119.866 -0.733 . . . . 2.2999999999999998 109.117 175.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.63 -36.65 84.53 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.754 -1.573 . . . . 10.550000000000001 106.754 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.61 -28.5 67.8 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.253 -1.529 . . . . 8.0199999999999996 110.807 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.6 mtm-85 -88.72 -9.98 50.02 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 120.914 -1.116 . . . . 10.210000000000001 112.403 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.54 34.21 23.98 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 123.316 1.531 . . . . 16.379999999999999 111.034 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.3 tttm -139.7 120.24 9.37 Favored Pre-proline 0 C--N 1.315 -0.934 0 O-C-N 117.645 -3.16 . . . . 20.210000000000001 103.879 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.27 152.3 61.28 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.269 3.313 . . . . 8.75 110.402 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -95.89 138.12 33.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.534 -1.654 . . . . 4.6500000000000004 106.534 178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -111.64 136.87 50.27 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.496 1.498 . . . . 10.619999999999999 111.285 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.67 150.69 40.53 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 120.397 1.453 . . . . 4.3099999999999996 107.366 169.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.466 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.39 126.62 37.56 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-N 120.244 1.384 . . . . 2.6699999999999999 110.617 172.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.89 129.81 42.05 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 125.217 1.573 . . . . 3.0800000000000001 110.68 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.98 -4.13 84.76 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.605 -0.725 . . . . 4.9500000000000002 114.044 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.09 -3.06 57.81 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 120.823 -1.398 . . . . 10.26 114.679 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.48 39.6 6.75 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.117 -1.615 . . . . 10.24 113.775 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.31 -0.88 13.71 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 114.725 1.38 . . . . 10.56 114.725 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.37 172.62 9.32 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.085 -1.08 . . . . 2.4500000000000002 108.085 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.73 152.07 8.41 Favored 'Isoleucine or valine' 0 C--O 1.257 1.496 0 CA-C-O 122.937 1.351 . . . . 5.5700000000000003 109.851 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.25 -35.73 67.74 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.361 -1.29 . . . . 19.109999999999999 114.466 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.73 -23.34 72.35 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-N 123.383 2.81 . . . . 2.9300000000000002 112.389 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.53 -54.67 7.07 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.51 1.155 . . . . 7.96 111.633 173.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.0 -44.43 15.06 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.951 1.834 . . . . 15.050000000000001 111.461 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.36 -35.3 47.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.485 -1.234 . . . . 20.27 114.084 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.11 -45.63 6.19 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 119.471 -1.347 . . . . 4.04 114.615 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.53 -27.17 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 121.348 -1.089 . . . . 5.3499999999999996 109.425 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.592 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.06 -18.83 64.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 118.538 -2.601 . . . . 3.0299999999999998 112.378 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.5 0.31 50.24 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 118.439 -0.791 . . . . 3.4900000000000002 113.016 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.7 mtp -107.82 143.18 36.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 120.821 1.646 . . . . 3.75 109.524 -171.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.524 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.9 p -94.79 154.93 17.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.695 0.798 . . . . 2.2999999999999998 109.842 174.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.3 t -57.53 130.09 20.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 119.965 1.257 . . . . 2.4700000000000002 109.868 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.21 -12.44 51.93 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 113.422 -1.717 . . . . 2.6099999999999999 113.069 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.524 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.4 144.8 28.55 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.883 0.849 . . . . 6.5300000000000002 112.623 -171.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.9 ttt180 -124.05 124.02 41.63 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 102.588 -3.116 . . . . 12.359999999999999 102.588 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.81 44.99 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.421 2.326 . . . . 5.8399999999999999 114.303 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.28 122.45 43.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.47 1.605 . . . . 16.57 108.556 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.02 114.51 28.69 Favored 'General case' 0 N--CA 1.44 -0.975 0 O-C-N 118.864 -2.398 . . . . 5.8600000000000003 106.786 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.5 m -98.81 120.49 39.34 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 105.801 -1.925 . . . . 5.7599999999999998 105.801 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.6 mt -119.65 122.55 69.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 108.671 -0.862 . . . . 3.3599999999999999 108.671 -167.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.38 154.03 91.52 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-O 117.802 -1.094 . . . . 4.9400000000000004 110.655 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.4 -35.07 91.09 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.333 2.689 . . . . 6.21 114.761 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.13 -13.88 62.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.795 1.035 . . . . 15.85 113.795 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.68 11.03 36.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 126.004 1.722 . . . . 11.52 111.734 175.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.86 -116.55 0.15 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 105.72 -1.955 . . . . 3.7000000000000002 105.72 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.61 4.16 38.05 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 122.025 2.193 . . . . 6.8399999999999999 115.511 -173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.45 -137.16 50.41 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-O 123.769 1.761 . . . . 5.9900000000000002 111.131 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.33 -18.64 41.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 111.603 -2.299 . . . . 10.109999999999999 111.024 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.36 -43.9 63.35 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.04 1.745 . . . . 13.76 112.497 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.28 -169.16 53.38 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 107.641 -2.184 . . . . 9.9800000000000004 107.641 -170.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.89 114.83 35.23 Favored Pre-proline 0 C--O 1.246 0.899 0 O-C-N 118.128 -2.984 . . . . 15.880000000000001 103.198 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -48.14 122.43 7.41 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 124.622 3.548 . . . . 11.41 110.975 -166.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.18 -26.96 3.22 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.979 -2.373 . . . . 14.199999999999999 117.412 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.0 mt -102.93 -50.02 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 121.102 2.451 . . . . 11.06 114.943 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.86 131.82 22.59 Favored Pre-proline 0 CA--C 1.516 -0.328 0 N-CA-C 103.233 -2.877 . . . . 8.0099999999999998 103.233 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.08 163.01 35.7 Favored 'Trans proline' 0 C--O 1.24 0.619 0 C-N-CA 125.229 3.953 . . . . 6.5199999999999996 112.909 171.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.27 144.49 71.08 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.547 2.165 . . . . 4.8200000000000003 110.275 162.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.26 27.26 16.34 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 112.886 -1.961 . . . . 7.4199999999999999 113.607 172.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.73 132.45 35.29 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.446 2.387 . . . . 2.2200000000000002 117.446 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -80.53 132.47 35.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.737 2.062 . . . . 4.6100000000000003 106.298 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.1 mt -108.99 146.69 33.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.469 -1.394 . . . . 5.3399999999999999 110.24 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.0 t -123.12 120.08 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 N-CA-C 103.657 -2.72 . . . . 3.9700000000000002 103.657 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.2 m-85 -116.75 136.97 52.54 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.594 -1.316 . . . . 4.4199999999999999 109.608 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.5 t0 -103.8 112.65 25.7 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.911 -4.477 . . . . 2.0899999999999999 98.911 174.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 88.0 t -126.77 132.4 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 114.194 -1.367 . . . . 3.5299999999999998 110.763 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.47 121.92 39.53 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.449 -2.056 . . . . 14.210000000000001 105.449 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.13 109.06 19.97 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 123.636 1.684 . . . . 2.4199999999999999 107.492 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.43 -43.33 13.71 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 115.193 1.553 . . . . 2.6200000000000001 115.193 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.2 tttt -161.78 153.59 19.06 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 113.475 -1.693 . . . . 11.710000000000001 109.153 -167.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.8 mt -120.01 133.24 55.6 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 105.186 -2.153 . . . . 4.7000000000000002 105.186 170.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.31 -1.141 0 CA-C-N 113.64 -1.618 . . . . 13.02 109.94 -179.848 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 106.096 -2.802 . . . . 6.3300000000000001 106.096 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.31 142.62 43.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 101.693 -3.447 . . . . 6.3499999999999996 101.693 176.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -117.13 130.12 56.42 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.736 -3.061 . . . . 16.98 102.736 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.57 117.2 54.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 103.58 -2.748 . . . . 5.5800000000000001 103.58 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.75 124.78 47.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 118.863 -2.398 . . . . 12.800000000000001 104.757 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.3 m -75.74 139.95 42.15 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 119.3 -2.125 . . . . 3.2400000000000002 115.646 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.2 mt -101.62 -51.94 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 105.837 -1.912 . . . . 4.79 105.837 171.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.4 m -138.94 138.9 22.03 Favored Pre-proline 0 C--O 1.242 0.684 0 O-C-N 119.603 -1.936 . . . . 11.59 106.347 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.9 Cg_exo -67.57 154.73 72.73 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.636 2.891 . . . . 4.5499999999999998 112.191 -176.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.7 -161.13 28.86 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 109.075 -1.61 . . . . 2.0 109.075 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -82.49 -9.22 59.52 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 117.618 -3.284 . . . . 3.2400000000000002 113.167 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.17 9.6 76.94 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-O 117.625 -1.653 . . . . 3.3799999999999999 113.81 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.63 -26.66 0.96 Allowed 'General case' 0 C--O 1.241 0.655 0 CA-C-N 122.703 3.252 . . . . 26.59 114.189 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.45 93.95 4.95 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 119.121 -2.237 . . . . 3.02 109.496 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.22 142.49 24.72 Favored Pre-proline 0 C--O 1.25 1.122 0 O-C-N 124.975 1.422 . . . . 4.7000000000000002 109.8 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.58 146.65 68.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.748 2.298 . . . . 2.9399999999999999 110.674 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.44 156.09 33.48 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.899 -1.5 . . . . 15.960000000000001 107.015 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.03 130.25 29.31 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 124.118 1.913 . . . . 11.69 112.797 174.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.22 -13.88 66.11 Favored Glycine 0 N--CA 1.422 -2.296 0 O-C-N 119.978 -1.701 . . . . 3.6299999999999999 112.694 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -86.24 149.41 25.1 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 120.094 1.947 . . . . 5.9000000000000004 112.253 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.92 120.21 30.94 Favored 'General case' 0 C--O 1.25 1.12 0 O-C-N 125.248 1.593 . . . . 3.0699999999999998 111.729 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.45 131.02 39.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.654 1.216 . . . . 4.1100000000000003 109.859 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.3 t -111.92 111.31 35.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 101.67 -3.456 . . . . 2.1600000000000001 101.67 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.53 154.5 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 121.885 0.85 . . . . 3.5899999999999999 112.263 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.15 145.46 30.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 105.178 -2.156 . . . . 3.1299999999999999 105.178 164.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.2 p90 -145.8 156.11 43.37 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 120.124 1.329 . . . . 2.5499999999999998 111.988 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -133.77 121.64 22.16 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 102.948 -2.982 . . . . 4.4699999999999998 102.948 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.22 131.99 10.78 Favored Glycine 0 N--CA 1.472 1.041 0 N-CA-C 109.184 -1.566 . . . . 3.4100000000000001 109.184 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.5 152.09 51.68 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 125.269 2.462 . . . . 18.219999999999999 110.383 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.49 164.63 22.85 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.664 -2.516 . . . . 5.9299999999999997 106.454 172.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.07 -20.64 41.06 Favored 'General case' 0 C--O 1.219 -0.512 0 O-C-N 117.262 -3.399 . . . . 12.33 117.708 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.73 5.38 40.17 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.663 -1.898 . . . . 7.1900000000000004 113.893 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.24 -10.39 69.58 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-O 123.976 1.876 . . . . 6.4699999999999998 113.678 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.58 124.24 22.28 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 116.628 -3.866 . . . . 21.859999999999999 110.532 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.9 130.78 37.02 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.381 -1.341 . . . . 16.18 107.381 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -107.67 -17.89 13.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.021 -1.072 . . . . 5.7300000000000004 110.693 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -172.68 155.49 3.29 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 118.181 -0.914 . . . . 6.1299999999999999 110.509 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.82 128.15 5.57 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.451 1.101 . . . . 2.9300000000000002 110.361 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 38.1 p -76.0 -20.66 57.66 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.982 -0.748 . . . . 2.2999999999999998 108.982 175.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.7 -36.61 84.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.722 -1.585 . . . . 10.550000000000001 106.722 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.71 -28.42 67.65 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.197 -1.565 . . . . 8.0199999999999996 110.833 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.68 -10.08 49.75 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.89 -1.131 . . . . 10.210000000000001 112.361 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.48 34.31 24.07 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-O 123.4 1.571 . . . . 16.379999999999999 111.007 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.66 120.16 9.38 Favored Pre-proline 0 C--O 1.248 1.017 0 O-C-N 117.693 -3.129 . . . . 20.210000000000001 103.897 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -59.24 152.31 61.02 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 124.277 3.318 . . . . 8.75 110.383 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -96.0 138.11 34.1 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.541 -1.652 . . . . 4.6500000000000004 106.541 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.62 136.87 50.24 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 120.539 1.518 . . . . 10.619999999999999 111.372 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.66 150.61 40.44 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.415 1.461 . . . . 4.3099999999999996 107.377 169.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.47 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.44 126.68 37.63 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.297 1.408 . . . . 2.6699999999999999 110.48 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.92 129.7 41.54 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 125.286 1.616 . . . . 3.0800000000000001 110.723 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.11 -4.22 84.56 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.879 0.752 . . . . 4.9500000000000002 113.989 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.05 -3.01 57.74 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.648 -1.501 . . . . 10.26 114.603 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.47 39.58 6.79 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.017 -1.677 . . . . 10.24 113.841 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.33 -0.84 13.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 114.736 1.384 . . . . 10.56 114.736 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.32 172.58 9.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 108.099 -1.074 . . . . 2.4500000000000002 108.099 171.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.71 152.07 8.42 Favored 'Isoleucine or valine' 0 C--O 1.259 1.567 0 CA-C-O 123.026 1.393 . . . . 5.5700000000000003 109.757 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.27 -35.73 67.79 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 114.391 -1.277 . . . . 19.109999999999999 114.432 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.86 -23.31 72.55 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.33 2.786 . . . . 2.9300000000000002 112.304 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.62 -54.61 7.13 Favored 'General case' 0 C--O 1.249 1.071 0 CA-C-N 118.616 1.208 . . . . 7.96 111.572 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.05 -44.35 15.27 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 123.983 1.849 . . . . 15.050000000000001 111.447 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.3 -35.42 47.91 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.541 -1.208 . . . . 20.27 114.093 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.03 -45.65 6.22 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 119.497 -1.335 . . . . 4.04 114.596 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.51 -27.28 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 O-C-N 121.37 -1.076 . . . . 5.3499999999999996 109.382 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.93 -18.88 64.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.688 -2.508 . . . . 3.0299999999999998 112.403 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.55 0.33 50.34 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 118.448 -0.787 . . . . 3.4900000000000002 112.985 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.9 mtp -107.89 143.02 37.09 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 120.791 1.632 . . . . 3.75 109.464 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.523 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.8 p -94.78 155.01 17.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.625 0.77 . . . . 2.2999999999999998 109.762 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.62 130.17 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 119.841 1.2 . . . . 2.4700000000000002 109.858 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.58 52.07 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 113.272 -1.785 . . . . 2.6099999999999999 113.064 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.523 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.43 144.75 28.56 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 121.907 0.86 . . . . 6.5300000000000002 112.57 -171.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.97 123.93 41.47 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 102.671 -3.085 . . . . 12.359999999999999 102.671 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.8 44.99 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 126.4 2.313 . . . . 5.8399999999999999 114.273 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.23 122.53 43.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.516 1.627 . . . . 16.57 108.62 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.12 114.47 28.63 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 118.854 -2.404 . . . . 5.8600000000000003 106.728 -176.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 86.3 m -98.77 120.47 39.25 Favored 'General case' 0 C--O 1.247 0.925 0 N-CA-C 105.858 -1.905 . . . . 5.7599999999999998 105.858 176.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.72 122.62 69.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.653 -0.869 . . . . 3.3599999999999999 108.653 -167.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.36 154.08 91.34 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.861 -1.066 . . . . 4.9400000000000004 110.682 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -55.48 -35.12 91.59 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.298 2.665 . . . . 6.21 114.752 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.03 -13.84 62.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.922 1.082 . . . . 15.85 113.922 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.64 11.07 36.54 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 126.009 1.723 . . . . 11.52 111.674 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.9 -116.6 0.15 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 105.739 -1.949 . . . . 3.7000000000000002 105.739 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -102.59 4.11 38.04 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 122.07 2.214 . . . . 6.8399999999999999 115.498 -173.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.47 -137.09 50.49 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-O 123.739 1.744 . . . . 5.9900000000000002 111.136 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.69 41.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 111.686 -2.257 . . . . 10.109999999999999 111.009 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.47 -43.89 63.08 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 121.039 1.745 . . . . 13.76 112.464 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.39 -169.16 53.46 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 107.606 -2.197 . . . . 9.9800000000000004 107.606 -170.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.85 114.76 35.34 Favored Pre-proline 0 C--O 1.246 0.896 0 O-C-N 117.924 -3.103 . . . . 15.880000000000001 103.253 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.14 122.35 7.3 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 124.679 3.586 . . . . 11.41 110.936 -166.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.15 -26.85 3.24 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-N 111.933 -2.394 . . . . 14.199999999999999 117.385 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.0 mt -102.99 -49.97 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 121.107 2.454 . . . . 11.06 114.938 -175.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.4 mm -112.84 131.87 22.56 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 103.118 -2.919 . . . . 8.0099999999999998 103.118 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.95 163.02 35.38 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 125.236 3.957 . . . . 6.5199999999999996 112.945 171.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.31 144.41 71.84 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.571 2.181 . . . . 4.8200000000000003 110.331 162.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.31 27.33 16.34 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 112.938 -1.937 . . . . 7.4199999999999999 113.577 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.79 132.31 35.28 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.388 2.366 . . . . 2.2200000000000002 117.388 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.37 132.42 35.77 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 121.799 2.091 . . . . 4.6100000000000003 106.349 168.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -109.0 146.79 33.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.379 -1.45 . . . . 5.3399999999999999 110.284 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.9 t -123.16 120.03 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 103.679 -2.711 . . . . 3.9700000000000002 103.679 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.0 m-85 -116.8 137.02 52.5 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.701 -1.25 . . . . 4.4199999999999999 109.577 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.8 t0 -103.8 112.72 25.79 Favored 'General case' 0 C--N 1.314 -0.95 1 N-CA-C 98.876 -4.49 . . . . 2.0899999999999999 98.876 174.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.7 t -126.75 132.43 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.153 -1.385 . . . . 3.5299999999999998 110.821 -172.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.48 121.93 39.56 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.466 -2.05 . . . . 14.210000000000001 105.466 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 tp -89.06 109.11 20.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.405 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.58 -43.25 13.66 Favored 'General case' 0 C--O 1.255 1.344 0 N-CA-C 115.19 1.552 . . . . 2.6200000000000001 115.19 -171.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.3 tttt -161.87 153.64 18.94 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 113.612 -1.631 . . . . 11.710000000000001 109.154 -167.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.9 mt -120.12 133.28 55.55 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 105.097 -2.186 . . . . 4.7000000000000002 105.097 170.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.311 -1.082 0 CA-C-N 113.552 -1.658 . . . . 13.02 109.82 -179.812 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 106.038 -2.825 . . . . 6.3300000000000001 106.038 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.28 142.6 43.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 101.745 -3.428 . . . . 6.3499999999999996 101.745 176.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.12 130.07 56.39 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.726 -3.065 . . . . 16.98 102.726 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.57 117.11 53.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 N-CA-C 103.674 -2.713 . . . . 5.5800000000000001 103.674 -175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.68 124.72 46.96 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 118.877 -2.389 . . . . 12.800000000000001 104.759 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.6 m -75.82 140.0 42.05 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.279 -2.138 . . . . 3.2400000000000002 115.603 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.407 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.54 -52.03 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 105.899 -1.889 . . . . 4.79 105.899 171.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.8 m -138.86 139.01 22.45 Favored Pre-proline 0 C--O 1.243 0.737 0 O-C-N 119.518 -1.989 . . . . 11.59 106.357 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.3 Cg_exo -67.69 154.73 72.51 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 123.627 2.885 . . . . 4.5499999999999998 112.23 -176.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.68 -161.22 28.9 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.09 -1.604 . . . . 2.0 109.09 175.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.54 -9.04 59.58 Favored 'General case' 0 C--O 1.241 0.628 0 O-C-N 117.639 -3.271 . . . . 3.2400000000000002 113.18 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.12 9.65 76.86 Favored Glycine 0 C--O 1.218 -0.887 0 CA-C-O 117.637 -1.646 . . . . 3.3799999999999999 113.874 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.62 -26.73 0.96 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 122.508 3.154 . . . . 26.59 114.241 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.4 93.98 4.97 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.072 -2.268 . . . . 3.02 109.579 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.21 142.54 24.82 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 125.023 1.452 . . . . 4.7000000000000002 109.79 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.58 146.75 68.59 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.704 2.269 . . . . 2.9399999999999999 110.702 -174.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.46 156.15 33.37 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.913 -1.494 . . . . 15.960000000000001 107.073 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.3 ttp180 -52.07 130.27 29.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 124.24 1.972 . . . . 11.69 112.804 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.29 -14.02 65.83 Favored Glycine 0 N--CA 1.422 -2.246 0 O-C-N 119.929 -1.732 . . . . 3.6299999999999999 112.757 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -86.24 149.47 25.05 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 120.029 1.915 . . . . 5.9000000000000004 112.243 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.2 m -89.97 120.29 31.05 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.312 1.633 . . . . 3.0699999999999998 111.746 174.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.46 131.0 39.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 122.55 1.167 . . . . 4.1100000000000003 109.891 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -111.96 111.39 35.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 101.624 -3.473 . . . . 2.1600000000000001 101.624 -174.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 m -129.48 154.42 40.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.806 0.812 . . . . 3.5899999999999999 112.282 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.4 30.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.187 -2.153 . . . . 3.1299999999999999 105.187 164.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.0 p90 -145.79 156.1 43.36 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 120.126 1.33 . . . . 2.5499999999999998 112.055 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -133.83 121.47 21.85 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 102.952 -2.981 . . . . 4.4699999999999998 102.952 167.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.11 131.87 10.73 Favored Glycine 0 N--CA 1.471 0.999 0 N-CA-C 109.248 -1.541 . . . . 3.4100000000000001 109.248 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.37 152.11 51.58 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 125.16 2.41 . . . . 18.219999999999999 110.481 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 164.64 22.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.745 -2.48 . . . . 5.9299999999999997 106.447 172.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -58.03 -20.62 40.37 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 117.17 -3.457 . . . . 12.33 117.699 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -87.74 5.32 40.52 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 119.545 -1.972 . . . . 7.1900000000000004 113.851 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.08 -10.2 69.96 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 124.013 1.896 . . . . 6.4699999999999998 113.789 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.7 124.27 22.41 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 116.688 -3.831 . . . . 21.859999999999999 110.564 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.84 130.78 37.07 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.404 -1.332 . . . . 16.18 107.404 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -107.67 -17.9 13.97 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.124 -1.03 . . . . 5.7300000000000004 110.667 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -172.76 155.4 3.21 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 118.087 -0.959 . . . . 6.1299999999999999 110.587 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -158.76 128.12 5.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.47 1.108 . . . . 2.9300000000000002 110.385 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 37.4 p -76.01 -20.67 57.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.937 -0.764 . . . . 2.2999999999999998 108.937 175.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.61 -36.74 84.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.742 -1.577 . . . . 10.550000000000001 106.742 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -67.55 -28.53 67.87 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.172 -1.58 . . . . 8.0199999999999996 110.807 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.68 -10.01 50.02 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 120.859 -1.15 . . . . 10.210000000000001 112.366 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.47 34.32 24.07 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-O 123.33 1.538 . . . . 16.379999999999999 110.945 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.76 120.14 9.29 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 117.594 -3.191 . . . . 20.210000000000001 103.887 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -59.22 152.27 61.14 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 124.231 3.288 . . . . 8.75 110.378 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -95.91 138.24 33.83 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.58 -1.637 . . . . 4.6500000000000004 106.58 178.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.7 136.84 50.39 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 120.622 1.555 . . . . 10.619999999999999 111.311 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.61 150.71 40.66 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 120.466 1.485 . . . . 4.3099999999999996 107.337 169.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.47 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.51 126.72 37.72 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 120.313 1.415 . . . . 2.6699999999999999 110.563 172.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 129.8 41.92 Favored 'General case' 0 N--CA 1.426 -1.627 0 O-C-N 125.285 1.616 . . . . 3.0800000000000001 110.639 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.97 -4.18 84.77 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.901 0.762 . . . . 4.9500000000000002 114.009 176.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.03 -3.09 57.78 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.788 -1.419 . . . . 10.26 114.647 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 64.57 39.48 6.63 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.046 -1.659 . . . . 10.24 113.756 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.23 -0.79 13.8 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 114.767 1.395 . . . . 10.56 114.767 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.42 172.7 9.25 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 107.978 -1.119 . . . . 2.4500000000000002 107.978 171.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.76 152.13 8.37 Favored 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.91 1.338 . . . . 5.5700000000000003 109.851 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.42 -35.68 68.08 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.381 -1.282 . . . . 19.109999999999999 114.386 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.62 -23.5 72.23 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 123.333 2.788 . . . . 2.9300000000000002 112.363 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.47 -54.67 7.1 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 118.535 1.168 . . . . 7.96 111.633 173.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.06 -44.43 15.37 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 124.028 1.871 . . . . 15.050000000000001 111.449 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.18 -35.49 48.63 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.639 -1.164 . . . . 20.27 114.111 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.95 -45.75 6.21 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 119.572 -1.299 . . . . 4.04 114.64 -175.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.49 -27.21 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 O-C-N 121.404 -1.056 . . . . 5.3499999999999996 109.454 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.92 -18.93 64.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 118.625 -2.547 . . . . 3.0299999999999998 112.343 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.49 0.27 50.35 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.454 -0.784 . . . . 3.4900000000000002 113.026 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.76 143.09 36.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 120.831 1.65 . . . . 3.75 109.476 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.523 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.7 p -94.86 155.02 16.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.66 0.784 . . . . 2.2999999999999998 109.8 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.1 t -57.63 130.2 20.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 119.954 1.252 . . . . 2.4700000000000002 109.711 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.7 52.05 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.381 -1.736 . . . . 2.6099999999999999 113.077 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.523 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.37 144.73 28.63 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.998 0.904 . . . . 6.5300000000000002 112.566 -171.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.96 123.87 41.35 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 102.65 -3.092 . . . . 12.359999999999999 102.65 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.82 156.79 45.01 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 126.501 2.376 . . . . 5.8399999999999999 114.323 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.28 122.38 43.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 123.449 1.595 . . . . 16.57 108.617 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.39 28.5 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 118.85 -2.406 . . . . 5.8600000000000003 106.793 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.6 m -98.69 120.47 39.17 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 105.822 -1.918 . . . . 5.7599999999999998 105.822 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.72 122.68 69.34 Favored 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 108.589 -0.893 . . . . 3.3599999999999999 108.589 -167.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.1 p -66.41 153.99 91.67 Favored Pre-proline 0 C--O 1.243 0.721 0 CA-C-O 117.838 -1.077 . . . . 4.9400000000000004 110.77 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -55.26 -35.11 90.53 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 123.285 2.656 . . . . 6.21 114.899 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.12 -13.85 62.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.792 1.034 . . . . 15.85 113.792 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -103.67 11.0 36.55 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 126.105 1.762 . . . . 11.52 111.737 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.83 -116.58 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.693 -1.965 . . . . 3.7000000000000002 105.693 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.54 4.04 38.1 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 122.036 2.198 . . . . 6.8399999999999999 115.453 -173.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.49 -137.15 50.44 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-O 123.733 1.74 . . . . 5.9900000000000002 111.078 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.22 -18.78 41.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 111.725 -2.238 . . . . 10.109999999999999 110.993 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.1 m -72.28 -43.98 63.46 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 121.064 1.756 . . . . 13.76 112.529 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.39 -169.25 53.39 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 107.715 -2.154 . . . . 9.9800000000000004 107.715 -170.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.85 114.93 35.27 Favored Pre-proline 0 C--O 1.247 0.962 0 O-C-N 118.012 -3.052 . . . . 15.880000000000001 103.164 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -48.14 122.36 7.32 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 124.781 3.654 . . . . 11.41 110.876 -166.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.17 -26.94 3.23 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.94 -2.391 . . . . 14.199999999999999 117.416 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.6 mt -102.87 -50.16 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 121.056 2.428 . . . . 11.06 114.918 -175.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.5 mm -112.85 131.88 22.55 Favored Pre-proline 0 CA--C 1.516 -0.337 0 N-CA-C 103.209 -2.885 . . . . 8.0099999999999998 103.209 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.03 163.05 35.45 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.282 3.988 . . . . 6.5199999999999996 112.915 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.2 Cg_exo -55.3 144.48 71.42 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.521 2.147 . . . . 4.8200000000000003 110.232 162.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.14 27.46 16.53 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 112.924 -1.943 . . . . 7.4199999999999999 113.622 172.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.91 132.42 35.27 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 117.382 2.364 . . . . 2.2200000000000002 117.382 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.55 132.37 35.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 121.695 2.043 . . . . 4.6100000000000003 106.359 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.82 146.84 32.99 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.457 -1.402 . . . . 5.3399999999999999 110.308 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.18 120.01 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 103.74 -2.689 . . . . 3.9700000000000002 103.74 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.7 m-85 -116.79 136.93 52.56 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.734 -1.229 . . . . 4.4199999999999999 109.553 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.6 t0 -103.78 112.77 25.86 Favored 'General case' 0 C--N 1.315 -0.933 1 N-CA-C 98.863 -4.495 . . . . 2.0899999999999999 98.863 174.014 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.2 t -126.86 132.31 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 114.143 -1.39 . . . . 3.5299999999999998 110.765 -172.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.42 121.99 39.74 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.45 -2.055 . . . . 14.210000000000001 105.45 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 tp -89.14 109.07 19.98 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 123.643 1.687 . . . . 2.4199999999999999 107.496 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.6 mt -85.53 -43.25 13.7 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.203 1.557 . . . . 2.6200000000000001 115.203 -171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.85 153.57 18.9 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.509 -1.678 . . . . 11.710000000000001 109.189 -167.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.1 mt -120.01 133.21 55.61 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 105.177 -2.157 . . . . 4.7000000000000002 105.177 170.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 . . . . . 0 C--N 1.312 -1.049 0 CA-C-N 113.591 -1.641 . . . . 13.02 109.823 -179.805 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 106.024 -2.83 . . . . 6.3300000000000001 106.024 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.33 142.48 43.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 101.784 -3.413 . . . . 6.3499999999999996 101.784 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -116.98 130.16 56.51 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 102.807 -3.034 . . . . 16.98 102.807 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.5 t -109.54 117.04 53.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 103.718 -2.697 . . . . 5.5800000000000001 103.718 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.65 124.7 46.94 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 118.927 -2.358 . . . . 12.800000000000001 104.834 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.3 m -75.7 140.03 42.25 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 119.365 -2.084 . . . . 3.2400000000000002 115.68 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.9 mt -101.63 -51.92 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 105.874 -1.899 . . . . 4.79 105.874 171.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.3 m -138.93 139.06 22.45 Favored Pre-proline 0 C--O 1.242 0.704 0 O-C-N 119.572 -1.955 . . . . 11.59 106.299 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.7 Cg_exo -67.73 154.71 72.49 Favored 'Trans proline' 0 C--N 1.328 -0.522 0 C-N-CA 123.626 2.884 . . . . 4.5499999999999998 112.166 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.71 -161.29 28.88 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 109.15 -1.58 . . . . 2.0 109.15 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -82.33 -9.21 59.56 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 117.677 -3.249 . . . . 3.2400000000000002 113.21 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.17 9.67 77.07 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-O 117.585 -1.675 . . . . 3.3799999999999999 113.799 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.62 -26.79 0.96 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.669 3.234 . . . . 26.59 114.225 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.47 94.04 4.99 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 119.111 -2.243 . . . . 3.02 109.525 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.27 142.53 24.8 Favored Pre-proline 0 C--O 1.251 1.14 0 O-C-N 124.95 1.406 . . . . 4.7000000000000002 109.769 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.62 146.71 68.18 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.743 2.295 . . . . 2.9399999999999999 110.671 -174.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -121.47 156.25 33.16 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.925 -1.489 . . . . 15.960000000000001 106.994 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.3 ttp180 -52.1 130.27 29.67 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 124.121 1.915 . . . . 11.69 112.831 174.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.21 -14.05 65.84 Favored Glycine 0 N--CA 1.421 -2.307 0 O-C-N 119.971 -1.706 . . . . 3.6299999999999999 112.763 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.15 149.41 25.13 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.098 1.949 . . . . 5.9000000000000004 112.311 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.6 m -89.97 120.42 31.16 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 125.257 1.598 . . . . 3.0699999999999998 111.689 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.52 131.06 39.12 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.592 1.187 . . . . 4.1100000000000003 109.799 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.4 t -112.06 111.33 35.69 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.649 -3.463 . . . . 2.1600000000000001 101.649 -174.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.9 m -129.43 154.43 40.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.77 0.795 . . . . 3.5899999999999999 112.313 -172.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.12 145.41 30.58 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.274 -2.121 . . . . 3.1299999999999999 105.274 164.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.86 156.13 43.35 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 120.172 1.351 . . . . 2.5499999999999998 111.87 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -133.86 121.48 21.82 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 102.924 -2.991 . . . . 4.4699999999999998 102.924 167.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.27 131.93 10.76 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 109.173 -1.571 . . . . 3.4100000000000001 109.173 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.46 152.18 51.61 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 125.291 2.472 . . . . 18.219999999999999 110.374 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 164.55 22.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 111.65 -2.523 . . . . 5.9299999999999997 106.435 172.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -57.96 -20.69 39.78 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 117.263 -3.398 . . . . 12.33 117.705 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.75 5.4 40.18 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.564 -1.96 . . . . 7.1900000000000004 113.874 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.36 69.71 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-O 124.113 1.952 . . . . 6.4699999999999998 113.754 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.42 124.18 22.04 Favored 'General case' 0 N--CA 1.438 -1.037 0 O-C-N 116.601 -3.882 . . . . 21.859999999999999 110.686 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.91 130.79 37.01 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.37 -1.344 . . . . 16.18 107.37 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.61 -17.93 13.97 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.095 -1.042 . . . . 5.7300000000000004 110.74 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.68 155.44 3.28 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 118.041 -0.98 . . . . 6.1299999999999999 110.665 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -158.77 128.2 5.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.484 1.113 . . . . 2.9300000000000002 110.312 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 38.9 p -76.03 -20.61 57.64 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.001 -0.74 . . . . 2.2999999999999998 109.001 175.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.63 84.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.685 -1.598 . . . . 10.550000000000001 106.685 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -67.64 -28.56 67.83 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.143 -1.598 . . . . 8.0199999999999996 110.827 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.3 mtm-85 -88.58 -10.04 50.14 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.861 -1.149 . . . . 10.210000000000001 112.427 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.5 34.26 24.0 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.311 1.529 . . . . 16.379999999999999 110.951 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.7 120.2 9.36 Favored Pre-proline 0 C--O 1.247 0.972 0 O-C-N 117.571 -3.206 . . . . 20.210000000000001 103.921 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -59.33 152.29 61.77 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.292 3.328 . . . . 8.75 110.276 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -95.85 138.18 33.86 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.572 -1.64 . . . . 4.6500000000000004 106.572 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.67 136.88 50.3 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 120.525 1.512 . . . . 10.619999999999999 111.253 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.6 150.7 40.67 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 120.475 1.489 . . . . 4.3099999999999996 107.368 169.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.466 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.46 126.61 37.62 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.324 1.42 . . . . 2.6699999999999999 110.542 172.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.87 129.9 42.45 Favored 'General case' 0 N--CA 1.427 -1.576 0 O-C-N 125.33 1.644 . . . . 3.0800000000000001 110.699 176.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.79 -4.02 84.92 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 123.862 0.744 . . . . 4.9500000000000002 114.043 176.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.08 -3.13 57.86 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.686 -1.479 . . . . 10.26 114.633 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 64.56 39.52 6.65 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 120.012 -1.68 . . . . 10.24 113.858 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.34 -0.89 13.69 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 114.722 1.378 . . . . 10.56 114.722 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.4 172.67 9.28 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 N-CA-C 108.085 -1.08 . . . . 2.4500000000000002 108.085 171.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 pt -71.82 152.17 8.32 Favored 'Isoleucine or valine' 0 C--O 1.256 1.445 0 CA-C-O 123.029 1.395 . . . . 5.5700000000000003 109.725 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -56.26 -35.71 67.75 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 114.316 -1.311 . . . . 19.109999999999999 114.471 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.86 -23.22 72.53 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 123.4 2.818 . . . . 2.9300000000000002 112.432 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.52 -54.76 6.89 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 118.555 1.178 . . . . 7.96 111.583 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.86 -44.43 14.36 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 124.045 1.878 . . . . 15.050000000000001 111.503 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.44 -35.35 46.98 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.564 -1.198 . . . . 20.27 114.007 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.94 -45.7 6.23 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 119.615 -1.279 . . . . 4.04 114.724 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.58 -27.18 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 119.09 -1.044 . . . . 5.3499999999999996 109.425 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.85 64.71 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.541 -2.6 . . . . 3.0299999999999998 112.35 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.42 0.18 50.46 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 118.425 -0.798 . . . . 3.4900000000000002 113.068 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.6 mtp -107.7 143.1 36.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 120.81 1.641 . . . . 3.75 109.572 -171.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.522 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.9 p -94.84 154.96 17.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.715 0.806 . . . . 2.2999999999999998 109.806 174.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.2 t -57.62 130.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 119.867 1.212 . . . . 2.4700000000000002 109.783 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 -12.53 52.08 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 113.35 -1.75 . . . . 2.6099999999999999 112.995 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.522 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.46 144.76 28.52 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.919 0.866 . . . . 6.5300000000000002 112.575 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.95 123.89 41.4 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 102.632 -3.099 . . . . 12.359999999999999 102.632 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.91 156.64 44.94 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 126.471 2.357 . . . . 5.8399999999999999 114.285 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.15 122.45 43.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 123.551 1.643 . . . . 16.57 108.638 174.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.05 114.59 28.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 118.741 -2.474 . . . . 5.8600000000000003 106.76 -176.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.9 m -98.74 120.44 39.18 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 105.77 -1.937 . . . . 5.7599999999999998 105.77 176.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.66 122.59 69.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 108.687 -0.857 . . . . 3.3599999999999999 108.687 -167.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.35 154.03 91.41 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.907 -1.044 . . . . 4.9400000000000004 110.683 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -55.45 -35.09 91.39 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.355 2.704 . . . . 6.21 114.738 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.07 -13.84 62.4 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.897 1.073 . . . . 15.85 113.897 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.61 10.99 36.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 126.106 1.762 . . . . 11.52 111.692 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.86 -116.6 0.15 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 105.712 -1.958 . . . . 3.7000000000000002 105.712 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.59 4.0 37.92 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-N 121.991 2.178 . . . . 6.8399999999999999 115.444 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.49 -137.15 50.44 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-O 123.739 1.744 . . . . 5.9900000000000002 111.032 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.29 -18.73 41.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 111.674 -2.263 . . . . 10.109999999999999 110.982 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.1 m -72.19 -43.98 63.69 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 121.131 1.787 . . . . 13.76 112.608 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.3 -169.17 53.38 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 107.652 -2.179 . . . . 9.9800000000000004 107.652 -170.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -118.83 114.9 35.32 Favored Pre-proline 0 C--O 1.247 0.959 0 O-C-N 117.982 -3.069 . . . . 15.880000000000001 103.268 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.21 122.44 7.5 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.622 3.548 . . . . 11.41 110.903 -166.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.21 -26.98 3.23 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.863 -2.426 . . . . 14.199999999999999 117.416 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.6 mt -102.88 -50.04 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 121.03 2.415 . . . . 11.06 114.894 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.7 mm -112.92 131.91 22.56 Favored Pre-proline 0 CA--C 1.516 -0.328 0 N-CA-C 103.203 -2.888 . . . . 8.0099999999999998 103.203 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.01 163.02 35.53 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.284 3.99 . . . . 6.5199999999999996 112.918 171.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.34 144.48 71.81 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.563 2.175 . . . . 4.8200000000000003 110.244 162.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.33 27.22 16.27 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 112.785 -2.007 . . . . 7.4199999999999999 113.581 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.84 132.35 35.27 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 117.396 2.369 . . . . 2.2200000000000002 117.396 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -80.51 132.43 35.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 121.722 2.055 . . . . 4.6100000000000003 106.328 168.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.89 146.86 33.06 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.451 -1.406 . . . . 5.3399999999999999 110.276 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.3 t -123.21 119.95 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 N-CA-C 103.743 -2.688 . . . . 3.9700000000000002 103.743 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.6 m-85 -116.77 137.01 52.5 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.724 -1.235 . . . . 4.4199999999999999 109.562 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.81 112.7 25.77 Favored 'General case' 0 C--N 1.314 -0.959 1 N-CA-C 98.91 -4.478 . . . . 2.0899999999999999 98.91 173.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.4 t -126.8 132.33 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.12 -1.4 . . . . 3.5299999999999998 110.82 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.44 121.84 39.39 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.524 -2.028 . . . . 14.210000000000001 105.524 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.09 109.01 19.92 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 123.618 1.675 . . . . 2.4199999999999999 107.484 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.41 -43.34 13.72 Favored 'General case' 0 C--O 1.255 1.378 0 N-CA-C 115.175 1.546 . . . . 2.6200000000000001 115.175 -171.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.405 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.5 tttt -161.79 153.59 19.05 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 113.559 -1.655 . . . . 11.710000000000001 109.229 -167.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.07 133.19 55.59 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 105.201 -2.148 . . . . 4.7000000000000002 105.201 170.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.31 -1.138 0 CA-C-N 113.554 -1.657 . . . . 13.02 109.912 -179.795 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 106.073 -2.811 . . . . 6.3300000000000001 106.073 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.34 142.55 43.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 101.741 -3.429 . . . . 6.3499999999999996 101.741 176.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.05 130.13 56.46 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 102.734 -3.061 . . . . 16.98 102.734 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.9 t -109.53 117.04 53.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 103.741 -2.689 . . . . 5.5800000000000001 103.741 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.62 124.72 47.01 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 118.957 -2.339 . . . . 12.800000000000001 104.824 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.4 m -75.68 140.02 42.28 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 119.292 -2.13 . . . . 3.2400000000000002 115.635 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.41 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.3 mt -101.61 -52.02 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.832 -1.914 . . . . 4.79 105.832 171.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.6 m -138.95 139.03 22.27 Favored Pre-proline 0 C--O 1.241 0.652 0 O-C-N 119.5 -2.0 . . . . 11.59 106.301 177.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.7 Cg_exo -67.7 154.78 72.34 Favored 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.46 2.774 . . . . 4.5499999999999998 112.201 -176.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.71 -161.17 28.86 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 109.135 -1.586 . . . . 2.0 109.135 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.49 -9.21 59.52 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 117.606 -3.291 . . . . 3.2400000000000002 113.161 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.15 9.68 77.02 Favored Glycine 0 C--O 1.219 -0.8 0 CA-C-O 117.691 -1.616 . . . . 3.3799999999999999 113.846 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.67 -26.58 0.96 Allowed 'General case' 0 C--O 1.24 0.587 0 CA-C-N 122.592 3.196 . . . . 26.59 114.214 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.57 94.0 4.96 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 119.057 -2.277 . . . . 3.02 109.45 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.13 142.53 24.81 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 125.01 1.444 . . . . 4.7000000000000002 109.798 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.56 146.76 68.69 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.754 2.303 . . . . 2.9399999999999999 110.627 -174.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.48 156.09 33.53 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.919 -1.491 . . . . 15.960000000000001 107.047 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.465 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.03 130.23 29.28 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 124.189 1.947 . . . . 11.69 112.721 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.36 -14.08 65.67 Favored Glycine 0 N--CA 1.423 -2.21 0 O-C-N 119.952 -1.717 . . . . 3.6299999999999999 112.713 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.12 149.36 25.18 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.061 1.93 . . . . 5.9000000000000004 112.326 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.92 120.36 31.08 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.176 1.548 . . . . 3.0699999999999998 111.766 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.51 130.94 39.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 122.606 1.193 . . . . 4.1100000000000003 109.874 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.3 t -111.89 111.39 35.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.638 -3.467 . . . . 2.1600000000000001 101.638 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.54 154.39 40.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 121.817 0.817 . . . . 3.5899999999999999 112.262 -172.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.04 145.49 30.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.173 -2.158 . . . . 3.1299999999999999 105.173 164.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.1 p90 -145.89 156.11 43.33 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 120.048 1.294 . . . . 2.5499999999999998 112.038 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.8 m -133.84 121.63 22.06 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 102.88 -3.007 . . . . 4.4699999999999998 102.88 167.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.24 131.94 10.76 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 109.22 -1.552 . . . . 3.4100000000000001 109.22 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.4 152.12 51.6 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 125.198 2.427 . . . . 18.219999999999999 110.405 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 164.62 22.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.741 -2.481 . . . . 5.9299999999999997 106.447 172.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -58.04 -20.58 40.22 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.238 -3.414 . . . . 12.33 117.708 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.75 5.3 40.65 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.59 -1.943 . . . . 7.1900000000000004 113.914 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.23 -10.33 69.62 Favored Glycine 0 C--N 1.357 1.697 0 CA-C-O 123.956 1.864 . . . . 6.4699999999999998 113.646 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.59 124.22 22.23 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 116.622 -3.869 . . . . 21.859999999999999 110.583 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -77.77 130.83 37.21 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.457 -1.312 . . . . 16.18 107.457 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.71 -17.87 13.97 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.075 -1.05 . . . . 5.7300000000000004 110.802 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -172.76 155.49 3.24 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 118.241 -0.885 . . . . 6.1299999999999999 110.55 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.81 128.05 5.54 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.48 1.112 . . . . 2.9300000000000002 110.371 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 40.3 p -75.89 -20.59 57.92 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.846 -0.741 . . . . 2.2999999999999998 109.093 175.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.73 -36.69 84.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.696 -1.594 . . . . 10.550000000000001 106.696 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -67.62 -28.49 67.78 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.191 -1.568 . . . . 8.0199999999999996 110.812 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.63 -10.1 49.81 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 120.854 -1.154 . . . . 10.210000000000001 112.341 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.51 34.28 24.05 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.346 1.546 . . . . 16.379999999999999 111.017 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.68 120.18 9.37 Favored Pre-proline 0 C--O 1.247 0.972 0 O-C-N 117.627 -3.171 . . . . 20.210000000000001 103.914 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -59.32 152.28 61.72 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 124.321 3.347 . . . . 8.75 110.32 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -95.84 138.13 33.92 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.534 -1.654 . . . . 4.6500000000000004 106.534 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -111.61 136.89 50.2 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 120.572 1.533 . . . . 10.619999999999999 111.297 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.66 150.7 40.55 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.402 1.456 . . . . 4.3099999999999996 107.373 169.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.51 126.67 37.7 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 120.311 1.414 . . . . 2.6699999999999999 110.585 172.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 129.86 42.19 Favored 'General case' 0 N--CA 1.426 -1.643 0 O-C-N 125.251 1.594 . . . . 3.0800000000000001 110.647 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.93 -4.12 84.8 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 123.841 0.734 . . . . 4.9500000000000002 114.099 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.1 -3.12 57.86 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.797 -1.414 . . . . 10.26 114.561 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.51 39.62 6.69 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.106 -1.621 . . . . 10.24 113.784 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.38 -0.81 13.69 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 114.676 1.361 . . . . 10.56 114.676 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.37 172.63 9.33 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.118 -1.067 . . . . 2.4500000000000002 108.118 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.2 pt -71.82 152.12 8.34 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.98 1.371 . . . . 5.5700000000000003 109.785 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -56.22 -35.75 67.69 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.354 -1.294 . . . . 19.109999999999999 114.458 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.76 -23.31 72.38 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.423 2.828 . . . . 2.9300000000000002 112.357 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.59 -54.68 7.0 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 118.621 1.21 . . . . 7.96 111.611 173.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -45.93 -44.45 14.74 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 124.015 1.864 . . . . 15.050000000000001 111.512 173.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.33 -35.31 47.77 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.517 -1.22 . . . . 20.27 114.084 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.05 -45.65 6.21 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.424 -1.37 . . . . 4.04 114.663 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.47 -27.25 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 121.317 -1.108 . . . . 5.3499999999999996 109.456 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.95 -18.89 64.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.506 -2.621 . . . . 3.0299999999999998 112.363 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.48 0.34 50.04 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.078 0.77 . . . . 3.4900000000000002 113.078 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.9 mtp -107.88 143.08 36.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 120.765 1.62 . . . . 3.75 109.493 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.522 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.9 p -94.71 154.92 17.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.714 0.805 . . . . 2.2999999999999998 109.877 174.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -57.58 130.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 119.965 1.257 . . . . 2.4700000000000002 109.828 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.12 -12.54 52.26 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 113.366 -1.743 . . . . 2.6099999999999999 113.124 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.522 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.48 144.8 28.49 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.915 0.864 . . . . 6.5300000000000002 112.605 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -124.01 123.99 41.57 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 102.578 -3.119 . . . . 12.359999999999999 102.578 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.82 45.01 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.467 2.354 . . . . 5.8399999999999999 114.292 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.28 122.39 43.59 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.463 1.601 . . . . 16.57 108.651 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.59 28.82 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.847 -2.408 . . . . 5.8600000000000003 106.709 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 86.2 m -98.79 120.47 39.28 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 105.822 -1.918 . . . . 5.7599999999999998 105.822 176.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.73 122.55 69.01 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 108.616 -0.883 . . . . 3.3599999999999999 108.616 -167.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.34 154.02 91.43 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-O 117.787 -1.101 . . . . 4.9400000000000004 110.737 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.4 -35.08 91.11 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.312 2.675 . . . . 6.21 114.749 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.17 -13.83 62.36 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 113.777 1.029 . . . . 15.85 113.777 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.69 11.05 36.45 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 126.038 1.735 . . . . 11.52 111.693 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.79 -116.54 0.15 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 105.751 -1.944 . . . . 3.7000000000000002 105.751 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.73 4.22 37.8 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 122.033 2.197 . . . . 6.8399999999999999 115.452 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.36 -137.18 50.33 Favored Glycine 0 C--N 1.354 1.578 0 CA-C-O 123.708 1.727 . . . . 5.9900000000000002 111.073 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.17 -18.75 41.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 111.661 -2.27 . . . . 10.109999999999999 111.047 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.25 -43.98 63.53 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 121.048 1.749 . . . . 13.76 112.575 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.4 -169.24 53.4 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 107.603 -2.199 . . . . 9.9800000000000004 107.603 -170.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.87 114.9 35.23 Favored Pre-proline 0 C--O 1.246 0.913 0 O-C-N 118.097 -3.002 . . . . 15.880000000000001 103.151 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.13 122.43 7.4 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.667 3.578 . . . . 11.41 110.901 -166.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.17 -27.05 3.2 Favored Glycine 0 CA--C 1.545 1.935 0 CA-C-N 111.897 -2.41 . . . . 14.199999999999999 117.454 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.9 mt -102.85 -50.08 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.046 2.423 . . . . 11.06 114.972 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.84 131.93 22.52 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 103.124 -2.917 . . . . 8.0099999999999998 103.124 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.09 163.08 35.43 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 125.218 3.945 . . . . 6.5199999999999996 112.871 171.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.511 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.3 Cg_exo -55.4 144.54 72.21 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.428 2.085 . . . . 4.8200000000000003 110.311 162.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.19 27.26 16.38 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 112.886 -1.961 . . . . 7.4199999999999999 113.722 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.67 132.36 35.29 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 117.381 2.363 . . . . 2.2200000000000002 117.381 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.47 132.46 35.71 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 121.796 2.089 . . . . 4.6100000000000003 106.348 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -108.94 146.78 33.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 120.379 -1.45 . . . . 5.3399999999999999 110.241 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.17 120.01 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 103.768 -2.679 . . . . 3.9700000000000002 103.768 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.6 m-85 -116.76 136.95 52.55 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.724 -1.235 . . . . 4.4199999999999999 109.591 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.8 t0 -103.75 112.7 25.77 Favored 'General case' 0 C--N 1.313 -1.0 1 N-CA-C 98.925 -4.472 . . . . 2.0899999999999999 98.925 173.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.6 t -126.82 132.34 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.212 -1.358 . . . . 3.5299999999999998 110.804 -172.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -120.47 121.9 39.5 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.464 -2.05 . . . . 14.210000000000001 105.464 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.6 tp -89.05 109.04 19.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 123.606 1.67 . . . . 2.4199999999999999 107.516 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.46 -43.26 13.74 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.181 1.549 . . . . 2.6200000000000001 115.181 -171.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.8 153.58 19.02 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 113.503 -1.68 . . . . 11.710000000000001 109.115 -167.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.04 133.24 55.59 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 105.206 -2.146 . . . . 4.7000000000000002 105.206 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.582 -1.645 . . . . 13.02 109.912 -179.84 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 106.082 -2.807 . . . . 6.3300000000000001 106.082 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.36 142.54 43.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 101.712 -3.44 . . . . 6.3499999999999996 101.712 176.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.06 130.11 56.44 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 102.824 -3.028 . . . . 16.98 102.824 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.1 t -109.49 117.12 53.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 103.67 -2.715 . . . . 5.5800000000000001 103.67 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.63 124.68 46.92 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 118.949 -2.345 . . . . 12.800000000000001 104.83 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.6 m -75.66 139.96 42.27 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.333 -2.105 . . . . 3.2400000000000002 115.621 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.5 mt -101.66 -52.01 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 105.82 -1.919 . . . . 4.79 105.82 171.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.5 m -138.93 139.1 22.58 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 119.652 -1.905 . . . . 11.59 106.233 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.3 Cg_exo -67.66 154.76 72.49 Favored 'Trans proline' 0 C--N 1.33 -0.433 0 C-N-CA 123.568 2.846 . . . . 4.5499999999999998 112.224 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.68 -161.08 28.88 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.106 -1.597 . . . . 2.0 109.106 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -82.55 -9.17 59.52 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 117.694 -3.239 . . . . 3.2400000000000002 113.146 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.1 9.77 76.98 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.636 -1.647 . . . . 3.3799999999999999 113.843 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.74 -26.66 0.95 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.592 3.196 . . . . 26.59 114.226 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 m -105.52 94.03 4.98 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 119.143 -2.223 . . . . 3.02 109.439 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.21 142.5 24.75 Favored Pre-proline 0 C--O 1.25 1.091 0 O-C-N 125.003 1.439 . . . . 4.7000000000000002 109.77 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.53 146.59 68.31 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.789 2.326 . . . . 2.9399999999999999 110.682 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.42 156.18 33.25 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.895 -1.502 . . . . 15.960000000000001 106.99 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.6 ttp180 -52.17 130.31 30.06 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 124.201 1.953 . . . . 11.69 112.828 174.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.28 -13.96 65.94 Favored Glycine 0 N--CA 1.424 -2.147 0 O-C-N 120.009 -1.682 . . . . 3.6299999999999999 112.682 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.47 25.09 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 120.111 1.956 . . . . 5.9000000000000004 112.356 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.9 m -89.89 120.31 31.01 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.308 1.63 . . . . 3.0699999999999998 111.726 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.55 131.05 39.17 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.614 1.197 . . . . 4.1100000000000003 109.851 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -112.0 111.41 36.04 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.643 -3.466 . . . . 2.1600000000000001 101.643 -174.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.1 m -129.6 154.4 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.89 0.852 . . . . 3.5899999999999999 112.249 -172.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.05 145.39 30.54 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.258 -2.127 . . . . 3.1299999999999999 105.258 164.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.8 156.19 43.42 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 120.173 1.351 . . . . 2.5499999999999998 111.923 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.4 m -133.86 121.54 21.91 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 102.99 -2.967 . . . . 4.4699999999999998 102.99 167.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.2 131.95 10.77 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 109.3 -1.52 . . . . 3.4100000000000001 109.3 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.39 152.19 51.56 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 125.263 2.459 . . . . 18.219999999999999 110.381 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.6 164.66 22.73 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.706 -2.497 . . . . 5.9299999999999997 106.408 172.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -58.11 -20.64 41.69 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 117.28 -3.387 . . . . 12.33 117.67 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.57 5.21 40.45 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 119.536 -1.977 . . . . 7.1900000000000004 113.927 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.22 -10.24 69.65 Favored Glycine 0 C--N 1.354 1.54 0 CA-C-O 123.973 1.874 . . . . 6.4699999999999998 113.67 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.67 124.32 22.54 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 116.728 -3.807 . . . . 21.859999999999999 110.583 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.97 130.76 36.93 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.383 -1.34 . . . . 16.18 107.383 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.56 -17.9 13.98 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.142 -1.023 . . . . 5.7300000000000004 110.845 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -172.71 155.44 3.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.064 -0.97 . . . . 6.1299999999999999 110.614 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -158.82 128.17 5.58 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.421 1.088 . . . . 2.9300000000000002 110.284 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.2 p -75.97 -20.74 57.66 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.841 -0.743 . . . . 2.2999999999999998 109.006 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.63 -36.67 84.6 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.674 -1.602 . . . . 10.550000000000001 106.674 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.59 -28.47 67.79 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.191 -1.568 . . . . 8.0199999999999996 110.881 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.67 -10.11 49.69 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 120.847 -1.158 . . . . 10.210000000000001 112.331 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.49 34.32 24.1 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-O 123.4 1.571 . . . . 16.379999999999999 110.989 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.69 120.2 9.36 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 117.703 -3.123 . . . . 20.210000000000001 103.926 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -59.24 152.26 61.35 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 124.209 3.273 . . . . 8.75 110.383 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -95.86 138.31 33.69 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.518 -1.66 . . . . 4.6500000000000004 106.518 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.76 136.78 50.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.588 1.54 . . . . 10.619999999999999 111.326 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -142.56 150.59 40.57 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 120.437 1.472 . . . . 4.3099999999999996 107.442 169.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.468 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.47 126.71 37.68 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.365 1.439 . . . . 2.6699999999999999 110.634 172.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.87 129.83 42.14 Favored 'General case' 0 N--CA 1.428 -1.56 0 O-C-N 125.32 1.637 . . . . 3.0800000000000001 110.654 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.87 -4.06 84.85 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 123.9 0.762 . . . . 4.9500000000000002 114.093 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.11 -3.01 57.79 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.765 -1.432 . . . . 10.26 114.64 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.51 39.55 6.72 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.045 -1.659 . . . . 10.24 113.795 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.73 13.7 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 114.671 1.36 . . . . 10.56 114.671 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.46 172.68 9.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 N-CA-C 107.938 -1.134 . . . . 2.4500000000000002 107.938 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 pt -71.77 152.12 8.37 Favored 'Isoleucine or valine' 0 C--O 1.259 1.604 0 CA-C-O 122.944 1.354 . . . . 5.5700000000000003 109.765 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.34 -35.73 67.96 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 114.401 -1.272 . . . . 19.109999999999999 114.395 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.78 -23.34 72.42 Favored Glycine 0 CA--C 1.539 1.583 0 O-C-N 118.226 -2.796 . . . . 2.9300000000000002 112.344 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.62 -54.55 7.23 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 118.556 1.178 . . . . 7.96 111.628 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.99 -44.45 15.03 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 124.015 1.864 . . . . 15.050000000000001 111.502 173.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.35 -35.25 47.71 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.544 -1.207 . . . . 20.27 114.101 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.04 -45.75 6.18 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.534 -1.317 . . . . 4.04 114.623 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.51 -27.22 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 121.338 -1.095 . . . . 5.3499999999999996 109.425 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.97 -18.8 64.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 118.531 -2.606 . . . . 3.0299999999999998 112.439 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.52 0.25 50.54 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.468 -0.777 . . . . 3.4900000000000002 113.026 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.8 143.05 36.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 120.852 1.66 . . . . 3.75 109.577 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.524 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.9 p -94.77 154.96 17.03 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.693 0.797 . . . . 2.2999999999999998 109.86 174.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.2 t -57.62 130.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 119.957 1.253 . . . . 2.4700000000000002 109.763 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.15 -12.46 52.12 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 113.311 -1.768 . . . . 2.6099999999999999 113.049 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.524 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.48 144.77 28.51 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-O 121.854 0.835 . . . . 6.5300000000000002 112.562 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.97 123.98 41.58 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 102.626 -3.102 . . . . 12.359999999999999 102.626 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.91 156.82 44.97 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.472 2.357 . . . . 5.8399999999999999 114.221 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.36 122.42 43.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 123.443 1.592 . . . . 16.57 108.699 174.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.98 114.4 28.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 O-C-N 118.841 -2.412 . . . . 5.8600000000000003 106.797 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.6 m -98.68 120.51 39.24 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 105.855 -1.905 . . . . 5.7599999999999998 105.855 176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.63 122.61 69.25 Favored 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 108.714 -0.847 . . . . 3.3599999999999999 108.714 -167.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.38 154.03 91.52 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.915 -1.04 . . . . 4.9400000000000004 110.739 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.32 -35.19 90.99 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 123.268 2.645 . . . . 6.21 114.786 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -69.95 -13.96 62.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.927 1.084 . . . . 15.85 113.927 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.6 11.06 36.61 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 126.113 1.765 . . . . 11.52 111.757 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.79 -116.62 0.15 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 105.786 -1.931 . . . . 3.7000000000000002 105.786 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -102.51 3.94 38.08 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 122.032 2.196 . . . . 6.8399999999999999 115.545 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.58 -137.17 50.48 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-O 123.757 1.754 . . . . 5.9900000000000002 111.011 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.64 41.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 111.622 -2.289 . . . . 10.109999999999999 110.983 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.26 -44.09 63.34 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 121.112 1.778 . . . . 13.76 112.529 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.4 -169.19 53.44 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.659 -2.177 . . . . 9.9800000000000004 107.659 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.81 114.8 35.4 Favored Pre-proline 0 C--O 1.247 0.922 0 O-C-N 117.999 -3.06 . . . . 15.880000000000001 103.323 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -48.19 122.47 7.52 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 124.707 3.605 . . . . 11.41 110.89 -166.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.19 -26.97 3.23 Favored Glycine 0 CA--C 1.547 2.079 0 CA-C-N 111.87 -2.423 . . . . 14.199999999999999 117.361 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.1 mt -102.96 -50.04 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 121.074 2.437 . . . . 11.06 114.917 -175.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.95 131.92 22.57 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 103.17 -2.9 . . . . 8.0099999999999998 103.17 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.0 163.07 35.32 Favored 'Trans proline' 0 C--O 1.24 0.592 1 C-N-CA 125.34 4.027 . . . . 6.5199999999999996 112.853 171.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.34 144.45 71.94 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.534 2.156 . . . . 4.8200000000000003 110.307 162.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.32 27.3 16.32 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 112.846 -1.979 . . . . 7.4199999999999999 113.562 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.86 132.35 35.27 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 117.392 2.367 . . . . 2.2200000000000002 117.392 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -80.57 132.45 35.65 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 121.696 2.043 . . . . 4.6100000000000003 106.283 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.88 146.78 33.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.442 -1.411 . . . . 5.3399999999999999 110.285 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.19 119.96 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 103.78 -2.674 . . . . 3.9700000000000002 103.78 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.4 m-85 -116.81 137.09 52.45 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.77 -1.206 . . . . 4.4199999999999999 109.541 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.81 112.73 25.81 Favored 'General case' 0 C--N 1.314 -0.975 1 N-CA-C 98.912 -4.477 . . . . 2.0899999999999999 98.912 174.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.5 t -126.72 132.36 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.109 -1.405 . . . . 3.5299999999999998 110.805 -172.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.49 121.82 39.29 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.57 -2.011 . . . . 14.210000000000001 105.57 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 tp -89.02 109.11 19.99 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.498 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.9 mt -85.47 -43.34 13.67 Favored 'General case' 0 C--O 1.254 1.34 0 N-CA-C 115.255 1.576 . . . . 2.6200000000000001 115.255 -171.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.86 153.54 18.84 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.422 -1.717 . . . . 11.710000000000001 109.153 -167.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.0 133.28 55.59 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 105.155 -2.165 . . . . 4.7000000000000002 105.155 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.313 -1.018 0 CA-C-N 113.548 -1.66 . . . . 13.02 109.8 -179.798 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 106.034 -2.826 . . . . 6.3300000000000001 106.034 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.31 142.46 43.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 101.725 -3.435 . . . . 6.3499999999999996 101.725 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -116.92 130.21 56.55 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 102.818 -3.03 . . . . 16.98 102.818 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.8 t -109.71 117.1 53.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 103.613 -2.736 . . . . 5.5800000000000001 103.613 -175.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.61 124.65 46.85 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 118.919 -2.363 . . . . 12.800000000000001 104.82 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.7 m -75.57 139.97 42.41 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.183 -2.198 . . . . 3.2400000000000002 115.598 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.7 mt -101.64 -52.07 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 105.844 -1.91 . . . . 4.79 105.844 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.7 m -138.9 139.03 22.4 Favored Pre-proline 0 C--O 1.243 0.723 0 O-C-N 119.684 -1.885 . . . . 11.59 106.358 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.7 Cg_exo -67.66 154.78 72.44 Favored 'Trans proline' 0 C--N 1.329 -0.48 0 C-N-CA 123.536 2.824 . . . . 4.5499999999999998 112.15 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.63 -161.1 28.93 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 109.222 -1.551 . . . . 2.0 109.222 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.49 -9.21 59.52 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 117.65 -3.265 . . . . 3.2400000000000002 113.163 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.14 9.69 76.98 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-O 117.585 -1.675 . . . . 3.3799999999999999 113.806 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.63 -26.81 0.96 Allowed 'General case' 0 C--O 1.24 0.568 0 CA-C-N 122.669 3.234 . . . . 26.59 114.208 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.38 93.92 4.93 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 119.101 -2.249 . . . . 3.02 109.602 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -104.22 142.46 24.65 Favored Pre-proline 0 C--O 1.25 1.08 0 O-C-N 125.005 1.441 . . . . 4.7000000000000002 109.82 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.48 146.67 68.91 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.704 2.27 . . . . 2.9399999999999999 110.657 -174.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.46 156.29 33.08 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.836 -1.529 . . . . 15.960000000000001 106.962 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.24 130.27 30.21 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 124.253 1.977 . . . . 11.69 112.764 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.3 -14.08 65.72 Favored Glycine 0 N--CA 1.424 -2.159 0 O-C-N 119.999 -1.688 . . . . 3.6299999999999999 112.766 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -86.18 149.43 25.11 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.095 1.948 . . . . 5.9000000000000004 112.333 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.95 120.29 31.04 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 125.308 1.63 . . . . 3.0699999999999998 111.729 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.3 m -93.57 131.09 39.17 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 122.616 1.198 . . . . 4.1100000000000003 109.827 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -111.99 111.5 36.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 N-CA-C 101.625 -3.472 . . . . 2.1600000000000001 101.625 -174.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.58 154.42 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.82 0.819 . . . . 3.5899999999999999 112.3 -172.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.46 30.52 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.215 -2.143 . . . . 3.1299999999999999 105.215 164.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.82 156.17 43.4 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 120.04 1.291 . . . . 2.5499999999999998 111.927 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.79 121.57 22.03 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 102.929 -2.989 . . . . 4.4699999999999998 102.929 167.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.22 131.93 10.76 Favored Glycine 0 N--CA 1.471 1.013 0 N-CA-C 109.192 -1.563 . . . . 3.4100000000000001 109.192 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.38 152.13 51.58 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 125.142 2.401 . . . . 18.219999999999999 110.435 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 164.56 22.85 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 111.797 -2.456 . . . . 5.9299999999999997 106.384 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.08 -20.54 40.39 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.242 -3.411 . . . . 12.33 117.684 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -87.75 5.29 40.67 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 119.659 -1.901 . . . . 7.1900000000000004 113.885 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.22 69.72 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-O 123.966 1.87 . . . . 6.4699999999999998 113.684 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.65 124.2 22.2 Favored 'General case' 0 N--CA 1.438 -1.045 0 O-C-N 116.678 -3.836 . . . . 21.859999999999999 110.593 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.81 130.81 37.14 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 107.477 -1.305 . . . . 16.18 107.477 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -107.62 -17.88 13.98 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.041 -1.064 . . . . 5.7300000000000004 110.913 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.68 155.5 3.3 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 118.16 -0.924 . . . . 6.1299999999999999 110.504 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.85 128.16 5.55 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.451 1.101 . . . . 2.9300000000000002 110.328 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 38.6 p -75.97 -20.59 57.77 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.827 -0.749 . . . . 2.2999999999999998 109.052 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.86 -36.54 84.25 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.639 -1.615 . . . . 10.550000000000001 106.639 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -67.74 -28.4 67.6 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.219 -1.551 . . . . 8.0199999999999996 110.819 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.57 -10.22 49.56 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 120.767 -1.208 . . . . 10.210000000000001 112.436 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.63 34.21 24.1 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 123.286 1.517 . . . . 16.379999999999999 110.908 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.4 tttm -139.71 120.18 9.34 Favored Pre-proline 0 C--N 1.315 -0.931 0 O-C-N 117.632 -3.168 . . . . 20.210000000000001 103.894 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.3 152.4 60.74 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 124.23 3.287 . . . . 8.75 110.318 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -96.05 138.09 34.17 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.505 -1.665 . . . . 4.6500000000000004 106.505 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -111.51 136.85 50.12 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 120.521 1.51 . . . . 10.619999999999999 111.367 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -142.57 150.62 40.6 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 120.513 1.506 . . . . 4.3099999999999996 107.457 169.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.46 126.69 37.65 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.348 1.431 . . . . 2.6699999999999999 110.613 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.96 129.91 42.44 Favored 'General case' 0 N--CA 1.428 -1.536 0 O-C-N 125.265 1.603 . . . . 3.0800000000000001 110.624 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.04 -4.27 84.69 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 115.603 -0.726 . . . . 4.9500000000000002 114.035 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.4 tttt -83.99 -3.13 57.78 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.735 -1.45 . . . . 10.26 114.566 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.52 39.53 6.73 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.156 -1.59 . . . . 10.24 113.836 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.76 13.69 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.69 1.367 . . . . 10.56 114.69 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.34 172.65 9.25 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 108.173 -1.047 . . . . 2.4500000000000002 108.173 171.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.82 152.1 8.35 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.987 1.375 . . . . 5.5700000000000003 109.803 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.27 -35.77 67.81 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.362 -1.29 . . . . 19.109999999999999 114.473 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.71 -23.34 72.3 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 123.254 2.752 . . . . 2.9300000000000002 112.373 177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -74.52 -54.63 7.15 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.552 1.176 . . . . 7.96 111.628 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.03 -44.4 15.19 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 124.007 1.86 . . . . 15.050000000000001 111.453 173.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.38 -35.4 47.36 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.637 -1.165 . . . . 20.27 114.001 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.02 -45.64 6.22 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 119.451 -1.357 . . . . 4.04 114.668 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.53 -27.23 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 119.125 -1.03 . . . . 5.3499999999999996 109.414 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.589 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.93 -18.88 64.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.498 -2.626 . . . . 3.0299999999999998 112.386 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.4 0.2 50.34 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 118.401 -0.809 . . . . 3.4900000000000002 113.083 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.72 143.07 36.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 120.81 1.641 . . . . 3.75 109.557 -171.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.523 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.8 p -94.78 155.05 16.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.706 0.802 . . . . 2.2999999999999998 109.771 174.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.3 t -57.66 130.1 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 119.835 1.198 . . . . 2.4700000000000002 109.795 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.41 52.01 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 113.309 -1.769 . . . . 2.6099999999999999 113.041 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.523 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.4 144.74 28.6 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 121.874 0.845 . . . . 6.5300000000000002 112.608 -171.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.97 123.98 41.58 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 102.671 -3.085 . . . . 12.359999999999999 102.671 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.71 44.99 Favored 'General case' 0 C--O 1.243 0.726 0 O-C-N 126.408 2.318 . . . . 5.8399999999999999 114.261 -176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.35 122.52 43.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.564 1.649 . . . . 16.57 108.584 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.07 114.56 28.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 118.825 -2.422 . . . . 5.8600000000000003 106.76 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 86.3 m -98.69 120.39 39.04 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 105.814 -1.921 . . . . 5.7599999999999998 105.814 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.55 122.63 69.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.733 -0.84 . . . . 3.3599999999999999 108.733 -167.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.36 153.97 91.59 Favored Pre-proline 0 C--O 1.243 0.738 0 CA-C-O 117.958 -1.02 . . . . 4.9400000000000004 110.632 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.33 -35.09 90.82 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.263 2.642 . . . . 6.21 114.85 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.13 -13.76 62.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.784 1.031 . . . . 15.85 113.784 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.67 10.84 36.62 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 126.145 1.778 . . . . 11.52 111.809 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.64 -116.52 0.16 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 105.763 -1.94 . . . . 3.7000000000000002 105.763 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -102.51 3.91 38.04 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 122.045 2.202 . . . . 6.8399999999999999 115.502 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.48 -137.08 50.51 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-O 123.679 1.711 . . . . 5.9900000000000002 111.101 172.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.2 -18.8 41.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 111.708 -2.246 . . . . 10.109999999999999 111.071 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.26 -43.93 63.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.048 1.749 . . . . 13.76 112.61 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.22 -169.2 53.29 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 107.746 -2.141 . . . . 9.9800000000000004 107.746 -170.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.82 114.81 35.39 Favored Pre-proline 0 C--O 1.246 0.913 0 O-C-N 118.048 -3.031 . . . . 15.880000000000001 103.252 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -48.17 122.44 7.47 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 124.682 3.588 . . . . 11.41 110.933 -166.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.15 -26.95 3.21 Favored Glycine 0 CA--C 1.547 2.044 0 CA-C-N 111.865 -2.425 . . . . 14.199999999999999 117.389 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.88 -50.04 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 121.14 2.47 . . . . 11.06 115.045 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.6 mm -112.87 131.89 22.55 Favored Pre-proline 0 CA--C 1.516 -0.334 0 N-CA-C 103.19 -2.893 . . . . 8.0099999999999998 103.19 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.0 163.04 35.44 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.268 3.978 . . . . 6.5199999999999996 112.969 171.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.518 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 12.9 Cg_exo -55.28 144.5 71.1 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.578 2.185 . . . . 4.8200000000000003 110.31 162.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.13 27.34 16.47 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 112.9 -1.954 . . . . 7.4199999999999999 113.692 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.78 132.42 35.28 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 117.409 2.374 . . . . 2.2200000000000002 117.409 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.53 132.36 35.66 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 121.698 2.045 . . . . 4.6100000000000003 106.382 168.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -108.84 146.72 33.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 120.423 -1.423 . . . . 5.3399999999999999 110.318 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.1 120.11 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 103.729 -2.693 . . . . 3.9700000000000002 103.729 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.485 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.9 m-85 -116.83 136.91 52.58 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.768 -1.208 . . . . 4.4199999999999999 109.539 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 33.0 t0 -103.74 112.73 25.81 Favored 'General case' 0 C--N 1.315 -0.917 1 N-CA-C 98.96 -4.459 . . . . 2.0899999999999999 98.96 173.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.9 t -126.78 132.29 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.045 -1.434 . . . . 3.5299999999999998 110.844 -172.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -120.47 121.91 39.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.485 -2.043 . . . . 14.210000000000001 105.485 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 tp -89.09 109.2 20.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 123.659 1.695 . . . . 2.4199999999999999 107.434 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.4 mt -85.65 -43.24 13.61 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 115.128 1.529 . . . . 2.6200000000000001 115.128 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.3 tttt -161.9 153.56 18.79 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 113.565 -1.652 . . . . 11.710000000000001 109.151 -167.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.8 mt -120.06 133.26 55.58 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 105.153 -2.166 . . . . 4.7000000000000002 105.153 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 113.505 -1.679 . . . . 13.02 109.711 -179.726 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 105.992 -2.843 . . . . 6.3300000000000001 105.992 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.42 142.51 43.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 101.754 -3.424 . . . . 6.3499999999999996 101.754 176.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -116.94 130.14 56.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 102.844 -3.021 . . . . 16.98 102.844 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.56 117.02 53.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 N-CA-C 103.692 -2.707 . . . . 5.5800000000000001 103.692 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.66 124.68 46.87 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 118.946 -2.346 . . . . 12.800000000000001 104.824 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.9 m -75.66 139.83 42.21 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.234 -2.166 . . . . 3.2400000000000002 115.624 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.42 -52.09 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 105.935 -1.876 . . . . 4.79 105.935 171.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.6 m -138.89 139.02 22.42 Favored Pre-proline 0 C--O 1.243 0.737 0 O-C-N 119.622 -1.924 . . . . 11.59 106.275 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.4 Cg_exo -67.69 154.77 72.41 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 123.538 2.825 . . . . 4.5499999999999998 112.194 -176.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.63 -161.16 28.94 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.169 -1.573 . . . . 2.0 109.169 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -82.41 -9.2 59.54 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 117.645 -3.268 . . . . 3.2400000000000002 113.188 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.01 9.78 76.67 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.654 -1.637 . . . . 3.3799999999999999 113.886 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.72 -26.57 0.96 Allowed 'General case' 0 C--O 1.241 0.631 0 CA-C-N 122.567 3.183 . . . . 26.59 114.251 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.54 93.96 4.95 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 119.08 -2.262 . . . . 3.02 109.544 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -104.22 142.52 24.78 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 124.969 1.418 . . . . 4.7000000000000002 109.84 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.59 146.75 68.48 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.738 2.292 . . . . 2.9399999999999999 110.636 -173.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.49 156.13 33.46 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.918 -1.492 . . . . 15.960000000000001 107.053 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.07 130.25 29.49 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 124.169 1.938 . . . . 11.69 112.819 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.24 -14.01 65.88 Favored Glycine 0 N--CA 1.421 -2.307 0 O-C-N 120.021 -1.674 . . . . 3.6299999999999999 112.845 -178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.4 25.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 120.047 1.924 . . . . 5.9000000000000004 112.396 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.94 120.37 31.1 Favored 'General case' 0 C--O 1.25 1.101 0 O-C-N 125.305 1.628 . . . . 3.0699999999999998 111.734 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.9 m -93.5 131.04 39.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.649 1.214 . . . . 4.1100000000000003 109.856 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -112.02 111.38 35.92 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 N-CA-C 101.607 -3.479 . . . . 2.1600000000000001 101.607 -174.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.53 154.44 40.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.842 0.829 . . . . 3.5899999999999999 112.242 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.14 145.44 30.56 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.259 -2.126 . . . . 3.1299999999999999 105.259 164.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.2 p90 -145.85 156.06 43.31 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 120.177 1.353 . . . . 2.5499999999999998 111.928 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.77 121.55 22.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 102.968 -2.975 . . . . 4.4699999999999998 102.968 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.24 131.96 10.77 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 109.198 -1.561 . . . . 3.4100000000000001 109.198 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.43 152.18 51.59 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 125.238 2.447 . . . . 18.219999999999999 110.391 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.56 164.58 22.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.694 -2.503 . . . . 5.9299999999999997 106.444 172.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.03 -20.64 40.5 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.16 -3.462 . . . . 12.33 117.624 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -87.7 5.34 40.29 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 119.634 -1.916 . . . . 7.1900000000000004 113.918 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.15 -10.23 69.82 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-O 124.009 1.894 . . . . 6.4699999999999998 113.719 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.56 124.19 22.13 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 116.616 -3.873 . . . . 21.859999999999999 110.554 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.89 130.77 37.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.415 -1.328 . . . . 16.18 107.415 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -107.67 -17.77 14.0 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.076 -1.05 . . . . 5.7300000000000004 110.811 173.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.77 155.36 3.19 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 118.121 -0.942 . . . . 6.1299999999999999 110.564 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.6 t -158.74 128.14 5.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.462 1.105 . . . . 2.9300000000000002 110.341 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.3 p -75.94 -20.65 57.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.006 -0.738 . . . . 2.2999999999999998 109.006 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.71 -36.65 84.57 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.698 -1.593 . . . . 10.550000000000001 106.698 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -67.64 -28.42 67.7 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.205 -1.559 . . . . 8.0199999999999996 110.906 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtm-85 -88.65 -10.03 50.03 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.859 -1.15 . . . . 10.210000000000001 112.411 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.46 34.29 24.02 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 123.329 1.538 . . . . 16.379999999999999 110.996 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.73 120.27 9.35 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 117.722 -3.111 . . . . 20.210000000000001 103.806 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -59.39 152.35 61.7 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 124.204 3.27 . . . . 8.75 110.294 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -95.99 138.15 34.03 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.47 -1.678 . . . . 4.6500000000000004 106.47 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.62 136.86 50.27 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.49 1.495 . . . . 10.619999999999999 111.316 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.6 150.62 40.56 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 120.424 1.465 . . . . 4.3099999999999996 107.372 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.48 126.63 37.65 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 120.31 1.414 . . . . 2.6699999999999999 110.583 172.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.83 129.77 41.91 Favored 'General case' 0 N--CA 1.427 -1.576 0 O-C-N 125.198 1.561 . . . . 3.0800000000000001 110.742 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.96 -4.04 84.75 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 123.874 0.75 . . . . 4.9500000000000002 113.968 176.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.12 -3.11 57.88 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 120.707 -1.467 . . . . 10.26 114.62 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.59 39.53 6.56 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.129 -1.607 . . . . 10.24 113.8 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.36 -0.84 13.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 114.701 1.371 . . . . 10.56 114.701 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.39 172.65 9.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 N-CA-C 108.078 -1.082 . . . . 2.4500000000000002 108.078 171.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.75 152.07 8.39 Favored 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.946 1.355 . . . . 5.5700000000000003 109.782 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.25 -35.85 67.87 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 114.327 -1.306 . . . . 19.109999999999999 114.393 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.65 -23.33 72.21 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-N 123.338 2.79 . . . . 2.9300000000000002 112.496 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.57 -54.62 7.13 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 118.49 1.145 . . . . 7.96 111.665 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.01 -44.45 15.12 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 123.982 1.848 . . . . 15.050000000000001 111.431 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.35 -35.31 47.65 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.531 -1.213 . . . . 20.27 114.06 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.98 -45.68 6.22 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 119.547 -1.311 . . . . 4.04 114.67 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.62 -27.15 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 O-C-N 121.382 -1.07 . . . . 5.3499999999999996 109.419 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.83 64.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.57 -2.581 . . . . 3.0299999999999998 112.35 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.49 0.36 50.02 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.107 0.78 . . . . 3.4900000000000002 113.107 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.7 mtp -107.9 143.08 37.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 120.786 1.63 . . . . 3.75 109.492 -171.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.524 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.8 p -94.82 155.04 16.97 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.604 0.762 . . . . 2.2999999999999998 109.786 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.72 130.27 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 119.917 1.235 . . . . 2.4700000000000002 109.757 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 -12.63 52.12 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 113.289 -1.778 . . . . 2.6099999999999999 113.056 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.524 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.42 144.79 28.55 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.915 0.864 . . . . 6.5300000000000002 112.558 -171.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -124.02 123.96 41.52 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 102.619 -3.104 . . . . 12.359999999999999 102.619 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.86 156.81 45.0 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.518 2.386 . . . . 5.8399999999999999 114.307 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.3 122.5 43.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.516 1.627 . . . . 16.57 108.587 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.1 114.48 28.65 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 118.822 -2.424 . . . . 5.8600000000000003 106.737 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.4 m -98.8 120.42 39.2 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 105.853 -1.906 . . . . 5.7599999999999998 105.853 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.63 122.58 69.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 108.683 -0.858 . . . . 3.3599999999999999 108.683 -167.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.38 153.95 91.7 Favored Pre-proline 0 C--O 1.244 0.777 0 CA-C-O 117.826 -1.083 . . . . 4.9400000000000004 110.731 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.3 -35.14 90.75 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.328 2.685 . . . . 6.21 114.754 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.06 -13.9 62.43 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.883 1.068 . . . . 15.85 113.883 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.67 11.04 36.51 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 126.088 1.755 . . . . 11.52 111.74 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.76 -116.51 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.765 -1.939 . . . . 3.7000000000000002 105.765 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.64 4.15 37.96 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-N 121.99 2.177 . . . . 6.8399999999999999 115.48 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.44 -137.13 50.43 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-O 123.745 1.747 . . . . 5.9900000000000002 111.038 171.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.66 41.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 111.624 -2.288 . . . . 10.109999999999999 110.972 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.37 -43.89 63.36 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 121.093 1.77 . . . . 13.76 112.581 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.32 -169.27 53.3 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 107.607 -2.197 . . . . 9.9800000000000004 107.607 -170.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.8 114.85 35.39 Favored Pre-proline 0 C--O 1.246 0.882 0 O-C-N 118.04 -3.036 . . . . 15.880000000000001 103.292 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -48.16 122.43 7.43 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 124.61 3.54 . . . . 11.41 110.909 -166.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.19 -26.94 3.23 Favored Glycine 0 CA--C 1.547 2.038 0 CA-C-N 111.881 -2.418 . . . . 14.199999999999999 117.4 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.2 mt -102.84 -50.1 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.05 2.425 . . . . 11.06 114.992 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.7 mm -112.83 131.99 22.5 Favored Pre-proline 0 CA--C 1.516 -0.343 0 N-CA-C 103.159 -2.904 . . . . 8.0099999999999998 103.159 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.09 163.08 35.44 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 125.218 3.945 . . . . 6.5199999999999996 112.871 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.3 144.47 71.37 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.518 2.146 . . . . 4.8200000000000003 110.307 162.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.31 27.24 16.29 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 112.886 -1.961 . . . . 7.4199999999999999 113.609 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.8 132.29 35.28 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 117.36 2.356 . . . . 2.2200000000000002 117.36 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.44 132.34 35.71 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 121.686 2.039 . . . . 4.6100000000000003 106.347 168.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.7 mt -108.81 146.87 32.94 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 120.451 -1.405 . . . . 5.3399999999999999 110.274 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.19 119.97 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 103.779 -2.674 . . . . 3.9700000000000002 103.779 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.485 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.2 m-85 -116.79 137.05 52.48 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.734 -1.229 . . . . 4.4199999999999999 109.519 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.6 t0 -103.92 112.74 25.84 Favored 'General case' 0 C--N 1.315 -0.928 1 N-CA-C 98.875 -4.491 . . . . 2.0899999999999999 98.875 174.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.9 t -126.79 132.37 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.077 -1.42 . . . . 3.5299999999999998 110.794 -172.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.52 121.84 39.32 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.509 -2.034 . . . . 14.210000000000001 105.509 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 tp -88.95 109.06 19.92 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.536 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.46 -43.31 13.7 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.193 1.553 . . . . 2.6200000000000001 115.193 -171.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.85 153.56 18.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 113.534 -1.666 . . . . 11.710000000000001 109.131 -167.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.2 mt -119.98 133.19 55.63 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 105.19 -2.152 . . . . 4.7000000000000002 105.19 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.589 -1.642 . . . . 13.02 109.884 -179.828 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 N-CA-C 106.07 -2.812 . . . . 6.3300000000000001 106.07 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.26 142.58 43.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 101.723 -3.436 . . . . 6.3499999999999996 101.723 176.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.11 130.01 56.35 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.776 -3.046 . . . . 16.98 102.776 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.3 t -109.44 117.07 53.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 103.771 -2.677 . . . . 5.5800000000000001 103.771 -175.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.61 124.69 46.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 118.863 -2.398 . . . . 12.800000000000001 104.83 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.8 m -75.72 139.97 42.19 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 119.313 -2.117 . . . . 3.2400000000000002 115.643 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.407 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.58 -52.05 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 105.84 -1.911 . . . . 4.79 105.84 171.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.4 m -138.85 139.11 22.82 Favored Pre-proline 0 C--O 1.244 0.77 0 O-C-N 119.647 -1.908 . . . . 11.59 106.305 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.3 Cg_exo -67.71 154.75 72.41 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 123.634 2.889 . . . . 4.5499999999999998 112.174 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.7 -161.22 28.88 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.09 -1.604 . . . . 2.0 109.09 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.43 -9.15 59.55 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 117.708 -3.231 . . . . 3.2400000000000002 113.205 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.09 9.73 76.87 Favored Glycine 0 C--O 1.218 -0.851 0 CA-C-O 117.647 -1.641 . . . . 3.3799999999999999 113.884 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.72 -26.62 0.96 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.576 3.188 . . . . 26.59 114.251 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.52 94.04 4.99 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 119.111 -2.243 . . . . 3.02 109.503 -175.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.18 142.53 24.8 Favored Pre-proline 0 C--O 1.252 1.204 0 O-C-N 125.016 1.448 . . . . 4.7000000000000002 109.867 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.5 Cg_endo -68.67 146.78 68.13 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.715 2.277 . . . . 2.9399999999999999 110.588 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.52 156.16 33.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.866 -1.516 . . . . 15.960000000000001 107.026 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.4 ttp180 -52.07 130.25 29.49 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 124.169 1.938 . . . . 11.69 112.819 174.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.33 -14.14 65.6 Favored Glycine 0 N--CA 1.422 -2.246 0 O-C-N 120.021 -1.674 . . . . 3.6299999999999999 112.755 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.37 25.17 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 120.066 1.933 . . . . 5.9000000000000004 112.357 174.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.85 120.31 30.98 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.249 1.593 . . . . 3.0699999999999998 111.684 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.53 130.99 39.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 122.65 1.214 . . . . 4.1100000000000003 109.86 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.5 t -111.92 111.39 35.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 N-CA-C 101.643 -3.465 . . . . 2.1600000000000001 101.643 -174.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.9 m -129.5 154.39 40.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-O 121.822 0.82 . . . . 3.5899999999999999 112.242 -172.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.06 145.43 30.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.22 -2.141 . . . . 3.1299999999999999 105.22 164.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.1 p90 -145.81 156.1 43.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 120.18 1.355 . . . . 2.5499999999999998 111.967 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.76 121.49 21.95 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 103.024 -2.954 . . . . 4.4699999999999998 103.024 167.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.13 131.87 10.74 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 109.251 -1.54 . . . . 3.4100000000000001 109.251 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.4 152.12 51.6 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 125.242 2.449 . . . . 18.219999999999999 110.391 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 164.59 22.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.707 -2.497 . . . . 5.9299999999999997 106.444 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -57.97 -20.65 39.72 Favored 'General case' 0 C--O 1.22 -0.469 0 O-C-N 117.197 -3.439 . . . . 12.33 117.737 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.75 5.44 39.95 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 119.642 -1.911 . . . . 7.1900000000000004 113.894 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.03 -10.26 70.07 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 123.956 1.864 . . . . 6.4699999999999998 113.807 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.53 124.23 22.24 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 116.803 -3.763 . . . . 21.859999999999999 110.556 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.89 130.84 37.11 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.403 -1.332 . . . . 16.18 107.403 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.67 -17.84 13.99 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.07 -1.052 . . . . 5.7300000000000004 110.809 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.77 155.43 3.22 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.153 -0.927 . . . . 6.1299999999999999 110.567 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -158.81 128.13 5.57 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.527 1.131 . . . . 2.9300000000000002 110.345 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.4 p -75.97 -20.65 57.73 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.977 -0.749 . . . . 2.2999999999999998 108.977 175.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.68 84.65 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.685 -1.598 . . . . 10.550000000000001 106.685 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -67.58 -28.57 67.87 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.215 -1.553 . . . . 8.0199999999999996 110.809 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.6 -10.12 49.81 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.9 -1.125 . . . . 10.210000000000001 112.368 176.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.62 34.22 24.11 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.349 1.547 . . . . 16.379999999999999 110.95 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.73 120.18 9.32 Favored Pre-proline 0 C--N 1.315 -0.934 0 O-C-N 117.627 -3.171 . . . . 20.210000000000001 103.882 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -59.24 152.27 61.32 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 124.274 3.316 . . . . 8.75 110.326 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -95.93 138.22 33.88 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.566 -1.642 . . . . 4.6500000000000004 106.566 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.72 136.87 50.38 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 120.584 1.538 . . . . 10.619999999999999 111.244 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.63 150.71 40.62 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 120.397 1.453 . . . . 4.3099999999999996 107.28 169.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.41 126.64 37.58 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 120.243 1.383 . . . . 2.6699999999999999 110.584 172.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 129.81 42.03 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.288 1.617 . . . . 3.0800000000000001 110.719 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.0 -4.12 84.73 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 123.865 0.745 . . . . 4.9500000000000002 114.009 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.1 -3.09 57.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.752 -1.44 . . . . 10.26 114.561 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 64.52 39.57 6.7 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 120.081 -1.637 . . . . 10.24 113.808 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.37 -0.82 13.69 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 114.684 1.365 . . . . 10.56 114.684 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.35 172.65 9.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 108.09 -1.078 . . . . 2.4500000000000002 108.09 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.79 152.04 8.38 Favored 'Isoleucine or valine' 0 C--O 1.259 1.567 0 CA-C-O 122.974 1.368 . . . . 5.5700000000000003 109.855 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.22 -35.8 67.74 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 114.442 1.275 . . . . 19.109999999999999 114.442 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.67 -23.35 72.24 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.351 2.796 . . . . 2.9300000000000002 112.415 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.58 -54.58 7.19 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 118.574 1.187 . . . . 7.96 111.643 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.0 -44.43 15.09 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 124.02 1.867 . . . . 15.050000000000001 111.514 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.36 -35.29 47.63 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.495 -1.23 . . . . 20.27 114.037 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.06 -45.73 6.17 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.571 -1.299 . . . . 4.04 114.6 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.6 t -67.46 -27.23 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 121.378 -1.072 . . . . 5.3499999999999996 109.495 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.83 64.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.506 -2.621 . . . . 3.0299999999999998 112.35 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.48 0.28 50.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.489 -0.767 . . . . 3.4900000000000002 113.057 175.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.83 143.03 36.97 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 120.831 1.65 . . . . 3.75 109.555 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.523 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.9 p -94.73 155.06 17.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.692 0.797 . . . . 2.2999999999999998 109.822 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.7 130.19 20.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 119.91 1.232 . . . . 2.4700000000000002 109.734 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.54 52.07 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.333 -1.758 . . . . 2.6099999999999999 112.989 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.523 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.39 144.69 28.63 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-O 121.874 0.845 . . . . 6.5300000000000002 112.601 -171.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.9 ttt180 -123.93 123.9 41.43 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 102.677 -3.083 . . . . 12.359999999999999 102.677 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.78 45.0 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 126.442 2.339 . . . . 5.8399999999999999 114.322 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.21 122.45 43.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 123.465 1.602 . . . . 16.57 108.59 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.07 114.49 28.66 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 118.787 -2.445 . . . . 5.8600000000000003 106.775 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.7 m -98.78 120.42 39.19 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 105.772 -1.936 . . . . 5.7599999999999998 105.772 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.63 122.55 69.09 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 108.71 -0.848 . . . . 3.3599999999999999 108.71 -167.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.37 153.99 91.57 Favored Pre-proline 0 C--O 1.243 0.723 0 CA-C-O 117.934 -1.031 . . . . 4.9400000000000004 110.712 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.21 -35.26 90.61 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.374 2.716 . . . . 6.21 114.803 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.03 -13.87 62.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.883 1.068 . . . . 15.85 113.883 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.73 11.09 36.32 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 125.959 1.703 . . . . 11.52 111.671 175.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.82 -116.53 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.754 -1.943 . . . . 3.7000000000000002 105.754 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.61 4.1 37.98 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 122.025 2.193 . . . . 6.8399999999999999 115.511 -173.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.53 -137.12 50.5 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 123.728 1.738 . . . . 5.9900000000000002 111.048 171.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.22 -18.71 41.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 111.705 -2.247 . . . . 10.109999999999999 111.036 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.38 -43.97 63.22 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.076 1.762 . . . . 13.76 112.458 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.34 -169.19 53.39 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.693 -2.163 . . . . 9.9800000000000004 107.693 -170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.87 114.77 35.3 Favored Pre-proline 0 C--O 1.247 0.962 0 O-C-N 118.014 -3.05 . . . . 15.880000000000001 103.215 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -48.03 122.3 7.13 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 124.72 3.613 . . . . 11.41 110.928 -166.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.3 -27.05 3.26 Favored Glycine 0 CA--C 1.546 2.022 0 CA-C-N 111.961 -2.382 . . . . 14.199999999999999 117.388 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.1 mt -102.89 -50.04 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 121.022 2.411 . . . . 11.06 114.971 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.88 131.97 22.52 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 103.178 -2.897 . . . . 8.0099999999999998 103.178 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.18 163.11 35.49 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.198 3.932 . . . . 6.5199999999999996 112.859 171.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.27 144.51 70.91 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.476 2.117 . . . . 4.8200000000000003 110.357 162.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.28 27.21 16.3 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 112.969 -1.923 . . . . 7.4199999999999999 113.618 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.8 132.4 35.28 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 117.358 2.355 . . . . 2.2200000000000002 117.358 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.47 132.41 35.7 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 121.667 2.031 . . . . 4.6100000000000003 106.347 168.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.8 mt -108.94 146.76 33.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.414 -1.429 . . . . 5.3399999999999999 110.239 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.1 t -123.08 120.02 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 103.764 -2.68 . . . . 3.9700000000000002 103.764 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.9 m-85 -116.79 136.96 52.55 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.705 -1.247 . . . . 4.4199999999999999 109.553 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.7 t0 -103.81 112.69 25.75 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.853 -4.499 . . . . 2.0899999999999999 98.853 174.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.5 t -126.79 132.28 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.092 -1.413 . . . . 3.5299999999999998 110.836 -172.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.38 121.89 39.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 105.563 -2.014 . . . . 14.210000000000001 105.563 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.08 109.02 19.92 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 123.653 1.692 . . . . 2.4199999999999999 107.494 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.46 -43.25 13.76 Favored 'General case' 0 C--O 1.254 1.293 0 N-CA-C 115.26 1.578 . . . . 2.6200000000000001 115.26 -171.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.8 153.62 19.08 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 113.501 -1.681 . . . . 11.710000000000001 109.248 -167.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.08 133.21 55.58 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 105.204 -2.147 . . . . 4.7000000000000002 105.204 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.568 -1.651 . . . . 13.02 109.761 -179.719 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.669 0 N-CA-C 106.08 -2.808 . . . . 6.3300000000000001 106.08 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.33 142.58 43.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 101.707 -3.442 . . . . 6.3499999999999996 101.707 176.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -117.16 130.05 56.36 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 102.802 -3.036 . . . . 16.98 102.802 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.9 t -109.53 117.12 53.85 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 103.663 -2.717 . . . . 5.5800000000000001 103.663 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.66 124.65 46.81 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 118.871 -2.393 . . . . 12.800000000000001 104.839 177.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.8 m -75.66 139.9 42.24 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.28 -2.138 . . . . 3.2400000000000002 115.656 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.406 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.5 mt -101.51 -52.02 8.85 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.86 -1.904 . . . . 4.79 105.86 171.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.5 m -138.89 139.13 22.76 Favored Pre-proline 0 C--O 1.244 0.783 0 O-C-N 119.548 -1.97 . . . . 11.59 106.27 177.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.8 Cg_exo -67.86 154.84 71.93 Favored 'Trans proline' 0 C--N 1.329 -0.454 0 C-N-CA 123.546 2.83 . . . . 4.5499999999999998 112.196 -176.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.72 -161.14 28.85 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.102 -1.599 . . . . 2.0 109.102 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -82.43 -9.27 59.51 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 117.659 -3.26 . . . . 3.2400000000000002 113.165 -177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.07 9.77 76.86 Favored Glycine 0 C--O 1.218 -0.884 0 CA-C-O 117.71 -1.606 . . . . 3.3799999999999999 113.87 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.66 -26.66 0.96 Allowed 'General case' 0 C--O 1.241 0.608 0 CA-C-N 122.593 3.196 . . . . 26.59 114.305 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.59 94.04 4.99 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 119.039 -2.288 . . . . 3.02 109.435 -175.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.2 142.52 24.78 Favored Pre-proline 0 C--O 1.252 1.211 0 O-C-N 125.007 1.442 . . . . 4.7000000000000002 109.761 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.59 146.73 68.4 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.728 2.285 . . . . 2.9399999999999999 110.688 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.49 156.2 33.31 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 113.932 -1.485 . . . . 15.960000000000001 107.121 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.6 ttp180 -52.17 130.36 30.18 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 124.263 1.982 . . . . 11.69 112.765 174.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.21 -13.97 65.97 Favored Glycine 0 N--CA 1.424 -2.122 0 O-C-N 119.919 -1.738 . . . . 3.6299999999999999 112.734 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.24 149.42 25.09 Favored 'General case' 0 C--O 1.251 1.133 0 CA-C-N 120.123 1.961 . . . . 5.9000000000000004 112.381 174.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.85 120.28 30.95 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.146 1.529 . . . . 3.0699999999999998 111.799 174.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.9 m -93.43 131.02 39.02 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.485 1.136 . . . . 4.1100000000000003 109.878 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.5 t -112.03 111.47 36.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 101.624 -3.473 . . . . 2.1600000000000001 101.624 -174.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.3 m -129.63 154.39 40.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 121.866 0.841 . . . . 3.5899999999999999 112.193 -172.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.09 145.45 30.5 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.264 -2.124 . . . . 3.1299999999999999 105.264 164.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.84 156.09 43.34 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-N 120.128 1.331 . . . . 2.5499999999999998 111.9 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.6 m -133.83 121.63 22.07 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 102.88 -3.007 . . . . 4.4699999999999998 102.88 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.21 131.84 10.73 Favored Glycine 0 N--CA 1.471 0.999 0 N-CA-C 109.237 -1.545 . . . . 3.4100000000000001 109.237 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.31 152.2 51.5 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 125.277 2.465 . . . . 18.219999999999999 110.421 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.56 164.59 22.82 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.694 -2.503 . . . . 5.9299999999999997 106.444 172.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.08 -20.56 40.59 Favored 'General case' 0 C--O 1.222 -0.366 0 O-C-N 117.19 -3.444 . . . . 12.33 117.684 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -87.64 5.31 40.24 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 119.603 -1.936 . . . . 7.1900000000000004 113.956 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.17 -10.42 69.74 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-O 123.896 1.831 . . . . 6.4699999999999998 113.661 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.64 124.26 22.37 Favored 'General case' 0 C--N 1.311 -1.071 0 O-C-N 116.724 -3.809 . . . . 21.859999999999999 110.529 -179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.82 130.86 37.2 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 107.349 -1.352 . . . . 16.18 107.349 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.7 -17.84 13.98 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 119.099 -1.04 . . . . 5.7300000000000004 110.809 173.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.71 155.37 3.24 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 118.08 -0.962 . . . . 6.1299999999999999 110.605 176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -158.78 128.19 5.61 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.518 1.127 . . . . 2.9300000000000002 110.38 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.6 p -76.1 -20.51 57.61 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.757 -0.777 . . . . 2.2999999999999998 109.043 175.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.72 84.78 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.637 -1.616 . . . . 10.550000000000001 106.637 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.58 -28.56 67.87 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.247 -1.533 . . . . 8.0199999999999996 110.827 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.6 -10.12 49.81 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 120.906 -1.121 . . . . 10.210000000000001 112.368 176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.56 34.2 23.98 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-O 123.382 1.563 . . . . 16.379999999999999 111.007 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.3 tttm -139.65 120.21 9.39 Favored Pre-proline 0 C--O 1.247 0.928 0 O-C-N 117.698 -3.126 . . . . 20.210000000000001 103.882 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.24 152.34 60.79 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 124.234 3.29 . . . . 8.75 110.43 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.468 ' CZ ' ' H32' ' A' ' 108' ' ' GPI . 84.9 t80 -95.95 138.17 33.97 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.518 -1.66 . . . . 4.6500000000000004 106.518 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.61 136.9 50.18 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 120.541 1.518 . . . . 10.619999999999999 111.313 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.67 150.71 40.55 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.458 1.481 . . . . 4.3099999999999996 107.308 169.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.5 126.68 37.69 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.304 1.411 . . . . 2.6699999999999999 110.549 172.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 129.84 42.14 Favored 'General case' 0 N--CA 1.426 -1.643 0 O-C-N 125.228 1.58 . . . . 3.0800000000000001 110.647 176.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.01 -4.19 84.73 Favored Glycine 0 C--N 1.342 0.896 0 C-N-CA 123.806 0.717 . . . . 4.9500000000000002 114.035 176.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.7 tttt -84.13 -3.05 57.85 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.752 -1.44 . . . . 10.26 114.561 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.55 39.56 6.64 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 120.132 -1.605 . . . . 10.24 113.778 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.74 13.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 114.75 1.389 . . . . 10.56 114.75 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG12 ' O1 ' ' A' ' 108' ' ' GPI . 5.4 m -122.42 172.67 9.31 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.057 -1.09 . . . . 2.4500000000000002 108.057 171.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.81 152.1 8.35 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.98 1.371 . . . . 5.5700000000000003 109.768 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.24 -35.88 67.88 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 114.343 -1.298 . . . . 19.109999999999999 114.386 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.62 -23.37 72.17 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-N 123.392 2.814 . . . . 2.9300000000000002 112.384 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.55 -54.65 7.09 Favored 'General case' 0 C--O 1.249 1.071 0 CA-C-N 118.559 1.179 . . . . 7.96 111.575 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.04 -44.39 15.26 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 124.026 1.87 . . . . 15.050000000000001 111.467 174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.37 -35.29 47.54 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.544 -1.207 . . . . 20.27 114.065 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.06 -45.72 6.18 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.502 -1.332 . . . . 4.04 114.612 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.55 -27.09 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.356 0 O-C-N 121.383 -1.069 . . . . 5.3499999999999996 109.486 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.86 64.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.537 -2.602 . . . . 3.0299999999999998 112.398 176.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.54 0.41 49.98 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 118.456 -0.783 . . . . 3.4900000000000002 113.025 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.9 mtp -107.95 143.02 37.17 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 120.812 1.642 . . . . 3.75 109.436 -171.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.521 ' H ' HE21 ' A' ' 70' ' ' GLN . 11.0 p -94.66 155.01 17.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.678 0.791 . . . . 2.2999999999999998 109.852 174.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.68 130.19 20.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 119.88 1.218 . . . . 2.4700000000000002 109.796 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.11 -12.53 52.28 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 113.35 -1.75 . . . . 2.6099999999999999 113.133 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.521 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.4 144.75 28.59 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.95 0.881 . . . . 6.5300000000000002 112.567 -171.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.406 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.99 123.92 41.44 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 102.576 -3.12 . . . . 12.359999999999999 102.576 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.8 156.73 45.01 Favored 'General case' 0 C--O 1.244 0.806 0 O-C-N 126.393 2.308 . . . . 5.8399999999999999 114.283 -176.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.26 122.55 43.87 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 123.429 1.585 . . . . 16.57 108.671 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.15 114.49 28.65 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.859 -2.401 . . . . 5.8600000000000003 106.745 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.4 m -98.73 120.42 39.13 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 105.766 -1.939 . . . . 5.7599999999999998 105.766 176.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.5 mt -119.55 122.57 69.21 Favored 'Isoleucine or valine' 0 C--O 1.248 0.997 0 N-CA-C 108.712 -0.847 . . . . 3.3599999999999999 108.712 -167.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.43 153.93 91.85 Favored Pre-proline 0 C--O 1.244 0.807 0 CA-C-O 117.878 -1.058 . . . . 4.9400000000000004 110.676 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -55.16 -35.26 90.4 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.328 2.686 . . . . 6.21 114.829 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -69.99 -13.92 62.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.869 1.062 . . . . 15.85 113.869 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -103.69 11.05 36.44 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 126.051 1.74 . . . . 11.52 111.751 175.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.74 -116.39 0.16 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 105.808 -1.923 . . . . 3.7000000000000002 105.808 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.68 4.16 37.85 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 122.067 2.212 . . . . 6.8399999999999999 115.447 -173.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.42 -137.11 50.45 Favored Glycine 0 C--N 1.353 1.527 0 CA-C-O 123.686 1.714 . . . . 5.9900000000000002 111.096 171.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.28 -18.8 41.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 111.738 -2.231 . . . . 10.109999999999999 110.932 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.26 -43.93 63.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.129 1.786 . . . . 13.76 112.547 175.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.23 -169.28 53.23 Favored Glycine 0 CA--C 1.529 0.96 0 N-CA-C 107.76 -2.136 . . . . 9.9800000000000004 107.76 -170.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.736 ' CE1' H111 ' A' ' 108' ' ' GPI . 65.3 t-80 -118.78 114.9 35.41 Favored Pre-proline 0 C--O 1.246 0.873 0 O-C-N 118.003 -3.057 . . . . 15.880000000000001 103.262 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -48.24 122.36 7.42 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.638 3.559 . . . . 11.41 110.939 -166.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.35 -27.07 3.28 Favored Glycine 0 CA--C 1.547 2.073 0 CA-C-N 111.788 -2.46 . . . . 14.199999999999999 117.374 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.8 mt -102.87 -50.05 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.041 2.421 . . . . 11.06 114.942 -175.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.6 mm -112.9 131.83 22.6 Favored Pre-proline 0 CA--C 1.516 -0.334 0 N-CA-C 103.174 -2.899 . . . . 8.0099999999999998 103.174 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.07 163.03 35.6 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.259 3.973 . . . . 6.5199999999999996 112.865 171.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.33 144.55 71.39 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.392 2.061 . . . . 4.8200000000000003 110.321 162.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.35 27.21 16.25 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 112.878 -1.965 . . . . 7.4199999999999999 113.579 172.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.87 132.42 35.27 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 117.345 2.35 . . . . 2.2200000000000002 117.345 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -80.56 132.45 35.65 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 121.695 2.043 . . . . 4.6100000000000003 106.31 168.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.5 mt -108.82 146.79 33.08 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 120.321 -1.487 . . . . 5.3399999999999999 110.281 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.27 119.93 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.778 0 N-CA-C 103.743 -2.688 . . . . 3.9700000000000002 103.743 -178.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.0 m-85 -116.7 136.96 52.55 Favored 'General case' 0 CA--C 1.535 0.371 0 O-C-N 120.796 -1.19 . . . . 4.4199999999999999 109.596 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.76 112.67 25.72 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.874 -4.491 . . . . 2.0899999999999999 98.874 174.017 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.5 t -126.72 132.3 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 114.206 -1.361 . . . . 3.5299999999999998 110.841 -172.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.44 121.91 39.56 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.578 -2.008 . . . . 14.210000000000001 105.578 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.02 109.07 19.95 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.498 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.5 -43.27 13.7 Favored 'General case' 0 C--O 1.253 1.28 0 N-CA-C 115.203 1.557 . . . . 2.6200000000000001 115.203 -171.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.82 153.63 19.03 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 113.509 -1.678 . . . . 11.710000000000001 109.167 -167.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.7 mt -120.04 133.17 55.61 Favored 'General case' 0 C--O 1.251 1.165 0 N-CA-C 105.25 -2.13 . . . . 4.7000000000000002 105.25 170.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.697 -1.592 . . . . 13.02 109.805 -179.746 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GPI . . . . . 0.736 H111 ' CE1' ' A' ' 87' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.695 0 N-CA-C 106.067 -2.813 . . . . 6.3300000000000001 106.067 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.41 142.56 43.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 101.672 -3.455 . . . . 6.3499999999999996 101.672 176.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -117.13 130.16 56.44 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 102.682 -3.081 . . . . 16.98 102.682 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.4 t -109.51 117.01 53.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 103.737 -2.69 . . . . 5.5800000000000001 103.737 -175.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.58 124.72 47.05 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 118.893 -2.379 . . . . 12.800000000000001 104.872 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.4 m -75.77 140.1 42.17 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 119.226 -2.171 . . . . 3.2400000000000002 115.55 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.67 -52.05 8.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 105.832 -1.914 . . . . 4.79 105.832 171.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.452 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.8 m -138.97 139.0 22.13 Favored Pre-proline 0 C--O 1.241 0.652 0 O-C-N 119.53 -1.981 . . . . 11.59 106.331 177.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 30.2 Cg_exo -67.67 154.85 72.22 Favored 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.501 2.801 . . . . 4.5499999999999998 112.125 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.84 -161.24 28.74 Favored Glycine 0 CA--C 1.536 1.405 0 N-CA-C 109.071 -1.611 . . . . 2.0 109.071 175.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.43 -9.1 59.57 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 117.674 -3.251 . . . . 3.2400000000000002 113.258 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.07 9.78 76.86 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.639 -1.645 . . . . 3.3799999999999999 113.793 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.7 -26.69 0.95 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-N 122.583 3.191 . . . . 26.59 114.244 -178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.44 94.08 5.02 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 119.049 -2.282 . . . . 3.02 109.503 -176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.24 142.55 24.85 Favored Pre-proline 0 C--O 1.252 1.211 0 O-C-N 124.963 1.414 . . . . 4.7000000000000002 109.799 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.592 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.6 146.74 68.41 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.754 2.303 . . . . 2.9399999999999999 110.6 -174.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.57 156.14 33.55 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.889 -1.505 . . . . 15.960000000000001 106.988 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.4 ttp180 -52.04 130.24 29.34 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 124.134 1.921 . . . . 11.69 112.709 174.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.36 -14.13 65.58 Favored Glycine 0 N--CA 1.423 -2.184 0 O-C-N 120.009 -1.682 . . . . 3.6299999999999999 112.762 -178.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.16 149.32 25.2 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 120.085 1.943 . . . . 5.9000000000000004 112.242 174.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.8 m -89.83 120.25 30.91 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.283 1.614 . . . . 3.0699999999999998 111.806 174.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.2 m -93.55 131.04 39.19 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 122.716 1.246 . . . . 4.1100000000000003 109.813 176.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.5 t -112.0 111.41 36.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 N-CA-C 101.593 -3.484 . . . . 2.1600000000000001 101.593 -174.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.57 154.34 40.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 CA-C-O 121.795 0.807 . . . . 3.5899999999999999 112.243 -172.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.42 30.57 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 105.129 -2.174 . . . . 3.1299999999999999 105.129 164.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.0 p90 -145.74 156.11 43.4 Favored 'General case' 0 C--O 1.244 0.785 0 CA-C-N 120.003 1.274 . . . . 2.5499999999999998 112.02 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -133.81 121.53 21.94 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 102.968 -2.975 . . . . 4.4699999999999998 102.968 167.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.19 131.94 10.76 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 109.28 -1.528 . . . . 3.4100000000000001 109.28 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.4 152.18 51.57 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-O 125.259 2.457 . . . . 18.219999999999999 110.435 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 164.59 22.9 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 111.746 -2.479 . . . . 5.9299999999999997 106.38 172.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.16 -20.55 41.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 O-C-N 117.283 -3.385 . . . . 12.33 117.639 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.67 5.29 40.44 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.56 -1.962 . . . . 7.1900000000000004 113.906 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.16 -10.34 69.77 Favored Glycine 0 C--N 1.356 1.663 0 CA-C-O 124.04 1.911 . . . . 6.4699999999999998 113.785 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.62 124.23 22.26 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 116.632 -3.864 . . . . 21.859999999999999 110.58 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.81 130.83 37.17 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 107.359 -1.348 . . . . 16.18 107.359 179.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -107.76 -17.76 14.0 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 118.998 -1.081 . . . . 5.7300000000000004 110.799 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -172.71 155.5 3.28 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 118.093 -0.956 . . . . 6.1299999999999999 110.652 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.87 128.08 5.51 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.428 1.091 . . . . 2.9300000000000002 110.314 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 41.2 p -75.83 -20.75 57.91 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 119.866 -0.733 . . . . 2.2999999999999998 109.117 175.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.63 -36.65 84.53 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.754 -1.573 . . . . 10.550000000000001 106.754 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.61 -28.5 67.8 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.253 -1.529 . . . . 8.0199999999999996 110.807 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.6 mtm-85 -88.72 -9.98 50.02 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 120.914 -1.116 . . . . 10.210000000000001 112.403 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.54 34.21 23.98 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 123.316 1.531 . . . . 16.379999999999999 111.034 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.3 tttm -139.7 120.24 9.37 Favored Pre-proline 0 C--N 1.315 -0.934 0 O-C-N 117.645 -3.16 . . . . 20.210000000000001 103.879 178.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -59.27 152.3 61.28 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.269 3.313 . . . . 8.75 110.402 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.432 ' CE2' ' H32' ' A' ' 108' ' ' GPI . 85.1 t80 -95.89 138.12 33.99 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.534 -1.654 . . . . 4.6500000000000004 106.534 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -111.64 136.87 50.27 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.496 1.498 . . . . 10.619999999999999 111.285 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.67 150.69 40.53 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 120.397 1.453 . . . . 4.3099999999999996 107.366 169.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.466 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.39 126.62 37.56 Favored 'General case' 0 C--O 1.249 1.059 0 CA-C-N 120.244 1.384 . . . . 2.6699999999999999 110.617 172.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.89 129.81 42.05 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 125.217 1.573 . . . . 3.0800000000000001 110.68 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.98 -4.13 84.76 Favored Glycine 0 C--N 1.34 0.795 0 CA-C-N 115.605 -0.725 . . . . 4.9500000000000002 114.044 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.09 -3.06 57.81 Favored 'General case' 0 N--CA 1.435 -1.22 0 O-C-N 120.823 -1.398 . . . . 10.26 114.679 -179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.48 39.6 6.75 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.117 -1.615 . . . . 10.24 113.775 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.31 -0.88 13.71 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 114.725 1.38 . . . . 10.56 114.725 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.403 ' HA ' ' O2 ' ' A' ' 108' ' ' GPI . 5.5 m -122.37 172.62 9.32 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.085 -1.08 . . . . 2.4500000000000002 108.085 171.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.73 152.07 8.41 Favored 'Isoleucine or valine' 0 C--O 1.257 1.496 0 CA-C-O 122.937 1.351 . . . . 5.5700000000000003 109.851 -178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.25 -35.73 67.74 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 114.361 -1.29 . . . . 19.109999999999999 114.466 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.73 -23.34 72.35 Favored Glycine 0 CA--C 1.54 1.62 0 CA-C-N 123.383 2.81 . . . . 2.9300000000000002 112.389 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.53 -54.67 7.07 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.51 1.155 . . . . 7.96 111.633 173.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.0 -44.43 15.06 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 123.951 1.834 . . . . 15.050000000000001 111.461 173.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.36 -35.3 47.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.485 -1.234 . . . . 20.27 114.084 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.11 -45.63 6.19 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 119.471 -1.347 . . . . 4.04 114.615 -175.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.4 t -67.53 -27.17 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 121.348 -1.089 . . . . 5.3499999999999996 109.425 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.592 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.06 -18.83 64.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 118.538 -2.601 . . . . 3.0299999999999998 112.378 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.5 0.31 50.24 Favored 'General case' 0 CA--C 1.502 -0.89 0 CA-C-O 118.439 -0.791 . . . . 3.4900000000000002 113.016 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.7 mtp -107.82 143.18 36.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 120.821 1.646 . . . . 3.75 109.524 -171.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.524 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.9 p -94.79 154.93 17.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.695 0.798 . . . . 2.2999999999999998 109.842 174.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.3 t -57.53 130.09 20.12 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 119.965 1.257 . . . . 2.4700000000000002 109.868 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.21 -12.44 51.93 Favored Glycine 0 N--CA 1.442 -0.923 0 CA-C-N 113.422 -1.717 . . . . 2.6099999999999999 113.069 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.524 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.4 144.8 28.55 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-O 121.883 0.849 . . . . 6.5300000000000002 112.623 -171.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.9 ttt180 -124.05 124.02 41.63 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 102.588 -3.116 . . . . 12.359999999999999 102.588 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.81 44.99 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.421 2.326 . . . . 5.8399999999999999 114.303 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.28 122.45 43.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.47 1.605 . . . . 16.57 108.556 174.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.02 114.51 28.69 Favored 'General case' 0 N--CA 1.44 -0.975 0 O-C-N 118.864 -2.398 . . . . 5.8600000000000003 106.786 -176.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.5 m -98.81 120.49 39.34 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 105.801 -1.925 . . . . 5.7599999999999998 105.801 176.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.6 mt -119.65 122.55 69.07 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 108.671 -0.862 . . . . 3.3599999999999999 108.671 -167.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.38 154.03 91.52 Favored Pre-proline 0 C--O 1.242 0.706 0 CA-C-O 117.802 -1.094 . . . . 4.9400000000000004 110.655 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.4 -35.07 91.09 Favored 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.333 2.689 . . . . 6.21 114.761 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.13 -13.88 62.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.795 1.035 . . . . 15.85 113.795 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.68 11.03 36.49 Favored 'General case' 0 CA--C 1.512 -0.517 0 C-N-CA 126.004 1.722 . . . . 11.52 111.734 175.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.86 -116.55 0.15 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 105.72 -1.955 . . . . 3.7000000000000002 105.72 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.61 4.16 38.05 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 122.025 2.193 . . . . 6.8399999999999999 115.511 -173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.45 -137.16 50.41 Favored Glycine 0 C--N 1.354 1.573 0 CA-C-O 123.769 1.761 . . . . 5.9900000000000002 111.131 172.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.33 -18.64 41.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 111.603 -2.299 . . . . 10.109999999999999 111.024 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.36 -43.9 63.35 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.04 1.745 . . . . 13.76 112.497 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.28 -169.16 53.38 Favored Glycine 0 CA--C 1.531 1.073 0 N-CA-C 107.641 -2.184 . . . . 9.9800000000000004 107.641 -170.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.89 114.83 35.23 Favored Pre-proline 0 C--O 1.246 0.899 0 O-C-N 118.128 -2.984 . . . . 15.880000000000001 103.198 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -48.14 122.43 7.41 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 124.622 3.548 . . . . 11.41 110.975 -166.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.18 -26.96 3.22 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.979 -2.373 . . . . 14.199999999999999 117.412 -177.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.718 HD13 ' C11' ' A' ' 108' ' ' GPI . 60.0 mt -102.93 -50.02 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 121.102 2.451 . . . . 11.06 114.943 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.86 131.82 22.59 Favored Pre-proline 0 CA--C 1.516 -0.328 0 N-CA-C 103.233 -2.877 . . . . 8.0099999999999998 103.233 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.08 163.01 35.7 Favored 'Trans proline' 0 C--O 1.24 0.619 0 C-N-CA 125.229 3.953 . . . . 6.5199999999999996 112.909 171.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.27 144.49 71.08 Favored 'Trans proline' 0 CA--C 1.535 0.541 0 C-N-CA 122.547 2.165 . . . . 4.8200000000000003 110.275 162.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.26 27.26 16.34 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 112.886 -1.961 . . . . 7.4199999999999999 113.607 172.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.73 132.45 35.29 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.446 2.387 . . . . 2.2200000000000002 117.446 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -80.53 132.47 35.68 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 121.737 2.062 . . . . 4.6100000000000003 106.298 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.1 mt -108.99 146.69 33.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 120.469 -1.394 . . . . 5.3399999999999999 110.24 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.0 t -123.12 120.08 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 N-CA-C 103.657 -2.72 . . . . 3.9700000000000002 103.657 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.2 m-85 -116.75 136.97 52.54 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.594 -1.316 . . . . 4.4199999999999999 109.608 178.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.5 t0 -103.8 112.65 25.7 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.911 -4.477 . . . . 2.0899999999999999 98.911 174.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 88.0 t -126.77 132.4 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-N 114.194 -1.367 . . . . 3.5299999999999998 110.763 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.47 121.92 39.53 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.449 -2.056 . . . . 14.210000000000001 105.449 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.13 109.06 19.97 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 123.636 1.684 . . . . 2.4199999999999999 107.492 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.43 -43.33 13.71 Favored 'General case' 0 C--O 1.253 1.272 0 N-CA-C 115.193 1.553 . . . . 2.6200000000000001 115.193 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.2 tttt -161.78 153.59 19.06 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-N 113.475 -1.693 . . . . 11.710000000000001 109.153 -167.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.8 mt -120.01 133.24 55.6 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 105.186 -2.153 . . . . 4.7000000000000002 105.186 170.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.31 -1.141 0 CA-C-N 113.64 -1.618 . . . . 13.02 109.94 -179.848 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GPI . . . . . 0.718 ' C11' HD13 ' A' ' 90' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.652 0 N-CA-C 106.096 -2.802 . . . . 6.3300000000000001 106.096 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.31 142.62 43.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 101.693 -3.447 . . . . 6.3499999999999996 101.693 176.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -117.13 130.12 56.42 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.736 -3.061 . . . . 16.98 102.736 178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.57 117.2 54.03 Favored 'Isoleucine or valine' 0 C--O 1.244 0.805 0 N-CA-C 103.58 -2.748 . . . . 5.5800000000000001 103.58 -175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.75 124.78 47.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 118.863 -2.398 . . . . 12.800000000000001 104.757 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.3 m -75.74 139.95 42.15 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 119.3 -2.125 . . . . 3.2400000000000002 115.646 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.2 mt -101.62 -51.94 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 105.837 -1.912 . . . . 4.79 105.837 171.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.4 m -138.94 138.9 22.03 Favored Pre-proline 0 C--O 1.242 0.684 0 O-C-N 119.603 -1.936 . . . . 11.59 106.347 177.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.9 Cg_exo -67.57 154.73 72.73 Favored 'Trans proline' 0 C--N 1.329 -0.477 0 C-N-CA 123.636 2.891 . . . . 4.5499999999999998 112.191 -176.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.7 -161.13 28.86 Favored Glycine 0 CA--C 1.537 1.438 0 N-CA-C 109.075 -1.61 . . . . 2.0 109.075 175.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -82.49 -9.22 59.52 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 117.618 -3.284 . . . . 3.2400000000000002 113.167 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.17 9.6 76.94 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-O 117.625 -1.653 . . . . 3.3799999999999999 113.81 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.63 -26.66 0.96 Allowed 'General case' 0 C--O 1.241 0.655 0 CA-C-N 122.703 3.252 . . . . 26.59 114.189 -178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.45 93.95 4.95 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 119.121 -2.237 . . . . 3.02 109.496 -175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.22 142.49 24.72 Favored Pre-proline 0 C--O 1.25 1.122 0 O-C-N 124.975 1.422 . . . . 4.7000000000000002 109.8 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.58 146.65 68.23 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.748 2.298 . . . . 2.9399999999999999 110.674 -174.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.44 156.09 33.48 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 113.899 -1.5 . . . . 15.960000000000001 107.015 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.03 130.25 29.31 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 124.118 1.913 . . . . 11.69 112.797 174.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.22 -13.88 66.11 Favored Glycine 0 N--CA 1.422 -2.296 0 O-C-N 119.978 -1.701 . . . . 3.6299999999999999 112.694 -178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -86.24 149.41 25.1 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 120.094 1.947 . . . . 5.9000000000000004 112.253 174.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.92 120.21 30.94 Favored 'General case' 0 C--O 1.25 1.12 0 O-C-N 125.248 1.593 . . . . 3.0699999999999998 111.729 174.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.45 131.02 39.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.654 1.216 . . . . 4.1100000000000003 109.859 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.3 t -111.92 111.31 35.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 101.67 -3.456 . . . . 2.1600000000000001 101.67 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.53 154.5 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-O 121.885 0.85 . . . . 3.5899999999999999 112.263 -172.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.15 145.46 30.54 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 105.178 -2.156 . . . . 3.1299999999999999 105.178 164.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.2 p90 -145.8 156.11 43.37 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 120.124 1.329 . . . . 2.5499999999999998 111.988 179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.5 m -133.77 121.64 22.16 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 102.948 -2.982 . . . . 4.4699999999999998 102.948 167.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.22 131.99 10.78 Favored Glycine 0 N--CA 1.472 1.041 0 N-CA-C 109.184 -1.566 . . . . 3.4100000000000001 109.184 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.5 152.09 51.68 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 125.269 2.462 . . . . 18.219999999999999 110.383 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.49 164.63 22.85 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.664 -2.516 . . . . 5.9299999999999997 106.454 172.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.07 -20.64 41.06 Favored 'General case' 0 C--O 1.219 -0.512 0 O-C-N 117.262 -3.399 . . . . 12.33 117.708 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.73 5.38 40.17 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.663 -1.898 . . . . 7.1900000000000004 113.893 177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.24 -10.39 69.58 Favored Glycine 0 C--N 1.355 1.602 0 CA-C-O 123.976 1.876 . . . . 6.4699999999999998 113.678 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.58 124.24 22.28 Favored 'General case' 0 N--CA 1.437 -1.086 0 O-C-N 116.628 -3.866 . . . . 21.859999999999999 110.532 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.9 130.78 37.02 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.381 -1.341 . . . . 16.18 107.381 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -107.67 -17.89 13.97 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 119.021 -1.072 . . . . 5.7300000000000004 110.693 173.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -172.68 155.49 3.29 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 118.181 -0.914 . . . . 6.1299999999999999 110.509 176.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.82 128.15 5.57 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.451 1.101 . . . . 2.9300000000000002 110.361 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 38.1 p -76.0 -20.66 57.66 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.982 -0.748 . . . . 2.2999999999999998 108.982 175.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.7 -36.61 84.43 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.722 -1.585 . . . . 10.550000000000001 106.722 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.71 -28.42 67.65 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.197 -1.565 . . . . 8.0199999999999996 110.833 175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.68 -10.08 49.75 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.89 -1.131 . . . . 10.210000000000001 112.361 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.48 34.31 24.07 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-O 123.4 1.571 . . . . 16.379999999999999 111.007 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.66 120.16 9.38 Favored Pre-proline 0 C--O 1.248 1.017 0 O-C-N 117.693 -3.129 . . . . 20.210000000000001 103.897 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -59.24 152.31 61.02 Favored 'Trans proline' 0 C--N 1.36 1.173 0 C-N-CA 124.277 3.318 . . . . 8.75 110.383 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.41 ' CE2' ' H32' ' A' ' 108' ' ' GPI . 84.9 t80 -96.0 138.11 34.1 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.541 -1.652 . . . . 4.6500000000000004 106.541 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.62 136.87 50.24 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 120.539 1.518 . . . . 10.619999999999999 111.372 177.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.66 150.61 40.44 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.415 1.461 . . . . 4.3099999999999996 107.377 169.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.47 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.44 126.68 37.63 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.297 1.408 . . . . 2.6699999999999999 110.48 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.92 129.7 41.54 Favored 'General case' 0 N--CA 1.429 -1.515 0 O-C-N 125.286 1.616 . . . . 3.0800000000000001 110.723 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.11 -4.22 84.56 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 123.879 0.752 . . . . 4.9500000000000002 113.989 176.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.05 -3.01 57.74 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.648 -1.501 . . . . 10.26 114.603 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.47 39.58 6.79 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.017 -1.677 . . . . 10.24 113.841 179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.33 -0.84 13.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 114.736 1.384 . . . . 10.56 114.736 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.32 172.58 9.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 108.099 -1.074 . . . . 2.4500000000000002 108.099 171.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.71 152.07 8.42 Favored 'Isoleucine or valine' 0 C--O 1.259 1.567 0 CA-C-O 123.026 1.393 . . . . 5.5700000000000003 109.757 -178.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.27 -35.73 67.79 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 114.391 -1.277 . . . . 19.109999999999999 114.432 -176.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.86 -23.31 72.55 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.33 2.786 . . . . 2.9300000000000002 112.304 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.62 -54.61 7.13 Favored 'General case' 0 C--O 1.249 1.071 0 CA-C-N 118.616 1.208 . . . . 7.96 111.572 173.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.05 -44.35 15.27 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 123.983 1.849 . . . . 15.050000000000001 111.447 173.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.3 -35.42 47.91 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.541 -1.208 . . . . 20.27 114.093 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.03 -45.65 6.22 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 119.497 -1.335 . . . . 4.04 114.596 -175.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.51 -27.28 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 O-C-N 121.37 -1.076 . . . . 5.3499999999999996 109.382 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.93 -18.88 64.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.688 -2.508 . . . . 3.0299999999999998 112.403 176.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.55 0.33 50.34 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 118.448 -0.787 . . . . 3.4900000000000002 112.985 175.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.9 mtp -107.89 143.02 37.09 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 120.791 1.632 . . . . 3.75 109.464 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.523 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.8 p -94.78 155.01 17.0 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.625 0.77 . . . . 2.2999999999999998 109.762 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.8 t -57.62 130.17 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 119.841 1.2 . . . . 2.4700000000000002 109.858 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.58 52.07 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 113.272 -1.785 . . . . 2.6099999999999999 113.064 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.523 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.43 144.75 28.56 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 121.907 0.86 . . . . 6.5300000000000002 112.57 -171.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.97 123.93 41.47 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 102.671 -3.085 . . . . 12.359999999999999 102.671 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.87 156.8 44.99 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 126.4 2.313 . . . . 5.8399999999999999 114.273 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.23 122.53 43.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.516 1.627 . . . . 16.57 108.62 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.12 114.47 28.63 Favored 'General case' 0 N--CA 1.441 -0.911 0 O-C-N 118.854 -2.404 . . . . 5.8600000000000003 106.728 -176.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 86.3 m -98.77 120.47 39.25 Favored 'General case' 0 C--O 1.247 0.925 0 N-CA-C 105.858 -1.905 . . . . 5.7599999999999998 105.858 176.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.72 122.62 69.19 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.653 -0.869 . . . . 3.3599999999999999 108.653 -167.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.36 154.08 91.34 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.861 -1.066 . . . . 4.9400000000000004 110.682 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -55.48 -35.12 91.59 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.298 2.665 . . . . 6.21 114.752 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.03 -13.84 62.41 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.922 1.082 . . . . 15.85 113.922 -179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.64 11.07 36.54 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 126.009 1.723 . . . . 11.52 111.674 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.9 -116.6 0.15 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 105.739 -1.949 . . . . 3.7000000000000002 105.739 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -102.59 4.11 38.04 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 122.07 2.214 . . . . 6.8399999999999999 115.498 -173.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.47 -137.09 50.49 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-O 123.739 1.744 . . . . 5.9900000000000002 111.136 172.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.516 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.69 41.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 111.686 -2.257 . . . . 10.109999999999999 111.009 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.47 -43.89 63.08 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-N 121.039 1.745 . . . . 13.76 112.464 175.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.39 -169.16 53.46 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 107.606 -2.197 . . . . 9.9800000000000004 107.606 -170.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.85 114.76 35.34 Favored Pre-proline 0 C--O 1.246 0.896 0 O-C-N 117.924 -3.103 . . . . 15.880000000000001 103.253 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.14 122.35 7.3 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 124.679 3.586 . . . . 11.41 110.936 -166.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.15 -26.85 3.24 Favored Glycine 0 CA--C 1.544 1.871 0 CA-C-N 111.933 -2.394 . . . . 14.199999999999999 117.385 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.531 HG21 ' C11' ' A' ' 108' ' ' GPI . 60.0 mt -102.99 -49.97 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.59 0 CA-C-N 121.107 2.454 . . . . 11.06 114.938 -175.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.4 mm -112.84 131.87 22.56 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 103.118 -2.919 . . . . 8.0099999999999998 103.118 -175.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.95 163.02 35.38 Favored 'Trans proline' 0 C--O 1.238 0.524 0 C-N-CA 125.236 3.957 . . . . 6.5199999999999996 112.945 171.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.516 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.31 144.41 71.84 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.571 2.181 . . . . 4.8200000000000003 110.331 162.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.31 27.33 16.34 Favored 'General case' 0 C--O 1.219 -0.527 0 CA-C-N 112.938 -1.937 . . . . 7.4199999999999999 113.577 172.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.79 132.31 35.28 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 117.388 2.366 . . . . 2.2200000000000002 117.388 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.37 132.42 35.77 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 121.799 2.091 . . . . 4.6100000000000003 106.349 168.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -109.0 146.79 33.32 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.379 -1.45 . . . . 5.3399999999999999 110.284 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.9 t -123.16 120.03 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 103.679 -2.711 . . . . 3.9700000000000002 103.679 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.0 m-85 -116.8 137.02 52.5 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.701 -1.25 . . . . 4.4199999999999999 109.577 178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.8 t0 -103.8 112.72 25.79 Favored 'General case' 0 C--N 1.314 -0.95 1 N-CA-C 98.876 -4.49 . . . . 2.0899999999999999 98.876 174.026 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.7 t -126.75 132.43 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.153 -1.385 . . . . 3.5299999999999998 110.821 -172.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -120.48 121.93 39.56 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.466 -2.05 . . . . 14.210000000000001 105.466 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 tp -89.06 109.11 20.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.405 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.58 -43.25 13.66 Favored 'General case' 0 C--O 1.255 1.344 0 N-CA-C 115.19 1.552 . . . . 2.6200000000000001 115.19 -171.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.3 tttt -161.87 153.64 18.94 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-N 113.612 -1.631 . . . . 11.710000000000001 109.154 -167.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.9 mt -120.12 133.28 55.55 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 105.097 -2.186 . . . . 4.7000000000000002 105.097 170.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.311 -1.082 0 CA-C-N 113.552 -1.658 . . . . 13.02 109.82 -179.812 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GPI . . . . . 0.531 ' C11' HG21 ' A' ' 90' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 106.038 -2.825 . . . . 6.3300000000000001 106.038 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.28 142.6 43.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 101.745 -3.428 . . . . 6.3499999999999996 101.745 176.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.12 130.07 56.39 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.726 -3.065 . . . . 16.98 102.726 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.57 117.11 53.83 Favored 'Isoleucine or valine' 0 C--O 1.245 0.841 0 N-CA-C 103.674 -2.713 . . . . 5.5800000000000001 103.674 -175.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.68 124.72 46.96 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 118.877 -2.389 . . . . 12.800000000000001 104.759 177.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.6 m -75.82 140.0 42.05 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 119.279 -2.138 . . . . 3.2400000000000002 115.603 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.407 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.54 -52.03 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 105.899 -1.889 . . . . 4.79 105.899 171.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 21.8 m -138.86 139.01 22.45 Favored Pre-proline 0 C--O 1.243 0.737 0 O-C-N 119.518 -1.989 . . . . 11.59 106.357 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.3 Cg_exo -67.69 154.73 72.51 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 123.627 2.885 . . . . 4.5499999999999998 112.23 -176.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.68 -161.22 28.9 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.09 -1.604 . . . . 2.0 109.09 175.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.54 -9.04 59.58 Favored 'General case' 0 C--O 1.241 0.628 0 O-C-N 117.639 -3.271 . . . . 3.2400000000000002 113.18 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.12 9.65 76.86 Favored Glycine 0 C--O 1.218 -0.887 0 CA-C-O 117.637 -1.646 . . . . 3.3799999999999999 113.874 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.62 -26.73 0.96 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 122.508 3.154 . . . . 26.59 114.241 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.4 93.98 4.97 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.072 -2.268 . . . . 3.02 109.579 -175.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.21 142.54 24.82 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 125.023 1.452 . . . . 4.7000000000000002 109.79 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.2 Cg_endo -68.58 146.75 68.59 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.704 2.269 . . . . 2.9399999999999999 110.702 -174.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.46 156.15 33.37 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.913 -1.494 . . . . 15.960000000000001 107.073 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.3 ttp180 -52.07 130.27 29.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 124.24 1.972 . . . . 11.69 112.804 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.29 -14.02 65.83 Favored Glycine 0 N--CA 1.422 -2.246 0 O-C-N 119.929 -1.732 . . . . 3.6299999999999999 112.757 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -86.24 149.47 25.05 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 120.029 1.915 . . . . 5.9000000000000004 112.243 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 65.2 m -89.97 120.29 31.05 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.312 1.633 . . . . 3.0699999999999998 111.746 174.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.46 131.0 39.08 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 122.55 1.167 . . . . 4.1100000000000003 109.891 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -111.96 111.39 35.94 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 N-CA-C 101.624 -3.473 . . . . 2.1600000000000001 101.624 -174.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.7 m -129.48 154.42 40.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.806 0.812 . . . . 3.5899999999999999 112.282 -172.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.4 30.6 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.187 -2.153 . . . . 3.1299999999999999 105.187 164.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.0 p90 -145.79 156.1 43.36 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 120.126 1.33 . . . . 2.5499999999999998 112.055 179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -133.83 121.47 21.85 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 102.952 -2.981 . . . . 4.4699999999999998 102.952 167.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.11 131.87 10.73 Favored Glycine 0 N--CA 1.471 0.999 0 N-CA-C 109.248 -1.541 . . . . 3.4100000000000001 109.248 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.37 152.11 51.58 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 125.16 2.41 . . . . 18.219999999999999 110.481 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 164.64 22.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.745 -2.48 . . . . 5.9299999999999997 106.447 172.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -58.03 -20.62 40.37 Favored 'General case' 0 CA--C 1.515 -0.378 0 O-C-N 117.17 -3.457 . . . . 12.33 117.699 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -87.74 5.32 40.52 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 119.545 -1.972 . . . . 7.1900000000000004 113.851 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.08 -10.2 69.96 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 124.013 1.896 . . . . 6.4699999999999998 113.789 179.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.7 124.27 22.41 Favored 'General case' 0 N--CA 1.439 -1.0 0 O-C-N 116.688 -3.831 . . . . 21.859999999999999 110.564 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.84 130.78 37.07 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.404 -1.332 . . . . 16.18 107.404 179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -107.67 -17.9 13.97 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.124 -1.03 . . . . 5.7300000000000004 110.667 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -172.76 155.4 3.21 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 118.087 -0.959 . . . . 6.1299999999999999 110.587 176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.4 t -158.76 128.12 5.6 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.47 1.108 . . . . 2.9300000000000002 110.385 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 37.4 p -76.01 -20.67 57.64 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.937 -0.764 . . . . 2.2999999999999998 108.937 175.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.61 -36.74 84.81 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 106.742 -1.577 . . . . 10.550000000000001 106.742 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -67.55 -28.53 67.87 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.172 -1.58 . . . . 8.0199999999999996 110.807 175.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.68 -10.01 50.02 Favored 'General case' 0 C--O 1.239 0.547 0 O-C-N 120.859 -1.15 . . . . 10.210000000000001 112.366 176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.47 34.32 24.07 Favored 'General case' 0 C--O 1.212 -0.871 0 CA-C-O 123.33 1.538 . . . . 16.379999999999999 110.945 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.76 120.14 9.29 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 117.594 -3.191 . . . . 20.210000000000001 103.887 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -59.22 152.27 61.14 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 124.231 3.288 . . . . 8.75 110.378 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CE2' ' H32' ' A' ' 108' ' ' GPI . 84.9 t80 -95.91 138.24 33.83 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 106.58 -1.637 . . . . 4.6500000000000004 106.58 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.7 136.84 50.39 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 120.622 1.555 . . . . 10.619999999999999 111.311 177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.61 150.71 40.66 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 120.466 1.485 . . . . 4.3099999999999996 107.337 169.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.47 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.51 126.72 37.72 Favored 'General case' 0 C--O 1.248 0.998 0 CA-C-N 120.313 1.415 . . . . 2.6699999999999999 110.563 172.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.01 129.8 41.92 Favored 'General case' 0 N--CA 1.426 -1.627 0 O-C-N 125.285 1.616 . . . . 3.0800000000000001 110.639 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.97 -4.18 84.77 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 123.901 0.762 . . . . 4.9500000000000002 114.009 176.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.03 -3.09 57.78 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.788 -1.419 . . . . 10.26 114.647 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 64.57 39.48 6.63 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.046 -1.659 . . . . 10.24 113.756 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.23 -0.79 13.8 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 114.767 1.395 . . . . 10.56 114.767 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.42 172.7 9.25 Favored 'Isoleucine or valine' 0 C--O 1.252 1.207 0 N-CA-C 107.978 -1.119 . . . . 2.4500000000000002 107.978 171.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.76 152.13 8.37 Favored 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.91 1.338 . . . . 5.5700000000000003 109.851 -178.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.42 -35.68 68.08 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-N 114.381 -1.282 . . . . 19.109999999999999 114.386 -176.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.62 -23.5 72.23 Favored Glycine 0 CA--C 1.539 1.579 0 CA-C-N 123.333 2.788 . . . . 2.9300000000000002 112.363 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.47 -54.67 7.1 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 118.535 1.168 . . . . 7.96 111.633 173.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.06 -44.43 15.37 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 124.028 1.871 . . . . 15.050000000000001 111.449 174.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.18 -35.49 48.63 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 114.639 -1.164 . . . . 20.27 114.111 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.95 -45.75 6.21 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 119.572 -1.299 . . . . 4.04 114.64 -175.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.0 t -67.49 -27.21 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 O-C-N 121.404 -1.056 . . . . 5.3499999999999996 109.454 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.92 -18.93 64.71 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 118.625 -2.547 . . . . 3.0299999999999998 112.343 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.49 0.27 50.35 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.454 -0.784 . . . . 3.4900000000000002 113.026 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.76 143.09 36.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 120.831 1.65 . . . . 3.75 109.476 -171.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.523 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.7 p -94.86 155.02 16.96 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.66 0.784 . . . . 2.2999999999999998 109.8 174.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.1 t -57.63 130.2 20.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 119.954 1.252 . . . . 2.4700000000000002 109.711 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.7 52.05 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 113.381 -1.736 . . . . 2.6099999999999999 113.077 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.523 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.37 144.73 28.63 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.998 0.904 . . . . 6.5300000000000002 112.566 -171.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.96 123.87 41.35 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 102.65 -3.092 . . . . 12.359999999999999 102.65 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.82 156.79 45.01 Favored 'General case' 0 C--O 1.243 0.738 0 O-C-N 126.501 2.376 . . . . 5.8399999999999999 114.323 -176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.28 122.38 43.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 123.449 1.595 . . . . 16.57 108.617 174.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.39 28.5 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 118.85 -2.406 . . . . 5.8600000000000003 106.793 -176.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.6 m -98.69 120.47 39.17 Favored 'General case' 0 C--O 1.247 0.928 0 N-CA-C 105.822 -1.918 . . . . 5.7599999999999998 105.822 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.72 122.68 69.34 Favored 'Isoleucine or valine' 0 C--O 1.248 0.988 0 N-CA-C 108.589 -0.893 . . . . 3.3599999999999999 108.589 -167.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 90.1 p -66.41 153.99 91.67 Favored Pre-proline 0 C--O 1.243 0.721 0 CA-C-O 117.838 -1.077 . . . . 4.9400000000000004 110.77 177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -55.26 -35.11 90.53 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 123.285 2.656 . . . . 6.21 114.899 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.12 -13.85 62.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 113.792 1.034 . . . . 15.85 113.792 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -103.67 11.0 36.55 Favored 'General case' 0 CA--C 1.511 -0.531 0 C-N-CA 126.105 1.762 . . . . 11.52 111.737 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.83 -116.58 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.693 -1.965 . . . . 3.7000000000000002 105.693 -176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.54 4.04 38.1 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 122.036 2.198 . . . . 6.8399999999999999 115.453 -173.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.49 -137.15 50.44 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-O 123.733 1.74 . . . . 5.9900000000000002 111.078 171.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.22 -18.78 41.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 111.725 -2.238 . . . . 10.109999999999999 110.993 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.1 m -72.28 -43.98 63.46 Favored 'General case' 0 C--O 1.245 0.844 0 CA-C-N 121.064 1.756 . . . . 13.76 112.529 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.39 -169.25 53.39 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 107.715 -2.154 . . . . 9.9800000000000004 107.715 -170.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.85 114.93 35.27 Favored Pre-proline 0 C--O 1.247 0.962 0 O-C-N 118.012 -3.052 . . . . 15.880000000000001 103.164 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -48.14 122.36 7.32 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 124.781 3.654 . . . . 11.41 110.876 -166.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.17 -26.94 3.23 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.94 -2.391 . . . . 14.199999999999999 117.416 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.588 HD13 ' C11' ' A' ' 108' ' ' GPI . 59.6 mt -102.87 -50.16 9.87 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 121.056 2.428 . . . . 11.06 114.918 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.5 mm -112.85 131.88 22.55 Favored Pre-proline 0 CA--C 1.516 -0.337 0 N-CA-C 103.209 -2.885 . . . . 8.0099999999999998 103.209 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.03 163.05 35.45 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.282 3.988 . . . . 6.5199999999999996 112.915 171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.514 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.2 Cg_exo -55.3 144.48 71.42 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.521 2.147 . . . . 4.8200000000000003 110.232 162.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.14 27.46 16.53 Favored 'General case' 0 C--O 1.218 -0.579 0 CA-C-N 112.924 -1.943 . . . . 7.4199999999999999 113.622 172.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.91 132.42 35.27 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 117.382 2.364 . . . . 2.2200000000000002 117.382 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.55 132.37 35.65 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 121.695 2.043 . . . . 4.6100000000000003 106.359 168.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.82 146.84 32.99 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 120.457 -1.402 . . . . 5.3399999999999999 110.308 -177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.18 120.01 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.734 0 N-CA-C 103.74 -2.689 . . . . 3.9700000000000002 103.74 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.7 m-85 -116.79 136.93 52.56 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.734 -1.229 . . . . 4.4199999999999999 109.553 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.6 t0 -103.78 112.77 25.86 Favored 'General case' 0 C--N 1.315 -0.933 1 N-CA-C 98.863 -4.495 . . . . 2.0899999999999999 98.863 174.014 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.2 t -126.86 132.31 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 114.143 -1.39 . . . . 3.5299999999999998 110.765 -172.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.42 121.99 39.74 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 105.45 -2.055 . . . . 14.210000000000001 105.45 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.7 tp -89.14 109.07 19.98 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 123.643 1.687 . . . . 2.4199999999999999 107.496 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.6 mt -85.53 -43.25 13.7 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.203 1.557 . . . . 2.6200000000000001 115.203 -171.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.85 153.57 18.9 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.509 -1.678 . . . . 11.710000000000001 109.189 -167.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.1 mt -120.01 133.21 55.61 Favored 'General case' 0 C--O 1.248 1.014 0 N-CA-C 105.177 -2.157 . . . . 4.7000000000000002 105.177 170.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 . . . . . 0 C--N 1.312 -1.049 0 CA-C-N 113.591 -1.641 . . . . 13.02 109.823 -179.805 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GPI . . . . . 0.588 ' C11' HD13 ' A' ' 90' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 106.024 -2.83 . . . . 6.3300000000000001 106.024 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.33 142.48 43.44 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 101.784 -3.413 . . . . 6.3499999999999996 101.784 176.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -116.98 130.16 56.51 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 102.807 -3.034 . . . . 16.98 102.807 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.5 t -109.54 117.04 53.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.871 0 N-CA-C 103.718 -2.697 . . . . 5.5800000000000001 103.718 -175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.65 124.7 46.94 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 118.927 -2.358 . . . . 12.800000000000001 104.834 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.3 m -75.7 140.03 42.25 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 119.365 -2.084 . . . . 3.2400000000000002 115.68 -177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.9 mt -101.63 -51.92 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 105.874 -1.899 . . . . 4.79 105.874 171.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.3 m -138.93 139.06 22.45 Favored Pre-proline 0 C--O 1.242 0.704 0 O-C-N 119.572 -1.955 . . . . 11.59 106.299 177.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.7 Cg_exo -67.73 154.71 72.49 Favored 'Trans proline' 0 C--N 1.328 -0.522 0 C-N-CA 123.626 2.884 . . . . 4.5499999999999998 112.166 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.71 -161.29 28.88 Favored Glycine 0 CA--C 1.536 1.399 0 N-CA-C 109.15 -1.58 . . . . 2.0 109.15 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -82.33 -9.21 59.56 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 117.677 -3.249 . . . . 3.2400000000000002 113.21 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.17 9.67 77.07 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-O 117.585 -1.675 . . . . 3.3799999999999999 113.799 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.62 -26.79 0.96 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.669 3.234 . . . . 26.59 114.225 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.47 94.04 4.99 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 119.111 -2.243 . . . . 3.02 109.525 -175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -104.27 142.53 24.8 Favored Pre-proline 0 C--O 1.251 1.14 0 O-C-N 124.95 1.406 . . . . 4.7000000000000002 109.769 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.62 146.71 68.18 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.743 2.295 . . . . 2.9399999999999999 110.671 -174.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.4 mmtm -121.47 156.25 33.16 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.925 -1.489 . . . . 15.960000000000001 106.994 -177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.464 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.3 ttp180 -52.1 130.27 29.67 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 124.121 1.915 . . . . 11.69 112.831 174.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.21 -14.05 65.84 Favored Glycine 0 N--CA 1.421 -2.307 0 O-C-N 119.971 -1.706 . . . . 3.6299999999999999 112.763 -178.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.15 149.41 25.13 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.098 1.949 . . . . 5.9000000000000004 112.311 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 64.6 m -89.97 120.42 31.16 Favored 'General case' 0 C--O 1.249 1.055 0 O-C-N 125.257 1.598 . . . . 3.0699999999999998 111.689 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.52 131.06 39.12 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.592 1.187 . . . . 4.1100000000000003 109.799 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.4 t -112.06 111.33 35.69 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.649 -3.463 . . . . 2.1600000000000001 101.649 -174.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.9 m -129.43 154.43 40.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 121.77 0.795 . . . . 3.5899999999999999 112.313 -172.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.12 145.41 30.58 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.274 -2.121 . . . . 3.1299999999999999 105.274 164.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.86 156.13 43.35 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-N 120.172 1.351 . . . . 2.5499999999999998 111.87 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.3 m -133.86 121.48 21.82 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 102.924 -2.991 . . . . 4.4699999999999998 102.924 167.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.27 131.93 10.76 Favored Glycine 0 N--CA 1.471 0.969 0 N-CA-C 109.173 -1.571 . . . . 3.4100000000000001 109.173 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.46 152.18 51.61 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 125.291 2.472 . . . . 18.219999999999999 110.374 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 164.55 22.88 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 111.65 -2.523 . . . . 5.9299999999999997 106.435 172.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -57.96 -20.69 39.78 Favored 'General case' 0 C--O 1.221 -0.438 0 O-C-N 117.263 -3.398 . . . . 12.33 117.705 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.75 5.4 40.18 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.564 -1.96 . . . . 7.1900000000000004 113.874 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.36 69.71 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-O 124.113 1.952 . . . . 6.4699999999999998 113.754 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.42 124.18 22.04 Favored 'General case' 0 N--CA 1.438 -1.037 0 O-C-N 116.601 -3.882 . . . . 21.859999999999999 110.686 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.91 130.79 37.01 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.37 -1.344 . . . . 16.18 107.37 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.61 -17.93 13.97 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 119.095 -1.042 . . . . 5.7300000000000004 110.74 173.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.68 155.44 3.28 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 118.041 -0.98 . . . . 6.1299999999999999 110.665 176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 37.0 t -158.77 128.2 5.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.484 1.113 . . . . 2.9300000000000002 110.312 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 38.9 p -76.03 -20.61 57.64 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.001 -0.74 . . . . 2.2999999999999998 109.001 175.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.63 84.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.685 -1.598 . . . . 10.550000000000001 106.685 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -67.64 -28.56 67.83 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 120.143 -1.598 . . . . 8.0199999999999996 110.827 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.3 mtm-85 -88.58 -10.04 50.14 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.861 -1.149 . . . . 10.210000000000001 112.427 176.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.5 34.26 24.0 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.311 1.529 . . . . 16.379999999999999 110.951 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.7 120.2 9.36 Favored Pre-proline 0 C--O 1.247 0.972 0 O-C-N 117.571 -3.206 . . . . 20.210000000000001 103.921 177.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_exo -59.33 152.29 61.77 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 124.292 3.328 . . . . 8.75 110.276 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CE2' ' H32' ' A' ' 108' ' ' GPI . 85.1 t80 -95.85 138.18 33.86 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.572 -1.64 . . . . 4.6500000000000004 106.572 178.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.67 136.88 50.3 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 120.525 1.512 . . . . 10.619999999999999 111.253 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -142.6 150.7 40.67 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 120.475 1.489 . . . . 4.3099999999999996 107.368 169.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.466 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.46 126.61 37.62 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.324 1.42 . . . . 2.6699999999999999 110.542 172.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.87 129.9 42.45 Favored 'General case' 0 N--CA 1.427 -1.576 0 O-C-N 125.33 1.644 . . . . 3.0800000000000001 110.699 176.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.464 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.79 -4.02 84.92 Favored Glycine 0 C--N 1.342 0.862 0 C-N-CA 123.862 0.744 . . . . 4.9500000000000002 114.043 176.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.08 -3.13 57.86 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.686 -1.479 . . . . 10.26 114.633 -179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 64.56 39.52 6.65 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 120.012 -1.68 . . . . 10.24 113.858 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.34 -0.89 13.69 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 114.722 1.378 . . . . 10.56 114.722 178.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.4 172.67 9.28 Favored 'Isoleucine or valine' 0 C--O 1.252 1.21 0 N-CA-C 108.085 -1.08 . . . . 2.4500000000000002 108.085 171.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 pt -71.82 152.17 8.32 Favored 'Isoleucine or valine' 0 C--O 1.256 1.445 0 CA-C-O 123.029 1.395 . . . . 5.5700000000000003 109.725 -178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -56.26 -35.71 67.75 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 114.316 -1.311 . . . . 19.109999999999999 114.471 -176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.86 -23.22 72.53 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 123.4 2.818 . . . . 2.9300000000000002 112.432 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.52 -54.76 6.89 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 118.555 1.178 . . . . 7.96 111.583 173.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.86 -44.43 14.36 Favored 'General case' 0 C--O 1.249 1.044 0 CA-C-O 124.045 1.878 . . . . 15.050000000000001 111.503 173.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.44 -35.35 46.98 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.564 -1.198 . . . . 20.27 114.007 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.94 -45.7 6.23 Favored Glycine 0 N--CA 1.433 -1.536 0 C-N-CA 119.615 -1.279 . . . . 4.04 114.724 -175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.58 -27.18 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 119.09 -1.044 . . . . 5.3499999999999996 109.425 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.85 64.71 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.541 -2.6 . . . . 3.0299999999999998 112.35 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.42 0.18 50.46 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 118.425 -0.798 . . . . 3.4900000000000002 113.068 175.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.6 mtp -107.7 143.1 36.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 120.81 1.641 . . . . 3.75 109.572 -171.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.522 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.9 p -94.84 154.96 17.0 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.715 0.806 . . . . 2.2999999999999998 109.806 174.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.2 t -57.62 130.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 119.867 1.212 . . . . 2.4700000000000002 109.783 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 -12.53 52.08 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 113.35 -1.75 . . . . 2.6099999999999999 112.995 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.522 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.46 144.76 28.52 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-O 121.919 0.866 . . . . 6.5300000000000002 112.575 -171.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.95 123.89 41.4 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 102.632 -3.099 . . . . 12.359999999999999 102.632 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.91 156.64 44.94 Favored 'General case' 0 C--O 1.243 0.737 0 O-C-N 126.471 2.357 . . . . 5.8399999999999999 114.285 -176.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.15 122.45 43.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 123.551 1.643 . . . . 16.57 108.638 174.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.05 114.59 28.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 O-C-N 118.741 -2.474 . . . . 5.8600000000000003 106.76 -176.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.9 m -98.74 120.44 39.18 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 105.77 -1.937 . . . . 5.7599999999999998 105.77 176.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.66 122.59 69.16 Favored 'Isoleucine or valine' 0 C--O 1.248 1.01 0 N-CA-C 108.687 -0.857 . . . . 3.3599999999999999 108.687 -167.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.35 154.03 91.41 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.907 -1.044 . . . . 4.9400000000000004 110.683 177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -55.45 -35.09 91.39 Favored 'Trans proline' 0 N--CA 1.445 -1.352 0 C-N-CA 123.355 2.704 . . . . 6.21 114.738 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.07 -13.84 62.4 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 113.897 1.073 . . . . 15.85 113.897 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.61 10.99 36.67 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 126.106 1.762 . . . . 11.52 111.692 175.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.86 -116.6 0.15 Allowed 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 105.712 -1.958 . . . . 3.7000000000000002 105.712 -176.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -102.59 4.0 37.92 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-N 121.991 2.178 . . . . 6.8399999999999999 115.444 -173.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.49 -137.15 50.44 Favored Glycine 0 C--N 1.355 1.608 0 CA-C-O 123.739 1.744 . . . . 5.9900000000000002 111.032 172.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.29 -18.73 41.33 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 111.674 -2.263 . . . . 10.109999999999999 110.982 -178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.1 m -72.19 -43.98 63.69 Favored 'General case' 0 C--O 1.244 0.795 0 CA-C-N 121.131 1.787 . . . . 13.76 112.608 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.3 -169.17 53.38 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 107.652 -2.179 . . . . 9.9800000000000004 107.652 -170.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.4 t-80 -118.83 114.9 35.32 Favored Pre-proline 0 C--O 1.247 0.959 0 O-C-N 117.982 -3.069 . . . . 15.880000000000001 103.268 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.21 122.44 7.5 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.622 3.548 . . . . 11.41 110.903 -166.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.21 -26.98 3.23 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 111.863 -2.426 . . . . 14.199999999999999 117.416 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.6 mt -102.88 -50.04 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.567 0 CA-C-N 121.03 2.415 . . . . 11.06 114.894 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.7 mm -112.92 131.91 22.56 Favored Pre-proline 0 CA--C 1.516 -0.328 0 N-CA-C 103.203 -2.888 . . . . 8.0099999999999998 103.203 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.01 163.02 35.53 Favored 'Trans proline' 0 C--O 1.24 0.586 0 C-N-CA 125.284 3.99 . . . . 6.5199999999999996 112.918 171.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.34 144.48 71.81 Favored 'Trans proline' 0 CA--C 1.535 0.531 0 C-N-CA 122.563 2.175 . . . . 4.8200000000000003 110.244 162.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.33 27.22 16.27 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-N 112.785 -2.007 . . . . 7.4199999999999999 113.581 172.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.84 132.35 35.27 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 117.396 2.369 . . . . 2.2200000000000002 117.396 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -80.51 132.43 35.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 121.722 2.055 . . . . 4.6100000000000003 106.328 168.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.89 146.86 33.06 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 120.451 -1.406 . . . . 5.3399999999999999 110.276 -177.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.3 t -123.21 119.95 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.744 0 N-CA-C 103.743 -2.688 . . . . 3.9700000000000002 103.743 -178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.6 m-85 -116.77 137.01 52.5 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.724 -1.235 . . . . 4.4199999999999999 109.562 178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.81 112.7 25.77 Favored 'General case' 0 C--N 1.314 -0.959 1 N-CA-C 98.91 -4.478 . . . . 2.0899999999999999 98.91 173.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.4 t -126.8 132.33 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.12 -1.4 . . . . 3.5299999999999998 110.82 -172.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.44 121.84 39.39 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 105.524 -2.028 . . . . 14.210000000000001 105.524 178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.09 109.01 19.92 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 123.618 1.675 . . . . 2.4199999999999999 107.484 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.41 -43.34 13.72 Favored 'General case' 0 C--O 1.255 1.378 0 N-CA-C 115.175 1.546 . . . . 2.6200000000000001 115.175 -171.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.405 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.5 tttt -161.79 153.59 19.05 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 113.559 -1.655 . . . . 11.710000000000001 109.229 -167.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.07 133.19 55.59 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 105.201 -2.148 . . . . 4.7000000000000002 105.201 170.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.31 -1.138 0 CA-C-N 113.554 -1.657 . . . . 13.02 109.912 -179.795 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GPI . . . . . 0.533 H132 H151 ' A' ' 108' ' ' GPI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.737 0 N-CA-C 106.073 -2.811 . . . . 6.3300000000000001 106.073 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.34 142.55 43.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 101.741 -3.429 . . . . 6.3499999999999996 101.741 176.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.05 130.13 56.46 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 102.734 -3.061 . . . . 16.98 102.734 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 85.9 t -109.53 117.04 53.66 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 103.741 -2.689 . . . . 5.5800000000000001 103.741 -175.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.62 124.72 47.01 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 118.957 -2.339 . . . . 12.800000000000001 104.824 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.4 m -75.68 140.02 42.28 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 119.292 -2.13 . . . . 3.2400000000000002 115.635 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.41 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.3 mt -101.61 -52.02 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 105.832 -1.914 . . . . 4.79 105.832 171.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.6 m -138.95 139.03 22.27 Favored Pre-proline 0 C--O 1.241 0.652 0 O-C-N 119.5 -2.0 . . . . 11.59 106.301 177.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.7 Cg_exo -67.7 154.78 72.34 Favored 'Trans proline' 0 C--N 1.329 -0.483 0 C-N-CA 123.46 2.774 . . . . 4.5499999999999998 112.201 -176.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.71 -161.17 28.86 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 109.135 -1.586 . . . . 2.0 109.135 175.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.49 -9.21 59.52 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 117.606 -3.291 . . . . 3.2400000000000002 113.161 -177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.15 9.68 77.02 Favored Glycine 0 C--O 1.219 -0.8 0 CA-C-O 117.691 -1.616 . . . . 3.3799999999999999 113.846 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.7 mtp85 -137.67 -26.58 0.96 Allowed 'General case' 0 C--O 1.24 0.587 0 CA-C-N 122.592 3.196 . . . . 26.59 114.214 -178.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.57 94.0 4.96 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 119.057 -2.277 . . . . 3.02 109.45 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.13 142.53 24.81 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 125.01 1.444 . . . . 4.7000000000000002 109.798 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.56 146.76 68.69 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.754 2.303 . . . . 2.9399999999999999 110.627 -174.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.48 156.09 33.53 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.919 -1.491 . . . . 15.960000000000001 107.047 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.465 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.03 130.23 29.28 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 124.189 1.947 . . . . 11.69 112.721 174.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.36 -14.08 65.67 Favored Glycine 0 N--CA 1.423 -2.21 0 O-C-N 119.952 -1.717 . . . . 3.6299999999999999 112.713 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.12 149.36 25.18 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.061 1.93 . . . . 5.9000000000000004 112.326 174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.92 120.36 31.08 Favored 'General case' 0 C--O 1.25 1.113 0 O-C-N 125.176 1.548 . . . . 3.0699999999999998 111.766 174.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.51 130.94 39.19 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 122.606 1.193 . . . . 4.1100000000000003 109.874 176.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.3 t -111.89 111.39 35.95 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.638 -3.467 . . . . 2.1600000000000001 101.638 -174.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.54 154.39 40.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 121.817 0.817 . . . . 3.5899999999999999 112.262 -172.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.04 145.49 30.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 105.173 -2.158 . . . . 3.1299999999999999 105.173 164.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.496 ' CZ ' ' H52' ' A' ' 108' ' ' GPI . 33.1 p90 -145.89 156.11 43.33 Favored 'General case' 0 C--O 1.245 0.818 0 CA-C-N 120.048 1.294 . . . . 2.5499999999999998 112.038 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.8 m -133.84 121.63 22.06 Favored 'General case' 0 N--CA 1.463 0.187 0 N-CA-C 102.88 -3.007 . . . . 4.4699999999999998 102.88 167.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.24 131.94 10.76 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 109.22 -1.552 . . . . 3.4100000000000001 109.22 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.4 152.12 51.6 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 125.198 2.427 . . . . 18.219999999999999 110.405 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.52 164.62 22.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.741 -2.481 . . . . 5.9299999999999997 106.447 172.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -58.04 -20.58 40.22 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.238 -3.414 . . . . 12.33 117.708 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -87.75 5.3 40.65 Favored 'General case' 0 C--O 1.24 0.581 0 O-C-N 119.59 -1.943 . . . . 7.1900000000000004 113.914 177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.23 -10.33 69.62 Favored Glycine 0 C--N 1.357 1.697 0 CA-C-O 123.956 1.864 . . . . 6.4699999999999998 113.646 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.59 124.22 22.23 Favored 'General case' 0 C--N 1.312 -1.055 0 O-C-N 116.622 -3.869 . . . . 21.859999999999999 110.583 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -77.77 130.83 37.21 Favored 'General case' 0 CA--C 1.501 -0.904 0 N-CA-C 107.457 -1.312 . . . . 16.18 107.457 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.71 -17.87 13.97 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.075 -1.05 . . . . 5.7300000000000004 110.802 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -172.76 155.49 3.24 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 118.241 -0.885 . . . . 6.1299999999999999 110.55 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.81 128.05 5.54 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.48 1.112 . . . . 2.9300000000000002 110.371 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 40.3 p -75.89 -20.59 57.92 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 119.846 -0.741 . . . . 2.2999999999999998 109.093 175.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.1 mtt85 -63.73 -36.69 84.71 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 106.696 -1.594 . . . . 10.550000000000001 106.696 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -67.62 -28.49 67.78 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 120.191 -1.568 . . . . 8.0199999999999996 110.812 175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.63 -10.1 49.81 Favored 'General case' 0 C--O 1.241 0.617 0 O-C-N 120.854 -1.154 . . . . 10.210000000000001 112.341 176.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.51 34.28 24.05 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.346 1.546 . . . . 16.379999999999999 111.017 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.68 120.18 9.37 Favored Pre-proline 0 C--O 1.247 0.972 0 O-C-N 117.627 -3.171 . . . . 20.210000000000001 103.914 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -59.32 152.28 61.72 Favored 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 124.321 3.347 . . . . 8.75 110.32 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.486 ' CZ ' ' H41' ' A' ' 108' ' ' GPI . 85.1 t80 -95.84 138.13 33.92 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.534 -1.654 . . . . 4.6500000000000004 106.534 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -111.61 136.89 50.2 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 120.572 1.533 . . . . 10.619999999999999 111.297 177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.66 150.7 40.55 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 120.402 1.456 . . . . 4.3099999999999996 107.373 169.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.51 126.67 37.7 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 120.311 1.414 . . . . 2.6699999999999999 110.585 172.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.99 129.86 42.19 Favored 'General case' 0 N--CA 1.426 -1.643 0 O-C-N 125.251 1.594 . . . . 3.0800000000000001 110.647 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.465 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.93 -4.12 84.8 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 123.841 0.734 . . . . 4.9500000000000002 114.099 176.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.5 tttt -84.1 -3.12 57.86 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.797 -1.414 . . . . 10.26 114.561 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.51 39.62 6.69 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.106 -1.621 . . . . 10.24 113.784 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.38 -0.81 13.69 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 114.676 1.361 . . . . 10.56 114.676 178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.37 172.63 9.33 Favored 'Isoleucine or valine' 0 C--O 1.253 1.24 0 N-CA-C 108.118 -1.067 . . . . 2.4500000000000002 108.118 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.2 pt -71.82 152.12 8.34 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.98 1.371 . . . . 5.5700000000000003 109.785 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -56.22 -35.75 67.69 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 114.354 -1.294 . . . . 19.109999999999999 114.458 -176.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.76 -23.31 72.38 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.423 2.828 . . . . 2.9300000000000002 112.357 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.59 -54.68 7.0 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 118.621 1.21 . . . . 7.96 111.611 173.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -45.93 -44.45 14.74 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 124.015 1.864 . . . . 15.050000000000001 111.512 173.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.33 -35.31 47.77 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 114.517 -1.22 . . . . 20.27 114.084 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.05 -45.65 6.21 Favored Glycine 0 N--CA 1.432 -1.569 0 C-N-CA 119.424 -1.37 . . . . 4.04 114.663 -175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.47 -27.25 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 121.317 -1.108 . . . . 5.3499999999999996 109.456 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.95 -18.89 64.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.506 -2.621 . . . . 3.0299999999999998 112.363 176.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -84.48 0.34 50.04 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.078 0.77 . . . . 3.4900000000000002 113.078 175.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.9 mtp -107.88 143.08 36.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 120.765 1.62 . . . . 3.75 109.493 -171.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.522 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.9 p -94.71 154.92 17.08 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 123.714 0.805 . . . . 2.2999999999999998 109.877 174.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.6 t -57.58 130.23 20.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 119.965 1.257 . . . . 2.4700000000000002 109.828 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.12 -12.54 52.26 Favored Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 113.366 -1.743 . . . . 2.6099999999999999 113.124 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.522 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.48 144.8 28.49 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-O 121.915 0.864 . . . . 6.5300000000000002 112.605 -171.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -124.01 123.99 41.57 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 102.578 -3.119 . . . . 12.359999999999999 102.578 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.82 45.01 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.467 2.354 . . . . 5.8399999999999999 114.292 -176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.28 122.39 43.59 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.463 1.601 . . . . 16.57 108.651 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.59 28.82 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.847 -2.408 . . . . 5.8600000000000003 106.709 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 86.2 m -98.79 120.47 39.28 Favored 'General case' 0 C--O 1.247 0.945 0 N-CA-C 105.822 -1.918 . . . . 5.7599999999999998 105.822 176.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.73 122.55 69.01 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 108.616 -0.883 . . . . 3.3599999999999999 108.616 -167.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.34 154.02 91.43 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-O 117.787 -1.101 . . . . 4.9400000000000004 110.737 177.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.4 -35.08 91.11 Favored 'Trans proline' 0 N--CA 1.446 -1.316 0 C-N-CA 123.312 2.675 . . . . 6.21 114.749 -178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.17 -13.83 62.36 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 113.777 1.029 . . . . 15.85 113.777 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.69 11.05 36.45 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 126.038 1.735 . . . . 11.52 111.693 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.79 -116.54 0.15 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 105.751 -1.944 . . . . 3.7000000000000002 105.751 -177.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.73 4.22 37.8 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 122.033 2.197 . . . . 6.8399999999999999 115.452 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.36 -137.18 50.33 Favored Glycine 0 C--N 1.354 1.578 0 CA-C-O 123.708 1.727 . . . . 5.9900000000000002 111.073 171.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.17 -18.75 41.67 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 111.661 -2.27 . . . . 10.109999999999999 111.047 -178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.25 -43.98 63.53 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 121.048 1.749 . . . . 13.76 112.575 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.4 -169.24 53.4 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 107.603 -2.199 . . . . 9.9800000000000004 107.603 -170.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.87 114.9 35.23 Favored Pre-proline 0 C--O 1.246 0.913 0 O-C-N 118.097 -3.002 . . . . 15.880000000000001 103.151 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -48.13 122.43 7.4 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 124.667 3.578 . . . . 11.41 110.901 -166.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.17 -27.05 3.2 Favored Glycine 0 CA--C 1.545 1.935 0 CA-C-N 111.897 -2.41 . . . . 14.199999999999999 117.454 -177.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.9 mt -102.85 -50.08 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.046 2.423 . . . . 11.06 114.972 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.84 131.93 22.52 Favored Pre-proline 0 N--CA 1.466 0.361 0 N-CA-C 103.124 -2.917 . . . . 8.0099999999999998 103.124 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.09 163.08 35.43 Favored 'Trans proline' 0 C--O 1.24 0.611 0 C-N-CA 125.218 3.945 . . . . 6.5199999999999996 112.871 171.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.511 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.3 Cg_exo -55.4 144.54 72.21 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.428 2.085 . . . . 4.8200000000000003 110.311 162.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.19 27.26 16.38 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 112.886 -1.961 . . . . 7.4199999999999999 113.722 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.67 132.36 35.29 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 117.381 2.363 . . . . 2.2200000000000002 117.381 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.47 132.46 35.71 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 121.796 2.089 . . . . 4.6100000000000003 106.348 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -108.94 146.78 33.25 Favored 'General case' 0 N--CA 1.447 -0.59 0 O-C-N 120.379 -1.45 . . . . 5.3399999999999999 110.241 -177.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.2 t -123.17 120.01 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 103.768 -2.679 . . . . 3.9700000000000002 103.768 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.6 m-85 -116.76 136.95 52.55 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.724 -1.235 . . . . 4.4199999999999999 109.591 178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.8 t0 -103.75 112.7 25.77 Favored 'General case' 0 C--N 1.313 -1.0 1 N-CA-C 98.925 -4.472 . . . . 2.0899999999999999 98.925 173.979 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.6 t -126.82 132.34 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.212 -1.358 . . . . 3.5299999999999998 110.804 -172.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -120.47 121.9 39.5 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.464 -2.05 . . . . 14.210000000000001 105.464 178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.6 tp -89.05 109.04 19.93 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 123.606 1.67 . . . . 2.4199999999999999 107.516 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.46 -43.26 13.74 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.181 1.549 . . . . 2.6200000000000001 115.181 -171.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.8 153.58 19.02 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 113.503 -1.68 . . . . 11.710000000000001 109.115 -167.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.0 mt -120.04 133.24 55.59 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 105.206 -2.146 . . . . 4.7000000000000002 105.206 170.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.582 -1.645 . . . . 13.02 109.912 -179.84 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GPI . . . . . 0.496 ' H52' ' CZ ' ' A' ' 26' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 106.082 -2.807 . . . . 6.3300000000000001 106.082 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.36 142.54 43.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 101.712 -3.44 . . . . 6.3499999999999996 101.712 176.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.06 130.11 56.44 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 102.824 -3.028 . . . . 16.98 102.824 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.1 t -109.49 117.12 53.82 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 103.67 -2.715 . . . . 5.5800000000000001 103.67 -175.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.63 124.68 46.92 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 118.949 -2.345 . . . . 12.800000000000001 104.83 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.6 m -75.66 139.96 42.27 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.333 -2.105 . . . . 3.2400000000000002 115.621 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.5 mt -101.66 -52.01 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 N-CA-C 105.82 -1.919 . . . . 4.79 105.82 171.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.5 m -138.93 139.1 22.58 Favored Pre-proline 0 C--O 1.243 0.717 0 O-C-N 119.652 -1.905 . . . . 11.59 106.233 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.3 Cg_exo -67.66 154.76 72.49 Favored 'Trans proline' 0 C--N 1.33 -0.433 0 C-N-CA 123.568 2.846 . . . . 4.5499999999999998 112.224 -176.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.68 -161.08 28.88 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.106 -1.597 . . . . 2.0 109.106 175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -82.55 -9.17 59.52 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 117.694 -3.239 . . . . 3.2400000000000002 113.146 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.1 9.77 76.98 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.636 -1.647 . . . . 3.3799999999999999 113.843 -177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.74 -26.66 0.95 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.592 3.196 . . . . 26.59 114.226 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.1 m -105.52 94.03 4.98 Favored 'General case' 0 N--CA 1.478 0.934 0 O-C-N 119.143 -2.223 . . . . 3.02 109.439 -175.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.21 142.5 24.75 Favored Pre-proline 0 C--O 1.25 1.091 0 O-C-N 125.003 1.439 . . . . 4.7000000000000002 109.77 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.53 146.59 68.31 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.789 2.326 . . . . 2.9399999999999999 110.682 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.42 156.18 33.25 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.895 -1.502 . . . . 15.960000000000001 106.99 -177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.6 ttp180 -52.17 130.31 30.06 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-O 124.201 1.953 . . . . 11.69 112.828 174.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.28 -13.96 65.94 Favored Glycine 0 N--CA 1.424 -2.147 0 O-C-N 120.009 -1.682 . . . . 3.6299999999999999 112.682 -178.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.47 25.09 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 120.111 1.956 . . . . 5.9000000000000004 112.356 174.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.9 m -89.89 120.31 31.01 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.308 1.63 . . . . 3.0699999999999998 111.726 174.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.55 131.05 39.17 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.614 1.197 . . . . 4.1100000000000003 109.851 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -112.0 111.41 36.04 Favored 'Isoleucine or valine' 0 C--O 1.247 0.959 0 N-CA-C 101.643 -3.466 . . . . 2.1600000000000001 101.643 -174.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.1 m -129.6 154.4 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 121.89 0.852 . . . . 3.5899999999999999 112.249 -172.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.05 145.39 30.54 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.258 -2.127 . . . . 3.1299999999999999 105.258 164.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.8 156.19 43.42 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-N 120.173 1.351 . . . . 2.5499999999999998 111.923 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.4 m -133.86 121.54 21.91 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 102.99 -2.967 . . . . 4.4699999999999998 102.99 167.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.2 131.95 10.77 Favored Glycine 0 N--CA 1.468 0.823 0 N-CA-C 109.3 -1.52 . . . . 3.4100000000000001 109.3 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.8 mtm -132.39 152.19 51.56 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-O 125.263 2.459 . . . . 18.219999999999999 110.381 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.6 164.66 22.73 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.706 -2.497 . . . . 5.9299999999999997 106.408 172.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -58.11 -20.64 41.69 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 117.28 -3.387 . . . . 12.33 117.67 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.57 5.21 40.45 Favored 'General case' 0 C--O 1.24 0.577 0 O-C-N 119.536 -1.977 . . . . 7.1900000000000004 113.927 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.22 -10.24 69.65 Favored Glycine 0 C--N 1.354 1.54 0 CA-C-O 123.973 1.874 . . . . 6.4699999999999998 113.67 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.67 124.32 22.54 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 116.728 -3.807 . . . . 21.859999999999999 110.583 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.97 130.76 36.93 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 107.383 -1.34 . . . . 16.18 107.383 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.56 -17.9 13.98 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 119.142 -1.023 . . . . 5.7300000000000004 110.845 173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -172.71 155.44 3.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.064 -0.97 . . . . 6.1299999999999999 110.614 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.9 t -158.82 128.17 5.58 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.421 1.088 . . . . 2.9300000000000002 110.284 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.2 p -75.97 -20.74 57.66 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.841 -0.743 . . . . 2.2999999999999998 109.006 175.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.63 -36.67 84.6 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 106.674 -1.602 . . . . 10.550000000000001 106.674 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -67.59 -28.47 67.79 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 120.191 -1.568 . . . . 8.0199999999999996 110.881 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.67 -10.11 49.69 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 120.847 -1.158 . . . . 10.210000000000001 112.331 176.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.49 34.32 24.1 Favored 'General case' 0 C--O 1.211 -0.924 0 CA-C-O 123.4 1.571 . . . . 16.379999999999999 110.989 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.69 120.2 9.36 Favored Pre-proline 0 C--N 1.315 -0.924 0 O-C-N 117.703 -3.123 . . . . 20.210000000000001 103.926 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -59.24 152.26 61.35 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 124.209 3.273 . . . . 8.75 110.383 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -95.86 138.31 33.69 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.518 -1.66 . . . . 4.6500000000000004 106.518 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.76 136.78 50.57 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.588 1.54 . . . . 10.619999999999999 111.326 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -142.56 150.59 40.57 Favored 'General case' 0 C--O 1.246 0.895 0 CA-C-N 120.437 1.472 . . . . 4.3099999999999996 107.442 169.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.468 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.47 126.71 37.68 Favored 'General case' 0 C--O 1.248 1.008 0 CA-C-N 120.365 1.439 . . . . 2.6699999999999999 110.634 172.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.87 129.83 42.14 Favored 'General case' 0 N--CA 1.428 -1.56 0 O-C-N 125.32 1.637 . . . . 3.0800000000000001 110.654 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.87 -4.06 84.85 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 123.9 0.762 . . . . 4.9500000000000002 114.093 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.11 -3.01 57.79 Favored 'General case' 0 N--CA 1.436 -1.152 0 O-C-N 120.765 -1.432 . . . . 10.26 114.64 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.51 39.55 6.72 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.045 -1.659 . . . . 10.24 113.795 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.73 13.7 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 114.671 1.36 . . . . 10.56 114.671 178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.46 172.68 9.34 Favored 'Isoleucine or valine' 0 C--O 1.252 1.188 0 N-CA-C 107.938 -1.134 . . . . 2.4500000000000002 107.938 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.3 pt -71.77 152.12 8.37 Favored 'Isoleucine or valine' 0 C--O 1.259 1.604 0 CA-C-O 122.944 1.354 . . . . 5.5700000000000003 109.765 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.34 -35.73 67.96 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 114.401 -1.272 . . . . 19.109999999999999 114.395 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.78 -23.34 72.42 Favored Glycine 0 CA--C 1.539 1.583 0 O-C-N 118.226 -2.796 . . . . 2.9300000000000002 112.344 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.62 -54.55 7.23 Favored 'General case' 0 C--O 1.248 0.981 0 CA-C-N 118.556 1.178 . . . . 7.96 111.628 173.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -45.99 -44.45 15.03 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-O 124.015 1.864 . . . . 15.050000000000001 111.502 173.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.35 -35.25 47.71 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 114.544 -1.207 . . . . 20.27 114.101 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.04 -45.75 6.18 Favored Glycine 0 N--CA 1.433 -1.514 0 C-N-CA 119.534 -1.317 . . . . 4.04 114.623 -175.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.1 t -67.51 -27.22 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 121.338 -1.095 . . . . 5.3499999999999996 109.425 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.97 -18.8 64.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 O-C-N 118.531 -2.606 . . . . 3.0299999999999998 112.439 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.52 0.25 50.54 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.468 -0.777 . . . . 3.4900000000000002 113.026 175.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.8 143.05 36.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 120.852 1.66 . . . . 3.75 109.577 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.524 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.9 p -94.77 154.96 17.03 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.693 0.797 . . . . 2.2999999999999998 109.86 174.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 90.2 t -57.62 130.16 20.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 119.957 1.253 . . . . 2.4700000000000002 109.763 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.15 -12.46 52.12 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 113.311 -1.768 . . . . 2.6099999999999999 113.049 179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.524 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.48 144.77 28.51 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-O 121.854 0.835 . . . . 6.5300000000000002 112.562 -171.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -123.97 123.98 41.58 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 102.626 -3.102 . . . . 12.359999999999999 102.626 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.91 156.82 44.97 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.472 2.357 . . . . 5.8399999999999999 114.221 -176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.36 122.42 43.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 123.443 1.592 . . . . 16.57 108.699 174.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.98 114.4 28.52 Favored 'General case' 0 N--CA 1.441 -0.905 0 O-C-N 118.841 -2.412 . . . . 5.8600000000000003 106.797 -176.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.6 m -98.68 120.51 39.24 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 105.855 -1.905 . . . . 5.7599999999999998 105.855 176.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.0 mt -119.63 122.61 69.25 Favored 'Isoleucine or valine' 0 C--O 1.247 0.933 0 N-CA-C 108.714 -0.847 . . . . 3.3599999999999999 108.714 -167.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.38 154.03 91.52 Favored Pre-proline 0 C--O 1.243 0.751 0 CA-C-O 117.915 -1.04 . . . . 4.9400000000000004 110.739 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.32 -35.19 90.99 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 123.268 2.645 . . . . 6.21 114.786 -178.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -69.95 -13.96 62.49 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.927 1.084 . . . . 15.85 113.927 -179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.6 11.06 36.61 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 126.113 1.765 . . . . 11.52 111.757 175.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.79 -116.62 0.15 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 105.786 -1.931 . . . . 3.7000000000000002 105.786 -176.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -102.51 3.94 38.08 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 122.032 2.196 . . . . 6.8399999999999999 115.545 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.58 -137.17 50.48 Favored Glycine 0 C--N 1.354 1.535 0 CA-C-O 123.757 1.754 . . . . 5.9900000000000002 111.011 171.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.64 41.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 111.622 -2.289 . . . . 10.109999999999999 110.983 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.26 -44.09 63.34 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 121.112 1.778 . . . . 13.76 112.529 175.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.4 -169.19 53.44 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.659 -2.177 . . . . 9.9800000000000004 107.659 -170.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.81 114.8 35.4 Favored Pre-proline 0 C--O 1.247 0.922 0 O-C-N 117.999 -3.06 . . . . 15.880000000000001 103.323 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -48.19 122.47 7.52 Favored 'Trans proline' 0 C--N 1.361 1.236 0 C-N-CA 124.707 3.605 . . . . 11.41 110.89 -166.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.19 -26.97 3.23 Favored Glycine 0 CA--C 1.547 2.079 0 CA-C-N 111.87 -2.423 . . . . 14.199999999999999 117.361 -177.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.606 HD13 ' C11' ' A' ' 108' ' ' GPI . 60.1 mt -102.96 -50.04 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 121.074 2.437 . . . . 11.06 114.917 -175.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.95 131.92 22.57 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 103.17 -2.9 . . . . 8.0099999999999998 103.17 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.0 163.07 35.32 Favored 'Trans proline' 0 C--O 1.24 0.592 1 C-N-CA 125.34 4.027 . . . . 6.5199999999999996 112.853 171.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.34 144.45 71.94 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.534 2.156 . . . . 4.8200000000000003 110.307 162.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.32 27.3 16.32 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 112.846 -1.979 . . . . 7.4199999999999999 113.562 172.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.86 132.35 35.27 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 117.392 2.367 . . . . 2.2200000000000002 117.392 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.1 m -80.57 132.45 35.65 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 121.696 2.043 . . . . 4.6100000000000003 106.283 168.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.6 mt -108.88 146.78 33.19 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 120.442 -1.411 . . . . 5.3399999999999999 110.285 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.19 119.96 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 103.78 -2.674 . . . . 3.9700000000000002 103.78 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.4 m-85 -116.81 137.09 52.45 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 120.77 -1.206 . . . . 4.4199999999999999 109.541 178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.9 t0 -103.81 112.73 25.81 Favored 'General case' 0 C--N 1.314 -0.975 1 N-CA-C 98.912 -4.477 . . . . 2.0899999999999999 98.912 174.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.5 t -126.72 132.36 70.2 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 114.109 -1.405 . . . . 3.5299999999999998 110.805 -172.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.49 121.82 39.29 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 105.57 -2.011 . . . . 14.210000000000001 105.57 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.9 tp -89.02 109.11 19.99 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.498 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.9 mt -85.47 -43.34 13.67 Favored 'General case' 0 C--O 1.254 1.34 0 N-CA-C 115.255 1.576 . . . . 2.6200000000000001 115.255 -171.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.86 153.54 18.84 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 113.422 -1.717 . . . . 11.710000000000001 109.153 -167.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.0 133.28 55.59 Favored 'General case' 0 C--O 1.248 0.983 0 N-CA-C 105.155 -2.165 . . . . 4.7000000000000002 105.155 170.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.313 -1.018 0 CA-C-N 113.548 -1.66 . . . . 13.02 109.8 -179.798 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GPI . . . . . 0.606 ' C11' HD13 ' A' ' 90' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 106.034 -2.826 . . . . 6.3300000000000001 106.034 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.31 142.46 43.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 101.725 -3.435 . . . . 6.3499999999999996 101.725 176.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -116.92 130.21 56.55 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 102.818 -3.03 . . . . 16.98 102.818 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 84.8 t -109.71 117.1 53.86 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 103.613 -2.736 . . . . 5.5800000000000001 103.613 -175.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.61 124.65 46.85 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 118.919 -2.363 . . . . 12.800000000000001 104.82 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.7 m -75.57 139.97 42.41 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.183 -2.198 . . . . 3.2400000000000002 115.598 -177.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.408 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.7 mt -101.64 -52.07 8.78 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 105.844 -1.91 . . . . 4.79 105.844 171.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.7 m -138.9 139.03 22.4 Favored Pre-proline 0 C--O 1.243 0.723 0 O-C-N 119.684 -1.885 . . . . 11.59 106.358 177.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.7 Cg_exo -67.66 154.78 72.44 Favored 'Trans proline' 0 C--N 1.329 -0.48 0 C-N-CA 123.536 2.824 . . . . 4.5499999999999998 112.15 -176.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.63 -161.1 28.93 Favored Glycine 0 CA--C 1.536 1.39 0 N-CA-C 109.222 -1.551 . . . . 2.0 109.222 175.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.49 -9.21 59.52 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 117.65 -3.265 . . . . 3.2400000000000002 113.163 -177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.14 9.69 76.98 Favored Glycine 0 C--O 1.219 -0.782 0 CA-C-O 117.585 -1.675 . . . . 3.3799999999999999 113.806 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.63 -26.81 0.96 Allowed 'General case' 0 C--O 1.24 0.568 0 CA-C-N 122.669 3.234 . . . . 26.59 114.208 -178.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.38 93.92 4.93 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 119.101 -2.249 . . . . 3.02 109.602 -175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -104.22 142.46 24.65 Favored Pre-proline 0 C--O 1.25 1.08 0 O-C-N 125.005 1.441 . . . . 4.7000000000000002 109.82 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.4 Cg_endo -68.48 146.67 68.91 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.704 2.27 . . . . 2.9399999999999999 110.657 -174.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.46 156.29 33.08 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 113.836 -1.529 . . . . 15.960000000000001 106.962 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.24 130.27 30.21 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-O 124.253 1.977 . . . . 11.69 112.764 174.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.3 -14.08 65.72 Favored Glycine 0 N--CA 1.424 -2.159 0 O-C-N 119.999 -1.688 . . . . 3.6299999999999999 112.766 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -86.18 149.43 25.11 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 120.095 1.948 . . . . 5.9000000000000004 112.333 174.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.95 120.29 31.04 Favored 'General case' 0 C--O 1.249 1.062 0 O-C-N 125.308 1.63 . . . . 3.0699999999999998 111.729 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.3 m -93.57 131.09 39.17 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 122.616 1.198 . . . . 4.1100000000000003 109.827 176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -111.99 111.5 36.45 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 N-CA-C 101.625 -3.472 . . . . 2.1600000000000001 101.625 -174.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.58 154.42 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.82 0.819 . . . . 3.5899999999999999 112.3 -172.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.13 145.46 30.52 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.215 -2.143 . . . . 3.1299999999999999 105.215 164.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.4 p90 -145.82 156.17 43.4 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 120.04 1.291 . . . . 2.5499999999999998 111.927 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.79 121.57 22.03 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 102.929 -2.989 . . . . 4.4699999999999998 102.929 167.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.22 131.93 10.76 Favored Glycine 0 N--CA 1.471 1.013 0 N-CA-C 109.192 -1.563 . . . . 3.4100000000000001 109.192 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.38 152.13 51.58 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-O 125.142 2.401 . . . . 18.219999999999999 110.435 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.55 164.56 22.85 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 111.797 -2.456 . . . . 5.9299999999999997 106.384 172.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.08 -20.54 40.39 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.242 -3.411 . . . . 12.33 117.684 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -87.75 5.29 40.67 Favored 'General case' 0 C--O 1.241 0.646 0 O-C-N 119.659 -1.901 . . . . 7.1900000000000004 113.885 177.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.22 69.72 Favored Glycine 0 C--N 1.355 1.601 0 CA-C-O 123.966 1.87 . . . . 6.4699999999999998 113.684 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.65 124.2 22.2 Favored 'General case' 0 N--CA 1.438 -1.045 0 O-C-N 116.678 -3.836 . . . . 21.859999999999999 110.593 -179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.81 130.81 37.14 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 107.477 -1.305 . . . . 16.18 107.477 179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -107.62 -17.88 13.98 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 119.041 -1.064 . . . . 5.7300000000000004 110.913 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.68 155.5 3.3 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 118.16 -0.924 . . . . 6.1299999999999999 110.504 176.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.8 t -158.85 128.16 5.55 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.451 1.101 . . . . 2.9300000000000002 110.328 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 38.6 p -75.97 -20.59 57.77 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 119.827 -0.749 . . . . 2.2999999999999998 109.052 175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.86 -36.54 84.25 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.639 -1.615 . . . . 10.550000000000001 106.639 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -67.74 -28.4 67.6 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 120.219 -1.551 . . . . 8.0199999999999996 110.819 175.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.2 mtm-85 -88.57 -10.22 49.56 Favored 'General case' 0 C--O 1.24 0.596 0 O-C-N 120.767 -1.208 . . . . 10.210000000000001 112.436 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 56.63 34.21 24.1 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 123.286 1.517 . . . . 16.379999999999999 110.908 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.4 tttm -139.71 120.18 9.34 Favored Pre-proline 0 C--N 1.315 -0.931 0 O-C-N 117.632 -3.168 . . . . 20.210000000000001 103.894 177.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.3 152.4 60.74 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 124.23 3.287 . . . . 8.75 110.318 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.486 ' CZ ' ' H32' ' A' ' 108' ' ' GPI . 84.8 t80 -96.05 138.09 34.17 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.505 -1.665 . . . . 4.6500000000000004 106.505 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -111.51 136.85 50.12 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 120.521 1.51 . . . . 10.619999999999999 111.367 177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -142.57 150.62 40.6 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 120.513 1.506 . . . . 4.3099999999999996 107.457 169.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.46 126.69 37.65 Favored 'General case' 0 C--O 1.249 1.05 0 CA-C-N 120.348 1.431 . . . . 2.6699999999999999 110.613 172.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.96 129.91 42.44 Favored 'General case' 0 N--CA 1.428 -1.536 0 O-C-N 125.265 1.603 . . . . 3.0800000000000001 110.624 176.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.04 -4.27 84.69 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-N 115.603 -0.726 . . . . 4.9500000000000002 114.035 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.4 tttt -83.99 -3.13 57.78 Favored 'General case' 0 N--CA 1.436 -1.167 0 O-C-N 120.735 -1.45 . . . . 10.26 114.566 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.52 39.53 6.73 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 120.156 -1.59 . . . . 10.24 113.836 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.4 -0.76 13.69 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 114.69 1.367 . . . . 10.56 114.69 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.34 172.65 9.25 Favored 'Isoleucine or valine' 0 C--O 1.253 1.283 0 N-CA-C 108.173 -1.047 . . . . 2.4500000000000002 108.173 171.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.82 152.1 8.35 Favored 'Isoleucine or valine' 0 C--O 1.258 1.503 0 CA-C-O 122.987 1.375 . . . . 5.5700000000000003 109.803 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.27 -35.77 67.81 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.362 -1.29 . . . . 19.109999999999999 114.473 -176.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.71 -23.34 72.3 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 123.254 2.752 . . . . 2.9300000000000002 112.373 177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -74.52 -54.63 7.15 Favored 'General case' 0 C--O 1.25 1.09 0 CA-C-N 118.552 1.176 . . . . 7.96 111.628 173.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.03 -44.4 15.19 Favored 'General case' 0 C--O 1.248 1.006 0 CA-C-O 124.007 1.86 . . . . 15.050000000000001 111.453 173.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.38 -35.4 47.36 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 114.637 -1.165 . . . . 20.27 114.001 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.02 -45.64 6.22 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 119.451 -1.357 . . . . 4.04 114.668 -175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.7 t -67.53 -27.23 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 C-N-CA 119.125 -1.03 . . . . 5.3499999999999996 109.414 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.589 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -63.93 -18.88 64.66 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.498 -2.626 . . . . 3.0299999999999998 112.386 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.4 0.2 50.34 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 118.401 -0.809 . . . . 3.4900000000000002 113.083 175.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.72 143.07 36.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 120.81 1.641 . . . . 3.75 109.557 -171.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.523 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.8 p -94.78 155.05 16.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.706 0.802 . . . . 2.2999999999999998 109.771 174.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.3 t -57.66 130.1 20.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 119.835 1.198 . . . . 2.4700000000000002 109.795 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.41 52.01 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 113.309 -1.769 . . . . 2.6099999999999999 113.041 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.523 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.4 144.74 28.6 Favored 'General case' 0 N--CA 1.428 -1.559 0 CA-C-O 121.874 0.845 . . . . 6.5300000000000002 112.608 -171.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.8 ttt180 -123.97 123.98 41.58 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 102.671 -3.085 . . . . 12.359999999999999 102.671 178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.71 44.99 Favored 'General case' 0 C--O 1.243 0.726 0 O-C-N 126.408 2.318 . . . . 5.8399999999999999 114.261 -176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.35 122.52 43.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.564 1.649 . . . . 16.57 108.584 174.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.07 114.56 28.77 Favored 'General case' 0 N--CA 1.441 -0.879 0 O-C-N 118.825 -2.422 . . . . 5.8600000000000003 106.76 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 86.3 m -98.69 120.39 39.04 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 105.814 -1.921 . . . . 5.7599999999999998 105.814 176.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.55 122.63 69.37 Favored 'Isoleucine or valine' 0 C--O 1.247 0.951 0 N-CA-C 108.733 -0.84 . . . . 3.3599999999999999 108.733 -167.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.5 p -66.36 153.97 91.59 Favored Pre-proline 0 C--O 1.243 0.738 0 CA-C-O 117.958 -1.02 . . . . 4.9400000000000004 110.632 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.33 -35.09 90.82 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.263 2.642 . . . . 6.21 114.85 -178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.13 -13.76 62.34 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.784 1.031 . . . . 15.85 113.784 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.67 10.84 36.62 Favored 'General case' 0 CA--C 1.512 -0.518 0 C-N-CA 126.145 1.778 . . . . 11.52 111.809 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.64 -116.52 0.16 Allowed 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 105.763 -1.94 . . . . 3.7000000000000002 105.763 -176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -102.51 3.91 38.04 Favored 'General case' 0 C--O 1.251 1.172 0 CA-C-N 122.045 2.202 . . . . 6.8399999999999999 115.502 -173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.48 -137.08 50.51 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-O 123.679 1.711 . . . . 5.9900000000000002 111.101 172.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.518 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.2 -18.8 41.38 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 111.708 -2.246 . . . . 10.109999999999999 111.071 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.3 m -72.26 -43.93 63.58 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.048 1.749 . . . . 13.76 112.61 175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.22 -169.2 53.29 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 107.746 -2.141 . . . . 9.9800000000000004 107.746 -170.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.82 114.81 35.39 Favored Pre-proline 0 C--O 1.246 0.913 0 O-C-N 118.048 -3.031 . . . . 15.880000000000001 103.252 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -48.17 122.44 7.47 Favored 'Trans proline' 0 C--N 1.363 1.31 0 C-N-CA 124.682 3.588 . . . . 11.41 110.933 -166.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.15 -26.95 3.21 Favored Glycine 0 CA--C 1.547 2.044 0 CA-C-N 111.865 -2.425 . . . . 14.199999999999999 117.389 -177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.88 -50.04 9.95 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.613 0 CA-C-N 121.14 2.47 . . . . 11.06 115.045 -175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.6 mm -112.87 131.89 22.55 Favored Pre-proline 0 CA--C 1.516 -0.334 0 N-CA-C 103.19 -2.893 . . . . 8.0099999999999998 103.19 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.0 163.04 35.44 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.268 3.978 . . . . 6.5199999999999996 112.969 171.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.518 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 12.9 Cg_exo -55.28 144.5 71.1 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.578 2.185 . . . . 4.8200000000000003 110.31 162.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.13 27.34 16.47 Favored 'General case' 0 C--O 1.217 -0.639 0 CA-C-N 112.9 -1.954 . . . . 7.4199999999999999 113.692 172.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.78 132.42 35.28 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 117.409 2.374 . . . . 2.2200000000000002 117.409 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.53 132.36 35.66 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 121.698 2.045 . . . . 4.6100000000000003 106.382 168.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.2 mt -108.84 146.72 33.22 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 120.423 -1.423 . . . . 5.3399999999999999 110.318 -177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 92.7 t -123.1 120.11 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 103.729 -2.693 . . . . 3.9700000000000002 103.729 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.485 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.9 m-85 -116.83 136.91 52.58 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.768 -1.208 . . . . 4.4199999999999999 109.539 178.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 33.0 t0 -103.74 112.73 25.81 Favored 'General case' 0 C--N 1.315 -0.917 1 N-CA-C 98.96 -4.459 . . . . 2.0899999999999999 98.96 173.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.9 t -126.78 132.29 70.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.045 -1.434 . . . . 3.5299999999999998 110.844 -172.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -120.47 121.91 39.51 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 105.485 -2.043 . . . . 14.210000000000001 105.485 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 tp -89.09 109.2 20.08 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 123.659 1.695 . . . . 2.4199999999999999 107.434 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.4 mt -85.65 -43.24 13.61 Favored 'General case' 0 C--O 1.253 1.289 0 N-CA-C 115.128 1.529 . . . . 2.6200000000000001 115.128 -171.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.3 tttt -161.9 153.56 18.79 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 113.565 -1.652 . . . . 11.710000000000001 109.151 -167.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.8 mt -120.06 133.26 55.58 Favored 'General case' 0 C--O 1.247 0.952 0 N-CA-C 105.153 -2.166 . . . . 4.7000000000000002 105.153 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 . . . . . 0 C--N 1.313 -0.987 0 CA-C-N 113.505 -1.679 . . . . 13.02 109.711 -179.726 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GPI . . . . . 0.486 ' H32' ' CZ ' ' A' ' 46' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.712 0 N-CA-C 105.992 -2.843 . . . . 6.3300000000000001 105.992 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.42 142.51 43.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 101.754 -3.424 . . . . 6.3499999999999996 101.754 176.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -116.94 130.14 56.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 102.844 -3.021 . . . . 16.98 102.844 178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.56 117.02 53.62 Favored 'Isoleucine or valine' 0 C--O 1.245 0.828 0 N-CA-C 103.692 -2.707 . . . . 5.5800000000000001 103.692 -175.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.66 124.68 46.87 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 118.946 -2.346 . . . . 12.800000000000001 104.824 177.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 48.9 m -75.66 139.83 42.21 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 119.234 -2.166 . . . . 3.2400000000000002 115.624 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.409 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.42 -52.09 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 105.935 -1.876 . . . . 4.79 105.935 171.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.448 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.6 m -138.89 139.02 22.42 Favored Pre-proline 0 C--O 1.243 0.737 0 O-C-N 119.622 -1.924 . . . . 11.59 106.275 177.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 29.4 Cg_exo -67.69 154.77 72.41 Favored 'Trans proline' 0 C--N 1.33 -0.444 0 C-N-CA 123.538 2.825 . . . . 4.5499999999999998 112.194 -176.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.63 -161.16 28.94 Favored Glycine 0 CA--C 1.536 1.396 0 N-CA-C 109.169 -1.573 . . . . 2.0 109.169 175.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -82.41 -9.2 59.54 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 117.645 -3.268 . . . . 3.2400000000000002 113.188 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.01 9.78 76.67 Favored Glycine 0 C--O 1.219 -0.836 0 CA-C-O 117.654 -1.637 . . . . 3.3799999999999999 113.886 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.72 -26.57 0.96 Allowed 'General case' 0 C--O 1.241 0.631 0 CA-C-N 122.567 3.183 . . . . 26.59 114.251 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.54 93.96 4.95 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 119.08 -2.262 . . . . 3.02 109.544 -175.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -104.22 142.52 24.78 Favored Pre-proline 0 C--O 1.251 1.152 0 O-C-N 124.969 1.418 . . . . 4.7000000000000002 109.84 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.3 Cg_endo -68.59 146.75 68.48 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.738 2.292 . . . . 2.9399999999999999 110.636 -173.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.49 156.13 33.46 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.918 -1.492 . . . . 15.960000000000001 107.053 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.5 ttp180 -52.07 130.25 29.49 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 124.169 1.938 . . . . 11.69 112.819 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.24 -14.01 65.88 Favored Glycine 0 N--CA 1.421 -2.307 0 O-C-N 120.021 -1.674 . . . . 3.6299999999999999 112.845 -178.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.4 25.15 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 120.047 1.924 . . . . 5.9000000000000004 112.396 174.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.3 m -89.94 120.37 31.1 Favored 'General case' 0 C--O 1.25 1.101 0 O-C-N 125.305 1.628 . . . . 3.0699999999999998 111.734 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 55.9 m -93.5 131.04 39.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 122.649 1.214 . . . . 4.1100000000000003 109.856 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.6 t -112.02 111.38 35.92 Favored 'Isoleucine or valine' 0 C--O 1.248 1.025 0 N-CA-C 101.607 -3.479 . . . . 2.1600000000000001 101.607 -174.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.8 m -129.53 154.44 40.2 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.842 0.829 . . . . 3.5899999999999999 112.242 -172.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.14 145.44 30.56 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.259 -2.126 . . . . 3.1299999999999999 105.259 164.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.2 p90 -145.85 156.06 43.31 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-N 120.177 1.353 . . . . 2.5499999999999998 111.928 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.77 121.55 22.02 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 102.968 -2.975 . . . . 4.4699999999999998 102.968 167.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.24 131.96 10.77 Favored Glycine 0 N--CA 1.47 0.955 0 N-CA-C 109.198 -1.561 . . . . 3.4100000000000001 109.198 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.43 152.18 51.59 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-O 125.238 2.447 . . . . 18.219999999999999 110.391 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.56 164.58 22.83 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.694 -2.503 . . . . 5.9299999999999997 106.444 172.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -58.03 -20.64 40.5 Favored 'General case' 0 C--O 1.221 -0.396 0 O-C-N 117.16 -3.462 . . . . 12.33 117.624 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -87.7 5.34 40.29 Favored 'General case' 0 C--O 1.241 0.63 0 O-C-N 119.634 -1.916 . . . . 7.1900000000000004 113.918 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.15 -10.23 69.82 Favored Glycine 0 C--N 1.355 1.629 0 CA-C-O 124.009 1.894 . . . . 6.4699999999999998 113.719 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.56 124.19 22.13 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 116.616 -3.873 . . . . 21.859999999999999 110.554 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.89 130.77 37.01 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.415 -1.328 . . . . 16.18 107.415 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -107.67 -17.77 14.0 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.076 -1.05 . . . . 5.7300000000000004 110.811 173.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.77 155.36 3.19 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 118.121 -0.942 . . . . 6.1299999999999999 110.564 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.6 t -158.74 128.14 5.62 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.462 1.105 . . . . 2.9300000000000002 110.341 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.3 p -75.94 -20.65 57.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 109.006 -0.738 . . . . 2.2999999999999998 109.006 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.71 -36.65 84.57 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.698 -1.593 . . . . 10.550000000000001 106.698 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -67.64 -28.42 67.7 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.205 -1.559 . . . . 8.0199999999999996 110.906 175.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.4 mtm-85 -88.65 -10.03 50.03 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.859 -1.15 . . . . 10.210000000000001 112.411 176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.46 34.29 24.02 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-O 123.329 1.538 . . . . 16.379999999999999 110.996 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.411 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.73 120.27 9.35 Favored Pre-proline 0 C--O 1.246 0.918 0 O-C-N 117.722 -3.111 . . . . 20.210000000000001 103.806 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -59.39 152.35 61.7 Favored 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 124.204 3.27 . . . . 8.75 110.294 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.402 ' CZ ' ' H32' ' A' ' 108' ' ' GPI . 84.8 t80 -95.99 138.15 34.03 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 106.47 -1.678 . . . . 4.6500000000000004 106.47 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.62 136.86 50.27 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 120.49 1.495 . . . . 10.619999999999999 111.316 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -142.6 150.62 40.56 Favored 'General case' 0 C--O 1.245 0.853 0 CA-C-N 120.424 1.465 . . . . 4.3099999999999996 107.372 169.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.8 ttm -92.48 126.63 37.65 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 120.31 1.414 . . . . 2.6699999999999999 110.583 172.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.83 129.77 41.91 Favored 'General case' 0 N--CA 1.427 -1.576 0 O-C-N 125.198 1.561 . . . . 3.0800000000000001 110.742 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 88.96 -4.04 84.75 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 123.874 0.75 . . . . 4.9500000000000002 113.968 176.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.12 -3.11 57.88 Favored 'General case' 0 N--CA 1.435 -1.178 0 O-C-N 120.707 -1.467 . . . . 10.26 114.62 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 64.59 39.53 6.56 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.129 -1.607 . . . . 10.24 113.8 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.36 -0.84 13.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 114.701 1.371 . . . . 10.56 114.701 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.39 172.65 9.3 Favored 'Isoleucine or valine' 0 C--O 1.251 1.164 0 N-CA-C 108.078 -1.082 . . . . 2.4500000000000002 108.078 171.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.5 pt -71.75 152.07 8.39 Favored 'Isoleucine or valine' 0 C--O 1.257 1.49 0 CA-C-O 122.946 1.355 . . . . 5.5700000000000003 109.782 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.25 -35.85 67.87 Favored 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 114.327 -1.306 . . . . 19.109999999999999 114.393 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.65 -23.33 72.21 Favored Glycine 0 CA--C 1.539 1.539 0 CA-C-N 123.338 2.79 . . . . 2.9300000000000002 112.496 177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.57 -54.62 7.13 Favored 'General case' 0 C--O 1.248 1.026 0 CA-C-N 118.49 1.145 . . . . 7.96 111.665 173.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.01 -44.45 15.12 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 123.982 1.848 . . . . 15.050000000000001 111.431 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.35 -35.31 47.65 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 114.531 -1.213 . . . . 20.27 114.06 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -83.98 -45.68 6.22 Favored Glycine 0 N--CA 1.433 -1.55 0 C-N-CA 119.547 -1.311 . . . . 4.04 114.67 -175.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 89.6 t -67.62 -27.15 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 O-C-N 121.382 -1.07 . . . . 5.3499999999999996 109.419 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.83 64.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.57 -2.581 . . . . 3.0299999999999998 112.35 176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -84.49 0.36 50.02 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.107 0.78 . . . . 3.4900000000000002 113.107 175.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.7 mtp -107.9 143.08 37.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 120.786 1.63 . . . . 3.75 109.492 -171.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.524 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.8 p -94.82 155.04 16.97 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.604 0.762 . . . . 2.2999999999999998 109.786 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.72 130.27 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 119.917 1.235 . . . . 2.4700000000000002 109.757 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.17 -12.63 52.12 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 113.289 -1.778 . . . . 2.6099999999999999 113.056 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.524 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.42 144.79 28.55 Favored 'General case' 0 N--CA 1.426 -1.64 0 CA-C-O 121.915 0.864 . . . . 6.5300000000000002 112.558 -171.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.7 ttt180 -124.02 123.96 41.52 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 102.619 -3.104 . . . . 12.359999999999999 102.619 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.86 156.81 45.0 Favored 'General case' 0 C--O 1.243 0.76 0 O-C-N 126.518 2.386 . . . . 5.8399999999999999 114.307 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -101.3 122.5 43.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 123.516 1.627 . . . . 16.57 108.587 174.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.1 114.48 28.65 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 118.822 -2.424 . . . . 5.8600000000000003 106.737 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.4 m -98.8 120.42 39.2 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 105.853 -1.906 . . . . 5.7599999999999998 105.853 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.7 mt -119.63 122.58 69.16 Favored 'Isoleucine or valine' 0 C--O 1.247 0.942 0 N-CA-C 108.683 -0.858 . . . . 3.3599999999999999 108.683 -167.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.7 p -66.38 153.95 91.7 Favored Pre-proline 0 C--O 1.244 0.777 0 CA-C-O 117.826 -1.083 . . . . 4.9400000000000004 110.731 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.3 -35.14 90.75 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.328 2.685 . . . . 6.21 114.754 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -70.06 -13.9 62.43 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 113.883 1.068 . . . . 15.85 113.883 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.67 11.04 36.51 Favored 'General case' 0 C--N 1.348 0.532 0 C-N-CA 126.088 1.755 . . . . 11.52 111.74 175.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.76 -116.51 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.765 -1.939 . . . . 3.7000000000000002 105.765 -176.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -102.64 4.15 37.96 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-N 121.99 2.177 . . . . 6.8399999999999999 115.48 -173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.44 -137.13 50.43 Favored Glycine 0 C--N 1.353 1.501 0 CA-C-O 123.745 1.747 . . . . 5.9900000000000002 111.038 171.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.27 -18.66 41.61 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 111.624 -2.288 . . . . 10.109999999999999 110.972 -178.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.37 -43.89 63.36 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 121.093 1.77 . . . . 13.76 112.581 175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.32 -169.27 53.3 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 107.607 -2.197 . . . . 9.9800000000000004 107.607 -170.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.8 114.85 35.39 Favored Pre-proline 0 C--O 1.246 0.882 0 O-C-N 118.04 -3.036 . . . . 15.880000000000001 103.292 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -48.16 122.43 7.43 Favored 'Trans proline' 0 C--N 1.361 1.221 0 C-N-CA 124.61 3.54 . . . . 11.41 110.909 -166.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.19 -26.94 3.23 Favored Glycine 0 CA--C 1.547 2.038 0 CA-C-N 111.881 -2.418 . . . . 14.199999999999999 117.4 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 59.2 mt -102.84 -50.1 9.92 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.606 0 CA-C-N 121.05 2.425 . . . . 11.06 114.992 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.7 mm -112.83 131.99 22.5 Favored Pre-proline 0 CA--C 1.516 -0.343 0 N-CA-C 103.159 -2.904 . . . . 8.0099999999999998 103.159 -175.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -67.09 163.08 35.44 Favored 'Trans proline' 0 C--O 1.239 0.547 0 C-N-CA 125.218 3.945 . . . . 6.5199999999999996 112.871 171.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.512 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.1 Cg_exo -55.3 144.47 71.37 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.518 2.146 . . . . 4.8200000000000003 110.307 162.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 62.31 27.24 16.29 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 112.886 -1.961 . . . . 7.4199999999999999 113.609 172.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.8 132.29 35.28 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 117.36 2.356 . . . . 2.2200000000000002 117.36 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.3 m -80.44 132.34 35.71 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 121.686 2.039 . . . . 4.6100000000000003 106.347 168.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.7 mt -108.81 146.87 32.94 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 120.451 -1.405 . . . . 5.3399999999999999 110.274 -177.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.19 119.97 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.765 0 N-CA-C 103.779 -2.674 . . . . 3.9700000000000002 103.779 -178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.485 ' HB3' HG23 ' A' ' 101' ' ' VAL . 49.2 m-85 -116.79 137.05 52.48 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 120.734 -1.229 . . . . 4.4199999999999999 109.519 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.454 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.6 t0 -103.92 112.74 25.84 Favored 'General case' 0 C--N 1.315 -0.928 1 N-CA-C 98.875 -4.491 . . . . 2.0899999999999999 98.875 174.001 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.485 HG23 ' HB3' ' A' ' 99' ' ' PHE . 86.9 t -126.79 132.37 70.15 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 114.077 -1.42 . . . . 3.5299999999999998 110.794 -172.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -120.52 121.84 39.32 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 105.509 -2.034 . . . . 14.210000000000001 105.509 178.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 29.0 tp -88.95 109.06 19.92 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 123.57 1.652 . . . . 2.4199999999999999 107.536 179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 81.0 mt -85.46 -43.31 13.7 Favored 'General case' 0 C--O 1.253 1.276 0 N-CA-C 115.193 1.553 . . . . 2.6200000000000001 115.193 -171.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.85 153.56 18.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 113.534 -1.666 . . . . 11.710000000000001 109.131 -167.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.2 mt -119.98 133.19 55.63 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 105.19 -2.152 . . . . 4.7000000000000002 105.19 170.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.589 -1.642 . . . . 13.02 109.884 -179.828 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GPI . . . . . 0.444 ' O8 ' H113 ' A' ' 108' ' ' GPI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.711 0 N-CA-C 106.07 -2.812 . . . . 6.3300000000000001 106.07 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 75' ' ' THR . 2.6 p -127.26 142.58 43.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 101.723 -3.436 . . . . 6.3499999999999996 101.723 176.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -117.11 130.01 56.35 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 102.776 -3.046 . . . . 16.98 102.776 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 86.3 t -109.44 117.07 53.7 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 N-CA-C 103.771 -2.677 . . . . 5.5800000000000001 103.771 -175.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.61 124.69 46.96 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 118.863 -2.398 . . . . 12.800000000000001 104.83 177.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 49.8 m -75.72 139.97 42.19 Favored 'General case' 0 CA--C 1.547 0.848 0 O-C-N 119.313 -2.117 . . . . 3.2400000000000002 115.643 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.407 ' HB ' ' HG2' ' A' ' 71' ' ' ARG . 91.4 mt -101.58 -52.05 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 N-CA-C 105.84 -1.911 . . . . 4.79 105.84 171.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 22.4 m -138.85 139.11 22.82 Favored Pre-proline 0 C--O 1.244 0.77 0 O-C-N 119.647 -1.908 . . . . 11.59 106.305 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 8' ' ' SER . 28.3 Cg_exo -67.71 154.75 72.41 Favored 'Trans proline' 0 C--N 1.329 -0.487 0 C-N-CA 123.634 2.889 . . . . 4.5499999999999998 112.174 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 70' ' ' GLN . . . -99.7 -161.22 28.88 Favored Glycine 0 CA--C 1.536 1.401 0 N-CA-C 109.09 -1.604 . . . . 2.0 109.09 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 48.5 p-10 -82.43 -9.15 59.55 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 117.708 -3.231 . . . . 3.2400000000000002 113.205 -177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.09 9.73 76.87 Favored Glycine 0 C--O 1.218 -0.851 0 CA-C-O 117.647 -1.641 . . . . 3.3799999999999999 113.884 -177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.412 HH11 ' HD2' ' A' ' 13' ' ' ARG . 14.8 mtp85 -137.72 -26.62 0.96 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 122.576 3.188 . . . . 26.59 114.251 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.0 m -105.52 94.04 4.99 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 119.111 -2.243 . . . . 3.02 109.503 -175.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -104.18 142.53 24.8 Favored Pre-proline 0 C--O 1.252 1.204 0 O-C-N 125.016 1.448 . . . . 4.7000000000000002 109.867 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.591 ' HG2' ' HA ' ' A' ' 64' ' ' ALA . 18.5 Cg_endo -68.67 146.78 68.13 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.715 2.277 . . . . 2.9399999999999999 110.588 -174.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -121.52 156.16 33.44 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.866 -1.516 . . . . 15.960000000000001 107.026 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' HA3' ' A' ' 51' ' ' GLY . 17.4 ttp180 -52.07 130.25 29.49 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-O 124.169 1.938 . . . . 11.69 112.819 174.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.33 -14.14 65.6 Favored Glycine 0 N--CA 1.422 -2.246 0 O-C-N 120.021 -1.674 . . . . 3.6299999999999999 112.755 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -86.14 149.37 25.17 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 120.066 1.933 . . . . 5.9000000000000004 112.357 174.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 m -89.85 120.31 30.98 Favored 'General case' 0 C--O 1.25 1.107 0 O-C-N 125.249 1.593 . . . . 3.0699999999999998 111.684 174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.1 m -93.53 130.99 39.2 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 122.65 1.214 . . . . 4.1100000000000003 109.86 176.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 105' ' ' LYS . 46.5 t -111.92 111.39 35.94 Favored 'Isoleucine or valine' 0 C--O 1.248 0.974 0 N-CA-C 101.643 -3.465 . . . . 2.1600000000000001 101.643 -174.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.9 m -129.5 154.39 40.13 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 CA-C-O 121.822 0.82 . . . . 3.5899999999999999 112.242 -172.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.06 145.43 30.5 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.22 -2.141 . . . . 3.1299999999999999 105.22 164.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 100' ' ' ASP . 33.1 p90 -145.81 156.1 43.35 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 120.18 1.355 . . . . 2.5499999999999998 111.967 179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 99.2 m -133.76 121.49 21.95 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 103.024 -2.954 . . . . 4.4699999999999998 103.024 167.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -101.13 131.87 10.74 Favored Glycine 0 N--CA 1.47 0.912 0 N-CA-C 109.251 -1.54 . . . . 3.4100000000000001 109.251 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 32.7 mtm -132.4 152.12 51.6 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-O 125.242 2.449 . . . . 18.219999999999999 110.391 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.51 164.59 22.87 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 111.707 -2.497 . . . . 5.9299999999999997 106.444 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -57.97 -20.65 39.72 Favored 'General case' 0 C--O 1.22 -0.469 0 O-C-N 117.197 -3.439 . . . . 12.33 117.737 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -87.75 5.44 39.95 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 119.642 -1.911 . . . . 7.1900000000000004 113.894 177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.03 -10.26 70.07 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 123.956 1.864 . . . . 6.4699999999999998 113.807 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tmmm? -66.53 124.23 22.24 Favored 'General case' 0 C--N 1.312 -1.06 0 O-C-N 116.803 -3.763 . . . . 21.859999999999999 110.556 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -77.89 130.84 37.11 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.403 -1.332 . . . . 16.18 107.403 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -107.67 -17.84 13.99 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 119.07 -1.052 . . . . 5.7300000000000004 110.809 173.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -172.77 155.43 3.22 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 118.153 -0.927 . . . . 6.1299999999999999 110.567 176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 36.5 t -158.81 128.13 5.57 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.527 1.131 . . . . 2.9300000000000002 110.345 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 44' ' ' LYS . 39.4 p -75.97 -20.65 57.73 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.977 -0.749 . . . . 2.2999999999999998 108.977 175.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 80.0 mtt85 -63.72 -36.68 84.65 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 106.685 -1.598 . . . . 10.550000000000001 106.685 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -67.58 -28.57 67.87 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.215 -1.553 . . . . 8.0199999999999996 110.809 175.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.5 mtm-85 -88.6 -10.12 49.81 Favored 'General case' 0 C--O 1.239 0.548 0 O-C-N 120.9 -1.125 . . . . 10.210000000000001 112.368 176.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 56.62 34.22 24.11 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-O 123.349 1.547 . . . . 16.379999999999999 110.95 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 39' ' ' SER . 49.2 tttm -139.73 120.18 9.32 Favored Pre-proline 0 C--N 1.315 -0.934 0 O-C-N 117.627 -3.171 . . . . 20.210000000000001 103.882 178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -59.24 152.27 61.32 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 124.274 3.316 . . . . 8.75 110.326 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -95.93 138.22 33.88 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.566 -1.642 . . . . 4.6500000000000004 106.566 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -111.72 136.87 50.38 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 120.584 1.538 . . . . 10.619999999999999 111.244 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -142.63 150.71 40.62 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 120.397 1.453 . . . . 4.3099999999999996 107.28 169.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.467 ' HB3' ' HD2' ' A' ' 52' ' ' LYS . 7.9 ttm -92.41 126.64 37.58 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-N 120.243 1.383 . . . . 2.6699999999999999 110.584 172.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 129.81 42.03 Favored 'General case' 0 N--CA 1.427 -1.598 0 O-C-N 125.288 1.617 . . . . 3.0800000000000001 110.719 176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 18' ' ' ARG . . . 89.0 -4.12 84.73 Favored Glycine 0 C--N 1.341 0.824 0 C-N-CA 123.865 0.745 . . . . 4.9500000000000002 114.009 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 49' ' ' MET . 44.6 tttt -84.1 -3.09 57.84 Favored 'General case' 0 N--CA 1.436 -1.137 0 O-C-N 120.752 -1.44 . . . . 10.26 114.561 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 64.52 39.57 6.7 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 120.081 -1.637 . . . . 10.24 113.808 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -114.37 -0.82 13.69 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 114.684 1.365 . . . . 10.56 114.684 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.35 172.65 9.26 Favored 'Isoleucine or valine' 0 C--O 1.253 1.253 0 N-CA-C 108.09 -1.078 . . . . 2.4500000000000002 108.09 171.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.4 pt -71.79 152.04 8.38 Favored 'Isoleucine or valine' 0 C--O 1.259 1.567 0 CA-C-O 122.974 1.368 . . . . 5.5700000000000003 109.855 -178.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -56.22 -35.8 67.74 Favored 'General case' 0 C--O 1.216 -0.708 0 N-CA-C 114.442 1.275 . . . . 19.109999999999999 114.442 -176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.67 -23.35 72.24 Favored Glycine 0 CA--C 1.538 1.525 0 CA-C-N 123.351 2.796 . . . . 2.9300000000000002 112.415 177.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 2.7 m95 -74.58 -54.58 7.19 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 118.574 1.187 . . . . 7.96 111.643 173.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -46.0 -44.43 15.09 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-O 124.02 1.867 . . . . 15.050000000000001 111.514 173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -78.36 -35.29 47.63 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.495 -1.23 . . . . 20.27 114.037 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.06 -45.73 6.17 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 119.571 -1.299 . . . . 4.04 114.6 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.6 t -67.46 -27.23 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 O-C-N 121.378 -1.072 . . . . 5.3499999999999996 109.495 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.591 ' HA ' ' HG2' ' A' ' 16' ' ' PRO . . . -64.01 -18.83 64.7 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.506 -2.621 . . . . 3.0299999999999998 112.35 176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -84.48 0.28 50.25 Favored 'General case' 0 CA--C 1.501 -0.906 0 CA-C-O 118.489 -0.767 . . . . 3.4900000000000002 113.057 175.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 87.8 mtp -107.83 143.03 36.97 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 120.831 1.65 . . . . 3.75 109.555 -171.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.523 ' H ' HE21 ' A' ' 70' ' ' GLN . 10.9 p -94.73 155.06 17.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.692 0.797 . . . . 2.2999999999999998 109.822 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 89.8 t -57.7 130.19 20.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 119.91 1.232 . . . . 2.4700000000000002 109.734 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.18 -12.54 52.07 Favored Glycine 0 N--CA 1.443 -0.87 0 CA-C-N 113.333 -1.758 . . . . 2.6099999999999999 112.989 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.523 HE21 ' H ' ' A' ' 67' ' ' SER . 6.3 tt0 -84.39 144.69 28.63 Favored 'General case' 0 N--CA 1.427 -1.616 0 CA-C-O 121.874 0.845 . . . . 6.5300000000000002 112.601 -171.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.407 ' HG2' ' HB ' ' A' ' 7' ' ' ILE . 51.9 ttt180 -123.93 123.9 41.43 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 102.677 -3.083 . . . . 12.359999999999999 102.677 178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -142.84 156.78 45.0 Favored 'General case' 0 C--O 1.244 0.783 0 O-C-N 126.442 2.339 . . . . 5.8399999999999999 114.322 -176.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -101.21 122.45 43.67 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 123.465 1.602 . . . . 16.57 108.59 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.07 114.49 28.66 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 118.787 -2.445 . . . . 5.8600000000000003 106.775 -176.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 85.7 m -98.78 120.42 39.19 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 105.772 -1.936 . . . . 5.7599999999999998 105.772 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 54.8 mt -119.63 122.55 69.09 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 108.71 -0.848 . . . . 3.3599999999999999 108.71 -167.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 89.6 p -66.37 153.99 91.57 Favored Pre-proline 0 C--O 1.243 0.723 0 CA-C-O 117.934 -1.031 . . . . 4.9400000000000004 110.712 177.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -55.21 -35.26 90.61 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 123.374 2.716 . . . . 6.21 114.803 -178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -70.03 -13.87 62.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.883 1.068 . . . . 15.85 113.883 -179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -103.73 11.09 36.32 Favored 'General case' 0 C--N 1.347 0.47 0 C-N-CA 125.959 1.703 . . . . 11.52 111.671 175.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.82 -116.53 0.15 Allowed 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 105.754 -1.943 . . . . 3.7000000000000002 105.754 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -102.61 4.1 37.98 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-N 122.025 2.193 . . . . 6.8399999999999999 115.511 -173.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.53 -137.12 50.5 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-O 123.728 1.738 . . . . 5.9900000000000002 111.048 171.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.515 ' O ' ' HB3' ' A' ' 93' ' ' PRO . . . -82.22 -18.71 41.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 111.705 -2.247 . . . . 10.109999999999999 111.036 -178.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.2 m -72.38 -43.97 63.22 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-N 121.076 1.762 . . . . 13.76 112.458 175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 73.34 -169.19 53.39 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 107.693 -2.163 . . . . 9.9800000000000004 107.693 -170.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 65.3 t-80 -118.87 114.77 35.3 Favored Pre-proline 0 C--O 1.247 0.962 0 O-C-N 118.014 -3.05 . . . . 15.880000000000001 103.215 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -48.03 122.3 7.13 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 124.72 3.613 . . . . 11.41 110.928 -166.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.3 -27.05 3.26 Favored Glycine 0 CA--C 1.546 2.022 0 CA-C-N 111.961 -2.382 . . . . 14.199999999999999 117.388 -177.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 60.1 mt -102.89 -50.04 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.641 0 CA-C-N 121.022 2.411 . . . . 11.06 114.971 -175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.88 131.97 22.52 Favored Pre-proline 0 CA--C 1.516 -0.346 0 N-CA-C 103.178 -2.897 . . . . 8.0099999999999998 103.178 -175.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.18 163.11 35.49 Favored 'Trans proline' 0 C--O 1.24 0.625 0 C-N-CA 125.198 3.932 . . . . 6.5199999999999996 112.859 171.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.515 ' HB3' ' O ' ' A' ' 84' ' ' ALA . 13.0 Cg_exo -55.27 144.51 70.91 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 122.476 2.117 . . . . 4.8200000000000003 110.357 162.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 62.28 27.21 16.3 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 112.969 -1.923 . . . . 7.4199999999999999 113.618 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -81.8 132.4 35.28 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 117.358 2.355 . . . . 2.2200000000000002 117.358 -178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.4 m -80.47 132.41 35.7 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 121.667 2.031 . . . . 4.6100000000000003 106.347 168.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 77.8 mt -108.94 146.76 33.3 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 120.414 -1.429 . . . . 5.3399999999999999 110.239 -177.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 93.1 t -123.08 120.02 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.71 0 N-CA-C 103.764 -2.68 . . . . 3.9700000000000002 103.764 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 101' ' ' VAL . 48.9 m-85 -116.79 136.96 52.55 Favored 'General case' 0 CA--C 1.534 0.336 0 O-C-N 120.705 -1.247 . . . . 4.4199999999999999 109.553 178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 26' ' ' TYR . 32.7 t0 -103.81 112.69 25.75 Favored 'General case' 0 C--N 1.313 -0.99 1 N-CA-C 98.853 -4.499 . . . . 2.0899999999999999 98.853 174.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 99' ' ' PHE . 87.5 t -126.79 132.28 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.092 -1.413 . . . . 3.5299999999999998 110.836 -172.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -120.38 121.89 39.57 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 105.563 -2.014 . . . . 14.210000000000001 105.563 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 28.8 tp -89.08 109.02 19.92 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 123.653 1.692 . . . . 2.4199999999999999 107.494 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 80.7 mt -85.46 -43.25 13.76 Favored 'General case' 0 C--O 1.254 1.293 0 N-CA-C 115.26 1.578 . . . . 2.6200000000000001 115.26 -171.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 23' ' ' VAL . 76.4 tttt -161.8 153.62 19.08 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 113.501 -1.681 . . . . 11.710000000000001 109.248 -167.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -120.08 133.21 55.58 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 105.204 -2.147 . . . . 4.7000000000000002 105.204 170.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 113.568 -1.651 . . . . 13.02 109.761 -179.719 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GPI . . . . . 0.62 H132 H151 ' A' ' 108' ' ' GPI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_